
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Statistical Rigor Dashboard</title>
    <style>:root {
  --bg-color: #0f172a;
  --card-bg: rgba(30, 41, 59, 0.7);
  --accent-primary: #38bdf8;
  --accent-success: #4ade80;
  --accent-warning: #fbbf24;
  --accent-danger: #f87171;
  --text-main: #f1f5f9;
  --text-muted: #94a3b8;
  --glass-border: rgba(255, 255, 255, 0.1);
}

body {
  background-color: var(--bg-color);
  color: var(--text-main);
  font-family: 'Inter', system-ui, -apple-system, sans-serif;
  margin: 0;
  padding: 2rem;
  line-height: 1.5;
}

.container {
  max-width: 1200px;
  margin: 0 auto;
}

header {
  margin-bottom: 3rem;
  text-align: center;
}

header h1 {
  font-size: 2.5rem;
  font-weight: 800;
  background: linear-gradient(to right, var(--accent-primary), var(--accent-success));
  -webkit-background-clip: text;
  -webkit-text-fill-color: transparent;
  margin-bottom: 0.5rem;
}

header p {
  color: var(--text-muted);
  font-size: 1.1rem;
}

/* Stats Overview */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
  gap: 1.5rem;
  margin-bottom: 3rem;
}

.stat-card {
  background: var(--card-bg);
  backdrop-filter: blur(12px);
  border: 1px solid var(--glass-border);
  padding: 1.5rem;
  border-radius: 1rem;
  text-align: center;
}

.stat-value {
  display: block;
  font-size: 2.5rem;
  font-weight: 700;
  color: var(--accent-primary);
}

.stat-label {
  color: var(--text-muted);
  font-size: 0.875rem;
  text-transform: uppercase;
  letter-spacing: 0.05em;
}

/* Common Problems Section */
.problem-section {
  background: rgba(248, 113, 113, 0.1);
  border: 1px solid rgba(248, 113, 113, 0.2);
  border-radius: 1rem;
  padding: 2rem;
  margin-bottom: 2rem;
}

.problem-section h2 {
  color: var(--accent-danger);
  margin-top: 0;
  display: flex;
  align-items: center;
  gap: 0.5rem;
}

.problem-list {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
  gap: 1rem;
}

.problem-item {
  background: rgba(15, 23, 42, 0.5);
  padding: 1rem;
  border-radius: 0.5rem;
  border-left: 4px solid var(--accent-danger);
}

.problem-item b {
  color: var(--text-main);
  display: block;
  margin-bottom: 0.25rem;
}

/* Common Strengths Section */
.strength-section {
  background: rgba(74, 222, 128, 0.1);
  border: 1px solid rgba(74, 222, 128, 0.2);
  border-radius: 1rem;
  padding: 2rem;
  margin-bottom: 3rem;
}

.strength-section h2 {
  color: var(--accent-success);
  margin-top: 0;
  display: flex;
  align-items: center;
  gap: 0.5rem;
}

.strength-list {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
  gap: 1rem;
}

.strength-item {
  background: rgba(15, 23, 42, 0.5);
  padding: 1rem;
  border-radius: 0.5rem;
  border-left: 4px solid var(--accent-success);
}

.strength-item b {
  color: var(--text-main);
  display: block;
  margin-bottom: 0.25rem;
}

/* Score Bar */
.score-container {
    display: flex;
    align-items: center;
    gap: 1rem;
}

.score-bar-bg {
    flex-grow: 1;
    height: 8px;
    background: rgba(255,255,255,0.1);
    border-radius: 4px;
    overflow: hidden;
    max-width: 100px;
}

.score-bar-fill {
    height: 100%;
    background: var(--accent-primary);
    border-radius: 4px;
}

/* Table Section */
.card {
  background: var(--card-bg);
  backdrop-filter: blur(12px);
  border: 1px solid var(--glass-border);
  border-radius: 1rem;
  overflow: hidden;
}

table {
  width: 100%;
  border-collapse: collapse;
  text-align: left;
}

th {
  background: rgba(255, 255, 255, 0.05);
  padding: 1rem;
  color: var(--text-muted);
  font-weight: 600;
  font-size: 0.875rem;
  text-transform: uppercase;
  letter-spacing: 0.05em;
}

td {
  padding: 1rem;
  border-top: 1px solid var(--glass-border);
}

.score-pill {
  padding: 0.25rem 0.75rem;
  border-radius: 9999px;
  font-weight: 600;
  font-size: 0.875rem;
}

.score-high { background: rgba(74, 222, 128, 0.2); color: #4ade80; }
.score-medium { background: rgba(251, 191, 36, 0.2); color: #fbbf24; }
.score-low { background: rgba(248, 113, 113, 0.2); color: #f87171; }

.truncate {
  max-width: 400px;
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}

.gaps-list {
  font-size: 0.875rem;
  color: var(--accent-danger);
  margin: 0;
  padding-left: 1.2rem;
}

footer {
  margin-top: 4rem;
  text-align: center;
  color: var(--text-muted);
  font-size: 0.875rem;
}
</style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Statistical Rigor Dashboard</h1>
            <p>Automated auditing of 124 scientific papers across clinical and computational domains.</p>
        </header>

        <div class="stats-grid">
            <div class="stat-card">
                <span class="stat-value">124</span>
                <span class="stat-label">Papers Audited</span>
            </div>
            <div class="stat-card" style="border-color: var(--accent-success)">
                <span class="stat-value" style="color: var(--accent-success)">5.6/10</span>
                <span class="stat-label">Average Rigor Score</span>
            </div>
            <div class="stat-card" style="border-color: var(--accent-primary)">
                <span class="stat-value">44%</span>
                <span class="stat-label">High Rigor Rate</span>
            </div>
            <div class="stat-card" style="border-color: #818cf8">
                <span class="stat-value" style="color: #818cf8">0</span>
                <span class="stat-label">Basic Science Papers</span>
            </div>
        </div>

        <section class="problem-section">
            <h2>⚠️ Recurring Problematic Points</h2>
            <div class="problem-list">
                <div class="problem-item"><b>Reporting of blinding or masking procedure is missing.</b> Found in 69 papers</div><div class="problem-item"><b>Sample size justification lacks explicit power calculation details.</b> Found in 47 papers</div><div class="problem-item"><b>P-values reported without effect sizes (e.g. Odds Ratio).</b> Found in 45 papers</div><div class="problem-item"><b>P-values reported only as thresholds (e.g., P<0.05).</b> Found in 43 papers</div><div class="problem-item"><b>Longitudinal/clustered data detected without hierarchical modeling.</b> Found in 28 papers</div><div class="problem-item"><b>Parametric tests used without documented normality checks.</b> Found in 24 papers</div>
            </div>
        </section>

        <section class="strength-section">
            <h2>✅ Common Strengths</h2>
            <div class="strength-list">
                <div class="strength-item"><b>Exclusion criteria explicitly defined (transparency).</b> Found in 58 papers</div><div class="strength-item"><b>Reported diagnostic metrics (AUC/ROC).</b> Found in 44 papers</div><div class="strength-item"><b>Detailed software versions provided.</b> Found in 43 papers</div><div class="strength-item"><b>Analysis context identifies basic science or bioinformatics (Softened clinical trial requirements).</b> Found in 41 papers</div><div class="strength-item"><b>Reported effect sizes (e.g., OR, HR, MD) alongside statistical significance.</b> Found in 41 papers</div><div class="strength-item"><b>Explicitly addressed multiplicity correction for multiple comparisons.</b> Found in 18 papers</div>
            </div>
        </section>

        <section class="card">
            <table>
                <thead>
                    <tr>
                        <th>Paper Title</th>
                        <th>Score</th>
                        <th>Critical Gaps</th>
                    </tr>
                </thead>
                <tbody>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="기능성 위십이지장질환 진단의 새로운 패러다임: 고해상도 위전도검사Gastroduodenal disordersChronic unexplained nausea and vomiting or gastric neuromuscular dysfunction (GND)? An update on nomenclature, pathophysiology and treatment, and relationship to gastroparesisDiagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Actionable biomarkers: the key to resolving disorders of gastrointestinal functionReferrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disordersUncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disordersAssociation between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysisThe relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesisAntroduodenal manometryMeasurement of gastrointestinal motility in the GI laboratoryThe [C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals[*C]octanoic acid breath test to measure gastric emptying rate of solidsA stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in researchThe electrogastrogram and what it showsRecent progress in gastric arrhythmia: pathophysiology, clinical significance and future horizonsElectrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activityElectrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task ForceSpatial patterns from high-resolution electrogastrography correlate with severity of symptoms in patients with functional dyspepsia and gastroparesisArtifact rejection methodology enables continuous, noninvasive measurement of gastric myoelectric activity in ambulatory subjectsElectrogastrography: poor correlation with antro-duodenal manometry and doubtful clinical usefulness in adultsElectrogastrography: basic knowledge, recording, processing and its clinical applicationsElectrogastrography and manometry of the stomach in patients with disturbances of basic electrical rhythmGut peristalsis is governed by a multitude of cooperating mechanismsPhysiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. VI. Pathogenesis and therapeutic approaches to human gastric dysrhythmiasGastric electrical stimulation with short pulses reduces vomiting but not dysrhythmias in dogsThe crucial role of the interstitial cells of Cajal in neurointestinal diseasesLoss of interstitial cells of Cajal may be central to poor intestinal motility in diabetes mellitusDisturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db miceInterstitial cells of Cajal in diabetic gastroenteropathyInterstitial cells of Cajal: crucial for the development of megacolon in human Chagas' disease?Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsiaThe bioelectrical basis and validity of gastrointestinal extracellular slow wave recordingsMovement based artifacts may contaminate extracellular electrical recordings from GI musclesWhat is measured in electrogastrography?Relation between electrogastrography and gastric electromyogram, mechanical activityElectrogastrography: methodology, validation and applicationsMultichannel electrogastrography (EGG) in symptomatic patients: a single center studyAbnormal gastric slow waves in patients with functional dyspepsia assessed by multichannel electrogastrographyA simulated anatomically accurate investigation into the effects of biodiversity on electrogastrographyPrediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapyBody surface Laplacian ECG mappingHigh-density multichannel electrode Array improves the accuracy of cutaneous electrogastrography across subjects with wide-ranging BMI: 1235Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomitingAbnormal initiation and conduction of slow-wave activity in gastroparesis, defined by highresolution electrical mappingPatterns of abnormal gastric pacemaking after sleeve gastrectomy defined by laparoscopic high-resolution electrical mappingSlow-wave coupling across a gastroduodenal anastomosis as a mechanism for postsurgical gastric dysfunction: evidence for a "gastrointestinal aberrant pathway"Motility: Mapping gastric dysrhythmias in gastroparesis--a slow wave of electrical activityGastric electrical stimulation in patients with gastroparesisHigh resolution electrical mapping in the gastrointestinal system: initial resultsHigh-resolution mapping of in vivo gastrointestinal slow wave activity using flexible printed circuit board electrodes: methodology and validationA novel laparoscopic device for measuring gastrointestinal slow-wave activityHigh-resolution electrical mapping of porcine gastric slow-wave propagation from the mucosal surfaceMethods for high-resolution electrical mapping in the gastrointestinal tractA multiscale model of the electrophysiological basis of the human electrogastrogramA theoretical analysis of electrogastrography (EGG) signatures associated with gastric dysrhythmiasToward the virtual stomach: progress in multiscale modeling of gastric electrophysiology and motilityIntsy: a low-cost, open-source, wireless multi-channel bioamplifier systemOpen-source 128-channel bioamplifier module for ambulatory monitoring of gastrointestinal electrical activityMinimally invasive gastric electrical stimulation using a newly developed wireless gastrostimulator: A pilot animal studyGastric pacing improves emptying and symptoms in patients with gastroparesisA novel gastric pacing device to modulate slow waves and assessment by high-resolution mappingHigh-resolution entrainment mapping of gastric pacing: a new analytical toolGastric electrical stimulation with the enterra system: A systematic reviewGastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesisFeasibility of high-resolution electrical mapping for characterizing conduction blocks created by gastric ablationThe significance of interstitial cells in neurogastroenterologyThe extraction of the new components from electrogastrogram (EGG), using both adaptive filtering and electrocardiographic (ECG) derived respiration signalThe impact and clinical implications of gastric surgery on the gastric conduction system">기능성 위십이지장질환 진단의 새로운 패러다임: 고해상도 위전도검사Gastroduodenal disordersChronic unexplained nausea and vomiting or gastric neuromuscular dysfunction (GND)? An update on nomenclature, pathophysiology and treatment, and relationship to gastroparesisDiagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Actionable biomarkers: the key to resolving disorders of gastrointestinal functionReferrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disordersUncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disordersAssociation between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysisThe relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesisAntroduodenal manometryMeasurement of gastrointestinal motility in the GI laboratoryThe [C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals[*C]octanoic acid breath test to measure gastric emptying rate of solidsA stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in researchThe electrogastrogram and what it showsRecent progress in gastric arrhythmia: pathophysiology, clinical significance and future horizonsElectrogastrography in adults and children: the strength, pitfalls, and clinical significance of the cutaneous recording of the gastric electrical activityElectrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task ForceSpatial patterns from high-resolution electrogastrography correlate with severity of symptoms in patients with functional dyspepsia and gastroparesisArtifact rejection methodology enables continuous, noninvasive measurement of gastric myoelectric activity in ambulatory subjectsElectrogastrography: poor correlation with antro-duodenal manometry and doubtful clinical usefulness in adultsElectrogastrography: basic knowledge, recording, processing and its clinical applicationsElectrogastrography and manometry of the stomach in patients with disturbances of basic electrical rhythmGut peristalsis is governed by a multitude of cooperating mechanismsPhysiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. VI. Pathogenesis and therapeutic approaches to human gastric dysrhythmiasGastric electrical stimulation with short pulses reduces vomiting but not dysrhythmias in dogsThe crucial role of the interstitial cells of Cajal in neurointestinal diseasesLoss of interstitial cells of Cajal may be central to poor intestinal motility in diabetes mellitusDisturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db miceInterstitial cells of Cajal in diabetic gastroenteropathyInterstitial cells of Cajal: crucial for the development of megacolon in human Chagas' disease?Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsiaThe bioelectrical basis and validity of gastrointestinal extracellular slow wave recordingsMovement based artifacts may contaminate extracellular electrical recordings from GI musclesWhat is measured in electrogastrography?Relation between electrogastrography and gastric electromyogram, mechanical activityElectrogastrography: methodology, validation and applicationsMultichannel electrogastrography (EGG) in symptomatic patients: a single center studyAbnormal gastric slow waves in patients with functional dyspepsia assessed by multichannel electrogastrographyA simulated anatomically accurate investigation into the effects of biodiversity on electrogastrographyPrediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapyBody surface Laplacian ECG mappingHigh-density multichannel electrode Array improves the accuracy of cutaneous electrogastrography across subjects with wide-ranging BMI: 1235Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomitingAbnormal initiation and conduction of slow-wave activity in gastroparesis, defined by highresolution electrical mappingPatterns of abnormal gastric pacemaking after sleeve gastrectomy defined by laparoscopic high-resolution electrical mappingSlow-wave coupling across a gastroduodenal anastomosis as a mechanism for postsurgical gastric dysfunction: evidence for a "gastrointestinal aberrant pathway"Motility: Mapping gastric dysrhythmias in gastroparesis--a slow wave of electrical activityGastric electrical stimulation in patients with gastroparesisHigh resolution electrical mapping in the gastrointestinal system: initial resultsHigh-resolution mapping of in vivo gastrointestinal slow wave activity using flexible printed circuit board electrodes: methodology and validationA novel laparoscopic device for measuring gastrointestinal slow-wave activityHigh-resolution electrical mapping of porcine gastric slow-wave propagation from the mucosal surfaceMethods for high-resolution electrical mapping in the gastrointestinal tractA multiscale model of the electrophysiological basis of the human electrogastrogramA theoretical analysis of electrogastrography (EGG) signatures associated with gastric dysrhythmiasToward the virtual stomach: progress in multiscale modeling of gastric electrophysiology and motilityIntsy: a low-cost, open-source, wireless multi-channel bioamplifier systemOpen-source 128-channel bioamplifier module for ambulatory monitoring of gastrointestinal electrical activityMinimally invasive gastric electrical stimulation using a newly developed wireless gastrostimulator: A pilot animal studyGastric pacing improves emptying and symptoms in patients with gastroparesisA novel gastric pacing device to modulate slow waves and assessment by high-resolution mappingHigh-resolution entrainment mapping of gastric pacing: a new analytical toolGastric electrical stimulation with the enterra system: A systematic reviewGastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesisFeasibility of high-resolution electrical mapping for characterizing conduction blocks created by gastric ablationThe significance of interstitial cells in neurogastroenterologyThe extraction of the new components from electrogastrogram (EGG), using both adaptive filtering and electrocardiographic (ECG) derived respiration signalThe impact and clinical implications of gastric surgery on the gastric conduction system</div>
                            <small style="color: var(--text-muted)">12285413.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">10.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 100.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease RegistryAtypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a Clinicopathologic study of 21 casesMolecular analyses of chorionic-type intermediate trophoblastic lesions: atypical placental site nodules are closer to placental site nodules than epithelioid trophoblastic tumorsAncillary studies for precision diagnosis of hydatidiform molesTreatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the charing cross hospital, 2000–2009Advances in the diagnosis and early management of gestational Trophoblastic diseaseGenetic studies on hydatidiform moles I the origin of partial molesHuman triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform moleChanging presentation of complete hydatidiform mole at the New England trophoblastic disease center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasiaGenetic mapping of a maternal locus responsible for familial hydatidiform molesThe relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcomeUterine gestational choriocarcinoma developing after a long latent period in a postmenopausal woman: the value of DNA polymorphism studiesTrends in incidence for gestational trophoblastic disease over the last 20 years in a population-based studyMaternal age-related rates of gestational trophoblastic diseaseGestational trophoblastic disease in the Asian population of Northern England and North WalesEpidemiology and aetiology of gestational trophoblastic diseasesGestational trophoblastic disease: current evaluation and managementGestational trophoblast disease: clinical presentation and treatmentInterobserver and intraobserver variability in the diagnosis of hydatidiform moleHydatidiform moles: ancillary techniques to refine diagnosisDiscrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57 KIP2p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 casesMorphology combined with HER2 D-DISH ploidy analysis to diagnose partial hydatidiform mole: an evaluation audit using molecular genotypingAccuracy of hydatidiform mole diagnosis using morphology and ploidy determination with HER2 D-DISH compared to molecular genotypingDiagnosis, staging and treatment of patients with gestational trophoblastic disease: national clinical guideline No.13Diagnosis and management of gestational trophoblastic disease: 2021 updateAssessment of current follow‐up for complete molar pregnancies: a single centre reviewLow risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyLow risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancyon behalf of the Royal College of Obstetricians andGynaecologists. Management of Gestational Trophoblastic DiseaseWorldwide survey of the results of treating gestational trophoblastic diseaseProgress to international harmonisation of care and future developmentsGestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort studyEuropean Journal of obstetrics & gynecology and reproductive biology challenging gestational trophoblastic disease cases and mimics: an exemplar for the management of rare tumoursExperience of women on the Irish national gestational trophoblastic disease registryA novel scoring system provides high separation of diploidy and triploidy to aid partial hydatidiform mole diagnosis: an adaption of HER2 D-DISH for ploidy analysisPerinatal Statistics report 2019South/Southwest Hospital Group Annual Report 2017South/Southwest Hospital Group Annual Report 2018South/Southwest Hospital Group Annual Report 2019Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysisHas the incidence of molar pregnancy changed over the last 10 yearsRisk of partial and complete hydatidiform molar pregnancy in relation to maternal ageGestational trophoblastic diseaseRecent advances in gestational trophoblastic diseaseDNA genotyping of suspected partial hydatidiform moles detects clinically significant aneuploidyPractical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform molesIncrease in the incidence of gestational trophoblastic disease in the NetherlandsHigh incidence of gestational trophoblastic disease in a third-level University-hospital, Italy: a retrospective cohort studyA reappraisal of the incidence of placental hydatidiform mole using selective molecular genotypingAn examination of care received by women with recurrent miscarriage and infertility against guideline-based key performance indicatorsPerinatal Mortality in Ireland: Biennial Report 2018/2019The diagnosis and prognosis of molar pregnancy: the experience of the National referral centre in LondonPersistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriageGestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysisTen steps to establish a national centre for gestational trophoblastic diseaseDecreasing incidence of registered hydatidiform moles in Denmark 1999–2014Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyRecent changes of the incidence of complete and partial mole in Chiba prefectureIncidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study">Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease RegistryAtypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a Clinicopathologic study of 21 casesMolecular analyses of chorionic-type intermediate trophoblastic lesions: atypical placental site nodules are closer to placental site nodules than epithelioid trophoblastic tumorsAncillary studies for precision diagnosis of hydatidiform molesTreatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the charing cross hospital, 2000–2009Advances in the diagnosis and early management of gestational Trophoblastic diseaseGenetic studies on hydatidiform moles I the origin of partial molesHuman triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform moleChanging presentation of complete hydatidiform mole at the New England trophoblastic disease center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasiaGenetic mapping of a maternal locus responsible for familial hydatidiform molesThe relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcomeUterine gestational choriocarcinoma developing after a long latent period in a postmenopausal woman: the value of DNA polymorphism studiesTrends in incidence for gestational trophoblastic disease over the last 20 years in a population-based studyMaternal age-related rates of gestational trophoblastic diseaseGestational trophoblastic disease in the Asian population of Northern England and North WalesEpidemiology and aetiology of gestational trophoblastic diseasesGestational trophoblastic disease: current evaluation and managementGestational trophoblast disease: clinical presentation and treatmentInterobserver and intraobserver variability in the diagnosis of hydatidiform moleHydatidiform moles: ancillary techniques to refine diagnosisDiscrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57 KIP2p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 casesMorphology combined with HER2 D-DISH ploidy analysis to diagnose partial hydatidiform mole: an evaluation audit using molecular genotypingAccuracy of hydatidiform mole diagnosis using morphology and ploidy determination with HER2 D-DISH compared to molecular genotypingDiagnosis, staging and treatment of patients with gestational trophoblastic disease: national clinical guideline No.13Diagnosis and management of gestational trophoblastic disease: 2021 updateAssessment of current follow‐up for complete molar pregnancies: a single centre reviewLow risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyLow risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancyon behalf of the Royal College of Obstetricians andGynaecologists. Management of Gestational Trophoblastic DiseaseWorldwide survey of the results of treating gestational trophoblastic diseaseProgress to international harmonisation of care and future developmentsGestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort studyEuropean Journal of obstetrics & gynecology and reproductive biology challenging gestational trophoblastic disease cases and mimics: an exemplar for the management of rare tumoursExperience of women on the Irish national gestational trophoblastic disease registryA novel scoring system provides high separation of diploidy and triploidy to aid partial hydatidiform mole diagnosis: an adaption of HER2 D-DISH for ploidy analysisPerinatal Statistics report 2019South/Southwest Hospital Group Annual Report 2017South/Southwest Hospital Group Annual Report 2018South/Southwest Hospital Group Annual Report 2019Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysisHas the incidence of molar pregnancy changed over the last 10 yearsRisk of partial and complete hydatidiform molar pregnancy in relation to maternal ageGestational trophoblastic diseaseRecent advances in gestational trophoblastic diseaseDNA genotyping of suspected partial hydatidiform moles detects clinically significant aneuploidyPractical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform molesIncrease in the incidence of gestational trophoblastic disease in the NetherlandsHigh incidence of gestational trophoblastic disease in a third-level University-hospital, Italy: a retrospective cohort studyA reappraisal of the incidence of placental hydatidiform mole using selective molecular genotypingAn examination of care received by women with recurrent miscarriage and infertility against guideline-based key performance indicatorsPerinatal Mortality in Ireland: Biennial Report 2018/2019The diagnosis and prognosis of molar pregnancy: the experience of the National referral centre in LondonPersistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriageGestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysisTen steps to establish a national centre for gestational trophoblastic diseaseDecreasing incidence of registered hydatidiform moles in Denmark 1999–2014Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyRecent changes of the incidence of complete and partial mole in Chiba prefectureIncidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study</div>
                            <small style="color: var(--text-muted)">12703346.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">10.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 100.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Investigation of causal effects of blood metabolites on insomnia and circadian rhythm sleep wake disordersMendelian randomization studies: a review of the approaches used and the quality of reportingMendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionCalculating statistical power in Mendelian randomization studiesMendelian randomization analysis with multiple genetic variants using summarized dataMultivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effectsInterpreting findings from Mendelian randomization using the MR-Egger methodInsomniaGlycerol-3-phosphate is a critical mobile inducer of systemic immunity in plantsAssessment of bidirectional relationships between physical activity and depression among adults: a 2-sample mendelian randomization studyCochran's Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracyEffect of sleep deprivation on the human metabolomeThe mammalian circadian timing system: from gene expression to physiologyAltered diurnal states in insomnia reflect peripheral hyperarousal and metabolic desynchrony: a preliminary studyThe MR-Base platform supports systematic causal inference across the human phenomeEffects of glycine on metabolic syndrome components: a reviewIdentification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidasesKEGG for integration and interpretation of large-scale molecular data setsImpacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120Nocturnal asthma and the use of theophyllineEpidemiology of insomnia: prevalence, course, risk factors, and public health burdenEffects of melatonin on the quality of life in patients with delayed sleep phase syndromeFunctional neuroimaging evidence for hyperarousal in insomniaDistinguishing genetic correlation from causation across 52 diseases and complex traitsCircadian rhythm sleep-wake disordersEfficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimatorsAnandamide and its metabolites: what are their roles in the kidney?Multivariable Mendelian Randomization and MediationInternational classification of sleep disorders-third edition: highlights and modificationsAn atlas of genetic influences on human blood metabolitesTreatment of circadian rhythm sleep-wake disordersMendelian randomization in health research: using appropriate genetic variants and avoiding biased estimatesFamilial resemblances in human plasma metabolites are attributable to both genetic and common environmental effectsDetection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseasesIs hearing impairment causally associated with falls? evidence from a two-sample mendelian randomization studyErythrocyte metabolic reprogramming by sphingosine 1-phosphate in chronic kidney disease and therapiesAssessing the causal effects of human serum metabolites on 5 major psychiatric disordersGenetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization studyCircadian rhythm sleep-wake disordersType 2 diabetes is causally associated with reduced serum osteocalcin: a genomewide association and mendelian randomization studyCurrent blockades of proteins inside nanopores for real-time metabolome analysisImpacts of circadian gene period2 knockout on intestinal metabolism and hepatic antioxidant and inflammation state in miceKidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis">Investigation of causal effects of blood metabolites on insomnia and circadian rhythm sleep wake disordersMendelian randomization studies: a review of the approaches used and the quality of reportingMendelian randomization with invalid instruments: effect estimation and bias detection through Egger regressionCalculating statistical power in Mendelian randomization studiesMendelian randomization analysis with multiple genetic variants using summarized dataMultivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effectsInterpreting findings from Mendelian randomization using the MR-Egger methodInsomniaGlycerol-3-phosphate is a critical mobile inducer of systemic immunity in plantsAssessment of bidirectional relationships between physical activity and depression among adults: a 2-sample mendelian randomization studyCochran's Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracyEffect of sleep deprivation on the human metabolomeThe mammalian circadian timing system: from gene expression to physiologyAltered diurnal states in insomnia reflect peripheral hyperarousal and metabolic desynchrony: a preliminary studyThe MR-Base platform supports systematic causal inference across the human phenomeEffects of glycine on metabolic syndrome components: a reviewIdentification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidasesKEGG for integration and interpretation of large-scale molecular data setsImpacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120Nocturnal asthma and the use of theophyllineEpidemiology of insomnia: prevalence, course, risk factors, and public health burdenEffects of melatonin on the quality of life in patients with delayed sleep phase syndromeFunctional neuroimaging evidence for hyperarousal in insomniaDistinguishing genetic correlation from causation across 52 diseases and complex traitsCircadian rhythm sleep-wake disordersEfficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimatorsAnandamide and its metabolites: what are their roles in the kidney?Multivariable Mendelian Randomization and MediationInternational classification of sleep disorders-third edition: highlights and modificationsAn atlas of genetic influences on human blood metabolitesTreatment of circadian rhythm sleep-wake disordersMendelian randomization in health research: using appropriate genetic variants and avoiding biased estimatesFamilial resemblances in human plasma metabolites are attributable to both genetic and common environmental effectsDetection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseasesIs hearing impairment causally associated with falls? evidence from a two-sample mendelian randomization studyErythrocyte metabolic reprogramming by sphingosine 1-phosphate in chronic kidney disease and therapiesAssessing the causal effects of human serum metabolites on 5 major psychiatric disordersGenetically predicted 486 blood metabolites in relation to risk of colorectal cancer: a Mendelian randomization studyCircadian rhythm sleep-wake disordersType 2 diabetes is causally associated with reduced serum osteocalcin: a genomewide association and mendelian randomization studyCurrent blockades of proteins inside nanopores for real-time metabolome analysisImpacts of circadian gene period2 knockout on intestinal metabolism and hepatic antioxidant and inflammation state in miceKidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis</div>
                            <small style="color: var(--text-muted)">12713914.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">10.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 100.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Copy Number Alteration of Cyclin D1 (CCND 1) Gene as a Prognostic Factor in Oral Squamous Cancers and its Correlation with Immunohistochemistry (IHC)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPrognostic and predictive factors in gingivo buccal complex squamous cell carcinoma: role of tumor budding and pattern of invasionCyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongueAbnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancerG1 phase progression: cycling on cueHow cells cycle toward cancerCyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinomaCyclin D1 over expression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinomaCyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumorsPrognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysisCyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinomaClinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinomaExpression of cyclin D1 and p53 as prognostic markers in treatment of oral squamous cell carcinomaCCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patientsCyclin D1 as a cellular proto-oncogeneInhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinasePrognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomasCyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongueCyclin D1 amplification in tongue and cheek squamous cell carcinoma">Copy Number Alteration of Cyclin D1 (CCND 1) Gene as a Prognostic Factor in Oral Squamous Cancers and its Correlation with Immunohistochemistry (IHC)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPrognostic and predictive factors in gingivo buccal complex squamous cell carcinoma: role of tumor budding and pattern of invasionCyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongueAbnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancerG1 phase progression: cycling on cueHow cells cycle toward cancerCyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinomaCyclin D1 over expression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinomaCyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumorsPrognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysisCyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinomaClinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinomaExpression of cyclin D1 and p53 as prognostic markers in treatment of oral squamous cell carcinomaCCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patientsCyclin D1 as a cellular proto-oncogeneInhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinasePrognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomasCyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongueCyclin D1 amplification in tongue and cheek squamous cell carcinoma</div>
                            <small style="color: var(--text-muted)">12714465.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">10.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 100.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Mutations in  bypass the stringent response dependency of virulence in Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infectionsA dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulenceProtein Secretion Systems in Pseudomonas aeruginosa: An Essay on Diversity, Evolution, and FunctionSynthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI familyStringent response activates quorum sensing and modulates cell density-dependent gene expression in Pseudomonas aeruginosaThe stringent response modulates 4-hydroxy-2-alkylquinoline biosynthesis and quorum-sensing hierarchy in Pseudomonas aeruginosa(p)ppGpp: still magical?Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Murine Cutaneous Infection ModelPlasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of gram-negative bacterial genomesCrystal Structure of the Regulatory Domain of MexT, a Transcriptional Activator of the MexEFOprN Efflux PumpA network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosaCharacterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosaRole of (p)ppGpp in antibiotic resistance, tolerance, persistence and survival in FirmicutesDecreased efficacy of antimicrobial agents in a polymicrobial environmentGene Regulatory Network Analysis of Perivascular Adipose Tissue of Abdominal Aortic Aneurysm Identifies Master Regulators of Key Pathogenetic PathwaysNADH Dehydrogenases in in Pseudomonas aeruginosa Growth and Virulenceis an indicator of PAO1 strain integrityEvolution and host-specific adaptation ofThe Pseudomonas aeruginosa Pan-Genome Provides New Insights on Its Population Structure, Horizontal Gene Transfer, and PathogenicitySurvival of the Fittest: The Relationship of (p)ppGpp With Bacterial VirulenceVirulence in Pectobacterium atrosepticum is regulated by a coincidence circuit involving quorum sensing and the stress alarmone,[(p)ppGppCharacterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosaTranscriptome profiling defines a novel regulon modulated by the LysR-type transcriptional regulator MexT in Pseudomonas aeruginosaCumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosidesAminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosaExtracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilmsCationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosaEvolution of the Pseudomonas aeruginosa quorum-sensing hierarchySelection for increased quorum-sensing cooperation in Pseudomonas aeruginosa through the shut-down of a drug resistance pumpMexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline)The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosaThe MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communicationThe second type VI secretion system of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing and Fur and modulates internalization in epithelial cellsThe T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell TargetingA Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cellsPseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid SignalingThe lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infectionEfflux-mediated fluoro-quinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operonAmino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosaMexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosaMexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pumpActive Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited BacteriaIdentification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseqFast and accurate short read alignment with Burrows–Wheeler transformfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresCytoscape: a software environment for integrated models of biomolecular interaction networksCytoscape StringApp: Network Analysis and Visualization of Proteomics DataVisualize omics data on networks with Omics Visualizer, a Cytoscape AppA Subtype of aPseudomonas aeruginosa Cystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory InfectionA simple and rapid method for the preparation of gram-negative bacterial genomic DNAPrecision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchangeA 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformationThe Sequence Alignment/Map format and SAMtoolsExploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivoGuidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment">Mutations in  bypass the stringent response dependency of virulence in Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infectionsA dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulenceProtein Secretion Systems in Pseudomonas aeruginosa: An Essay on Diversity, Evolution, and FunctionSynthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI familyStringent response activates quorum sensing and modulates cell density-dependent gene expression in Pseudomonas aeruginosaThe stringent response modulates 4-hydroxy-2-alkylquinoline biosynthesis and quorum-sensing hierarchy in Pseudomonas aeruginosa(p)ppGpp: still magical?Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Murine Cutaneous Infection ModelPlasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of gram-negative bacterial genomesCrystal Structure of the Regulatory Domain of MexT, a Transcriptional Activator of the MexEFOprN Efflux PumpA network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosaCharacterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosaRole of (p)ppGpp in antibiotic resistance, tolerance, persistence and survival in FirmicutesDecreased efficacy of antimicrobial agents in a polymicrobial environmentGene Regulatory Network Analysis of Perivascular Adipose Tissue of Abdominal Aortic Aneurysm Identifies Master Regulators of Key Pathogenetic PathwaysNADH Dehydrogenases in in Pseudomonas aeruginosa Growth and Virulenceis an indicator of PAO1 strain integrityEvolution and host-specific adaptation ofThe Pseudomonas aeruginosa Pan-Genome Provides New Insights on Its Population Structure, Horizontal Gene Transfer, and PathogenicitySurvival of the Fittest: The Relationship of (p)ppGpp With Bacterial VirulenceVirulence in Pectobacterium atrosepticum is regulated by a coincidence circuit involving quorum sensing and the stress alarmone,[(p)ppGppCharacterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosaTranscriptome profiling defines a novel regulon modulated by the LysR-type transcriptional regulator MexT in Pseudomonas aeruginosaCumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosidesAminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosaExtracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilmsCationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosaEvolution of the Pseudomonas aeruginosa quorum-sensing hierarchySelection for increased quorum-sensing cooperation in Pseudomonas aeruginosa through the shut-down of a drug resistance pumpMexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline)The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosaThe MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communicationThe second type VI secretion system of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing and Fur and modulates internalization in epithelial cellsThe T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell TargetingA Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cellsPseudomonas aeruginosa Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid SignalingThe lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infectionEfflux-mediated fluoro-quinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operonAmino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosaMexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosaMexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pumpActive Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited BacteriaIdentification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseqFast and accurate short read alignment with Burrows–Wheeler transformfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresCytoscape: a software environment for integrated models of biomolecular interaction networksCytoscape StringApp: Network Analysis and Visualization of Proteomics DataVisualize omics data on networks with Omics Visualizer, a Cytoscape AppA Subtype of aPseudomonas aeruginosa Cystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory InfectionA simple and rapid method for the preparation of gram-negative bacterial genomic DNAPrecision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchangeA 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformationThe Sequence Alignment/Map format and SAMtoolsExploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivoGuidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment</div>
                            <small style="color: var(--text-muted)">7618369.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">10.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 100.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in Drosophila.SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in Drosophila.Mitochondrial and metabolic dysfunction in ageing and age-related diseases.Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular diseaseLinking nutrient sensing, mitochondrial function, and PRR immune cell signaling in liver diseaseThe metabolism and function of phospholipids in MitochondriaDisorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesMitochondrial lipid traffickingImport of phosphatidylserine to and export of phosphatidylethanolamine molecular species from mitochondriaCharacterization of brain phosphatidylserine decarboxylase: Localization in the mitochondrial inner membranePhosphatidylserine decarboxylase is located on the external side of the inner mitochondrial membraneLipids of mitochondriaPhospholipid synthesis and transport in mammalian cellsThe genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondriaRegulation of mitochondrial phospholipids by Ups1/PRELI-like proteins depends on proteolysis and Mdm35Ups1p and Ups2p antagonistically regulate cardiolipin metabolism in mitochondriaMICOS and phospholipid transfer by Ups2-Mdm35 organize membrane lipid synthesis in mitochondriaIntramitochondrial transport of phosphatidic acid in yeast by a lipid transfer proteinStructural determinants of lipid specificity within Ups/PRELI lipid transfer proteins.TRIAP1/PRELI complexes prevent apoptosis by mediating intramitochondrial transport of phosphatidic acidPhosphatidylserine decarboxylase is critical for the maintenance of skeletal muscle mitochondrial integrity and muscle mass.Perturbation of phosphatidylethanolamine synthesis affects mitochondrial morphology and cell-cycle progression in procyclic-form Trypanosoma bruceiDisruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defectsPhosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphologyStarD7 Protein Deficiency Adversely Affects the Phosphatidylcholine Composition, Respiratory Activity, and Cristae Structure of MitochondriaPhosphatidylethanolamine made in the inner mitochondrial membrane is essential for yeast cytochrome bc1 complex function.Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity.PISD is a mitochondrial disease gene causing skeletal dysplasia, cataracts, and white matter changesPhosphatidylcholine biosynthesis and lipoprotein metabolismPhosphatidylinositol synthase from mammalian tissuesPE homeostasis rebalanced through mitochondria-ER lipid exchange prevents retinal degeneration in .Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver DiseaseA Fluorescence-Based Genetic Screen to Study Retinal Degeneration in .An efficient and multiple target transgenic RNAi technique with low toxicity in .pNP Transgenic RNAi System Manual in .Drosophila spermiogenesis: Big things come from little packages.Investigating spermatogenesis in  melanogaster.Split Green Fluorescent Proteins: Scope, Limitations, and Outlook.A novel fluorescent reporter detects plastic remodeling of mitochondria-ER contact sitesRoles of PINK1 in regulation of systemic growth inhibition induced by mutations of PTEN in DrosophilaMICU1 controls cristae junction and spatially anchors mitochondrial Ca2+ uniporter complex.Phosphatidylserine Externalization Results from and Causes Neurite Degeneration in Phosphatidylserine dynamics in cellular membranes.Crystal Structure of Lactadherin C2 Domain at 1.7Å Resolution with Mutational and Computational Analyses of Its Membrane-binding MotifOPA1 and MICOS Regulate mitochondrial crista dynamics and formationOPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseasesHepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in miceCirculating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors.Parkinson’s disease: proteinopathy or lipidopathy?Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranesDefining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice.Phospholipid ebb and flow makes mitochondria goMdm35p imports Ups proteins into the mitochondrial intermembrane space by functional complex formationDynamic subcompartmentalization of the mitochondrial inner membraneThe cell biology of mitochondrial membrane dynamicsReconstitution of Phosphatidylserine Transport from Chemically Defined Donor Membranes to Phosphatidylserine Decarboxylase 2 Implicates Specific Lipid Domains in the ProcessReconstitution of phosphatidylserine import into rat liver mitochondriaFormation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cellsNewly made phosphatidylserine and phosphatidylethanolamine are preferentially translocated between rat liver mitochondria and endoplasmic reticulumPhosphatidylserine Decarboxylase 1 (Psd1) Promotes Mitochondrial Fusion by Regulating the Biophysical Properties of the Mitochondrial Membrane and Alternative Topogenesis of Mitochondrial Genome Maintenance Protein 1 (Mgm1).Using mutants, knockdowns, and transgenesis to investigate gene function in .A genome-scale shRNA resource for transgenic RNAi in .CRISPR-Cas9 genome editing in .Highly Efficient Targeted Mutagenesis of  with the CRISPR/Cas9 System.Evidence of off-target effects associated with long dsRNAs in  cell-based assays.CULD is required for rhodopsin and TRPL channel endocytic trafficking and survival of photoreceptor cellsPINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality controlGenome engineering using the CRISPR-Cas9 system.Genome-wide RNAi analysis of growth and viability in  cellsA nanoscale, multi-parametric flow cytometry-based platform to study mitochondrial heterogeneity and mitochondrial DNA dynamics.Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome1Toward one step analysis of cellular lipidomes using liquid chromatography coupled with mass spectrometry: application to Saccharomyces cerevisiae and Schizosaccharomyces pombe lipidomics.Triangle matching method for the sparse environment of geomagnetic information.Discovery of NDM-1 inhibitors from natural products.Development and testing of a general amber force fieldff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.Exploring protein native states and large-scale conformational changes with a modified generalized born modelApproximate atomic surfaces from linear combinations of pairwise overlaps (LCPO).Store-Operated Calcium Entry through Orai Is Required for Transcriptional Maturation of the Flight Circuit in Decision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2Author response to Decision Letter 2Decision Letter 3">SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in Drosophila.SLMO transfers phosphatidylserine between the outer and inner mitochondrial membrane in Drosophila.Mitochondrial and metabolic dysfunction in ageing and age-related diseases.Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular diseaseLinking nutrient sensing, mitochondrial function, and PRR immune cell signaling in liver diseaseThe metabolism and function of phospholipids in MitochondriaDisorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesMitochondrial lipid traffickingImport of phosphatidylserine to and export of phosphatidylethanolamine molecular species from mitochondriaCharacterization of brain phosphatidylserine decarboxylase: Localization in the mitochondrial inner membranePhosphatidylserine decarboxylase is located on the external side of the inner mitochondrial membraneLipids of mitochondriaPhospholipid synthesis and transport in mammalian cellsThe genetic interactome of prohibitins: coordinated control of cardiolipin and phosphatidylethanolamine by conserved regulators in mitochondriaRegulation of mitochondrial phospholipids by Ups1/PRELI-like proteins depends on proteolysis and Mdm35Ups1p and Ups2p antagonistically regulate cardiolipin metabolism in mitochondriaMICOS and phospholipid transfer by Ups2-Mdm35 organize membrane lipid synthesis in mitochondriaIntramitochondrial transport of phosphatidic acid in yeast by a lipid transfer proteinStructural determinants of lipid specificity within Ups/PRELI lipid transfer proteins.TRIAP1/PRELI complexes prevent apoptosis by mediating intramitochondrial transport of phosphatidic acidPhosphatidylserine decarboxylase is critical for the maintenance of skeletal muscle mitochondrial integrity and muscle mass.Perturbation of phosphatidylethanolamine synthesis affects mitochondrial morphology and cell-cycle progression in procyclic-form Trypanosoma bruceiDisruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defectsPhosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphologyStarD7 Protein Deficiency Adversely Affects the Phosphatidylcholine Composition, Respiratory Activity, and Cristae Structure of MitochondriaPhosphatidylethanolamine made in the inner mitochondrial membrane is essential for yeast cytochrome bc1 complex function.Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity.PISD is a mitochondrial disease gene causing skeletal dysplasia, cataracts, and white matter changesPhosphatidylcholine biosynthesis and lipoprotein metabolismPhosphatidylinositol synthase from mammalian tissuesPE homeostasis rebalanced through mitochondria-ER lipid exchange prevents retinal degeneration in .Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver DiseaseA Fluorescence-Based Genetic Screen to Study Retinal Degeneration in .An efficient and multiple target transgenic RNAi technique with low toxicity in .pNP Transgenic RNAi System Manual in .Drosophila spermiogenesis: Big things come from little packages.Investigating spermatogenesis in  melanogaster.Split Green Fluorescent Proteins: Scope, Limitations, and Outlook.A novel fluorescent reporter detects plastic remodeling of mitochondria-ER contact sitesRoles of PINK1 in regulation of systemic growth inhibition induced by mutations of PTEN in DrosophilaMICU1 controls cristae junction and spatially anchors mitochondrial Ca2+ uniporter complex.Phosphatidylserine Externalization Results from and Causes Neurite Degeneration in Phosphatidylserine dynamics in cellular membranes.Crystal Structure of Lactadherin C2 Domain at 1.7Å Resolution with Mutational and Computational Analyses of Its Membrane-binding MotifOPA1 and MICOS Regulate mitochondrial crista dynamics and formationOPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseasesHepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in miceCirculating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors.Parkinson’s disease: proteinopathy or lipidopathy?Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranesDefining the importance of phosphatidylserine synthase-1 (PSS1): unexpected viability of PSS1-deficient mice.Phospholipid ebb and flow makes mitochondria goMdm35p imports Ups proteins into the mitochondrial intermembrane space by functional complex formationDynamic subcompartmentalization of the mitochondrial inner membraneThe cell biology of mitochondrial membrane dynamicsReconstitution of Phosphatidylserine Transport from Chemically Defined Donor Membranes to Phosphatidylserine Decarboxylase 2 Implicates Specific Lipid Domains in the ProcessReconstitution of phosphatidylserine import into rat liver mitochondriaFormation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cellsNewly made phosphatidylserine and phosphatidylethanolamine are preferentially translocated between rat liver mitochondria and endoplasmic reticulumPhosphatidylserine Decarboxylase 1 (Psd1) Promotes Mitochondrial Fusion by Regulating the Biophysical Properties of the Mitochondrial Membrane and Alternative Topogenesis of Mitochondrial Genome Maintenance Protein 1 (Mgm1).Using mutants, knockdowns, and transgenesis to investigate gene function in .A genome-scale shRNA resource for transgenic RNAi in .CRISPR-Cas9 genome editing in .Highly Efficient Targeted Mutagenesis of  with the CRISPR/Cas9 System.Evidence of off-target effects associated with long dsRNAs in  cell-based assays.CULD is required for rhodopsin and TRPL channel endocytic trafficking and survival of photoreceptor cellsPINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality controlGenome engineering using the CRISPR-Cas9 system.Genome-wide RNAi analysis of growth and viability in  cellsA nanoscale, multi-parametric flow cytometry-based platform to study mitochondrial heterogeneity and mitochondrial DNA dynamics.Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome1Toward one step analysis of cellular lipidomes using liquid chromatography coupled with mass spectrometry: application to Saccharomyces cerevisiae and Schizosaccharomyces pombe lipidomics.Triangle matching method for the sparse environment of geomagnetic information.Discovery of NDM-1 inhibitors from natural products.Development and testing of a general amber force fieldff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.Exploring protein native states and large-scale conformational changes with a modified generalized born modelApproximate atomic surfaces from linear combinations of pairwise overlaps (LCPO).Store-Operated Calcium Entry through Orai Is Required for Transcriptional Maturation of the Flight Circuit in Decision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2Author response to Decision Letter 2Decision Letter 3</div>
                            <small style="color: var(--text-muted)">11649117.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...ad Software Inc.). A value of p < 0.05 was considered statistically...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencingSingle-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALLReference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophageMIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitmentMetronomic chemotherapy modulates clonal interactions to prevent drug resistance in non-small cell lung cancerStalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistanceOverexpression of close homolog of L1 enhances the chemosensitivity of lung cancer cells via inhibition of the Akt pathwayInhibition of the glycolytic activator pfkfb3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapyMetabolic competition in the tumor microenvironment is a driver of cancer progressionDissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapyLandscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaNovel dipeptides bearing sulfonamide as antimalarial and antitrypanosomal agents: Synthesis and molecular dockingMetabolic reprogramming and cancer progressionA flexible R package for nonnegative matrix factorizationscCancer: a package for automated processing of single-cell RNA-seq data in cancerInhibition of NADPH Oxidase-4 Potentiates 2-Deoxy-D-Glucose-Induced suppression of glycolysis, migration, and invasion in glioblastoma cells: role of the Akt/HIF1α/HK-2 signaling axisProspective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapiesPhosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responsesElucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic statesInference and analysis of cell-cell communication using CellChatDifferences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomasSingle-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaPhenotype molding of stromal cells in the lung tumor microenvironmentSingle-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodulesHighly parallel genome-wide expression profiling of individual cells using nanoliter dropletsTumor-associated macrophage status in cancer treatmentSingle-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomasEffect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approachesSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaTargeting tumor-associated macrophages in cancerReversed graph embedding resolves complex single-cell trajectoriesSingle-cell connectomic analysis of adult mammalian lungsCell-programmed nutrient partitioning in the tumour microenvironmentClinical significance of a circulating tumor cell-based classifier in stage ib lung adenocarcinoma: a multicenter, cohort studyFumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionChemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneityCancer statistics, 2020Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinomaStandard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancerOvercoming chemoresistance by targeting reprogrammed metabolism: the Achilles’ heel of pancreatic ductal adenocarcinomaCD8 T lymphocyte and nk cell network: circuitry in the cytotoxic domain of immunityUnderstanding the Warburg effect: the metabolic requirements of cell proliferationTherapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibitionA molecular atlas of cell types and zonation in the brain vasculatureSIRT1/PGC1α-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancerMetabolic landscape of the tumor microenvironment at single cell resolutionSingle-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosisTargeting cellular metabolism to improve cancer therapeuticsMitochondria and CancereLife AssessmentReviewer #1 (Public review):Author response">Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencingSingle-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALLReference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophageMIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitmentMetronomic chemotherapy modulates clonal interactions to prevent drug resistance in non-small cell lung cancerStalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistanceOverexpression of close homolog of L1 enhances the chemosensitivity of lung cancer cells via inhibition of the Akt pathwayInhibition of the glycolytic activator pfkfb3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapyMetabolic competition in the tumor microenvironment is a driver of cancer progressionDissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapyLandscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinomaNovel dipeptides bearing sulfonamide as antimalarial and antitrypanosomal agents: Synthesis and molecular dockingMetabolic reprogramming and cancer progressionA flexible R package for nonnegative matrix factorizationscCancer: a package for automated processing of single-cell RNA-seq data in cancerInhibition of NADPH Oxidase-4 Potentiates 2-Deoxy-D-Glucose-Induced suppression of glycolysis, migration, and invasion in glioblastoma cells: role of the Akt/HIF1α/HK-2 signaling axisProspective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapiesPhosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responsesElucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic statesInference and analysis of cell-cell communication using CellChatDifferences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomasSingle-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaPhenotype molding of stromal cells in the lung tumor microenvironmentSingle-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodulesHighly parallel genome-wide expression profiling of individual cells using nanoliter dropletsTumor-associated macrophage status in cancer treatmentSingle-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomasEffect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approachesSingle-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaTargeting tumor-associated macrophages in cancerReversed graph embedding resolves complex single-cell trajectoriesSingle-cell connectomic analysis of adult mammalian lungsCell-programmed nutrient partitioning in the tumour microenvironmentClinical significance of a circulating tumor cell-based classifier in stage ib lung adenocarcinoma: a multicenter, cohort studyFumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transitionChemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneityCancer statistics, 2020Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinomaStandard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancerOvercoming chemoresistance by targeting reprogrammed metabolism: the Achilles’ heel of pancreatic ductal adenocarcinomaCD8 T lymphocyte and nk cell network: circuitry in the cytotoxic domain of immunityUnderstanding the Warburg effect: the metabolic requirements of cell proliferationTherapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibitionA molecular atlas of cell types and zonation in the brain vasculatureSIRT1/PGC1α-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancerMetabolic landscape of the tumor microenvironment at single cell resolutionSingle-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosisTargeting cellular metabolism to improve cancer therapeuticsMitochondria and CancereLife AssessmentReviewer #1 (Public review):Author response</div>
                            <small style="color: var(--text-muted)">11677239.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': 'No direct quote found.'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="International collaboration in cohort studies in China: opportunities and challengesMortality in relation to smoking: 50 years’ observations on male British doctorsCohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiologyEmerging tobacco hazards in China: 2. Early mortality results from a prospective studyThe Shanghai Women’s Health Study: rationale, study design, and baseline characteristicsChina Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-upContrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studiesEmerging tobacco hazards in China: 2. Early mortality results from a prospective studyCohort profile: The Shanghai Men’s Health StudyData resource profile: China Chronic Disease and Risk Factor Surveillance (CCDRFS)Rationales, design and recruitment of the Taizhou Longitudinal Study[Establishment of Shanghai suburban adult cohort and biobank] [Chinese]. The diverse life-course cohort (DLCC): protocol of a large-scale prospective study in ChinaCohort profile: Regional Ethnic Cohort Study in Northwest ChinaCohort profile: South China Cohort[Design and performance of a prospective cohort study of common chronic and non-communicable diseases in central China] [Chinese] . Cohort profile: the China Multi-Ethnic Cohort (CMEC) studyCohort profile: The Northeast China Biobank (NEC-Biobank)[Established and on-going cohort studies in China: a literature study] [Chinese]Data resource profile: China Cohort Consortium (CCC)Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrationsCausal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adultsMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in ChinaMTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adultsTobacco control in ChinaPlasma proteomic associations with genetics and health in the UK BiobankWhole-genome sequencing of half-a-million UK Biobank participants.Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication[Data harmonization and sharing in study cohorts of respiratory diseases] [Chinese]Trump’s NIH research cuts are temporarily blocked as 22 US states suePrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studySolid fuel use and risks of respiratory diseases. A cohort study of 280,000 Chinese never-smokers">International collaboration in cohort studies in China: opportunities and challengesMortality in relation to smoking: 50 years’ observations on male British doctorsCohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiologyEmerging tobacco hazards in China: 2. Early mortality results from a prospective studyThe Shanghai Women’s Health Study: rationale, study design, and baseline characteristicsChina Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-upContrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studiesEmerging tobacco hazards in China: 2. Early mortality results from a prospective studyCohort profile: The Shanghai Men’s Health StudyData resource profile: China Chronic Disease and Risk Factor Surveillance (CCDRFS)Rationales, design and recruitment of the Taizhou Longitudinal Study[Establishment of Shanghai suburban adult cohort and biobank] [Chinese]. The diverse life-course cohort (DLCC): protocol of a large-scale prospective study in ChinaCohort profile: Regional Ethnic Cohort Study in Northwest ChinaCohort profile: South China Cohort[Design and performance of a prospective cohort study of common chronic and non-communicable diseases in central China] [Chinese] . Cohort profile: the China Multi-Ethnic Cohort (CMEC) studyCohort profile: The Northeast China Biobank (NEC-Biobank)[Established and on-going cohort studies in China: a literature study] [Chinese]Data resource profile: China Cohort Consortium (CCC)Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrationsCausal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adultsMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in ChinaMTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adultsTobacco control in ChinaPlasma proteomic associations with genetics and health in the UK BiobankWhole-genome sequencing of half-a-million UK Biobank participants.Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication[Data harmonization and sharing in study cohorts of respiratory diseases] [Chinese]Trump’s NIH research cuts are temporarily blocked as 22 US states suePrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studySolid fuel use and risks of respiratory diseases. A cohort study of 280,000 Chinese never-smokers</div>
                            <small style="color: var(--text-muted)">12542859.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trialPost-myocardial infarction heart failureHeart failure after myocardial infarction: incidence and predictorsLong-term trends in the incidence of heart failure after myocardial infarctionThe effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trialIntracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialMesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trialsTransendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialThe safety of MSC therapy over the past 15 years: a meta-analysisEffect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trialMinimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementClinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trialHuman Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeDelphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeuticsLong-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survivalImproved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialIntracoronary bone marrow-derived progenitor cells in acute myocardial infarctionMajor cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trialsIntracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialIntracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trialIntracoronary injection of mononuclear bone marrow cells in acute myocardial infarctionLong term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarctionSustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trialEffect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical ResultsIntracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialPredictors of hospital mortality in the global registry of acute coronary eventsSex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MISex Differences in Heart Failure Following Acute Coronary SyndromesSex difference in the development and progression of heart failure after firsttime ST-elevation myocardial infarctionRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart FailureMesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regenerationConcise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical ApplicationsThe therapeutic potential of mesenchymal stem cells for cardiovascular diseasesCardiac Stem Cells for Myocardial Regeneration: They Are Not AloneFirst-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarctionIs the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imagingStem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells">Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trialPost-myocardial infarction heart failureHeart failure after myocardial infarction: incidence and predictorsLong-term trends in the incidence of heart failure after myocardial infarctionThe effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trialIntracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialMesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trialsTransendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialThe safety of MSC therapy over the past 15 years: a meta-analysisEffect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trialMinimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementClinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trialHuman Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeDelphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeuticsLong-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survivalImproved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialIntracoronary bone marrow-derived progenitor cells in acute myocardial infarctionMajor cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trialsIntracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialIntracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trialIntracoronary injection of mononuclear bone marrow cells in acute myocardial infarctionLong term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarctionSustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trialEffect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical ResultsIntracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialPredictors of hospital mortality in the global registry of acute coronary eventsSex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MISex Differences in Heart Failure Following Acute Coronary SyndromesSex difference in the development and progression of heart failure after firsttime ST-elevation myocardial infarctionRandomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart FailureMesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regenerationConcise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical ApplicationsThe therapeutic potential of mesenchymal stem cells for cardiovascular diseasesCardiac Stem Cells for Myocardial Regeneration: They Are Not AloneFirst-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarctionIs the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imagingStem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells</div>
                            <small style="color: var(--text-muted)">12570275.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...lls, we anticipated a rate of dropout and consent withdrawal of 8-1...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Cardiotropic AAV gene therapy for heart failure: a phase 1 trialHeart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of AmericaGlobal public health burden of heart failure: an updated review2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesHeart failure in humans reduces contractile force in myocardium from both ventriclesCardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failureModulation of cardiac contractility by the phospholamban/SERCA2a regulatomeCounteracting protein kinase activity in the heart: the multiple roles of protein phosphatasesType 1 phosphatase, a negative regulator of cardiac functionEnhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiologyInducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injuryAbnormal intracellular calcium handling in myocardium from patients with end-stage heart failureSarcoplasmic reticulum Ca ATPase as a therapeutic target for heart failureIncreased expression of cardiac phosphatases in patients with end-stage heart failureProtein phosphatase inhibitor-1 gene therapy in a swine model of nonischemic heart failureActive inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing heartsExpression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosisCardiac gene therapy with adeno-associated virus-based vectorsAAV-mediated gene therapy: advancing cardiovascular disease treatmentHuman cardiac gene therapyRescuing the failing heart by targeted gene transferIntracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trialEffects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trialsCalcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trialCardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failureA first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel re-engineered adeno-associated vectorReengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleGene therapy for the treatment of heart failure: promise postponedRoutinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction6-minute walking test: a useful tool in the management of heart failure patientsTargeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pumpCalcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca-ATPase in patients with advanced heart failureCalcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trialBarriers in heart failure gene therapy and approaches to overcome themSERCA2a protein levels are unaltered in human heart failureCombined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac stateSynergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca-ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cellsFunction and regulation of phosphatase 1 in healthy and diseased heart">Cardiotropic AAV gene therapy for heart failure: a phase 1 trialHeart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of AmericaGlobal public health burden of heart failure: an updated review2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesHeart failure in humans reduces contractile force in myocardium from both ventriclesCardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failureModulation of cardiac contractility by the phospholamban/SERCA2a regulatomeCounteracting protein kinase activity in the heart: the multiple roles of protein phosphatasesType 1 phosphatase, a negative regulator of cardiac functionEnhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiologyInducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injuryAbnormal intracellular calcium handling in myocardium from patients with end-stage heart failureSarcoplasmic reticulum Ca ATPase as a therapeutic target for heart failureIncreased expression of cardiac phosphatases in patients with end-stage heart failureProtein phosphatase inhibitor-1 gene therapy in a swine model of nonischemic heart failureActive inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing heartsExpression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosisCardiac gene therapy with adeno-associated virus-based vectorsAAV-mediated gene therapy: advancing cardiovascular disease treatmentHuman cardiac gene therapyRescuing the failing heart by targeted gene transferIntracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trialEffects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trialsCalcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trialCardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failureA first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel re-engineered adeno-associated vectorReengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleGene therapy for the treatment of heart failure: promise postponedRoutinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction6-minute walking test: a useful tool in the management of heart failure patientsTargeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pumpCalcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca-ATPase in patients with advanced heart failureCalcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trialBarriers in heart failure gene therapy and approaches to overcome themSERCA2a protein levels are unaltered in human heart failureCombined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac stateSynergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca-ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cellsFunction and regulation of phosphatase 1 in healthy and diseased heart</div>
                            <small style="color: var(--text-muted)">12618250.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...n of investigational product. No formal hypothesis testing was planned, and no sample si...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Spatial multiomic landscape of the human placenta at molecular resolutionAuthor Correction: Spatial multiomic landscape of the human placenta at molecular resolutionPlacenta: the forgotten organPlacental related disorders of pregnancy 2.0The placenta: a multifaceted, transient organExploring the links between cancer and placenta developmentSingle-cell reconstruction of the early maternal–fetal interface in humansA spatially resolved timeline of the human maternal–fetal interfaceSpatial multiomics map of trophoblast development in early pregnancySlide-tags enables single-nucleus barcoding for multimodal spatial genomicsThree-dimensional intact-tissue sequencing of single-cell transcriptional statesTransforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placentaEmerging role of lymphocyte antigen-6 family of genes in cancer and immune cellsSingle-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancerThe emerging role of QSOX1 in cancerFGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinomaTargeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitorsAn alternative splicing switch regulates embryonic stem cell pluripotency and reprogrammingTriiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent mannerAnnexin-A1: therapeutic potential in microvascular diseaseCandesartan does not activate PPARγ and its target genes in early gestation trophoblastsDefects in placental syncytiotrophoblast cells are a common cause of developmental heart diseaseTarget prediction and validation of microRNAs expressed from FSHR and aromatase genes in human ovarian granulosa cellsExosomal miR-23b from bone marrow mesenchymal stem cells alleviates oxidative stress and pyroptosis after intracerebral hemorrhageThe FOS transcription factor family differentially controls trophoblast migration and invasionp45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionMiR-133a-3p relieves the oxidative stress induced trophoblast cell apoptosis through the BACH1/Nrf2/HO-1 signaling pathwayMSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cellsMiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsiaAssociation of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cellsTranscription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinomaWNT and NOTCH signaling in human trophoblast development and differentiationASCL2 reciprocally controls key trophoblast lineage decisions during hemochorial placenta developmentEBF1 Gene mRNA levels in maternal blood and spontaneous preterm birthEBF1 is expressed in pericytes and contributes to pericyte cell commitmentA MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancerNR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human gliomachromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic dataE2F transcription factor 1 (E2F1) enhances the proliferation, invasion and EMT of trophoblast cells by binding to Zinc Finger E-Box Binding Homeobox 1 (ZEB1)EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expressionThe Mesp2 transcription factor establishes segmental borders by suppressing Notch activityMesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signallingMolecular determinants of epithelial mesenchymal transition in mouse placenta and trophoblast stem cellIntegrin linked kinase regulates syncytialization of BeWo trophoblast cellsComplex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placentaHOXA13 Is essential for placental vascular patterning and labyrinth endothelial specificationHMGA1 Is a potential driver of preeclampsia pathogenesis by interference with extravillous trophoblasts invasionChromatin potential identified by shared single-cell profiling of RNA and chromatinRole of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placentaFOXF1 mediates endothelial progenitor functions and regulates vascular sproutingAberrant expression of imprinted lncRNA MEG8 causes trophoblast dysfunction and abortionLong noncoding RNA maternally expressed gene 3 improves trophoblast dysfunction and inflammation in preeclampsia through the Wnt/β-Catenin/nod-like receptor pyrin domain-containing 3 axisAberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCCThe polarity protein Par6 induces cell proliferation and is overexpressed in breast cancerA review of FOXI3 regulation of development and possible roles in cancer progression and metastasisTAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastomaVGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscleBone morphogenetic protein 2 promotes human trophoblast cell invasion and endothelial-like tube formation through ID1-mediated upregulation of IGF binding protein-3FOXF1 inhibits hematopoietic lineage commitment during early mesoderm specificationTBX5: a key regulator of heart developmentCellRank for directed single-cell fate mappingMusashi2 is required for the self-renewal and pluripotency of embryonic stem cellsA novel human endogenous retroviral protein inhibits cell-cell fusionThe BMP2 signaling axis promotes invasive differentiation of human trophoblastsPeroxidasin is essential for endothelial cell survival and growth signaling by sulfilimine crosslink-dependent matrix assemblyInference and analysis of cell-cell communication using CellChatThe epidermal growth factor receptor in healthy pregnancy and preeclampsiaHGF/c-Met signaling regulates early differentiation of placental trophoblast cellsExpression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesisSyndecan-4 modulates cell polarity and migration by influencing centrosome positioning and intracellular calcium distributionSelf-renewing trophoblast organoids recapitulate the developmental program of the early human placentaNotch1 controls development of the extravillous trophoblast lineage in the human placentaCumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seqArchR is a scalable software package for integrative single-cell chromatin accessibility analysisFast, sensitive and accurate integration of single-cell data with HarmonyOrchestrating high-throughput genomic analysis with BioconductorDemuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methodsThe UK Biobank resource with deep phenotyping and genomic dataGenome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohortSurgical necrotizing enterocolitis in extremely premature neonates is associated with genetic variations in an intergenic region of chromosome 8Genetic variations and risk of placental abruption: a genome-wide association study and meta-analysis of genome-wide association studiesHeritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell typesIdentifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human geneticsActivity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbationsLD score regression distinguishes confounding from polygenicity in genome-wide association studiesMAGMA: generalized gene-set analysis of GWAS dataIntegrated analysis of multimodal single-cell dataUMAP: Uniform Manifold Approximation and ProjectionModel-based analysis of ChIP-Seq (MACS)Comparing implementations of global and local indicators of spatial associationSciPy 1.0: fundamental algorithms for scientific computing in Pythonstarfish: scalable pipelines for image-based transcriptomicsClusterMap for multi-scale clustering analysis of spatial gene expressionSCANPY: large-scale single-cell gene expression data analysisIntegration of spatial and single-cell transcriptomic data elucidates mouse organogenesis">Spatial multiomic landscape of the human placenta at molecular resolutionAuthor Correction: Spatial multiomic landscape of the human placenta at molecular resolutionPlacenta: the forgotten organPlacental related disorders of pregnancy 2.0The placenta: a multifaceted, transient organExploring the links between cancer and placenta developmentSingle-cell reconstruction of the early maternal–fetal interface in humansA spatially resolved timeline of the human maternal–fetal interfaceSpatial multiomics map of trophoblast development in early pregnancySlide-tags enables single-nucleus barcoding for multimodal spatial genomicsThree-dimensional intact-tissue sequencing of single-cell transcriptional statesTransforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placentaEmerging role of lymphocyte antigen-6 family of genes in cancer and immune cellsSingle-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancerThe emerging role of QSOX1 in cancerFGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinomaTargeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitorsAn alternative splicing switch regulates embryonic stem cell pluripotency and reprogrammingTriiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent mannerAnnexin-A1: therapeutic potential in microvascular diseaseCandesartan does not activate PPARγ and its target genes in early gestation trophoblastsDefects in placental syncytiotrophoblast cells are a common cause of developmental heart diseaseTarget prediction and validation of microRNAs expressed from FSHR and aromatase genes in human ovarian granulosa cellsExosomal miR-23b from bone marrow mesenchymal stem cells alleviates oxidative stress and pyroptosis after intracerebral hemorrhageThe FOS transcription factor family differentially controls trophoblast migration and invasionp45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restrictionMiR-133a-3p relieves the oxidative stress induced trophoblast cell apoptosis through the BACH1/Nrf2/HO-1 signaling pathwayMSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cellsMiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsiaAssociation of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cellsTranscription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinomaWNT and NOTCH signaling in human trophoblast development and differentiationASCL2 reciprocally controls key trophoblast lineage decisions during hemochorial placenta developmentEBF1 Gene mRNA levels in maternal blood and spontaneous preterm birthEBF1 is expressed in pericytes and contributes to pericyte cell commitmentA MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancerNR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human gliomachromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic dataE2F transcription factor 1 (E2F1) enhances the proliferation, invasion and EMT of trophoblast cells by binding to Zinc Finger E-Box Binding Homeobox 1 (ZEB1)EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expressionThe Mesp2 transcription factor establishes segmental borders by suppressing Notch activityMesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signallingMolecular determinants of epithelial mesenchymal transition in mouse placenta and trophoblast stem cellIntegrin linked kinase regulates syncytialization of BeWo trophoblast cellsComplex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placentaHOXA13 Is essential for placental vascular patterning and labyrinth endothelial specificationHMGA1 Is a potential driver of preeclampsia pathogenesis by interference with extravillous trophoblasts invasionChromatin potential identified by shared single-cell profiling of RNA and chromatinRole of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placentaFOXF1 mediates endothelial progenitor functions and regulates vascular sproutingAberrant expression of imprinted lncRNA MEG8 causes trophoblast dysfunction and abortionLong noncoding RNA maternally expressed gene 3 improves trophoblast dysfunction and inflammation in preeclampsia through the Wnt/β-Catenin/nod-like receptor pyrin domain-containing 3 axisAberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCCThe polarity protein Par6 induces cell proliferation and is overexpressed in breast cancerA review of FOXI3 regulation of development and possible roles in cancer progression and metastasisTAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastomaVGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscleBone morphogenetic protein 2 promotes human trophoblast cell invasion and endothelial-like tube formation through ID1-mediated upregulation of IGF binding protein-3FOXF1 inhibits hematopoietic lineage commitment during early mesoderm specificationTBX5: a key regulator of heart developmentCellRank for directed single-cell fate mappingMusashi2 is required for the self-renewal and pluripotency of embryonic stem cellsA novel human endogenous retroviral protein inhibits cell-cell fusionThe BMP2 signaling axis promotes invasive differentiation of human trophoblastsPeroxidasin is essential for endothelial cell survival and growth signaling by sulfilimine crosslink-dependent matrix assemblyInference and analysis of cell-cell communication using CellChatThe epidermal growth factor receptor in healthy pregnancy and preeclampsiaHGF/c-Met signaling regulates early differentiation of placental trophoblast cellsExpression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesisSyndecan-4 modulates cell polarity and migration by influencing centrosome positioning and intracellular calcium distributionSelf-renewing trophoblast organoids recapitulate the developmental program of the early human placentaNotch1 controls development of the extravillous trophoblast lineage in the human placentaCumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seqArchR is a scalable software package for integrative single-cell chromatin accessibility analysisFast, sensitive and accurate integration of single-cell data with HarmonyOrchestrating high-throughput genomic analysis with BioconductorDemuxafy: improvement in droplet assignment by integrating multiple single-cell demultiplexing and doublet detection methodsThe UK Biobank resource with deep phenotyping and genomic dataGenome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohortSurgical necrotizing enterocolitis in extremely premature neonates is associated with genetic variations in an intergenic region of chromosome 8Genetic variations and risk of placental abruption: a genome-wide association study and meta-analysis of genome-wide association studiesHeritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell typesIdentifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human geneticsActivity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbationsLD score regression distinguishes confounding from polygenicity in genome-wide association studiesMAGMA: generalized gene-set analysis of GWAS dataIntegrated analysis of multimodal single-cell dataUMAP: Uniform Manifold Approximation and ProjectionModel-based analysis of ChIP-Seq (MACS)Comparing implementations of global and local indicators of spatial associationSciPy 1.0: fundamental algorithms for scientific computing in Pythonstarfish: scalable pipelines for image-based transcriptomicsClusterMap for multi-scale clustering analysis of spatial gene expressionSCANPY: large-scale single-cell gene expression data analysisIntegration of spatial and single-cell transcriptomic data elucidates mouse organogenesis</div>
                            <small style="color: var(--text-muted)">12660148.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': 'No direct quote found.'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trialAdjuvant nivolumab versus ipilimumab in resected stage III or IV melanomaAdjuvant pembrolizumab versus placebo in resected stage III melanomaFive-year analysis of adjuvant pembrolizumab or placebo in stage III melanomaFinal results for adjuvant dabrafenib plus trametinib in stage III melanomaAdjuvant nivolumab versus ipilimumab in resected stage III/IV melanoma: 5-year efficacy and biomarker results for CheckMate 238Relatlimab and nivolumab versus nivolumab in untreated advanced melanomaOverall survival and response with nivolumab and relatlimab in advanced melanomaNivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year updateNeoadjuvant relatlimab and nivolumab in resectable melanomaNeoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trialNeoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trialNeoadjuvant anti–PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trialAdjuvant therapy of nivolumab combined with ipilimumab versus nivolumab alone in patients with resected stage IIIB–D or stage IV melanoma (CheckMate 915)Neoadjuvant nivolumab and ipilimumab in resectable stage III melanomaIndividualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomized, phase 2b study">Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trialAdjuvant nivolumab versus ipilimumab in resected stage III or IV melanomaAdjuvant pembrolizumab versus placebo in resected stage III melanomaFive-year analysis of adjuvant pembrolizumab or placebo in stage III melanomaFinal results for adjuvant dabrafenib plus trametinib in stage III melanomaAdjuvant nivolumab versus ipilimumab in resected stage III/IV melanoma: 5-year efficacy and biomarker results for CheckMate 238Relatlimab and nivolumab versus nivolumab in untreated advanced melanomaOverall survival and response with nivolumab and relatlimab in advanced melanomaNivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year updateNeoadjuvant relatlimab and nivolumab in resectable melanomaNeoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trialNeoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trialNeoadjuvant anti–PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trialAdjuvant therapy of nivolumab combined with ipilimumab versus nivolumab alone in patients with resected stage IIIB–D or stage IV melanoma (CheckMate 915)Neoadjuvant nivolumab and ipilimumab in resectable stage III melanomaIndividualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomized, phase 2b study</div>
                            <small style="color: var(--text-muted)">12705465.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...and reported out as relative frequencies. A PBMC sample from the same...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Virtual first: implementation of a novel sleep telehealth platform in the United States militaryEngaging stakeholders to optimize sleep disorders' management in the U. S. military: a qualitative analysisRemote clinical research operations during COVID-19: lessons learned and recommendationsCognitive behavioral therapy for insomnia in older veterans using nonclinician sleep coaches: randomized controlled trialA randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apneaEffectiveness of guided internet-based cognitive behavioral therapy vs face-to-face clinical care for treatment of tinnitus: a randomized clinical trialPreliminary validation of the Defense and Veterans Pain Rating Scale (DVPRS) in a military populationOptimizing sleep in the military: challenges and opportunitiesDaytime sleep-tracking performance of four commercial wearable devices during unrestricted home sleepSleep disturbances and predictors of nondeployability among active-duty Army soldiers: an odds ratio analysis of medical healthcare data from fiscal year 2018Evaluating the public health impact of health promotion interventions: the RE-AIM frameworkRE-AIM in clinical, community, and corporate settings: perspectives, strategies, and recommendations to enhance public health impactNational Sleep Foundation's sleep time duration recommendations: methodology and results summaryGuided internet cognitive behavioral therapy for insomnia compared to a control treatment - a randomized trialValidity of a commercial wearable sleep tracker in adult insomnia disorder patients and good sleepersAcute Effects of Online Mind-Body Skills Training on Resilience, Mindfulness, and EmpathyA randomized controlled trial comparing guided internet-based multi-component treatment and internet-based guided sleep restriction treatment to care as usual in insomniaThe PHQ-9: validity of a brief depression severity measureSleep duration in the United States: a cross-sectional population-based studyField-based measurement of sleep: agreement between six commercial activity monitors and a validated accelerometerProvider types and outcomes in obstructive sleep apnea case finding and treatment: a systematic reviewGuided online or face-to-face cognitive behavioral treatment for insomnia: a randomized wait-list controlled trialValidation of fitbit inspire 2Prevalence and impact of short sleep duration in redeployed OIF soldiersIncidence of insomnia and obstructive sleep apnea in active duty united states military service membersSleep disorders and associated medical comorbidities in active duty military personnelUsing the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeA randomized controlled trial of an alternative care provider clinic for severe sleep-disordered breathingThe primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sampleScreening for traumatic brain injury in troops returning from deployment in Afghanistan and Iraq: initial investigation of the usefulness of a short screening tool for traumatic brain injuryThe effectiveness of psychotherapy: the consumer reports studybrief measure for assessing generalized anxiety disorder: the GAD-7Evaluations of commercial sleep technologies for objective monitoring during routine sleeping conditionsPrimary versus specialist care for obstructive sleep apnea: a systematic review and individual-participant data-level meta-analysisRecommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research SocietyActive duty service members, primary managers, and administrators' perspectives on a novel sleep telehealth management platform in the U.S. military healthcare systemThe impact of treatments for osa on monetized health economic outcomes: a systematic reviewHealth economics of insomnia treatments: the return on investment for a good night's sleepThe impact of sleep on soldier performance">Virtual first: implementation of a novel sleep telehealth platform in the United States militaryEngaging stakeholders to optimize sleep disorders' management in the U. S. military: a qualitative analysisRemote clinical research operations during COVID-19: lessons learned and recommendationsCognitive behavioral therapy for insomnia in older veterans using nonclinician sleep coaches: randomized controlled trialA randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apneaEffectiveness of guided internet-based cognitive behavioral therapy vs face-to-face clinical care for treatment of tinnitus: a randomized clinical trialPreliminary validation of the Defense and Veterans Pain Rating Scale (DVPRS) in a military populationOptimizing sleep in the military: challenges and opportunitiesDaytime sleep-tracking performance of four commercial wearable devices during unrestricted home sleepSleep disturbances and predictors of nondeployability among active-duty Army soldiers: an odds ratio analysis of medical healthcare data from fiscal year 2018Evaluating the public health impact of health promotion interventions: the RE-AIM frameworkRE-AIM in clinical, community, and corporate settings: perspectives, strategies, and recommendations to enhance public health impactNational Sleep Foundation's sleep time duration recommendations: methodology and results summaryGuided internet cognitive behavioral therapy for insomnia compared to a control treatment - a randomized trialValidity of a commercial wearable sleep tracker in adult insomnia disorder patients and good sleepersAcute Effects of Online Mind-Body Skills Training on Resilience, Mindfulness, and EmpathyA randomized controlled trial comparing guided internet-based multi-component treatment and internet-based guided sleep restriction treatment to care as usual in insomniaThe PHQ-9: validity of a brief depression severity measureSleep duration in the United States: a cross-sectional population-based studyField-based measurement of sleep: agreement between six commercial activity monitors and a validated accelerometerProvider types and outcomes in obstructive sleep apnea case finding and treatment: a systematic reviewGuided online or face-to-face cognitive behavioral treatment for insomnia: a randomized wait-list controlled trialValidation of fitbit inspire 2Prevalence and impact of short sleep duration in redeployed OIF soldiersIncidence of insomnia and obstructive sleep apnea in active duty united states military service membersSleep disorders and associated medical comorbidities in active duty military personnelUsing the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeA randomized controlled trial of an alternative care provider clinic for severe sleep-disordered breathingThe primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sampleScreening for traumatic brain injury in troops returning from deployment in Afghanistan and Iraq: initial investigation of the usefulness of a short screening tool for traumatic brain injuryThe effectiveness of psychotherapy: the consumer reports studybrief measure for assessing generalized anxiety disorder: the GAD-7Evaluations of commercial sleep technologies for objective monitoring during routine sleeping conditionsPrimary versus specialist care for obstructive sleep apnea: a systematic review and individual-participant data-level meta-analysisRecommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research SocietyActive duty service members, primary managers, and administrators' perspectives on a novel sleep telehealth management platform in the U.S. military healthcare systemThe impact of treatments for osa on monetized health economic outcomes: a systematic reviewHealth economics of insomnia treatments: the return on investment for a good night's sleepThe impact of sleep on soldier performance</div>
                            <small style="color: var(--text-muted)">12713946.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Caracterización y factores asociados a la malnutrición en menores de 5 años en el municipio de Neiva, ColombiaMalnutrición infantil e inseguridad alimentaria como expresión de las condiciones socio-económicas familiares en Villaguay, Argentina (2010-2012). Un enfoque bioculturalSecond International Conference of Nutrition: Why Nutrition Matters [Internet]Dynamics of the double burden of malnutrition and the changing nutrition realityFed to Fail? The Crisis of Children’s Diets in Early LifeLineamientos Nacionales Para la Vigilancia, 2022 [Internet]Desnutrición Infantil [Internet]Malnutrition [Internet]The double burden of malnutrition: a systematic review of operational definitionsEncuesta Nacional de la Situación Nutricional en Colombia - ENSIN 2015 [Internet]Boletín del Comportamiento de los Indicadores de la Dimensión de Seguridad Alimentaria y Nutricional del Departamento del Huila 2021Prevalencia de Desnutrición Aguda en menores de 5 Años: Huila y municipios - 2016 a 2022 [Internet]Población Huila y Municipios - 1995 a 2035 [Internet]Información del Municipio de Neiva [Internet]Prevalencia y determinantes sociales de malnutrición en menores de 5 años afiliados al Sistema de Selección de Beneficiarios para Programas Sociales (SISBEN) del área urbana del municipio de Palermo en Colombia, 2017Ley 1581 de 2012 «Por la cual se dictan disposiciones generales para la protección de datos personales» [Internet]Resolución 2465 de 2016 [Internet]Portal ICBF - Instituto Colombiano de Bienestar Familiar ICBFBuen Vivir (Sumak Kawsay): definiciones, crítica e implicaciones en la planificación del desarrollo en EcuadorAmérica Latina y el Caribe - Panorama regional de la seguridad alimentaria y nutricional 2023: Estadísticas y tendencias [Internet]Nutrition gap in children, urban-rural: the key education and food. Colombia, 2015: educación y alimentos, la clave. Colombia, 2015Reducing childhood malnutrition in Bangladesh: the importance of addressing socio-economic inequalitiesDeterminants of undernutrition among young children in EthiopiaAcute malnutrition and its determinants of preschool children in Bangladesh: gender differentiationUnderstanding sex differences in childhood undernutrition: a narrative reviewA study to assess undernutrition and its sociodemographic correlates in under-five children in urban and rural areas of Rishikesh, UttarakhandPrevalence and factors associated with stunting and excess weight in children aged 0-5 years from the Brazilian semi-arid regionSociodemographic risk factors of under-five stunting in Bangladesh: assessing the role of interactions using a machine learning methodPrevalence and determinants of the double burden of malnutrition with a focus on concurrent stunting and overweight/obesity in children and adolescentsIdentifying access barriers faced by rural and dispersed communities to better address their needs: implications and lessons learned for rural proofing for health in the Americas and beyondMalnutrition in all its forms and socio-economic disparities in children under 5 years of age and women of reproductive age in PeruDouble burden of maternal and child malnutrition and socioeconomic status in urban Sri LankaDeterminantes socioeconómicos del exceso de peso en niños preescolares y escolares colombianos. Encuesta Nacional de Situación Nutricional 2015Espacios de pobreza en la periferia urbana y suburbios interiores de la Ciudad de México: las desventajas acumuladasRepresentación geográfica de la malnutrición en niños y adolescentes de Medellín, Colombia">Caracterización y factores asociados a la malnutrición en menores de 5 años en el municipio de Neiva, ColombiaMalnutrición infantil e inseguridad alimentaria como expresión de las condiciones socio-económicas familiares en Villaguay, Argentina (2010-2012). Un enfoque bioculturalSecond International Conference of Nutrition: Why Nutrition Matters [Internet]Dynamics of the double burden of malnutrition and the changing nutrition realityFed to Fail? The Crisis of Children’s Diets in Early LifeLineamientos Nacionales Para la Vigilancia, 2022 [Internet]Desnutrición Infantil [Internet]Malnutrition [Internet]The double burden of malnutrition: a systematic review of operational definitionsEncuesta Nacional de la Situación Nutricional en Colombia - ENSIN 2015 [Internet]Boletín del Comportamiento de los Indicadores de la Dimensión de Seguridad Alimentaria y Nutricional del Departamento del Huila 2021Prevalencia de Desnutrición Aguda en menores de 5 Años: Huila y municipios - 2016 a 2022 [Internet]Población Huila y Municipios - 1995 a 2035 [Internet]Información del Municipio de Neiva [Internet]Prevalencia y determinantes sociales de malnutrición en menores de 5 años afiliados al Sistema de Selección de Beneficiarios para Programas Sociales (SISBEN) del área urbana del municipio de Palermo en Colombia, 2017Ley 1581 de 2012 «Por la cual se dictan disposiciones generales para la protección de datos personales» [Internet]Resolución 2465 de 2016 [Internet]Portal ICBF - Instituto Colombiano de Bienestar Familiar ICBFBuen Vivir (Sumak Kawsay): definiciones, crítica e implicaciones en la planificación del desarrollo en EcuadorAmérica Latina y el Caribe - Panorama regional de la seguridad alimentaria y nutricional 2023: Estadísticas y tendencias [Internet]Nutrition gap in children, urban-rural: the key education and food. Colombia, 2015: educación y alimentos, la clave. Colombia, 2015Reducing childhood malnutrition in Bangladesh: the importance of addressing socio-economic inequalitiesDeterminants of undernutrition among young children in EthiopiaAcute malnutrition and its determinants of preschool children in Bangladesh: gender differentiationUnderstanding sex differences in childhood undernutrition: a narrative reviewA study to assess undernutrition and its sociodemographic correlates in under-five children in urban and rural areas of Rishikesh, UttarakhandPrevalence and factors associated with stunting and excess weight in children aged 0-5 years from the Brazilian semi-arid regionSociodemographic risk factors of under-five stunting in Bangladesh: assessing the role of interactions using a machine learning methodPrevalence and determinants of the double burden of malnutrition with a focus on concurrent stunting and overweight/obesity in children and adolescentsIdentifying access barriers faced by rural and dispersed communities to better address their needs: implications and lessons learned for rural proofing for health in the Americas and beyondMalnutrition in all its forms and socio-economic disparities in children under 5 years of age and women of reproductive age in PeruDouble burden of maternal and child malnutrition and socioeconomic status in urban Sri LankaDeterminantes socioeconómicos del exceso de peso en niños preescolares y escolares colombianos. Encuesta Nacional de Situación Nutricional 2015Espacios de pobreza en la periferia urbana y suburbios interiores de la Ciudad de México: las desventajas acumuladasRepresentación geográfica de la malnutrición en niños y adolescentes de Medellín, Colombia</div>
                            <small style="color: var(--text-muted)">12715316.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Candidate stem cell isolation and transplantation in HexacoralliaInduced pluripotent stem cells, a giant leap for mankind therapeutic applicationsPeripheral Blood Stem Cells for Allogeneic Transplantation: A ReviewAlzheimer’s disease, dementia, and stem cell therapyStem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspectsStem Cells: Units of Development, Units of Regeneration, and Units in EvolutionTranslating Stem and Progenitor Cell Biology to the Clinic: Barriers and OpportunitiesStem cells are units of natural selection in a colonial ascidianA Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow CellsIntravenous Infusion of Bone Marrow in Patients Receiving Radiation and ChemotherapyIsolation of a candidate human hematopoietic stem-cell populationMouse Hematopoietic Stem CellsThe interstitial stem cells in Hydractinia and their role in regenerationIsolation of planarian X-ray-sensitive stem cells by fluorescence-activated cell sortingTotipotent migratory stem cells in a hydroidPlanarian stem cells specify fate yet retain potency during the cell cycleComplex mammalian-like haematopoietic system found in a colonial chordateClonogenic neoblasts are pluripotent adult stem cells that underlie planarian regenerationStem cell dynamics in Cnidaria: are there unifying principles?Cell proliferation and migration during early development of a symbiotic scleractinian coralCnidarian Cell Type Diversity and Regulation Revealed by Whole-Organism Single-Cell RNA-SeqSingle-cell transcriptomics identifies conserved regulators of neuroglandular lineagesAn adult stem-like cell population generates germline and neurons in the sea anemone Nematostella vectensisExperimental Tools to Study Regeneration in the Sea Anemone Nematostella vectensisGlobal warming and recurrent mass bleaching of coralsIntegrating physiology with remote sensing to advance the prediction of coral bleaching eventsPhylogenomic Analyses Support Traditional Relationships within CnidariaTATA Binding Protein (TBP) Promoter Drives Ubiquitous Expression of Marker Transgene in the Adult Sea Anemone Nematostella vectensisInsm1-expressing neurons and secretory cells develop from a common pool of progenitors in the sea anemone Nematostella vectensisSynergic coordination of stem cells is required to induce a regenerative response in anthozoan cnidariansNanos2 marks precursors of somatic lineages and is required for germline formation in the sea anemone Nematostella vectensisIdentification and In Vivo Characterization of NvFP-7R, a Developmentally Regulated Red Fluorescent Protein of Nematostella vectensisIsolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activityvasa and nanos expression patterns in a sea anemone and the evolution of bilaterian germ cell specification mechanismsPIWI-piRNA pathway-mediated transposable element repression in Hydra somatic stem cellsPIWI proteins and PIWI-interacting RNAs function in Hydra somatic stem cellsCharacterization of the piRNA pathway during development of the sea anemone Nematostella vectensisAnalysis of Soluble Protein Contents from the Nematocysts of a Model Sea Anemone Sheds Light on Venom EvolutionDynamics of venom composition across a complex life cycleEvolution of complex structures: minicollagens shape the cnidarian nematocystMorphological and Molecular Analysis of the Nematostella vectensis CnidomUnexpected complexity of the Wnt gene family in a sea anemoneAnatomy and development of the nervous system of Nematostella vectensis, an anthozoan cnidarianThe ancestral role of Brachyury: Expression of NemBra1 in the basal cnidarian Nematostella vectensis (Anthozoa)The Bilaterian Head Patterning Gene six3/6 Controls Aboral Domain Development in a CnidarianDevelopment of the aboral domain in Nematostella requires β-catenin and the opposing activities of Six3/6 and Frizzled5/8Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantationGraded FGF activity patterns distinct cell types within the apical sensory organ of the sea anemone Nematostella vectensisAssessment of Aldehyde Dehydrogenase in Viable CellsTransdifferentiation of pigmented multipotent epithelium during morphallactic development of budding tunicatesRetinoic Acid can Induce a Secondary Axis in Developing Buds of a Colonial Ascidian, Polyandrocarpa misakiensisCellular and molecular characterization of transdifferentiation in the process of morphallaxis of budding tunicatesMultiQC: summarize analysis results for multiple tools and samples in a single reportTrimmomatic: a flexible trimmer for Illumina sequence dataCoral cell separation and isolation by fluorescence-activated cell sorting (FACS)STAR: ultrafast universal RNA-seq alignerfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresModerated estimation of fold change and dispersion for RNA-seq data with DESeq2EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labelingggplot2">Candidate stem cell isolation and transplantation in HexacoralliaInduced pluripotent stem cells, a giant leap for mankind therapeutic applicationsPeripheral Blood Stem Cells for Allogeneic Transplantation: A ReviewAlzheimer’s disease, dementia, and stem cell therapyStem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspectsStem Cells: Units of Development, Units of Regeneration, and Units in EvolutionTranslating Stem and Progenitor Cell Biology to the Clinic: Barriers and OpportunitiesStem cells are units of natural selection in a colonial ascidianA Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow CellsIntravenous Infusion of Bone Marrow in Patients Receiving Radiation and ChemotherapyIsolation of a candidate human hematopoietic stem-cell populationMouse Hematopoietic Stem CellsThe interstitial stem cells in Hydractinia and their role in regenerationIsolation of planarian X-ray-sensitive stem cells by fluorescence-activated cell sortingTotipotent migratory stem cells in a hydroidPlanarian stem cells specify fate yet retain potency during the cell cycleComplex mammalian-like haematopoietic system found in a colonial chordateClonogenic neoblasts are pluripotent adult stem cells that underlie planarian regenerationStem cell dynamics in Cnidaria: are there unifying principles?Cell proliferation and migration during early development of a symbiotic scleractinian coralCnidarian Cell Type Diversity and Regulation Revealed by Whole-Organism Single-Cell RNA-SeqSingle-cell transcriptomics identifies conserved regulators of neuroglandular lineagesAn adult stem-like cell population generates germline and neurons in the sea anemone Nematostella vectensisExperimental Tools to Study Regeneration in the Sea Anemone Nematostella vectensisGlobal warming and recurrent mass bleaching of coralsIntegrating physiology with remote sensing to advance the prediction of coral bleaching eventsPhylogenomic Analyses Support Traditional Relationships within CnidariaTATA Binding Protein (TBP) Promoter Drives Ubiquitous Expression of Marker Transgene in the Adult Sea Anemone Nematostella vectensisInsm1-expressing neurons and secretory cells develop from a common pool of progenitors in the sea anemone Nematostella vectensisSynergic coordination of stem cells is required to induce a regenerative response in anthozoan cnidariansNanos2 marks precursors of somatic lineages and is required for germline formation in the sea anemone Nematostella vectensisIdentification and In Vivo Characterization of NvFP-7R, a Developmentally Regulated Red Fluorescent Protein of Nematostella vectensisIsolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activityvasa and nanos expression patterns in a sea anemone and the evolution of bilaterian germ cell specification mechanismsPIWI-piRNA pathway-mediated transposable element repression in Hydra somatic stem cellsPIWI proteins and PIWI-interacting RNAs function in Hydra somatic stem cellsCharacterization of the piRNA pathway during development of the sea anemone Nematostella vectensisAnalysis of Soluble Protein Contents from the Nematocysts of a Model Sea Anemone Sheds Light on Venom EvolutionDynamics of venom composition across a complex life cycleEvolution of complex structures: minicollagens shape the cnidarian nematocystMorphological and Molecular Analysis of the Nematostella vectensis CnidomUnexpected complexity of the Wnt gene family in a sea anemoneAnatomy and development of the nervous system of Nematostella vectensis, an anthozoan cnidarianThe ancestral role of Brachyury: Expression of NemBra1 in the basal cnidarian Nematostella vectensis (Anthozoa)The Bilaterian Head Patterning Gene six3/6 Controls Aboral Domain Development in a CnidarianDevelopment of the aboral domain in Nematostella requires β-catenin and the opposing activities of Six3/6 and Frizzled5/8Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantationGraded FGF activity patterns distinct cell types within the apical sensory organ of the sea anemone Nematostella vectensisAssessment of Aldehyde Dehydrogenase in Viable CellsTransdifferentiation of pigmented multipotent epithelium during morphallactic development of budding tunicatesRetinoic Acid can Induce a Secondary Axis in Developing Buds of a Colonial Ascidian, Polyandrocarpa misakiensisCellular and molecular characterization of transdifferentiation in the process of morphallaxis of budding tunicatesMultiQC: summarize analysis results for multiple tools and samples in a single reportTrimmomatic: a flexible trimmer for Illumina sequence dataCoral cell separation and isolation by fluorescence-activated cell sorting (FACS)STAR: ultrafast universal RNA-seq alignerfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresModerated estimation of fold change and dispersion for RNA-seq data with DESeq2EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labelingggplot2</div>
                            <small style="color: var(--text-muted)">12715556.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...2 fold change >1 and adjusted p\xa0<\xa00.05. PCA was computed on vst tran...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="High Prevalence of Psychological Comorbidities and Functional Neurological Symptoms in Women With Urinary RetentionDo we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017Fowler's syndrome—a cause of unexplained urinary retention in young women?Sacral neuromodulation for urinary retentionOpen-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome)Fowler's syndrome of urinary retention: a retrospective study of co-morbidityDepression, anxiety and the bladderThe presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retentionScreening for depression and anxiety in patients with storage or voiding dysfunction: a retrospective cohort study predicting outcome of sacral neuromodulationPsychological co-morbidities in young women presenting with chronic urinary retentionFunctional neurological disorder: new subtypes and shared mechanismsAn International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunctionInternational Continence Society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow studyAbnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retentionAbnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?The unstructured clinical interviewThe clinical interviewScreening for anxiety disorders with the GAD-7 and GAD- 2: a systematic review and diagnostic metaanalysisCase-finding instrument for depression. Two questions are as good as manySevere depression and anxiety in women with overactive bladderAn investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological modelAffective symptoms and the overactive bladder—a systematic reviewDoes depression screening in primary care improve mental health outcomes?Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunctionPrevalence of non-suicidal self-harm and service contact in England, 2000-14: repeated cross-sectional surveys of the general populationBorderline personality disorder: health service use and social functioning among a national household populationBorderline personality disorderUrinary retention in sexually abused womenLong-term outcomes of childhood sexual abuse: an umbrella reviewSystematic review exploring the relationship between sexual abuse and lower urinary tract symptomsPTSD correlates with somatization in sexually abused children: type of abuse moderates the effect of PTSD on somatizationInternational online survey of 1048 individuals with functional neurological disorderLower urinary tract dysfunction in patients with functional movement disordersAutonomic, endocrine, and inflammation profiles in functional neurological disorder: a systematic review and meta-analysisCentral control of micturition in women: brain-bladder pathways in continence and urgency urinary incontinencePsychological and psychiatric factors as predictors for success in sacral neuromodulation treatmentShould we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI-RS 2019?Psychological comorbidities and functional neurological disorders in women with idiopathic urinary retention: International Consultation on Incontinence Research Society (ICI-RS) 2019Urologic presentation and risk factors in pediatric functional neurological 1 symptom disorder: a case reportRecall bias: a proposal for assessment and control">High Prevalence of Psychological Comorbidities and Functional Neurological Symptoms in Women With Urinary RetentionDo we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017Fowler's syndrome—a cause of unexplained urinary retention in young women?Sacral neuromodulation for urinary retentionOpen-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome)Fowler's syndrome of urinary retention: a retrospective study of co-morbidityDepression, anxiety and the bladderThe presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retentionScreening for depression and anxiety in patients with storage or voiding dysfunction: a retrospective cohort study predicting outcome of sacral neuromodulationPsychological co-morbidities in young women presenting with chronic urinary retentionFunctional neurological disorder: new subtypes and shared mechanismsAn International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunctionInternational Continence Society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow studyAbnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retentionAbnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?The unstructured clinical interviewThe clinical interviewScreening for anxiety disorders with the GAD-7 and GAD- 2: a systematic review and diagnostic metaanalysisCase-finding instrument for depression. Two questions are as good as manySevere depression and anxiety in women with overactive bladderAn investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological modelAffective symptoms and the overactive bladder—a systematic reviewDoes depression screening in primary care improve mental health outcomes?Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015Improvement in depression and health-related quality of life after sacral nerve stimulation therapy for treatment of voiding dysfunctionPrevalence of non-suicidal self-harm and service contact in England, 2000-14: repeated cross-sectional surveys of the general populationBorderline personality disorder: health service use and social functioning among a national household populationBorderline personality disorderUrinary retention in sexually abused womenLong-term outcomes of childhood sexual abuse: an umbrella reviewSystematic review exploring the relationship between sexual abuse and lower urinary tract symptomsPTSD correlates with somatization in sexually abused children: type of abuse moderates the effect of PTSD on somatizationInternational online survey of 1048 individuals with functional neurological disorderLower urinary tract dysfunction in patients with functional movement disordersAutonomic, endocrine, and inflammation profiles in functional neurological disorder: a systematic review and meta-analysisCentral control of micturition in women: brain-bladder pathways in continence and urgency urinary incontinencePsychological and psychiatric factors as predictors for success in sacral neuromodulation treatmentShould we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI-RS 2019?Psychological comorbidities and functional neurological disorders in women with idiopathic urinary retention: International Consultation on Incontinence Research Society (ICI-RS) 2019Urologic presentation and risk factors in pediatric functional neurological 1 symptom disorder: a case reportRecall bias: a proposal for assessment and control</div>
                            <small style="color: var(--text-muted)">12721647.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria TrialCurrent perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladderEditorial Comment.Editorial Comment.Microhematuria: AUA/SUFU guidelineComparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuriaDisparities in the diagnostic evaluation of microhematuria and implications for the detection of urologic malignancyQuality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic reviewEvaluation of the new American Urological Association guidelines risk classification for hematuriaA segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinomaUrinary analysis of FGFR3 and TERT gene mutations enhances performance of Cxbladder tests and improves patient risk stratificationA multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuriaReduction of pain during flexible cystoscopy: a systematic review and meta-analysisDiscomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopyLife cycle assessment of reusable and disposable cystoscopes: a path to greener urological proceduresPerformance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter studyAssessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopyCxbladder monitor testing to reduce cystoscopy frequency in patients with bladder cancerBudgetary impact of including the urinary genomic marker Cxbladder detect in the evaluation of microhematuria patients">A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria TrialCurrent perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladderEditorial Comment.Editorial Comment.Microhematuria: AUA/SUFU guidelineComparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuriaDisparities in the diagnostic evaluation of microhematuria and implications for the detection of urologic malignancyQuality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic reviewEvaluation of the new American Urological Association guidelines risk classification for hematuriaA segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinomaUrinary analysis of FGFR3 and TERT gene mutations enhances performance of Cxbladder tests and improves patient risk stratificationA multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuriaReduction of pain during flexible cystoscopy: a systematic review and meta-analysisDiscomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopyLife cycle assessment of reusable and disposable cystoscopes: a path to greener urological proceduresPerformance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter studyAssessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopyCxbladder monitor testing to reduce cystoscopy frequency in patients with bladder cancerBudgetary impact of including the urinary genomic marker Cxbladder detect in the evaluation of microhematuria patients</div>
                            <small style="color: var(--text-muted)">12721662.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...re based on the test of equal proportions (prop.test in R). Confidence...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Decoding the Knacks of Ellagitannin Lead Compounds to Treat Nonalcoholic Fatty Liver Disease using Computer-aided Drug DesigningThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review.Drug-induced fatty liver disease: An overview of pathogenesis and management.Global incidence and prevalence of nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: A systematic review and meta-analysis.Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.Non-alcoholic fatty liver disease: Growing burden, adverse outcomes and associations.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.NAFLD as a continuum: From obesity to metabolic syndrome and diabetes.NASH: The emerging most common form of chronic liver disease.Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.NAFLD and cardiovascular diseases: A clinical review.The utility of radiological imaging in nonalcoholic fatty liver disease.Recent insights into the pathogenesis of nonalcoholic fatty liver disease.Oxidative stress in non-alcoholic fatty liver disease. An updated mini review.Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice.An overview of the genetics, mechanisms and management of NAFLD and ALD.Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development.Health disparities in chronic liver disease.Steatohepatitis: A tale of two “hits”?Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.The strategies and techniques of drug discovery from natural products.Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.MicroRNAs as regulatory elements in immune system logic.NASH limits anti-tumour surveillance in immunotherapy-treated HCC.A-Jee, H.B.; Cukura, A.; Denny, P.; Dogan, T.; Ebenezer, T.G.; Fan, J.; Garmiri, P.; da Costa Gonzales, L.J.; Hatton-Ellis, E.; Hussein, A.; Ignatchenko, A.; Insana, G.; Ishtiaq, R.; Joshi, V.; Jyothi, D.; Kandasaamy, S.; Lock, A.; Luciani, A.; Lugaric, M.; Luo, J.; Lussi, Y.; MacDougall, A.; Madeira, F.; Mahmoudy, M.; Mishra, A.; Moulang, K.; Nightingale, A.; Pundir, S.; Qi, G.; Raj, S.; Raposo, P.; Rice, D.L.; Saidi, R.; Santos, R.; Speretta, E.; Stephenson, J.; Totoo, P.; Turner, E.; Tyagi, N.; Vasudev, P.; Warner, K.; Watkins, X.; Zaru, R.; Zellner, H.; Wu, C.H.; Arighi, C.N.; Arminski, L.; Chen, C.; Chen, Y.; Huang, H.; Laiho, K.; McGarvey, P.; Natale, D.A.; Ross, K.; Vinayaka, C.R.; Wang, Q.; Wang, Y. Annotation of biologically relevant ligands in UniProtKB using ChEBI.The EMBL Nucleotide Sequence Database.The Protein Data Bank.Protein variety and functional diversity: Swiss-Prot annotation in its biological context.Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.message: "SQLSTATE[HY000] [2002] php_network_getaddresses: getaddrinfo failed: Temporary failure in name resolution (SQL: select * from `users`...)".Open Babel: An open chemical toolbox.High-quality and universal empirical atomic charges for chemoinformatics applications.AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.Lead- and drug-like compounds: the rule-of-five revolution.The performance of several docking programs at reproducing protein–macrolide-like crystal structures.Molecular docking studies of a cyclic octapeptide-cyclosaplin from Sandalwood.In silico strategies to support fragment-to-lead optimization in drug discovery.A critical assessment of predicted interaction.Drug design by pharmacophore and virtual screening approach.Protein interface pharmacophore mapping tools for small molecule protein: protein interaction inhibitor discovery.LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions.LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.The burden of nonalcoholic fatty liver disease in Asia, Middle East and North Africa: Data from Global Burden of Disease 2009-2019.Synthesis, spectroscopic investigation, molecular docking, ADME/T toxicity predictions, and DFT study of two trendy ortho vanillin-based scaffolds.ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties.admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties.NCBI Taxonomy: A comprehensive update on curation, resources and tools.Molecular dynamics simulations in drug discovery and pharmaceutical development.Molecular dynamics simulations and drug discovery.Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: A machine learning-based solution.Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.The Bio3D packages for structural bioinformatics.On the uses of PCA to characterise molecular dynamics simulations of biological macromolecules: Basics and tips for an effective use.Therapies for non-alcoholic fatty liver disease: A 2022 update.Nonalcoholic fatty liver disease in severely obese subjects.Key topics in molecular docking for drug design.Predicting drug metabolism: Experiment and/or computation?Non-alcoholic fatty liver disease: A practical approach to diagnosis and staging.Medical nutrition therapy in non-alcoholic fatty liver disease-A review of literature.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Molecular docking: A powerful approach for structure-based drug discovery.A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs.LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery.Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management.The prebiotic potential of geraniin and geraniin-enriched extract against high-fat-diet-induced metabolic syndrome in sprague dawley rats.Evidence for health properties of pomegranate juices and extracts beyond nutrition: A critical systematic review of human studies.Phenolic composition and antioxidant activity of red, rosé and white wines originating from Romanian grape cultivars.Nonalcoholic fatty liver disease—A concise review of noninvasive tests and biomarkers.Nonalcoholic fatty liver disease: An emerging modern-day risk factor for cardiovascular disease.">Decoding the Knacks of Ellagitannin Lead Compounds to Treat Nonalcoholic Fatty Liver Disease using Computer-aided Drug DesigningThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review.Drug-induced fatty liver disease: An overview of pathogenesis and management.Global incidence and prevalence of nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: A systematic review and meta-analysis.Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.Non-alcoholic fatty liver disease: Growing burden, adverse outcomes and associations.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.NAFLD as a continuum: From obesity to metabolic syndrome and diabetes.NASH: The emerging most common form of chronic liver disease.Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.NAFLD and cardiovascular diseases: A clinical review.The utility of radiological imaging in nonalcoholic fatty liver disease.Recent insights into the pathogenesis of nonalcoholic fatty liver disease.Oxidative stress in non-alcoholic fatty liver disease. An updated mini review.Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice.An overview of the genetics, mechanisms and management of NAFLD and ALD.Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development.Health disparities in chronic liver disease.Steatohepatitis: A tale of two “hits”?Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.The strategies and techniques of drug discovery from natural products.Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.MicroRNAs as regulatory elements in immune system logic.NASH limits anti-tumour surveillance in immunotherapy-treated HCC.A-Jee, H.B.; Cukura, A.; Denny, P.; Dogan, T.; Ebenezer, T.G.; Fan, J.; Garmiri, P.; da Costa Gonzales, L.J.; Hatton-Ellis, E.; Hussein, A.; Ignatchenko, A.; Insana, G.; Ishtiaq, R.; Joshi, V.; Jyothi, D.; Kandasaamy, S.; Lock, A.; Luciani, A.; Lugaric, M.; Luo, J.; Lussi, Y.; MacDougall, A.; Madeira, F.; Mahmoudy, M.; Mishra, A.; Moulang, K.; Nightingale, A.; Pundir, S.; Qi, G.; Raj, S.; Raposo, P.; Rice, D.L.; Saidi, R.; Santos, R.; Speretta, E.; Stephenson, J.; Totoo, P.; Turner, E.; Tyagi, N.; Vasudev, P.; Warner, K.; Watkins, X.; Zaru, R.; Zellner, H.; Wu, C.H.; Arighi, C.N.; Arminski, L.; Chen, C.; Chen, Y.; Huang, H.; Laiho, K.; McGarvey, P.; Natale, D.A.; Ross, K.; Vinayaka, C.R.; Wang, Q.; Wang, Y. Annotation of biologically relevant ligands in UniProtKB using ChEBI.The EMBL Nucleotide Sequence Database.The Protein Data Bank.Protein variety and functional diversity: Swiss-Prot annotation in its biological context.Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.message: "SQLSTATE[HY000] [2002] php_network_getaddresses: getaddrinfo failed: Temporary failure in name resolution (SQL: select * from `users`...)".Open Babel: An open chemical toolbox.High-quality and universal empirical atomic charges for chemoinformatics applications.AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.Lead- and drug-like compounds: the rule-of-five revolution.The performance of several docking programs at reproducing protein–macrolide-like crystal structures.Molecular docking studies of a cyclic octapeptide-cyclosaplin from Sandalwood.In silico strategies to support fragment-to-lead optimization in drug discovery.A critical assessment of predicted interaction.Drug design by pharmacophore and virtual screening approach.Protein interface pharmacophore mapping tools for small molecule protein: protein interaction inhibitor discovery.LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions.LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.The burden of nonalcoholic fatty liver disease in Asia, Middle East and North Africa: Data from Global Burden of Disease 2009-2019.Synthesis, spectroscopic investigation, molecular docking, ADME/T toxicity predictions, and DFT study of two trendy ortho vanillin-based scaffolds.ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties.admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties.NCBI Taxonomy: A comprehensive update on curation, resources and tools.Molecular dynamics simulations in drug discovery and pharmaceutical development.Molecular dynamics simulations and drug discovery.Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: A machine learning-based solution.Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.The Bio3D packages for structural bioinformatics.On the uses of PCA to characterise molecular dynamics simulations of biological macromolecules: Basics and tips for an effective use.Therapies for non-alcoholic fatty liver disease: A 2022 update.Nonalcoholic fatty liver disease in severely obese subjects.Key topics in molecular docking for drug design.Predicting drug metabolism: Experiment and/or computation?Non-alcoholic fatty liver disease: A practical approach to diagnosis and staging.Medical nutrition therapy in non-alcoholic fatty liver disease-A review of literature.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Molecular docking: A powerful approach for structure-based drug discovery.A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs.LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery.Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management.The prebiotic potential of geraniin and geraniin-enriched extract against high-fat-diet-induced metabolic syndrome in sprague dawley rats.Evidence for health properties of pomegranate juices and extracts beyond nutrition: A critical systematic review of human studies.Phenolic composition and antioxidant activity of red, rosé and white wines originating from Romanian grape cultivars.Nonalcoholic fatty liver disease—A concise review of noninvasive tests and biomarkers.Nonalcoholic fatty liver disease: An emerging modern-day risk factor for cardiovascular disease.</div>
                            <small style="color: var(--text-muted)">12728524.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...ression of PLPL3 genes with a p\u2009<\u20090.01 was considered significant. T...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal  polysaccharide conjugate vaccineA phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal  polysaccharide conjugate vaccineInvasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in AfricaBacteremia among children admitted to a rural hospital in KenyaEpidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The GambiaCommunity-acquired bacteremia among children admitted to a rural hospital in MozambiqueInvasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine DevelopmentThe global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protectionThe global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017Introduction of Typhoid Conjugate Vaccines in Africa and AsiaDevelopment of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan AfricaSalmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidisImmunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate FormulationTyphoid conjugate vaccine gets WHO prequalificationGavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country IntroductionA scalable method for biochemical purification of Salmonella flagellinImmunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult miceEngineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strainsNeutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharideCross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypesThe global burden and epidemiology of invasive non-typhoidal Salmonella infectionsInvasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosisGenetic changes associated with the temporal shift in invasive non-typhoidal Salmonella serovars in Bamako MaliEpidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotypeSupporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina FasoDevelopment of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseSafety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adultsSafety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adultsVi-specific serological correlates of protection for typhoid feverDifferentiation and homing of IgA-secreting cellsGut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in HumansCritical role for beta7 integrins in formation of the gut-associated lymphoid tissueFunctional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella">A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal  polysaccharide conjugate vaccineA phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal  polysaccharide conjugate vaccineInvasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in AfricaBacteremia among children admitted to a rural hospital in KenyaEpidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The GambiaCommunity-acquired bacteremia among children admitted to a rural hospital in MozambiqueInvasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine DevelopmentThe global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protectionThe global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017Introduction of Typhoid Conjugate Vaccines in Africa and AsiaDevelopment of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan AfricaSalmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidisImmunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate FormulationTyphoid conjugate vaccine gets WHO prequalificationGavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country IntroductionA scalable method for biochemical purification of Salmonella flagellinImmunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult miceEngineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strainsNeutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharideCross-reactivity between six Enterobacteriaceae complete lipopolysaccharide core chemotypesThe global burden and epidemiology of invasive non-typhoidal Salmonella infectionsInvasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosisGenetic changes associated with the temporal shift in invasive non-typhoidal Salmonella serovars in Bamako MaliEpidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotypeSupporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina FasoDevelopment of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune responseSafety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adultsSafety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adultsVi-specific serological correlates of protection for typhoid feverDifferentiation and homing of IgA-secreting cellsGut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in HumansCritical role for beta7 integrins in formation of the gut-associated lymphoid tissueFunctional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella</div>
                            <small style="color: var(--text-muted)">7618460.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-high">8.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 85.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...8.1) or using FlowJo V10.7.1. No formal power calculations or hypothesis testing was performed. The sample siz...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Environmental fungi target thiol homeostasis to compete with Environmental sphagnum-associated fungi target thiol homeostasis to compete with Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.Tuberculosis treatment-shortening.Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamideHit Generation in TB Drug Discovery: From Genome to GranulomaA Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis TreatmentIn vitro drug discovery models for Mycobacterium tuberculosis relevant for host infectionEnvironmental mycobacteria from alpine and subalpine habitatsThe Sphagnum microbiome supports bog ecosystem functioning under extreme conditionsDiversity and Distribution Characteristics of Soil Microbes across Forest-Peatland Ecotones in the Permafrost Regions.Leprosy in Norway. An epidemiological study based on a national patient registry.Isolation of non-cultivable acid-fast bacilli in sphagnum and moss vegetation by foot pad technique in mice.The Sphagnum microbiome: new insights from an ancient plant lineageSubstrate-induced growth and isolation of Acidobacteria from acidic Sphagnum peat.Development and optimization of chromosomally-integrated fluorescent Mycobacterium tuberculosis reporter constructsReengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infectionITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biasesNanopore sequencing data analysis: state of the art, applications and challengesAssembly of long error-prone reads using de Bruijn graphsAn Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement.QUAST: quality assessment tool for genome assembliesNextgenusfs/Funannotate: Funannotate v1. 5.1.The nf-core framework for community-curated bioinformatics pipelinesSTAR: ultrafast universal RNA-seq alignerTwelve years of SAMtools and BCFtools.RSeQC: quality control of RNA-seq experimentsQualimap 2: advanced multi-sample quality control for high-throughput sequencing datafeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresModerated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatusMEGA X: molecular evolutionary genetics analysis across computing platformsantiSMASH 7.0: New and improved predictions for detection, regulation, chemical structures and visualisationRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomelimma powers differential expression analyses for RNA-sequencing and microarray studiesDashboard-style interactive plots for RNA-seq analysis are R Markdown ready with Glimma 2.0.Reactivity-based screening for natural product discoveryTargeting Mycobacterium tuberculosis sensitivity to thiol stress at acidic pH kills the bacterium and potentiates antibioticsEnergy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis’Touchdown’PCR to circumvent spurious priming during gene amplification.A one pot, one step, precision cloning method with high throughput capability.CVTree: A Parallel Alignment-free Phylogeny and Taxonomy Tool Based on Composition Vectors of Genomes.antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisationSequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from Penicillium expansumMultiQC: summarize analysis results for multiple tools and samples in a single reportBioinformatical analysis of the sequences, structures and functions of fungal polyketide synthase product template domains.Genome, Transcriptome, and Functional Analyses of Penicillium expansum Provide New Insights Into Secondary Metabolism and Pathogenicity.Analysis of the Sequences, Structures, and Functions of Product-Releasing Enzyme Domains in Fungal Polyketide Synthases.Characterisation of the biosynthetic pathway to agnestins A and B reveals the reductive route to chrysophanol in fungi.Genetic Characterization of Neosartorin Biosynthesis Provides Insight into Heterodimeric Natural Product GenerationStructures of a New Dihydroxanthone Derivative, Nidulalin-a, and a New Benzophenone Derivative, Nidulalin-B, from Emericella NidulansTargeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates AntibioticsDeciphering the Proteomic Landscape of Mycobacterium tuberculosis in Response to Acid and Oxidative Stresses.The sigma factors of Mycobacterium tuberculosis: regulation of the regulatorsThe alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosisThe response of mycobacterium tuberculosis to reactive oxygen and nitrogen speciesRole of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression.AC2P20 selectively kills at acidic pH by depleting free thiols.SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expressionThe Oxidative Stress Network of Mycobacterium tuberculosis Reveals Coordination between Radical Detoxification SystemsReengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infectionAuranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasisAuranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in[11] Diamide: An oxidant probe for thiols.Thiol specific oxidative stress response in MycobacteriaMycothiol: synthesis, biosynthesis and biological functions of the major low molecular weight thiol in actinomycetesA novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidaseComprehensive Definition of the SigH Regulon of Mycobacterium tuberculosis Reveals Transcriptional Control of Diverse Stress ResponsesPestalone, a new antibiotic produced by a marine fungus in response to bacterial challengeActivation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteriaGenetic Regulation of Mycotoxin Biosynthesis.F390B and C, new antitumor dihydroxanthone derivatives isolated from Penicillium spSyntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase IIInhibition of DNA topoisomerases by nidulalin A derivativesNine constituents including six xanthone-related compounds isolated from two ascomycetes, Gelasinospora santi-florii and Emericella quadrilineata, found in a screening study focused on immunomodulatory activityThe first total synthesis of nidulalin A, a dihydroxanthone possessing multiple bioactivitiesAsymmetric Synthesis of Nidulalin A and Nidulaxanthone A: Selective Carbonyl Desaturation Using an Oxoammonium SaltTriple-Dearomative Photocycloaddition: A Strategy to Construct Caged Molecular FrameworksGenome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosisAC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiolsTargeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics6,11-Dioxobenzo[f]pyrido[1,2-a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor.Compounds with Potential Activity against Mycobacterium tuberculosisDecision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2">Environmental fungi target thiol homeostasis to compete with Environmental sphagnum-associated fungi target thiol homeostasis to compete with Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.Tuberculosis treatment-shortening.Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamideHit Generation in TB Drug Discovery: From Genome to GranulomaA Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis TreatmentIn vitro drug discovery models for Mycobacterium tuberculosis relevant for host infectionEnvironmental mycobacteria from alpine and subalpine habitatsThe Sphagnum microbiome supports bog ecosystem functioning under extreme conditionsDiversity and Distribution Characteristics of Soil Microbes across Forest-Peatland Ecotones in the Permafrost Regions.Leprosy in Norway. An epidemiological study based on a national patient registry.Isolation of non-cultivable acid-fast bacilli in sphagnum and moss vegetation by foot pad technique in mice.The Sphagnum microbiome: new insights from an ancient plant lineageSubstrate-induced growth and isolation of Acidobacteria from acidic Sphagnum peat.Development and optimization of chromosomally-integrated fluorescent Mycobacterium tuberculosis reporter constructsReengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infectionITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biasesNanopore sequencing data analysis: state of the art, applications and challengesAssembly of long error-prone reads using de Bruijn graphsAn Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement.QUAST: quality assessment tool for genome assembliesNextgenusfs/Funannotate: Funannotate v1. 5.1.The nf-core framework for community-curated bioinformatics pipelinesSTAR: ultrafast universal RNA-seq alignerTwelve years of SAMtools and BCFtools.RSeQC: quality control of RNA-seq experimentsQualimap 2: advanced multi-sample quality control for high-throughput sequencing datafeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresModerated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatusMEGA X: molecular evolutionary genetics analysis across computing platformsantiSMASH 7.0: New and improved predictions for detection, regulation, chemical structures and visualisationRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomelimma powers differential expression analyses for RNA-sequencing and microarray studiesDashboard-style interactive plots for RNA-seq analysis are R Markdown ready with Glimma 2.0.Reactivity-based screening for natural product discoveryTargeting Mycobacterium tuberculosis sensitivity to thiol stress at acidic pH kills the bacterium and potentiates antibioticsEnergy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis’Touchdown’PCR to circumvent spurious priming during gene amplification.A one pot, one step, precision cloning method with high throughput capability.CVTree: A Parallel Alignment-free Phylogeny and Taxonomy Tool Based on Composition Vectors of Genomes.antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisationSequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from Penicillium expansumMultiQC: summarize analysis results for multiple tools and samples in a single reportBioinformatical analysis of the sequences, structures and functions of fungal polyketide synthase product template domains.Genome, Transcriptome, and Functional Analyses of Penicillium expansum Provide New Insights Into Secondary Metabolism and Pathogenicity.Analysis of the Sequences, Structures, and Functions of Product-Releasing Enzyme Domains in Fungal Polyketide Synthases.Characterisation of the biosynthetic pathway to agnestins A and B reveals the reductive route to chrysophanol in fungi.Genetic Characterization of Neosartorin Biosynthesis Provides Insight into Heterodimeric Natural Product GenerationStructures of a New Dihydroxanthone Derivative, Nidulalin-a, and a New Benzophenone Derivative, Nidulalin-B, from Emericella NidulansTargeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates AntibioticsDeciphering the Proteomic Landscape of Mycobacterium tuberculosis in Response to Acid and Oxidative Stresses.The sigma factors of Mycobacterium tuberculosis: regulation of the regulatorsThe alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosisThe response of mycobacterium tuberculosis to reactive oxygen and nitrogen speciesRole of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression.AC2P20 selectively kills at acidic pH by depleting free thiols.SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expressionThe Oxidative Stress Network of Mycobacterium tuberculosis Reveals Coordination between Radical Detoxification SystemsReengineering redox sensitive GFP to measure mycothiol redox potential of Mycobacterium tuberculosis during infectionAuranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasisAuranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in[11] Diamide: An oxidant probe for thiols.Thiol specific oxidative stress response in MycobacteriaMycothiol: synthesis, biosynthesis and biological functions of the major low molecular weight thiol in actinomycetesA novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidaseComprehensive Definition of the SigH Regulon of Mycobacterium tuberculosis Reveals Transcriptional Control of Diverse Stress ResponsesPestalone, a new antibiotic produced by a marine fungus in response to bacterial challengeActivation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteriaGenetic Regulation of Mycotoxin Biosynthesis.F390B and C, new antitumor dihydroxanthone derivatives isolated from Penicillium spSyntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase IIInhibition of DNA topoisomerases by nidulalin A derivativesNine constituents including six xanthone-related compounds isolated from two ascomycetes, Gelasinospora santi-florii and Emericella quadrilineata, found in a screening study focused on immunomodulatory activityThe first total synthesis of nidulalin A, a dihydroxanthone possessing multiple bioactivitiesAsymmetric Synthesis of Nidulalin A and Nidulaxanthone A: Selective Carbonyl Desaturation Using an Oxoammonium SaltTriple-Dearomative Photocycloaddition: A Strategy to Construct Caged Molecular FrameworksGenome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosisAC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiolsTargeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics6,11-Dioxobenzo[f]pyrido[1,2-a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-Sulfur Protein Rv0338c (IspQ), A Putative Redox Sensor.Compounds with Potential Activity against Mycobacterium tuberculosisDecision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2</div>
                            <small style="color: var(--text-muted)">11614215.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...embly were transformed into 5-alpha competent E. coli cells (NEB)...'}</li><li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': 'No direct quote found.'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathwayBiotin, a universal and essential cofactor: Synthesis, ligation and regulationImpairment of gut microbial biotin metabolism and host biotin status in severe obesity: Effect of biotin and prebiotic supplementation on improved metabolismBiotin controls intestinal stem cell mitosis and host-microbiome interactionsRelevance of biotin deficiency in patients with inflammatory bowel disease and utility of serum 3-hydroxyisovaleryl carnitine as a practical everyday markerBiotin synthesis begins by hijacking the fatty acid synthetic pathwayStructure of the enzyme-acyl carrier protein (ACP) substrate gatekeeper complex required for biotin synthesisThe BioC O-methyltransferase catalyzes methyl esterification of malonyl-acyl carrier protein, an essential step in biotin synthesisThe pimeloyl-CoA synthetase BioW defines a new fold for adenylate-forming enzymesUsing the pimeloyl-CoA synthetase adenylation fold to synthesize fatty acid thioestersStructural insights from a P450 carrier protein complex reveal how specificity is achieved in the P450(BioI) ACP complexBiochemical and structural characterization of the BioZ enzyme engaged in bacterial biotin synthesis pathwayα-Proteobacteria synthesize biotin precursor pimeloyl-ACP using BioZ 3-ketoacyl-ACP synthase and lysine catabolismA canonical biotin synthesis enzyme, 8-amino-7-oxononanoate synthase (BioF), utilizes different acyl chain donors in  and Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug targetHarnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genesGlobal burden of bacterial antimicrobial resistance in 2019: A systematic analysisHeterogeneity and clinical genomics of -producing, carbapenem-resistant Intestinal dysbiosis and biotin peprivation induce alopecia through overgrowth of  in miceLongitudinal and comparative analysis of gut microbiota of Tunisian newborns according to delivery modeTargeting protein biotinylation enhances tuberculosis chemotherapyThe biotin biosynthetic pathway in  is a validated target for the development of antibacterial agentsMimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogensThe opportunistic pathogen  exploits bacterial biotin synthesis pathway to benefit its infectivityThe classical, yet controversial, first enzyme of lipid synthesis:  acetyl-CoA carboxylaseBiotin-dependent cell envelope remodelling is required for  survival in lung infectionInhibiting fatty acid synthesis overcomes colistin resistanceExpression and activity of the BioH esterase of biotin synthesis is independent of genome contextProfligate biotin synthesis in α-proteobacteria – A developing or degenerating regulatory system? BioQ defines a new regulatory network for biotin metabolismCrystal structure and acetylation of BioQ suggests a novel regulatory switch for biotin biosynthesis in Production of odd-carbon dicarboxylic acids in  using an engineered biotin-fatty acid biosynthetic pathwayA highly efficient CRISPR-Cas9-based genome engineering platform in  to understand the HO-sensing mechanism of OxyRMutants of  with temperature-sensitive malonyl coenzyme A-acyl carrier protein transacylaseDali server: Structural unification of protein familiesDeletion and complementation analysis of biotin gene cluster of Location of promoter and operator sites in the biotin gene cluster of Sinefungin, a potent inhibitor or S-adenosylmethionine: Protein O-methyltransferaseMolecular basis of BioJ, a unique gatekeeper in bacterial biotin synthesisMapping the active site of  malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallographyThe  malonyl-CoA:acyl carrier protein transacylase at 1.5-A resolution. Crystal structure of a fatty acid synthase componentColistin resistance in : Molecular mechanisms and epidemiologyGenetic and biochemical mechanisms for bacterial lipid A modifiers associated with polymyxin resistanceMechanistic insights into transferable polymyxin resistance among gut bacteriaAn evolutionarily conserved mechanism for intrinsic and transferable polymyxin resistanceMetabolic suppression identifies new antibacterial inhibitors under nutrient limitationDiversified -harbouring plasmid reservoirs confer resistance to colistin in human gut microbiotaDissemination and mechanism for the MCR-1 colistin resistanceIdentification of a novel plasmid carrying  in an  strain in ChinaAction and mechanism of the colistin resistance enzyme MCR-4Definition of a family of nonmobile colistin resistance (NMCR-1) determinants suggests aquatic reservoirs for MCR-4Sporadic dissemination of -ST11  isolates in ChinaCharacterization of NMCR-2, a new non-mobile colistin resistance enzyme: Implications for an MCR-8 ancestorChasing the landscape for intrahospital transmission and evolution of hypervirulent carbapenem-resistant Invasive  syndrome in North AmericaIncreasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous)  isolates in ChinaHypervirulence and hypermucoviscosity: Two different but complementary  spp. phenotypes?Clinical and microbiological characteristics of  liver abscess in East ChinaSequencing and analysis of the large virulence plasmid pLVPK of  CG43Transmission of pLVPK-like virulence plasmid in  mediated by an Incl1 conjugative helper plasmidCorrelation between  carrying pLVPK-derived loci and abscess formationRmpA regulation of capsular polysaccharide biosynthesis in  CG43A  virulence factor catalyses an essential reaction of biotin synthesisEvaluating the sensitivity of  to biotin deprivation using regulated gene expressionInhibition of  transaminase BioA by aryl hydrazines and hydrazidesClosing in on complete pathways of biotin biosynthesisSynthesis of the α,ω-dicarboxylic acid precursor of biotin by the canonical fatty acid biosynthetic pathwaySinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2′-)-methyltransferase, and viral multiplicationSinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits  biofilm growthSinefungin-PLGA nanoparticles: Drug loading, characterization, in vitro drug release and in vivo studiesTransferability of MCR-1/2 polymyxin resistance: Complex dissemination and genetic mechanismExpanding landscapes of the diversified -bearing plasmid reservoirsGenetic determinants of intrinsic colistin tolerance in A. baumanniiLink between intraphagosomal biotin and rapid phagosomal escape in A new member of the  regulon: Transcriptional regulation of  ()A nucleosidase required for in vivo function of the S-adenosyl-L-methionine radical enzyme, biotin synthaseComplete genome sequence of  strain ATCC 43816Genome organization is not conserved between  and Tandem SUMO fusion vectors for improving soluble protein expression and purificationConstruction of versatile low-copy-number vectors for cloning, sequencing and gene expression in The acyl carrier proteins of lipid synthesis are busy having other affairsAcyl carrier protein phosphodiesterase (AcpH) of  is a non-canonical member of the HD phosphatase/phosphodiesterase familyCharacterization of Sfp, a  phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetasesCloning and expression of  5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase: Identification of the  gene productOf its five acyl carrier proteins, only AcpP1 functions in  fatty acid synthesisIdentification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Yeast Ulp1, an Smt3-specific protease, associates with nucleoporinsUlp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeastPromiscuous protein biotinylation by  biotin protein ligasePhaser.MRage: Automated molecular replacementA graphical user interface to the CCP4 program suiteHighly accurate protein structure prediction with AlphaFoldCoot: Model-building tools for molecular graphicsFunctional replacement of the BioC and BioH proteins of  biotin precursor biosynthesis by  novel proteinsMUSCLE: Multiple sequence alignment with high accuracy and high throughputModelFinder: Fast model selection for accurate phylogenetic estimatesIQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogeniesInteractive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotationIsolation and characterization of : A gene that functions in the production of the lipopeptide biosurfactant, surfactin, in Bacillus subtilis">A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathwayBiotin, a universal and essential cofactor: Synthesis, ligation and regulationImpairment of gut microbial biotin metabolism and host biotin status in severe obesity: Effect of biotin and prebiotic supplementation on improved metabolismBiotin controls intestinal stem cell mitosis and host-microbiome interactionsRelevance of biotin deficiency in patients with inflammatory bowel disease and utility of serum 3-hydroxyisovaleryl carnitine as a practical everyday markerBiotin synthesis begins by hijacking the fatty acid synthetic pathwayStructure of the enzyme-acyl carrier protein (ACP) substrate gatekeeper complex required for biotin synthesisThe BioC O-methyltransferase catalyzes methyl esterification of malonyl-acyl carrier protein, an essential step in biotin synthesisThe pimeloyl-CoA synthetase BioW defines a new fold for adenylate-forming enzymesUsing the pimeloyl-CoA synthetase adenylation fold to synthesize fatty acid thioestersStructural insights from a P450 carrier protein complex reveal how specificity is achieved in the P450(BioI) ACP complexBiochemical and structural characterization of the BioZ enzyme engaged in bacterial biotin synthesis pathwayα-Proteobacteria synthesize biotin precursor pimeloyl-ACP using BioZ 3-ketoacyl-ACP synthase and lysine catabolismA canonical biotin synthesis enzyme, 8-amino-7-oxononanoate synthase (BioF), utilizes different acyl chain donors in  and Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug targetHarnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genesGlobal burden of bacterial antimicrobial resistance in 2019: A systematic analysisHeterogeneity and clinical genomics of -producing, carbapenem-resistant Intestinal dysbiosis and biotin peprivation induce alopecia through overgrowth of  in miceLongitudinal and comparative analysis of gut microbiota of Tunisian newborns according to delivery modeTargeting protein biotinylation enhances tuberculosis chemotherapyThe biotin biosynthetic pathway in  is a validated target for the development of antibacterial agentsMimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogensThe opportunistic pathogen  exploits bacterial biotin synthesis pathway to benefit its infectivityThe classical, yet controversial, first enzyme of lipid synthesis:  acetyl-CoA carboxylaseBiotin-dependent cell envelope remodelling is required for  survival in lung infectionInhibiting fatty acid synthesis overcomes colistin resistanceExpression and activity of the BioH esterase of biotin synthesis is independent of genome contextProfligate biotin synthesis in α-proteobacteria – A developing or degenerating regulatory system? BioQ defines a new regulatory network for biotin metabolismCrystal structure and acetylation of BioQ suggests a novel regulatory switch for biotin biosynthesis in Production of odd-carbon dicarboxylic acids in  using an engineered biotin-fatty acid biosynthetic pathwayA highly efficient CRISPR-Cas9-based genome engineering platform in  to understand the HO-sensing mechanism of OxyRMutants of  with temperature-sensitive malonyl coenzyme A-acyl carrier protein transacylaseDali server: Structural unification of protein familiesDeletion and complementation analysis of biotin gene cluster of Location of promoter and operator sites in the biotin gene cluster of Sinefungin, a potent inhibitor or S-adenosylmethionine: Protein O-methyltransferaseMolecular basis of BioJ, a unique gatekeeper in bacterial biotin synthesisMapping the active site of  malonyl-CoA-acyl carrier protein transacylase (FabD) by protein crystallographyThe  malonyl-CoA:acyl carrier protein transacylase at 1.5-A resolution. Crystal structure of a fatty acid synthase componentColistin resistance in : Molecular mechanisms and epidemiologyGenetic and biochemical mechanisms for bacterial lipid A modifiers associated with polymyxin resistanceMechanistic insights into transferable polymyxin resistance among gut bacteriaAn evolutionarily conserved mechanism for intrinsic and transferable polymyxin resistanceMetabolic suppression identifies new antibacterial inhibitors under nutrient limitationDiversified -harbouring plasmid reservoirs confer resistance to colistin in human gut microbiotaDissemination and mechanism for the MCR-1 colistin resistanceIdentification of a novel plasmid carrying  in an  strain in ChinaAction and mechanism of the colistin resistance enzyme MCR-4Definition of a family of nonmobile colistin resistance (NMCR-1) determinants suggests aquatic reservoirs for MCR-4Sporadic dissemination of -ST11  isolates in ChinaCharacterization of NMCR-2, a new non-mobile colistin resistance enzyme: Implications for an MCR-8 ancestorChasing the landscape for intrahospital transmission and evolution of hypervirulent carbapenem-resistant Invasive  syndrome in North AmericaIncreasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous)  isolates in ChinaHypervirulence and hypermucoviscosity: Two different but complementary  spp. phenotypes?Clinical and microbiological characteristics of  liver abscess in East ChinaSequencing and analysis of the large virulence plasmid pLVPK of  CG43Transmission of pLVPK-like virulence plasmid in  mediated by an Incl1 conjugative helper plasmidCorrelation between  carrying pLVPK-derived loci and abscess formationRmpA regulation of capsular polysaccharide biosynthesis in  CG43A  virulence factor catalyses an essential reaction of biotin synthesisEvaluating the sensitivity of  to biotin deprivation using regulated gene expressionInhibition of  transaminase BioA by aryl hydrazines and hydrazidesClosing in on complete pathways of biotin biosynthesisSynthesis of the α,ω-dicarboxylic acid precursor of biotin by the canonical fatty acid biosynthetic pathwaySinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2′-)-methyltransferase, and viral multiplicationSinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits  biofilm growthSinefungin-PLGA nanoparticles: Drug loading, characterization, in vitro drug release and in vivo studiesTransferability of MCR-1/2 polymyxin resistance: Complex dissemination and genetic mechanismExpanding landscapes of the diversified -bearing plasmid reservoirsGenetic determinants of intrinsic colistin tolerance in A. baumanniiLink between intraphagosomal biotin and rapid phagosomal escape in A new member of the  regulon: Transcriptional regulation of  ()A nucleosidase required for in vivo function of the S-adenosyl-L-methionine radical enzyme, biotin synthaseComplete genome sequence of  strain ATCC 43816Genome organization is not conserved between  and Tandem SUMO fusion vectors for improving soluble protein expression and purificationConstruction of versatile low-copy-number vectors for cloning, sequencing and gene expression in The acyl carrier proteins of lipid synthesis are busy having other affairsAcyl carrier protein phosphodiesterase (AcpH) of  is a non-canonical member of the HD phosphatase/phosphodiesterase familyCharacterization of Sfp, a  phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetasesCloning and expression of  5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase: Identification of the  gene productOf its five acyl carrier proteins, only AcpP1 functions in  fatty acid synthesisIdentification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Yeast Ulp1, an Smt3-specific protease, associates with nucleoporinsUlp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeastPromiscuous protein biotinylation by  biotin protein ligasePhaser.MRage: Automated molecular replacementA graphical user interface to the CCP4 program suiteHighly accurate protein structure prediction with AlphaFoldCoot: Model-building tools for molecular graphicsFunctional replacement of the BioC and BioH proteins of  biotin precursor biosynthesis by  novel proteinsMUSCLE: Multiple sequence alignment with high accuracy and high throughputModelFinder: Fast model selection for accurate phylogenetic estimatesIQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogeniesInteractive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotationIsolation and characterization of : A gene that functions in the production of the lipopeptide biosurfactant, surfactin, in Bacillus subtilis</div>
                            <small style="color: var(--text-muted)">11661456.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...oC structure predicted by the AlphaFold2 program (92) was used as...'}</li><li>{'message': 'Diagnostic metrics reported without Confidence Intervals.', 'evidence': '...ically processed by the auto PROC program developed by the beam...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A transcription network underlies the dual genomic coordination of mitochondrial biogenesisA transcription network underlies the dual genomic coordination of mitochondrial biogenesisXBP1 controls diverse cell type- and condition-specific transcriptional regulatory networksHuman mitochondrial DNA is packaged with TFAMUnderstanding gene regulatory mechanisms by integrating ChIP-seq and RNA-seq data: statistical solutions to biological problemsThe mechanisms of action of PPARsThe SANT domain: a unique histone-tail-binding module?Genetic mosaic analysis of a deleterious mitochondrial DNA mutation in  reveals novel aspects of mitochondrial regulation and functionHuman mitochondrial DNA diseases and  modelsMitochondrial DNA segregation and replication restrict the transmission of detrimental mutationSynchronized mitochondrial and cytosolic translation programsFunctional and physiological genomics of estrogen-related receptors (ERRs) in health and diseaseSTAR: ultrafast universal RNA-seq alignerCluster analysis and display of genome-wide expression patternsMitochondrial transcription factors B1 and B2 activate transcription of human mtDNAC2H2 zinc finger proteins: the largest but poorly explored family of higher eukaryotic transcription factorsTissue-specific differences in mitochondrial activity and biogenesisPeroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and diseaseMitochondrial diseasesSelective propagation of functional mitochondrial DNA during oogenesis restricts the transmission of a deleterious mitochondrial variantTranscriptional control of mitochondrial biogenesis and functionIntegrating ChIP-seq with other functional genomics dataGenomic analysis reveals a tight link between transcription factor dynamics and regulatory network architectureHighly accurate protein structure prediction with AlphaFoldThe ModERN Resource: Genome-wide binding profiles for hundreds of  and  transcription factorsOrigin and evolution of the mitochondrial proteomeGenetic mosaic analysis of stem cell lineages in the  OvaryFast and accurate short read alignment with Burrows-Wheeler transformThe sequence alignment/map format and samtoolsStructural basis of H2A.Z recognition by SRCAP chromatin-remodeling subunit YL1An efficient genetic screen in  to identify nuclear-encoded genes with mitochondrial functionThe PPR domain of mitochondrial RNA polymerase is an exoribonuclease required for mtDNA replication in Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Homeostatic control of nuclear-encoded mitochondrial gene expression by the histone variant H2A.Z is essential for neuronal survivalRecurrent positive selection of the  hybrid incompatibility gene HmrMitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpointChIP-seq: advantages and challenges of a maturing technologyBorn to bind: the BTB protein-protein interaction domainA systematic survey of the Cys2His2 zinc finger DNA-binding landscapeRas1 promotes cellular growth in the  wingAnalysing high-throughput sequencing data in Python with HTSeq 2.0MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotationsA new gene encoding A putative transcription factor regulated by the  circadian clockTranscriptional paradigms in mammalian mitochondrial biogenesis and functionTranscriptional integration of mitochondrial biogenesispiggyBac-based mosaic screen identifies a postmitotic function for cohesin in regulating developmental axon pruningSMART: a web-based tool for the study of genetically mobile domainsMitochondria as cellular and organismal signaling hubsKRAB-ZFP transcriptional regulators acting as oncogenes and tumor suppressors: an overviewThe multifaceted contributions of mitochondria to cellular metabolismMitochondrial DNA mutations in human diseaseA complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifsThe Why of YY1: Mechanisms of transcriptional regulation by yin yang 1Electron transport chain biogenesis activated by a JNK-insulin-Myc relay primes mitochondrial inheritance in Mechanical stimulation from the surrounding tissue activates mitochondrial energy metabolism in  differentiating germ cellsMitochondrial machineries for protein import and assemblyDNA recognition by Cys2His2 zinc finger proteinsA PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodellingManipulating the metazoan mitochondrial genome with targeted restriction enzymesThe SRCAP chromatin remodeling complex promotes oxidative metabolism during prenatal heart developmentclusterProfiler: an R package for comparing biological themes among gene clustersChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualizationModel-based analysis of chip-seq (MACS)The cAMP phosphodiesterase Prune localizes to the mitochondrial matrix and promotes mtDNA replication by stabilizing TFAMThe mitochondrial outer membrane protein MDI promotes local protein synthesis and mtDNA replicationPINK1 inhibits local protein synthesis to limit transmission of deleterious mitochondrial DNA mutationsMitochondria regulate intestinal stem cell proliferation and epithelial homeostasis through FOXOComputational prediction of the global functional genomic landscape: applications, methods, and challengeseLife AssessmentReviewer #1 (Public review):Reviewer #2 (Public review):Author response">A transcription network underlies the dual genomic coordination of mitochondrial biogenesisA transcription network underlies the dual genomic coordination of mitochondrial biogenesisXBP1 controls diverse cell type- and condition-specific transcriptional regulatory networksHuman mitochondrial DNA is packaged with TFAMUnderstanding gene regulatory mechanisms by integrating ChIP-seq and RNA-seq data: statistical solutions to biological problemsThe mechanisms of action of PPARsThe SANT domain: a unique histone-tail-binding module?Genetic mosaic analysis of a deleterious mitochondrial DNA mutation in  reveals novel aspects of mitochondrial regulation and functionHuman mitochondrial DNA diseases and  modelsMitochondrial DNA segregation and replication restrict the transmission of detrimental mutationSynchronized mitochondrial and cytosolic translation programsFunctional and physiological genomics of estrogen-related receptors (ERRs) in health and diseaseSTAR: ultrafast universal RNA-seq alignerCluster analysis and display of genome-wide expression patternsMitochondrial transcription factors B1 and B2 activate transcription of human mtDNAC2H2 zinc finger proteins: the largest but poorly explored family of higher eukaryotic transcription factorsTissue-specific differences in mitochondrial activity and biogenesisPeroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and diseaseMitochondrial diseasesSelective propagation of functional mitochondrial DNA during oogenesis restricts the transmission of a deleterious mitochondrial variantTranscriptional control of mitochondrial biogenesis and functionIntegrating ChIP-seq with other functional genomics dataGenomic analysis reveals a tight link between transcription factor dynamics and regulatory network architectureHighly accurate protein structure prediction with AlphaFoldThe ModERN Resource: Genome-wide binding profiles for hundreds of  and  transcription factorsOrigin and evolution of the mitochondrial proteomeGenetic mosaic analysis of stem cell lineages in the  OvaryFast and accurate short read alignment with Burrows-Wheeler transformThe sequence alignment/map format and samtoolsStructural basis of H2A.Z recognition by SRCAP chromatin-remodeling subunit YL1An efficient genetic screen in  to identify nuclear-encoded genes with mitochondrial functionThe PPR domain of mitochondrial RNA polymerase is an exoribonuclease required for mtDNA replication in Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Homeostatic control of nuclear-encoded mitochondrial gene expression by the histone variant H2A.Z is essential for neuronal survivalRecurrent positive selection of the  hybrid incompatibility gene HmrMitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpointChIP-seq: advantages and challenges of a maturing technologyBorn to bind: the BTB protein-protein interaction domainA systematic survey of the Cys2His2 zinc finger DNA-binding landscapeRas1 promotes cellular growth in the  wingAnalysing high-throughput sequencing data in Python with HTSeq 2.0MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotationsA new gene encoding A putative transcription factor regulated by the  circadian clockTranscriptional paradigms in mammalian mitochondrial biogenesis and functionTranscriptional integration of mitochondrial biogenesispiggyBac-based mosaic screen identifies a postmitotic function for cohesin in regulating developmental axon pruningSMART: a web-based tool for the study of genetically mobile domainsMitochondria as cellular and organismal signaling hubsKRAB-ZFP transcriptional regulators acting as oncogenes and tumor suppressors: an overviewThe multifaceted contributions of mitochondria to cellular metabolismMitochondrial DNA mutations in human diseaseA complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifsThe Why of YY1: Mechanisms of transcriptional regulation by yin yang 1Electron transport chain biogenesis activated by a JNK-insulin-Myc relay primes mitochondrial inheritance in Mechanical stimulation from the surrounding tissue activates mitochondrial energy metabolism in  differentiating germ cellsMitochondrial machineries for protein import and assemblyDNA recognition by Cys2His2 zinc finger proteinsA PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodellingManipulating the metazoan mitochondrial genome with targeted restriction enzymesThe SRCAP chromatin remodeling complex promotes oxidative metabolism during prenatal heart developmentclusterProfiler: an R package for comparing biological themes among gene clustersChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualizationModel-based analysis of chip-seq (MACS)The cAMP phosphodiesterase Prune localizes to the mitochondrial matrix and promotes mtDNA replication by stabilizing TFAMThe mitochondrial outer membrane protein MDI promotes local protein synthesis and mtDNA replicationPINK1 inhibits local protein synthesis to limit transmission of deleterious mitochondrial DNA mutationsMitochondria regulate intestinal stem cell proliferation and epithelial homeostasis through FOXOComputational prediction of the global functional genomic landscape: applications, methods, and challengeseLife AssessmentReviewer #1 (Public review):Reviewer #2 (Public review):Author response</div>
                            <small style="color: var(--text-muted)">11677238.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '..., 2021). Two-tailed Student’s t-test was used for statistical anal...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...tatistically significant when p<0.05. Results are represented as m...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Total synthesis and target identification of marine cyclopiane diterpenesNavigating the chiral pool in the total synthesis of complex terpene natural productsConvergent strategies in total syntheses of complex terpenoidsModern synthetic efforts toward biologically active terpenesNovel diterpenes with potent conidiation inducing activityNew alkaloids and diterpenes from a deep ocean sediment derived fungus Conidiogenones H and I, Two New Diterpenes of Cyclopiane Class from a Marine-Derived Endophytic Fungus  QEN-24SSpirograterpene A, a tetracyclic spiro-diterpene with a fused 5/5/5/5 ring system from the deep-sea-derived fungus  MCCC 3A00475Cyclopiane-type Diterpenes from The Deep-Sea-Derived Fungus  MCCC 3A00940Two new meroterpenoids and two new monoterpenoids from the deep sea-derived fungus . YPGA11Three new cyclopiane-type diterpenes from a deep-sea derived fungus . YPGA11 and their effects against human esophageal carcinoma cellsSesquiterpenoids and Diterpenes with Antimicrobial Activity from . XL026, an Eendophytic Fungus in New cyclopiane diterpenes with anti-inflammatory activity from the sea sediment-derived fungus . TJ403-2Bioassay-directed isolation of antibacterial metabolites from an arthropod-derived Recent advances in the total synthesis of natural products bearing the contiguous all-carbon quaternary stereocentersContiguous quaternary carbons: a selection of total synthesesSynthetic strategies toward natural products containing contiguous stereogenic quaternary carbon atomsDirect construction of vicinal all-carbon quaternary stereocenters in natural product synthesisSynthesis of cyclohexane-angularly-fused triquinanesCycloaddition of Annulated Cyclo-hexa-2,4-Dienones and Novel Reduction of Halogen at Bridge-head: an Expedient Route to Tetracyclo[6.5.2.02,7.09,13]Pentadec-2(7),11-Dien-14-One and Framework of Conidiogenol and ConidiogenoneMolecular complexity and diversity from aromatics intramolecular cycloaddition of cyclo-hexa-2,4-dienones and sigmatropic shift in excited state: a unified approach towards synthesis of polycyclic frameworks related to crotogoudin, conidiogenol, and crinipellinsAn Intramolecular Para-Phenolic Allylation Ffree Radical Cyclization Strategy For the Synthesis of Alkaloids and Terpenes with Spiro[4.5]Decane ArchitecturesUnexpected Selectivity of Intramolecular [3+2] Cycloaddition of Trimethylenemethane (TMM) Diyl toward Total Synthesis of Conidiogenone BTotal Syntheses of the Tetracyclic Cyclopiane Diterpenes Conidiogenone, Conidiogenol, and Conidiogenone BQuaternary-Centre-Guided Synthesis of Complex Polycyclic TerpenesTotal Syntheses of Spiroviolene and Spirograterpene A: a Structural Reas-signment with Biosynthetic ImplicationsTotal Syntheses of (−)-Conidiogenone B, (−)-Conidiogenone, and (−)-ConidiogenolDivergent Synthesis of Conidiogenones B-F and 12β-hydroxy Conidiogenone CEnantioselective Total Synthesis of (+)-AberraroneTotal Synthesis of (+)-AberraroneComputational planning of the synthesis of complex natural productsAn Enzyme-Mediated Aza-Michael addition is involved in the biosynthesis of an imidazoyl hybrid product of conidiogenone BBiosynthetic study of conidiation-inducing factor conidiogenone: heterologous production and cyclization mechanism of a key bifunctional diterpene synthaseCrystalline sponge method enabled the investigation of a prenyltransferase-terpene synthase chimeric enzyme, whose product exhibits broadened NMR signalsEfficient Synthesis of Cyclopentenones from Enynyl Acetates via Tandem Au(I)-Catalyzed 3,3-Rearrangement and the Nazarov ReactionTotal Synthesis of (−)-Merochlorin AGold (I)-Catalyzed Stereoselective Cyclization of 1,3-Enyne Aldehydes by a 1,3-Acyloxy Migration/Nazarov Cyclization/Aldol Addition CascadeTotal synthesis of kadcoccinic acid a trimethyl esterDFT Study of the Mechanisms of In Water Au (I)-Catalyzed Tandem [3,3]-Rearrangement/Nazarov Reaction/[1,2]-Hydrogen Shift of Enynyl Acetates:  A Proton-Transport Catalysis Strategy in the Water-Catalyzed [1,2]-Hydrogen ShiftThe role of bent acyclic allene gold complexes in axis-to-center chirality transfersGeneration and Trapping of Cyclopentenylidene Gold Species: Four Pathways to Polycyclic CompoundsL Facile Synthesis of (3as)-1,3a-Dimethyl-2,3,3a,5,6,7-Hyxahydroinden-4(5h)-One, an Intermediate for Steroid SynthesisA practical protocol for asymmetric synthesis of wieland-miescher and hajos–parrish ketones catalyzed by a simple chiral primary amineNavigating the Pauson–Khand reaction in total syntheses of complex natural productsEvolution of Pauson-Khand reaction: strategic applications in total syntheses of architecturally complex natural products (2016–2020)An effective synthesis of angular tricyclic compounds having two contiguous quaternary centers by intramolecular pauson-khand reaction of exocyclic enynesInvestigation of the synthesis of angular tricyclic compounds by intra-molecular pauson–khand reaction of exo- and endo-cyclic enynesA Synthetic Route to the Core Structure of (−)-Retigeranic Acid AGold catalyzed synthesis of chiral cyclopentadienyl esters via chirality transferHydrocyanation. IV. New Hydrocyanation Methods Using Hydrogen Cyanide and an Alkyl-aluminum, and an Alkylaluminum CyanideConcise and Stereoselective Total Syntheses of Annotinolides C, D, and EA modular and enantioselective synthesis of the pleuromutilin antibioticsTotal synthesis of paecilomycine ATotal Synthesis of (−)-Scabronine G, an Inducer of Neurotrophic Factor ProductionTotal Synthesis of (±)-Scopadulcic Acid BPd(OH)/C-mediated selective oxidation of silyl enol ethers by tert-butylhydroperoxide, a useful method for the conversion of ketones to α,β-Enones or β-Silyloxy-α,β-EnonesSynthetic study of pyrrocidines: first entry to the decahydrofluorene core of pyrrocidinesEnantiospecific first total synthesis of -AllothapsenolA Concise Synthesis of (+)-Batzelladine B from simple pyrrole-based starting materialsRegiospecific alkylation of cyclic beta-diketone enol ethers. general synthesis of 4-AlkylcyclohexenonesChemoselective reduction of aldehydes via a combination of NaBH and AcetylacetoneA Highly Convergent Cascade Cyclization to cis-Hydrindanes with All-Carbon Quaternary Centers and Its Application in the Synthesis of the Aglycon of Dendronobiloside AHydrogenolysis of Enol Triflates; A New Method for the Reduction of Ketones to Methylene CompoundsTotal synthesis of dendrobate alkaloid (+)-241D, isosolenopsin and isosolenopsin a: application of a gold-catalyzed cyclizationTotal Synthesis of (±)-Batrachotoxinin AStereospecific total syntheses of decahydroquinoline alkaloids (±)-195A and (±)-2-Epi-195ARegulation of type I Interferon ResponsesIRGM1 links mitochondrial quality control to autoimmunityIRGM1, a Guardian of Mitochondrial DAMP–mediated AutoinflammationAutoimmunity Gene IRGM Suppresses cGAS-STING and RIG-I-MAVS Signaling to Control Interferon ResponseThe Crohn’s Disease Risk Factor IRGM Limits NLRP3 inflammasome activation by impeding its assembly and by mediating its selective autophagyCovalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition ReactionsParthenolide covalently targets and inhibits focal adhesion kinase in breast cancer cellsTotal synthesis, biological evaluation, and target identification of rare  SesquiterpenoidsDivergent synthesis and identification of the cellular targets of deoxyelephantopinsTotal synthesis and target identification of the curcusone diterpenesApoptotic caspases prevent the induction of type i interferons by mitochondrial DNAδPKC-Mediated DRP1 phosphorylation impacts macrophage mitochondrial function and inflammatory response to endotoxin">Total synthesis and target identification of marine cyclopiane diterpenesNavigating the chiral pool in the total synthesis of complex terpene natural productsConvergent strategies in total syntheses of complex terpenoidsModern synthetic efforts toward biologically active terpenesNovel diterpenes with potent conidiation inducing activityNew alkaloids and diterpenes from a deep ocean sediment derived fungus Conidiogenones H and I, Two New Diterpenes of Cyclopiane Class from a Marine-Derived Endophytic Fungus  QEN-24SSpirograterpene A, a tetracyclic spiro-diterpene with a fused 5/5/5/5 ring system from the deep-sea-derived fungus  MCCC 3A00475Cyclopiane-type Diterpenes from The Deep-Sea-Derived Fungus  MCCC 3A00940Two new meroterpenoids and two new monoterpenoids from the deep sea-derived fungus . YPGA11Three new cyclopiane-type diterpenes from a deep-sea derived fungus . YPGA11 and their effects against human esophageal carcinoma cellsSesquiterpenoids and Diterpenes with Antimicrobial Activity from . XL026, an Eendophytic Fungus in New cyclopiane diterpenes with anti-inflammatory activity from the sea sediment-derived fungus . TJ403-2Bioassay-directed isolation of antibacterial metabolites from an arthropod-derived Recent advances in the total synthesis of natural products bearing the contiguous all-carbon quaternary stereocentersContiguous quaternary carbons: a selection of total synthesesSynthetic strategies toward natural products containing contiguous stereogenic quaternary carbon atomsDirect construction of vicinal all-carbon quaternary stereocenters in natural product synthesisSynthesis of cyclohexane-angularly-fused triquinanesCycloaddition of Annulated Cyclo-hexa-2,4-Dienones and Novel Reduction of Halogen at Bridge-head: an Expedient Route to Tetracyclo[6.5.2.02,7.09,13]Pentadec-2(7),11-Dien-14-One and Framework of Conidiogenol and ConidiogenoneMolecular complexity and diversity from aromatics intramolecular cycloaddition of cyclo-hexa-2,4-dienones and sigmatropic shift in excited state: a unified approach towards synthesis of polycyclic frameworks related to crotogoudin, conidiogenol, and crinipellinsAn Intramolecular Para-Phenolic Allylation Ffree Radical Cyclization Strategy For the Synthesis of Alkaloids and Terpenes with Spiro[4.5]Decane ArchitecturesUnexpected Selectivity of Intramolecular [3+2] Cycloaddition of Trimethylenemethane (TMM) Diyl toward Total Synthesis of Conidiogenone BTotal Syntheses of the Tetracyclic Cyclopiane Diterpenes Conidiogenone, Conidiogenol, and Conidiogenone BQuaternary-Centre-Guided Synthesis of Complex Polycyclic TerpenesTotal Syntheses of Spiroviolene and Spirograterpene A: a Structural Reas-signment with Biosynthetic ImplicationsTotal Syntheses of (−)-Conidiogenone B, (−)-Conidiogenone, and (−)-ConidiogenolDivergent Synthesis of Conidiogenones B-F and 12β-hydroxy Conidiogenone CEnantioselective Total Synthesis of (+)-AberraroneTotal Synthesis of (+)-AberraroneComputational planning of the synthesis of complex natural productsAn Enzyme-Mediated Aza-Michael addition is involved in the biosynthesis of an imidazoyl hybrid product of conidiogenone BBiosynthetic study of conidiation-inducing factor conidiogenone: heterologous production and cyclization mechanism of a key bifunctional diterpene synthaseCrystalline sponge method enabled the investigation of a prenyltransferase-terpene synthase chimeric enzyme, whose product exhibits broadened NMR signalsEfficient Synthesis of Cyclopentenones from Enynyl Acetates via Tandem Au(I)-Catalyzed 3,3-Rearrangement and the Nazarov ReactionTotal Synthesis of (−)-Merochlorin AGold (I)-Catalyzed Stereoselective Cyclization of 1,3-Enyne Aldehydes by a 1,3-Acyloxy Migration/Nazarov Cyclization/Aldol Addition CascadeTotal synthesis of kadcoccinic acid a trimethyl esterDFT Study of the Mechanisms of In Water Au (I)-Catalyzed Tandem [3,3]-Rearrangement/Nazarov Reaction/[1,2]-Hydrogen Shift of Enynyl Acetates:  A Proton-Transport Catalysis Strategy in the Water-Catalyzed [1,2]-Hydrogen ShiftThe role of bent acyclic allene gold complexes in axis-to-center chirality transfersGeneration and Trapping of Cyclopentenylidene Gold Species: Four Pathways to Polycyclic CompoundsL Facile Synthesis of (3as)-1,3a-Dimethyl-2,3,3a,5,6,7-Hyxahydroinden-4(5h)-One, an Intermediate for Steroid SynthesisA practical protocol for asymmetric synthesis of wieland-miescher and hajos–parrish ketones catalyzed by a simple chiral primary amineNavigating the Pauson–Khand reaction in total syntheses of complex natural productsEvolution of Pauson-Khand reaction: strategic applications in total syntheses of architecturally complex natural products (2016–2020)An effective synthesis of angular tricyclic compounds having two contiguous quaternary centers by intramolecular pauson-khand reaction of exocyclic enynesInvestigation of the synthesis of angular tricyclic compounds by intra-molecular pauson–khand reaction of exo- and endo-cyclic enynesA Synthetic Route to the Core Structure of (−)-Retigeranic Acid AGold catalyzed synthesis of chiral cyclopentadienyl esters via chirality transferHydrocyanation. IV. New Hydrocyanation Methods Using Hydrogen Cyanide and an Alkyl-aluminum, and an Alkylaluminum CyanideConcise and Stereoselective Total Syntheses of Annotinolides C, D, and EA modular and enantioselective synthesis of the pleuromutilin antibioticsTotal synthesis of paecilomycine ATotal Synthesis of (−)-Scabronine G, an Inducer of Neurotrophic Factor ProductionTotal Synthesis of (±)-Scopadulcic Acid BPd(OH)/C-mediated selective oxidation of silyl enol ethers by tert-butylhydroperoxide, a useful method for the conversion of ketones to α,β-Enones or β-Silyloxy-α,β-EnonesSynthetic study of pyrrocidines: first entry to the decahydrofluorene core of pyrrocidinesEnantiospecific first total synthesis of -AllothapsenolA Concise Synthesis of (+)-Batzelladine B from simple pyrrole-based starting materialsRegiospecific alkylation of cyclic beta-diketone enol ethers. general synthesis of 4-AlkylcyclohexenonesChemoselective reduction of aldehydes via a combination of NaBH and AcetylacetoneA Highly Convergent Cascade Cyclization to cis-Hydrindanes with All-Carbon Quaternary Centers and Its Application in the Synthesis of the Aglycon of Dendronobiloside AHydrogenolysis of Enol Triflates; A New Method for the Reduction of Ketones to Methylene CompoundsTotal synthesis of dendrobate alkaloid (+)-241D, isosolenopsin and isosolenopsin a: application of a gold-catalyzed cyclizationTotal Synthesis of (±)-Batrachotoxinin AStereospecific total syntheses of decahydroquinoline alkaloids (±)-195A and (±)-2-Epi-195ARegulation of type I Interferon ResponsesIRGM1 links mitochondrial quality control to autoimmunityIRGM1, a Guardian of Mitochondrial DAMP–mediated AutoinflammationAutoimmunity Gene IRGM Suppresses cGAS-STING and RIG-I-MAVS Signaling to Control Interferon ResponseThe Crohn’s Disease Risk Factor IRGM Limits NLRP3 inflammasome activation by impeding its assembly and by mediating its selective autophagyCovalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition ReactionsParthenolide covalently targets and inhibits focal adhesion kinase in breast cancer cellsTotal synthesis, biological evaluation, and target identification of rare  SesquiterpenoidsDivergent synthesis and identification of the cellular targets of deoxyelephantopinsTotal synthesis and target identification of the curcusone diterpenesApoptotic caspases prevent the induction of type i interferons by mitochondrial DNAδPKC-Mediated DRP1 phosphorylation impacts macrophage mitochondrial function and inflammatory response to endotoxin</div>
                            <small style="color: var(--text-muted)">11686375.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="JAK inhibition decreases the autoimmune burden in Down syndromeJAK inhibition decreases the autoimmune burden in Down syndromeEarly-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in down syndromeImmune-mediated necrotizing myopathy: clinical features and pathogenesisAntibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal miceMAIT cells in barrier tissues: lessons from immediate neighborsThyroid disorders in subjects with down syndrome: an updateDown syndromeTrisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityIGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromeEpidemiological and clinical aspects of autoimmune thyroid diseases in children with Down’s syndromeflowVS: channel-specific variance stabilization in flow cytometryLifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndromePersonalized immunomonitoring uncovers molecular networks that stratify lupus patientsA Trisomy 21 Lung Cell AtlasPrevalence and clinical characteristics of celiac disease in Downs syndrome in a US studyAutoimmune inner ear disease: a systematic review of managementCompensation of signal spillover in suspension and imaging mass cytometryInterferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signalingPrevalence of common disease conditions in a large cohort of individuals with down syndrome in the united statesLong-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trialsDistinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesVariegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMultimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMyasthenia gravis: epidemiologyOtitis media in children with down syndrome is associated with shifts in the nasopharyngeal and middle ear microbiotasThe role of infections in autoimmune diseaseNormalization of mass cytometry data with bead standardsEvolution of neuroinflammation across the lifespan of individuals with Down syndromeMultidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionDysregulation of the immune system in a natural history study of 1299 individuals with down syndromeDown syndrome, accelerated aging and immunosenescenceMuscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junctionHigh-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneouslyHemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibitionFlowcore: a bioconductor package for high throughput flow cytometryResearch electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics supportType I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factorsTen-year longitudinal study of thyroid function in children with Down’s syndromeTrisomy 21 is a cause of permanent neonatal diabetes that is autoimmune but not HLA associatedDown syndrome: insights into autoimmune mechanismsJanus kinase inhibitors for alopecia areataAssociation between endocrine diseases and serous otitis media in childrenBoth normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytesHidradenitis suppurativa and down syndrome: a systematic review and meta-analysisDeep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityMongolism; a chromosomal disease (trisomy)Biallelic variants in WARS1 cause a highly variable neurodevelopmental syndrome and implicate a critical exon for normal auditory functionRoutine screening for celiac disease in children with down syndrome improves case findingModerated estimation of fold change and dispersion for RNA-seq data with DESeq2Dermatological manifestations of Down’s syndromeAutoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cellsSex differences in the gut microbiome drive hormone-dependent regulation of autoimmunityPartial IFN-  and IFN-  receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viabilityCluster analysis of autoimmune rheumatic diseases based on autoantibodies: new insights for polyautoimmunityJAK inhibition for treatment of psoriatic arthritis in Down syndromeCharacterization of thyroid abnormalities in a large cohort of children with down syndromeNovel somatic mutations in UBA1 as a cause of VEXAS syndromeTrisomy 21 activates the kynurenine pathway via increased dosage of interferon receptorsJanus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areataJAK inhibition in Down Syndrome Regression DisorderDermatologic conditions in down syndrome: a multi-site retrospective review of international classification of diseases codesType I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overviewTofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialAssessment and diagnosis of down syndrome regression disorder: international expert consensusType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesJAK inhibition as a therapeutic strategy for immune and inflammatory diseasesEvolution of interferons and interferon receptorsA comprehensive overview of globally approved JAK inhibitorsGlobal prevalence of celiac disease: systematic review and meta-analysisGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesTrisomy 21 consistently activates the interferon responseTrisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammationPhenotypic and dermatological manifestations in Down SyndromeA new horizon for atopic dermatitis treatments: jak inhibitorsInflammatory and Immunological parameters in adults with Down syndromeJAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndromeFlowSOM: using self-organizing maps for visualization and interpretation of cytometry dataMass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type i interferon in down syndromeTriplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelDown’s syndrome, neuroinflammation, and Alzheimer neuropathogenesisCardiovascular and cancer risk with tofacitinib in rheumatoid arthritisPrevalence of celiac disease in down syndrome in the united statesAberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysisPalladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithmeLife AssessmentReviewer #1 (Public review):Reviewer #2 (Public review):Reviewer #3 (Public review):Author response">JAK inhibition decreases the autoimmune burden in Down syndromeJAK inhibition decreases the autoimmune burden in Down syndromeEarly-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in down syndromeImmune-mediated necrotizing myopathy: clinical features and pathogenesisAntibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal miceMAIT cells in barrier tissues: lessons from immediate neighborsThyroid disorders in subjects with down syndrome: an updateDown syndromeTrisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityIGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromeEpidemiological and clinical aspects of autoimmune thyroid diseases in children with Down’s syndromeflowVS: channel-specific variance stabilization in flow cytometryLifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndromePersonalized immunomonitoring uncovers molecular networks that stratify lupus patientsA Trisomy 21 Lung Cell AtlasPrevalence and clinical characteristics of celiac disease in Downs syndrome in a US studyAutoimmune inner ear disease: a systematic review of managementCompensation of signal spillover in suspension and imaging mass cytometryInterferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signalingPrevalence of common disease conditions in a large cohort of individuals with down syndrome in the united statesLong-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trialsDistinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesVariegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMultimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndromeMyasthenia gravis: epidemiologyOtitis media in children with down syndrome is associated with shifts in the nasopharyngeal and middle ear microbiotasThe role of infections in autoimmune diseaseNormalization of mass cytometry data with bead standardsEvolution of neuroinflammation across the lifespan of individuals with Down syndromeMultidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionDysregulation of the immune system in a natural history study of 1299 individuals with down syndromeDown syndrome, accelerated aging and immunosenescenceMuscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junctionHigh-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneouslyHemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibitionFlowcore: a bioconductor package for high throughput flow cytometryResearch electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics supportType I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factorsTen-year longitudinal study of thyroid function in children with Down’s syndromeTrisomy 21 is a cause of permanent neonatal diabetes that is autoimmune but not HLA associatedDown syndrome: insights into autoimmune mechanismsJanus kinase inhibitors for alopecia areataAssociation between endocrine diseases and serous otitis media in childrenBoth normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytesHidradenitis suppurativa and down syndrome: a systematic review and meta-analysisDeep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunityMongolism; a chromosomal disease (trisomy)Biallelic variants in WARS1 cause a highly variable neurodevelopmental syndrome and implicate a critical exon for normal auditory functionRoutine screening for celiac disease in children with down syndrome improves case findingModerated estimation of fold change and dispersion for RNA-seq data with DESeq2Dermatological manifestations of Down’s syndromeAutoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cellsSex differences in the gut microbiome drive hormone-dependent regulation of autoimmunityPartial IFN-  and IFN-  receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viabilityCluster analysis of autoimmune rheumatic diseases based on autoantibodies: new insights for polyautoimmunityJAK inhibition for treatment of psoriatic arthritis in Down syndromeCharacterization of thyroid abnormalities in a large cohort of children with down syndromeNovel somatic mutations in UBA1 as a cause of VEXAS syndromeTrisomy 21 activates the kynurenine pathway via increased dosage of interferon receptorsJanus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areataJAK inhibition in Down Syndrome Regression DisorderDermatologic conditions in down syndrome: a multi-site retrospective review of international classification of diseases codesType I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overviewTofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialAssessment and diagnosis of down syndrome regression disorder: international expert consensusType I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesJAK inhibition as a therapeutic strategy for immune and inflammatory diseasesEvolution of interferons and interferon receptorsA comprehensive overview of globally approved JAK inhibitorsGlobal prevalence of celiac disease: systematic review and meta-analysisGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesTrisomy 21 consistently activates the interferon responseTrisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammationPhenotypic and dermatological manifestations in Down SyndromeA new horizon for atopic dermatitis treatments: jak inhibitorsInflammatory and Immunological parameters in adults with Down syndromeJAK1 inhibition blocks lethal immune hypersensitivity in a mouse model of down syndromeFlowSOM: using self-organizing maps for visualization and interpretation of cytometry dataMass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type i interferon in down syndromeTriplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelDown’s syndrome, neuroinflammation, and Alzheimer neuropathogenesisCardiovascular and cancer risk with tofacitinib in rheumatoid arthritisPrevalence of celiac disease in down syndrome in the united statesAberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysisPalladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithmeLife AssessmentReviewer #1 (Public review):Reviewer #2 (Public review):Reviewer #3 (Public review):Author response</div>
                            <small style="color: var(--text-muted)">11687933.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...ge flagged. For each analyte, missing values were replaced with either the...'}</li><li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': 'No direct quote found.'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="간섬유화 평가를 위한 비침습적 영상검사: 순간 탄성측정법KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver diseaseEvaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panelUltrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniquesElastography assessment of liver fibrosis: Society of radiologists in ultrasound consensus conference statementTransient elastography: a new noninvasive method for assessment of hepatic fibrosisUltrasound elastography for liver disease with focus on hepatic fibrosisWFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminologyLiver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminasesFood intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infectionVariability in liver stiffness values from different intercostal spacesTransient elastography in chronic hepatitis B: an Asian perspectiveFactors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis CPrevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsyTransient elastography is unreliable for detection of cirrhosis in patients with acute liver damageAcute viral hepatitis increases liver stiffness values measured by transient elastographyTransient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminasesHow can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosisLiver stiffness is directly influenced by central venous pressureEffect of alcohol consumption on liver stiffness measured by transient elastographyIncreased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitisRapid decline of liver stiffness following alcohol withdrawal in heavy drinkersNon-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis BAlanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis BProspective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis BProspective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infectionDiagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study)Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative studyDual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validationEvaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and CDirect comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis CPerformance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysisSystematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis BTransient elastography for significant liver fibrosis and cirrhosis in chronic hepatitis B: A meta-analysisDiagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysisEtiology-related determinants of liver stiffness values in chronic viral hepatitis B or CEASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisVibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysisNoninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CRelative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standardAccuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study">간섬유화 평가를 위한 비침습적 영상검사: 순간 탄성측정법KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver diseaseEvaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panelUltrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniquesElastography assessment of liver fibrosis: Society of radiologists in ultrasound consensus conference statementTransient elastography: a new noninvasive method for assessment of hepatic fibrosisUltrasound elastography for liver disease with focus on hepatic fibrosisWFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminologyLiver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminasesFood intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infectionVariability in liver stiffness values from different intercostal spacesTransient elastography in chronic hepatitis B: an Asian perspectiveFactors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis CPrevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsyTransient elastography is unreliable for detection of cirrhosis in patients with acute liver damageAcute viral hepatitis increases liver stiffness values measured by transient elastographyTransient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminasesHow can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosisLiver stiffness is directly influenced by central venous pressureEffect of alcohol consumption on liver stiffness measured by transient elastographyIncreased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitisRapid decline of liver stiffness following alcohol withdrawal in heavy drinkersNon-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis BAlanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis BProspective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis BProspective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infectionDiagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study)Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative studyDual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validationEvaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and CDirect comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis CPerformance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysisSystematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis BTransient elastography for significant liver fibrosis and cirrhosis in chronic hepatitis B: A meta-analysisDiagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysisEtiology-related determinants of liver stiffness values in chronic viral hepatitis B or CEASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisVibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysisNoninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CRelative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standardAccuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study</div>
                            <small style="color: var(--text-muted)">12285383.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="간섬유화 평가를 위한 혈청 표지자의 종류와 의미Liver biopsySerum markers detect the presence of liver fibrosis: a cohort studyKASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver diseaseImpact of non-invasive biomarkers on hepatology practice: Past, present and futureDiagnostic efficacy of serum asialo α1-acid glycoprotein levels for advanced liver fibrosis and cirrhosis in patients with chronic hepatitis B compared to that in healthy subjects: A prospective studyDevelopment of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic diseaseAST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infectionRatio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosisA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CDevelopment and validation of a simple NAFLD clinical scoring system for identifying patients without advanced diseaseDevelopment of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionIdentification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelSimple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseNeed for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis CUse of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis CComparison of blood tests for liver fibrosis specific or not to NAFLDAST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisThe NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDDevelopment of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnosticsA blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyMac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosisADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosisPerformance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseNoninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersDiagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseNIS2+™, an optimisation of the blood-based biomarker NIS4 technology for the detection of at-risk NASH: A prospective derivation and validation studyDiagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological referenceComparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysisThe impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 casesProspective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infectionDiagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysisProspective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis BFibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysisWisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysisFIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestProspective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis CSystematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BCost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationA non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validationPerformance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysisAssessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis CThe Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off valuesSystematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosisBiochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyAccuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysisDiagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisExternal validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patientsEvaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgeryA simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver diseaseDiagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseComparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver diseaseMeta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityThe utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLDValidation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosisEnhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysisAccuracy of the Enhanced Liver Fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver diseaseThe Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort studyPrediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4Non-invasive diagnosis of advanced fibrosis and cirrhosisRecent advances in the non-invasive assessment of fibrosis using biomarkersAge as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosisNoninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience">간섬유화 평가를 위한 혈청 표지자의 종류와 의미Liver biopsySerum markers detect the presence of liver fibrosis: a cohort studyKASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver diseaseImpact of non-invasive biomarkers on hepatology practice: Past, present and futureDiagnostic efficacy of serum asialo α1-acid glycoprotein levels for advanced liver fibrosis and cirrhosis in patients with chronic hepatitis B compared to that in healthy subjects: A prospective studyDevelopment of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic diseaseAST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infectionRatio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosisA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CDevelopment and validation of a simple NAFLD clinical scoring system for identifying patients without advanced diseaseDevelopment of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionIdentification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelSimple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseNeed for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis CUse of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis CComparison of blood tests for liver fibrosis specific or not to NAFLDAST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisThe NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDDevelopment of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnosticsA blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyMac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosisADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosisPerformance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseNoninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersDiagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseNIS2+™, an optimisation of the blood-based biomarker NIS4 technology for the detection of at-risk NASH: A prospective derivation and validation studyDiagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological referenceComparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysisThe impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 casesProspective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infectionDiagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysisProspective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis BFibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysisWisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysisFIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestProspective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis CSystematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and BCost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationA non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validationPerformance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysisAssessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis CThe Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off valuesSystematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosisBiochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective studyAccuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysisDiagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisExternal validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patientsEvaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgeryA simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver diseaseDiagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseComparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver diseaseMeta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityThe utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLDValidation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosisEnhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysisAccuracy of the Enhanced Liver Fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver diseaseThe Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort studyPrediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4Non-invasive diagnosis of advanced fibrosis and cirrhosisRecent advances in the non-invasive assessment of fibrosis using biomarkersAge as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosisNoninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience</div>
                            <small style="color: var(--text-muted)">12285504.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Neural assemblies coordinated by cortical waves are associated with waking and hallucinatory brain states
Neural assemblies coordinated by cortical waves are associated with waking and hallucinatory brain states
Increased synchronization of neuromagnetic responses during conscious perceptionPerception’s shadow: long-distance synchronization of human brain activitySynchronization of neural activity across cortical areas correlates with conscious perceptionConsciousness and neuronal synchronizationOscillatory neuronal synchronization in primary visual cortex as a correlate of stimulus selectionInvestigating neural correlates of conscious perception by frequency-tagged neuromagnetic responsesCortical travelling waves: Mechanisms and computational principlesTraveling electrical waves in cortex: Insights from phase dynamics and speculation on a computational roleHorizontal propagation of visual activity in the synaptic integration field of area 17 neuronsThe stimulus-evoked population response in visual cortex of awake monkey is a propagating waveVisual evoked feedforward–feedback traveling waves organize neural activity across the cortical hierarchy in miceCompression and Reflection of Visually Evoked Cortical WavesEffects of barbiturates and ether on spontaneous electrical activity of dog brainVisual stimuli induce waves of electrical activity in turtle cortexTraveling waves of activity in primary visual cortex during binocular rivalryPerceptual echoes at 10 Hz in the human brainWaves traveling over a map of visual space can ignite short-term predictions of sensory inputAlpha oscillations and traveling waves: Signatures of predictive coding?Complexity of cortical wave patterns of the wake mouse cortexRotating waves during human sleep spindles organize global patterns of activity that repeat precisely through the nightThe Sleep Slow Oscillation as a Traveling WaveCortical point-spread function and long-range lateral interactions revealed by real-time optical imaging of macaque monkey primary visual cortexSpontaneous travelling cortical waves gate perception in behaving primatesSpontaneously emerging cortical representations of visual attributesThe ability of bispectral index to detect intra-operative wakefulness during isoflurane/air anaesthesia, compared with the isolated forearm techniqueElectroencephalogram signatures of ketamine anesthesia-induced unconsciousnessKetamine triggers a switch in excitatory neuronal activity across neocortexKetamine effects on somatosensory cortical single neurons and on behavior in ratsQuantifying cortical EEG responses to TMS in (Un)consciousnessConsciousness and complexity during unresponsiveness induced by propofol, xenon, and ketamineKetamine and the conscious mindOn anesthesia using ketamine (CI-581): Report o 1st experience in 500 casesIntravenous nonbarbiturate, nonnarcotic analgesics: preliminary studies. I. cyclohexylaminesDissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative Cl-581Taming the ketamine tigerKetamine anesthesiaDeep posteromedial cortical rhythm in dissociationCharacterizing brain dynamics during ketamine-induced dissociation and subsequent interactions with propofol using human intracranial neurophysiologyGeneral anaesthesia: From molecular targets to neuronal pathways of sleep and arousalUnconsciousness with an Active Cortex: Ketamine Anesthesia and Rapid Eye Movement SleepWhat is it like to be a bat?Coherence of visual-evoked gamma oscillations is disrupted by propofol but preserved under equipotent doses of isofluraneVisually evoked 3-5 Hz membrane potential oscillations reduce the responsiveness of visual cortex neurons in awake behaving miceLayer-Specific Physiological Features and Interlaminar Interactions in the Primary Visual Cortex of the MouseStimulus dependence of directed information exchange between cortical layers in macaque V1Alpha and gamma oscillations characterize feedback and feedforward processing in monkey visual cortexThe origin of extracellular fields and currents — EEG, ECoG, LFP and spikesMouse color and wavelength-specific luminance contrast sensitivity are non-uniform across visual spacePsychophysical measurement of contrast sensitivity in the behaving mouseEvoked potentials during isoflurane anaesthesiaBrief latency click-evoked potentials during waking and sleep in manHuman auditory evoked potentials during natural sleep: the early componentsAwake perception is associated with dedicated neuronal assemblies in the cerebral cortexArchitecture and organization of mouse posterior parietal cortex relative to extrastriate areasGateways of ventral and dorsal streams in mouse visual cortexThe mouse posterior parietal cortex: Anatomy and functionsDynamical representation of odors by oscillating and evolving neural assembliesNeuronal oscillations in cortical networksDiverse Phase Relations among Neuronal Rhythms and Their Potential FunctionSynchronous oscillatory neural ensembles for rules in the prefrontal cortexHippocampal theta oscillations are travelling wavesRapid feature selective neuronal synchronization through correlated latency shiftingWhat does gamma coherence tell us about inter-regional neural communication?Dynamics of Ongoing Activity : Explanation of the Large Variability in Evoked Cortical ResponsesA Sensorimotor Role for Traveling Waves in Primate Visual CortexSpontaneous traveling waves naturally emerge from horizontal fiber time delays and travel through locally asynchronous-irregular statesActivated cortical states: experiments, analyses and modelsNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neuronsKetamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortexPreferential effect of isoflurane on top-down vs . bottom-up pathways in sensory cortexExcitatory synaptic transmission mediated by NMDA receptors is more sensitive to isoflurane than are non-NMDA receptor-mediated responsesNeural Correlates of Unconsciousness in Large-Scale Brain NetworksDevelopment of a large-scale functional brain network during human non-rapid eye movement sleepDisruption of Frontal–Parietal Communication by Ketamine, Propofol, and SevofluraneEEG entropy measures indicate decrease of cortical information processing in Disorders of ConsciousnessNeuroscience: Breakdown of cortical effective connectivity during sleepPreserved Feedforward But Impaired Top-Down Processes in the Vegetative StateA Theoretically Based Index of Consciousness Independent of Sensory Processing and BehaviorBreakdown in cortical effective connectivity during midazolam-induced loss of consciousnessKetamine alters rat flash evoked potentialsMesoscale cortical dynamics reflect the interaction of sensory evidence and temporal expectation during perceptual decision-makingDistributed coding of choice, action and engagement across the mouse brainSensory coding and the causal impact of mouse cortex in a visual decisionIsolated correlates of somatosensory perception in the mouse posterior cortexHierarchical models of object recognition in cortexReceptive fields, binocular interaction and functional architecture in the cat’s visual cortexPrimary visual cortex and visual awarenessThe anatomy of conscious vision: an fMRI study of visual hallucinationsCerebral cortex lesions: The dream process and sleep spindlesDreaming and the brain: from phenomenology to neurophysiologyWhat geometric visual hallucinations tell us about the visual cortexDynamic stimulation of visual cortex produces form vision in sighted and blind humansScalp block’ during craniotomy: A classic technique revisitedExperimental Optimization of Current Source-Density Technique for Anuran CerebellumA method for calculating current source density (CSD) analysis without resorting to recording sites outside the sampling volumeA Practical Guide to Wavelet AnalysisFast and accurate spike sorting of high-channel count probes with KiloSortMeasuring phase-amplitude coupling between neuronal oscillations of different frequencies">Neural assemblies coordinated by cortical waves are associated with waking and hallucinatory brain states
Neural assemblies coordinated by cortical waves are associated with waking and hallucinatory brain states
Increased synchronization of neuromagnetic responses during conscious perceptionPerception’s shadow: long-distance synchronization of human brain activitySynchronization of neural activity across cortical areas correlates with conscious perceptionConsciousness and neuronal synchronizationOscillatory neuronal synchronization in primary visual cortex as a correlate of stimulus selectionInvestigating neural correlates of conscious perception by frequency-tagged neuromagnetic responsesCortical travelling waves: Mechanisms and computational principlesTraveling electrical waves in cortex: Insights from phase dynamics and speculation on a computational roleHorizontal propagation of visual activity in the synaptic integration field of area 17 neuronsThe stimulus-evoked population response in visual cortex of awake monkey is a propagating waveVisual evoked feedforward–feedback traveling waves organize neural activity across the cortical hierarchy in miceCompression and Reflection of Visually Evoked Cortical WavesEffects of barbiturates and ether on spontaneous electrical activity of dog brainVisual stimuli induce waves of electrical activity in turtle cortexTraveling waves of activity in primary visual cortex during binocular rivalryPerceptual echoes at 10 Hz in the human brainWaves traveling over a map of visual space can ignite short-term predictions of sensory inputAlpha oscillations and traveling waves: Signatures of predictive coding?Complexity of cortical wave patterns of the wake mouse cortexRotating waves during human sleep spindles organize global patterns of activity that repeat precisely through the nightThe Sleep Slow Oscillation as a Traveling WaveCortical point-spread function and long-range lateral interactions revealed by real-time optical imaging of macaque monkey primary visual cortexSpontaneous travelling cortical waves gate perception in behaving primatesSpontaneously emerging cortical representations of visual attributesThe ability of bispectral index to detect intra-operative wakefulness during isoflurane/air anaesthesia, compared with the isolated forearm techniqueElectroencephalogram signatures of ketamine anesthesia-induced unconsciousnessKetamine triggers a switch in excitatory neuronal activity across neocortexKetamine effects on somatosensory cortical single neurons and on behavior in ratsQuantifying cortical EEG responses to TMS in (Un)consciousnessConsciousness and complexity during unresponsiveness induced by propofol, xenon, and ketamineKetamine and the conscious mindOn anesthesia using ketamine (CI-581): Report o 1st experience in 500 casesIntravenous nonbarbiturate, nonnarcotic analgesics: preliminary studies. I. cyclohexylaminesDissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative Cl-581Taming the ketamine tigerKetamine anesthesiaDeep posteromedial cortical rhythm in dissociationCharacterizing brain dynamics during ketamine-induced dissociation and subsequent interactions with propofol using human intracranial neurophysiologyGeneral anaesthesia: From molecular targets to neuronal pathways of sleep and arousalUnconsciousness with an Active Cortex: Ketamine Anesthesia and Rapid Eye Movement SleepWhat is it like to be a bat?Coherence of visual-evoked gamma oscillations is disrupted by propofol but preserved under equipotent doses of isofluraneVisually evoked 3-5 Hz membrane potential oscillations reduce the responsiveness of visual cortex neurons in awake behaving miceLayer-Specific Physiological Features and Interlaminar Interactions in the Primary Visual Cortex of the MouseStimulus dependence of directed information exchange between cortical layers in macaque V1Alpha and gamma oscillations characterize feedback and feedforward processing in monkey visual cortexThe origin of extracellular fields and currents — EEG, ECoG, LFP and spikesMouse color and wavelength-specific luminance contrast sensitivity are non-uniform across visual spacePsychophysical measurement of contrast sensitivity in the behaving mouseEvoked potentials during isoflurane anaesthesiaBrief latency click-evoked potentials during waking and sleep in manHuman auditory evoked potentials during natural sleep: the early componentsAwake perception is associated with dedicated neuronal assemblies in the cerebral cortexArchitecture and organization of mouse posterior parietal cortex relative to extrastriate areasGateways of ventral and dorsal streams in mouse visual cortexThe mouse posterior parietal cortex: Anatomy and functionsDynamical representation of odors by oscillating and evolving neural assembliesNeuronal oscillations in cortical networksDiverse Phase Relations among Neuronal Rhythms and Their Potential FunctionSynchronous oscillatory neural ensembles for rules in the prefrontal cortexHippocampal theta oscillations are travelling wavesRapid feature selective neuronal synchronization through correlated latency shiftingWhat does gamma coherence tell us about inter-regional neural communication?Dynamics of Ongoing Activity : Explanation of the Large Variability in Evoked Cortical ResponsesA Sensorimotor Role for Traveling Waves in Primate Visual CortexSpontaneous traveling waves naturally emerge from horizontal fiber time delays and travel through locally asynchronous-irregular statesActivated cortical states: experiments, analyses and modelsNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neuronsKetamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortexPreferential effect of isoflurane on top-down vs . bottom-up pathways in sensory cortexExcitatory synaptic transmission mediated by NMDA receptors is more sensitive to isoflurane than are non-NMDA receptor-mediated responsesNeural Correlates of Unconsciousness in Large-Scale Brain NetworksDevelopment of a large-scale functional brain network during human non-rapid eye movement sleepDisruption of Frontal–Parietal Communication by Ketamine, Propofol, and SevofluraneEEG entropy measures indicate decrease of cortical information processing in Disorders of ConsciousnessNeuroscience: Breakdown of cortical effective connectivity during sleepPreserved Feedforward But Impaired Top-Down Processes in the Vegetative StateA Theoretically Based Index of Consciousness Independent of Sensory Processing and BehaviorBreakdown in cortical effective connectivity during midazolam-induced loss of consciousnessKetamine alters rat flash evoked potentialsMesoscale cortical dynamics reflect the interaction of sensory evidence and temporal expectation during perceptual decision-makingDistributed coding of choice, action and engagement across the mouse brainSensory coding and the causal impact of mouse cortex in a visual decisionIsolated correlates of somatosensory perception in the mouse posterior cortexHierarchical models of object recognition in cortexReceptive fields, binocular interaction and functional architecture in the cat’s visual cortexPrimary visual cortex and visual awarenessThe anatomy of conscious vision: an fMRI study of visual hallucinationsCerebral cortex lesions: The dream process and sleep spindlesDreaming and the brain: from phenomenology to neurophysiologyWhat geometric visual hallucinations tell us about the visual cortexDynamic stimulation of visual cortex produces form vision in sighted and blind humansScalp block’ during craniotomy: A classic technique revisitedExperimental Optimization of Current Source-Density Technique for Anuran CerebellumA method for calculating current source density (CSD) analysis without resorting to recording sites outside the sampling volumeA Practical Guide to Wavelet AnalysisFast and accurate spike sorting of high-channel count probes with KiloSortMeasuring phase-amplitude coupling between neuronal oscillations of different frequencies</div>
                            <small style="color: var(--text-muted)">12455724.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...tical significance was set at p < 0.05 unless otherwise stated. To d...'}</li><li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...s manner (11 out of 14 mice). Continuous wavelet transform with Morlet...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for -Positive Breast CancerTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsEarly breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSSix versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialEffect of adjuvant trastuzumab for a duration of 9 weeks vs 1 year with concomitant chemotherapy for early human epidermal growth factor receptor 2-positive breast cancer: the SOLD randomized clinical trialNine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER studyNine-week versus one-year trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: 10-year update of the ShortHER phase III randomized trialTrastuzumab and chemotherapeutics: drug interactions and synergiesFour-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III studyLonger-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trialRisk of congestive heart failure in early breast cancer patients undergoing adjuvant treatment with trastuzumab: a meta-analysisAccess to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional surveyMetastatic behavior of breast cancer subtypes">Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for -Positive Breast CancerTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsEarly breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upPan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSSix versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialEffect of adjuvant trastuzumab for a duration of 9 weeks vs 1 year with concomitant chemotherapy for early human epidermal growth factor receptor 2-positive breast cancer: the SOLD randomized clinical trialNine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER studyNine-week versus one-year trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: 10-year update of the ShortHER phase III randomized trialTrastuzumab and chemotherapeutics: drug interactions and synergiesFour-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III studyLonger-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trialRisk of congestive heart failure in early breast cancer patients undergoing adjuvant treatment with trastuzumab: a meta-analysisAccess to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional surveyMetastatic behavior of breast cancer subtypes</div>
                            <small style="color: var(--text-muted)">12507463.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...f 1.3, 1-sided testing, and a dropout rate of 3%, the estimated fin...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Early-life serological profiles and the development of natural protective humoral immunity to  in a high-burden settingPublisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to  in a high-burden settingThe global burden of group A streptococcal diseasesGlobal, regional, and national burden of rheumatic heart disease, 1990–2015The  vaccine landscapeThe path to Group A  vaccines: World Health Organization research and development technology roadmap and preferred product characteristicsHigh burden and seasonal variation of paediatric scabies and pyoderma prevalence in The Gambia: a cross-sectional studyCorrelates of immunity to Group A Streptococcus: a pathway to vaccine developmentWHO/IVI global stakeholder consultation on group A  vaccine development: report from a meeting held on 12–13 December 2016Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis carriage and infection within households in The Gambia: a longitudinal cohort studyIdentification of the  surface antigens recognised by pooled human immunoglobulinNaturally acquired functional antibody responses to group A  differ between major strain typesCorrelates of protection for M protein-based vaccines against group A streptococcusProtective study with a Group A streptococcal M protein vaccine: infectivity challenge of human volunteersNew 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciSafety and immunogenicity of a 30-valent M protein-based group A streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I studyStudies on immunity to streptococcal infections in manType-specific immunity and pharyngeal acquisition of group A Acquisition of Group A streptococcal M protein antibodiesGlobal  type distribution of group A streptococci: systematic review and implications for vaccine developmentGlobal  strain diversity, disease associations, and implications for vaccine development: a systematic reviewMulti high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseProspective longitudinal analysis of immune responses in pediatric subjects after pharyngeal acquisition of group A StreptococciAn experimental Group A  vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate modelSerum immune responses to group A Streptococcal antigens following pharyngeal acquisitions among children in Cape Town, South AfricaSite-specific conjugation of cell wall polyrhamnose to protein SpyAD envisioning a safe universal group A Streptococcal vaccineImpact of immunization against SpyCEP during invasive disease with two streptococcal species:  and Development and characterisation of a four-plex assay to measure  antigen-specific IgG in human seraAn eight-plex immunoassay for Group A streptococcus serology and vaccine developmentImmune cross-opsonization within  clusters following Group A  skin infection: broadening the scope of type-specific immunitySystematic review and meta-analysis of the prevalence of group A Streptococcal  clusters in Africa to inform vaccine developmentMolecular epidemiology of Group A  infections in The GambiaGenomic characterization of skin and soft tissue 
 isolates from a low-income and a high-income settingDevelopment and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human seraCharacterization of an IL-8 cleavage inhibition assay to determine the functionality of anti-SpyCEP antibodies in human seraA flow cytometry-based assay to determine the ability of anti- antibodies to mediate monocytic phagocytosis in human seraPrime-pull immunization with a bivalent M-protein and Spy-CEP peptide vaccine adjuvanted with CAF®01 liposomes induces both mucosal and peripheral protection from  mutant Normal ranges of Streptococcal antibody titers are similar whether streptococci are endemic to the setting or notCross-sectional study of population-specific streptococcal antibody titres in Uganda pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsThe role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tractSerological profiling of group A  infections in acute rheumatic feverIncreased breadth of Group A  antibody responses in children with acute rheumatic fever compared to precursor pharyngitis and skin infectionsAn acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and -specific antibodiesFc glycan-mediated regulation of placental antibody transferImmunoglobulin G and subclasses placental transfer in fetuses and preterm newborns: a systematic reviewModeling the potential health impact of prospective Strep A vaccinesHigh burden of impetigo and scabies in a tropical countryStructure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccineMolecular methods enhance the detection of pyoderma-related 
- type distribution in childrenA double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent Group A  vaccine in healthy adultsProgress towards a glycoconjugate vaccine against Group A StreptococcusGroup A Streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infectionThe classical Lancefield antigen of Group A  is a virulence determinant with implications for vaccine designEvaluation of a Group A  synthetic oligosaccharide as vaccine candidateStreptococcal immunity is constrained by lack of immunological memory following a single episode of pyodermaImmune signature of acute pharyngitis in a  human challenge trialEvaluating clinical decision rules and rapid diagnostic tests for the diagnosis of  pharyngitis in Gambian children: a diagnostic accuracy studyConstructing time-specific reference rangesReconstruction of antibody dynamics and infection histories to evaluate dengue risk">Early-life serological profiles and the development of natural protective humoral immunity to  in a high-burden settingPublisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to  in a high-burden settingThe global burden of group A streptococcal diseasesGlobal, regional, and national burden of rheumatic heart disease, 1990–2015The  vaccine landscapeThe path to Group A  vaccines: World Health Organization research and development technology roadmap and preferred product characteristicsHigh burden and seasonal variation of paediatric scabies and pyoderma prevalence in The Gambia: a cross-sectional studyCorrelates of immunity to Group A Streptococcus: a pathway to vaccine developmentWHO/IVI global stakeholder consultation on group A  vaccine development: report from a meeting held on 12–13 December 2016Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis carriage and infection within households in The Gambia: a longitudinal cohort studyIdentification of the  surface antigens recognised by pooled human immunoglobulinNaturally acquired functional antibody responses to group A  differ between major strain typesCorrelates of protection for M protein-based vaccines against group A streptococcusProtective study with a Group A streptococcal M protein vaccine: infectivity challenge of human volunteersNew 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciSafety and immunogenicity of a 30-valent M protein-based group A streptococcal vaccine in healthy adult volunteers: a randomized, controlled phase I studyStudies on immunity to streptococcal infections in manType-specific immunity and pharyngeal acquisition of group A Acquisition of Group A streptococcal M protein antibodiesGlobal  type distribution of group A streptococci: systematic review and implications for vaccine developmentGlobal  strain diversity, disease associations, and implications for vaccine development: a systematic reviewMulti high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseProspective longitudinal analysis of immune responses in pediatric subjects after pharyngeal acquisition of group A StreptococciAn experimental Group A  vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate modelSerum immune responses to group A Streptococcal antigens following pharyngeal acquisitions among children in Cape Town, South AfricaSite-specific conjugation of cell wall polyrhamnose to protein SpyAD envisioning a safe universal group A Streptococcal vaccineImpact of immunization against SpyCEP during invasive disease with two streptococcal species:  and Development and characterisation of a four-plex assay to measure  antigen-specific IgG in human seraAn eight-plex immunoassay for Group A streptococcus serology and vaccine developmentImmune cross-opsonization within  clusters following Group A  skin infection: broadening the scope of type-specific immunitySystematic review and meta-analysis of the prevalence of group A Streptococcal  clusters in Africa to inform vaccine developmentMolecular epidemiology of Group A  infections in The GambiaGenomic characterization of skin and soft tissue 
 isolates from a low-income and a high-income settingDevelopment and characterization of a hemolysis inhibition assay to determine functionality of anti-Streptolysin O antibodies in human seraCharacterization of an IL-8 cleavage inhibition assay to determine the functionality of anti-SpyCEP antibodies in human seraA flow cytometry-based assay to determine the ability of anti- antibodies to mediate monocytic phagocytosis in human seraPrime-pull immunization with a bivalent M-protein and Spy-CEP peptide vaccine adjuvanted with CAF®01 liposomes induces both mucosal and peripheral protection from  mutant Normal ranges of Streptococcal antibody titers are similar whether streptococci are endemic to the setting or notCross-sectional study of population-specific streptococcal antibody titres in Uganda pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infectionsThe role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tractSerological profiling of group A  infections in acute rheumatic feverIncreased breadth of Group A  antibody responses in children with acute rheumatic fever compared to precursor pharyngitis and skin infectionsAn acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and -specific antibodiesFc glycan-mediated regulation of placental antibody transferImmunoglobulin G and subclasses placental transfer in fetuses and preterm newborns: a systematic reviewModeling the potential health impact of prospective Strep A vaccinesHigh burden of impetigo and scabies in a tropical countryStructure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccineMolecular methods enhance the detection of pyoderma-related 
- type distribution in childrenA double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent Group A  vaccine in healthy adultsProgress towards a glycoconjugate vaccine against Group A StreptococcusGroup A Streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infectionThe classical Lancefield antigen of Group A  is a virulence determinant with implications for vaccine designEvaluation of a Group A  synthetic oligosaccharide as vaccine candidateStreptococcal immunity is constrained by lack of immunological memory following a single episode of pyodermaImmune signature of acute pharyngitis in a  human challenge trialEvaluating clinical decision rules and rapid diagnostic tests for the diagnosis of  pharyngitis in Gambian children: a diagnostic accuracy studyConstructing time-specific reference rangesReconstruction of antibody dynamics and infection histories to evaluate dengue risk</div>
                            <small style="color: var(--text-muted)">12532705.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'Paired data mentioned but no paired statistical tests found.', 'evidence': '...nes events within the SpyCATS longitudinal cohort study. RFEs were defin...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trialPembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinomaNCCN Guidelines® Insights: Kidney Cancer, Version 2.2024Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-upPredictive biomarkers of response to immunotherapy in metastatic renal cell cancerManagement of renal cell carcinoma: promising biomarkers and the challenges to reach the clinicMolecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockadeAvelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialFinal overall survival and molecular analysis in IMmotion151, a phase 3 trial comparing atezolizumab plus bevacizumab vs sunitinib in patients with previously untreated metastatic renal cell carcinomaImpact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenal cell carcinoma in the era of precision medicine: from molecular pathology to tissue-based biomarkersA pan-cancer analysis of PBAF complex mutations and their association with immunotherapy responseTranscriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trialClinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinomaGenomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma and  cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancerClinical validation of  alterations as a marker of immune checkpoint inhibitor response in renal cell carcinomaBiomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC)1694MO Novel serum glycoproteomic biomarkers predict response to nivolumab plus cabozantinib (NIVO+CABO) versus sunitinib (SUN) in advanced RCC (aRCC): analysis from CheckMate 9ERKIM-1 as a circulating biomarker in metastatic RCC: post-hoc analysis of JAVELIN Renal 101Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): post-hoc analysis of CheckMate 214Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapyTranscriptomic determinants of response to pembrolizumab monotherapy across solid tumor typesPutative biomarkers of clinical benefit with pembrolizumab in advanced urothelial cancer: results from the KEYNOTE-045 and KEYNOTE-052 landmark trialsT-cell-inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with pembrolizumab across 20 cancers: KEYNOTE-028Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trialAssociation of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427IFN-γ-related mRNA profile predicts clinical response to PD-1 blockadeUpdate on biomarkers in renal cell carcinomaPembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trialPembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 KEYNOTE-426 studyBiomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaUnderstanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effectImmunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patientsTyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapyLenvatinib plus pembrolizumab versus sunitinib in first-line treatment of advanced renal cell carcinoma: final prespecified overall survival analysis of CLEAR, a phase III studyNivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase 3 CheckMate 214 trialNivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): final follow-up results from the CheckMate 9ER trialBiomarker-driven prospective clinical trial in renal cell carcinoma: developing machine learning models to allocate patients to treatment arms using RNA sequencingSAMETA: a phase III study of savolitinib + durvalumab vs sunitinib and durvalumab monotherapy in patients with MET-driven, unresectable, locally advanced/metastatic papillary renal cell carcinomaThe tumor immune microenvironment in clear cell renal cell carcinomaOSA: a fast and accurate alignment tool for RNAseqRSEM: accurate transcript quantification from RNA-seq data with or without a reference genomeTumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumorsSensitive detection of somatic point mutations in impure and heterogeneous cancer samplesThe COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteMolecular profiling of cohorts of tumor samples to guide clinical development of pembrolizumab as monotherapy">Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trialPembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinomaNCCN Guidelines® Insights: Kidney Cancer, Version 2.2024Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-upPredictive biomarkers of response to immunotherapy in metastatic renal cell cancerManagement of renal cell carcinoma: promising biomarkers and the challenges to reach the clinicMolecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockadeAvelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trialFinal overall survival and molecular analysis in IMmotion151, a phase 3 trial comparing atezolizumab plus bevacizumab vs sunitinib in patients with previously untreated metastatic renal cell carcinomaImpact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenal cell carcinoma in the era of precision medicine: from molecular pathology to tissue-based biomarkersA pan-cancer analysis of PBAF complex mutations and their association with immunotherapy responseTranscriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trialClinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinomaGenomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma and  cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancerClinical validation of  alterations as a marker of immune checkpoint inhibitor response in renal cell carcinomaBiomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC)1694MO Novel serum glycoproteomic biomarkers predict response to nivolumab plus cabozantinib (NIVO+CABO) versus sunitinib (SUN) in advanced RCC (aRCC): analysis from CheckMate 9ERKIM-1 as a circulating biomarker in metastatic RCC: post-hoc analysis of JAVELIN Renal 101Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): post-hoc analysis of CheckMate 214Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapyTranscriptomic determinants of response to pembrolizumab monotherapy across solid tumor typesPutative biomarkers of clinical benefit with pembrolizumab in advanced urothelial cancer: results from the KEYNOTE-045 and KEYNOTE-052 landmark trialsT-cell-inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with pembrolizumab across 20 cancers: KEYNOTE-028Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trialAssociation of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427IFN-γ-related mRNA profile predicts clinical response to PD-1 blockadeUpdate on biomarkers in renal cell carcinomaPembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trialPembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 KEYNOTE-426 studyBiomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaUnderstanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effectImmunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patientsTyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapyLenvatinib plus pembrolizumab versus sunitinib in first-line treatment of advanced renal cell carcinoma: final prespecified overall survival analysis of CLEAR, a phase III studyNivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase 3 CheckMate 214 trialNivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): final follow-up results from the CheckMate 9ER trialBiomarker-driven prospective clinical trial in renal cell carcinoma: developing machine learning models to allocate patients to treatment arms using RNA sequencingSAMETA: a phase III study of savolitinib + durvalumab vs sunitinib and durvalumab monotherapy in patients with MET-driven, unresectable, locally advanced/metastatic papillary renal cell carcinomaThe tumor immune microenvironment in clear cell renal cell carcinomaOSA: a fast and accurate alignment tool for RNAseqRSEM: accurate transcript quantification from RNA-seq data with or without a reference genomeTumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumorsSensitive detection of somatic point mutations in impure and heterogeneous cancer samplesThe COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteMolecular profiling of cohorts of tumor samples to guide clinical development of pembrolizumab as monotherapy</div>
                            <small style="color: var(--text-muted)">12532709.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...nature and PD-L1 CPS indicate nominal statistical significance (α\u2009<...'}</li><li>{'message': 'Includes exploratory/post hoc analyses without clear multiplicity correction.', 'evidence': '...sk category and PD-L1 status. Post hoc analysis of efficacy was also...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingPatient access to medicines for rare diseases in European countriesReference pricing as a deterrent to entry: evidence from the European Pharmaceutical MarketAssessing the consequences of external reference pricing for global access to medicines and innovation: economic analysis and policy implicationsDoes external reference pricing deliver what it promises? Evidence on its impact at national levelThe implications of external price referencing on pharmaceutical list prices in EuropeComparison of prices and affordability of cancer medicines in 16 countries in Europe and Latin AmericaActual costs of cancer drugs in 15 European countriesRegulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicinesA systematic review of pooled procurement of medicines and vaccines: identifying elements of successCost containment through pharmaceutical procurement: a Caribbean case studyMulti-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemicA win-win solution? A critical analysis of tiered pricing to improve access to medicines in developing countriesValue-based tiered pricing for universal health coverage: an idea worth revisitingDifferential pricing of pharmaceuticals: a bibliometric review of the literature">Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingPatient access to medicines for rare diseases in European countriesReference pricing as a deterrent to entry: evidence from the European Pharmaceutical MarketAssessing the consequences of external reference pricing for global access to medicines and innovation: economic analysis and policy implicationsDoes external reference pricing deliver what it promises? Evidence on its impact at national levelThe implications of external price referencing on pharmaceutical list prices in EuropeComparison of prices and affordability of cancer medicines in 16 countries in Europe and Latin AmericaActual costs of cancer drugs in 15 European countriesRegulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicinesA systematic review of pooled procurement of medicines and vaccines: identifying elements of successCost containment through pharmaceutical procurement: a Caribbean case studyMulti-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemicA win-win solution? A critical analysis of tiered pricing to improve access to medicines in developing countriesValue-based tiered pricing for universal health coverage: an idea worth revisitingDifferential pricing of pharmaceuticals: a bibliometric review of the literature</div>
                            <small style="color: var(--text-muted)">12599524.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Policies to promote affordability and access across the life cycle of costly new drugsScientific advancements in gene therapies: opportunities for global regulatory convergenceTowards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)PB2215: global epidemiology of sickle cell disease: a systematic literature reviewContribution of NIH funding to new drug approvals 2010-2016Using Bayh-Dole Act march-in rights to lower US drug pricesThe Lancet Commission on lessons for the future from the COVID-19 pandemicUS public investment in development of mRNA covid-19 vaccines: retrospective cohort studyWhich roads lead to access? A global landscape of six COVID-19 vaccine innovation modelsDeveloping globally-accessible medicines for pandemic preparedness: An analysis of three alternative innovation modelsDrug regulation and pricing—Can regulators influence affordability?Navigating facilitated regulatory pathways during a disease X pandemicRegulatory pathways supporting expedited drug development and approval in ICH member countriesReliance is key to effective access and oversight of medical products in case of public health emergenciesGlobal regulatory progress in delivering on the promise of gene therapies for unmet medical needsChallenges and strategies for improving access to cancer drugs in Malaysia: summary of opinions expressed at the 2nd MACR International Scientific Conference 2022Political economy of vaccine diplomacy: explaining varying strategies of China, India, and Russia’s COVID-19 vaccine diplomacyRe-envisioning pharmaceutical manufacturing: increasing agility for global patient accessBarriers to Treg therapy in Europe: from production to regulationDecentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in IndiaCost of decentralized CAR T-cell production in an academic nonprofit settingPathways to ensure universal and affordable access to hepatitis C treatmentInternational collaboration to improve assessment of drug value to include stakeholder perspectives and better managed entry agreementsCollective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingWhere national medicines policies have taken us with patient involvement and health technology assessment in AfricaEuropean Medicines Agency-Health Technology Assessment Parallel Consultation Platform: An industry perspective">Policies to promote affordability and access across the life cycle of costly new drugsScientific advancements in gene therapies: opportunities for global regulatory convergenceTowards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)PB2215: global epidemiology of sickle cell disease: a systematic literature reviewContribution of NIH funding to new drug approvals 2010-2016Using Bayh-Dole Act march-in rights to lower US drug pricesThe Lancet Commission on lessons for the future from the COVID-19 pandemicUS public investment in development of mRNA covid-19 vaccines: retrospective cohort studyWhich roads lead to access? A global landscape of six COVID-19 vaccine innovation modelsDeveloping globally-accessible medicines for pandemic preparedness: An analysis of three alternative innovation modelsDrug regulation and pricing—Can regulators influence affordability?Navigating facilitated regulatory pathways during a disease X pandemicRegulatory pathways supporting expedited drug development and approval in ICH member countriesReliance is key to effective access and oversight of medical products in case of public health emergenciesGlobal regulatory progress in delivering on the promise of gene therapies for unmet medical needsChallenges and strategies for improving access to cancer drugs in Malaysia: summary of opinions expressed at the 2nd MACR International Scientific Conference 2022Political economy of vaccine diplomacy: explaining varying strategies of China, India, and Russia’s COVID-19 vaccine diplomacyRe-envisioning pharmaceutical manufacturing: increasing agility for global patient accessBarriers to Treg therapy in Europe: from production to regulationDecentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in IndiaCost of decentralized CAR T-cell production in an academic nonprofit settingPathways to ensure universal and affordable access to hepatitis C treatmentInternational collaboration to improve assessment of drug value to include stakeholder perspectives and better managed entry agreementsCollective international action to increase access to costly drugs: pooled procurement and equity based tiered pricingWhere national medicines policies have taken us with patient involvement and health technology assessment in AfricaEuropean Medicines Agency-Health Technology Assessment Parallel Consultation Platform: An industry perspective</div>
                            <small style="color: var(--text-muted)">12599526.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEmergency department management and 1-year outcomes of patients with atrial flutterThe epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the emergency departmentDevelopment of a care pathway for atrial fibrillation patients in the emergency departmentCanadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency departmentOutcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in Canadian hospitalsEmergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 20142025 Heart disease and stroke statistics: a report of US and global data from the American Heart AssociationVariation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departmentsEarly rhythm-control therapy in patients with atrial fibrillationBenefits of rhythm control and rate control in recent-onset atrial fibrillation: the HERMES-AF studyElectrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trialEarly or delayed cardioversion in recent-onset atrial fibrillationThe 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillationAdverse events associated with electrical cardioversion in patients with acute atrial fibrillation and atrial flutter2021 CAEP acute atrial fibrillation/flutter best practices checklistAn international view of how recent-onset atrial fibrillation is treated in the emergency departmentVernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesUse of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agentsTorsade de pointes: the clinical considerationsComparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythmMyth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency departmentConversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trialsAmiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysisEffectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysisEfficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trialsSingle oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillationOutpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approachComparison of intravenous vernakalant and electrical cardioversion in recent-onset atrial fibrillation: effect on time to restore sinus rhythm and length of hospital stayVernakalant for rapid cardioversion of recent-onset atrial fibrillation: results from the SPECTRUM studyPharmacologic cardioversion in patients with paroxysmal atrial fibrillation: a network meta-analysisSafety and effectiveness of antidysrhythmic drugs for pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and Bayesian network meta-analysisRecommendations for patient engagement in patient-oriented emergency medicine research2016 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillationApplying the intention-to-treat principle in practice: guidance on handling randomisation errorsImproper analysis of trials randomised using stratified blocks or minimisationThe risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studiesEmergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Resuscitation Council Guidelines 2021: adult advanced life support">Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEmergency department management and 1-year outcomes of patients with atrial flutterThe epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the emergency departmentDevelopment of a care pathway for atrial fibrillation patients in the emergency departmentCanadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency departmentOutcomes for emergency department patients with recent-onset atrial fibrillation and flutter treated in Canadian hospitalsEmergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 20142025 Heart disease and stroke statistics: a report of US and global data from the American Heart AssociationVariation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departmentsEarly rhythm-control therapy in patients with atrial fibrillationBenefits of rhythm control and rate control in recent-onset atrial fibrillation: the HERMES-AF studyElectrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trialEarly or delayed cardioversion in recent-onset atrial fibrillationThe 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillationAdverse events associated with electrical cardioversion in patients with acute atrial fibrillation and atrial flutter2021 CAEP acute atrial fibrillation/flutter best practices checklistAn international view of how recent-onset atrial fibrillation is treated in the emergency departmentVernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesUse of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agentsTorsade de pointes: the clinical considerationsComparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythmMyth: Intravenous amiodarone is safe in patients with atrial fibrillation and Wolff-Parkinson-White syndrome in the emergency departmentConversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trialsAmiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysisEffectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysisEfficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trialsSingle oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillationOutpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approachComparison of intravenous vernakalant and electrical cardioversion in recent-onset atrial fibrillation: effect on time to restore sinus rhythm and length of hospital stayVernakalant for rapid cardioversion of recent-onset atrial fibrillation: results from the SPECTRUM studyPharmacologic cardioversion in patients with paroxysmal atrial fibrillation: a network meta-analysisSafety and effectiveness of antidysrhythmic drugs for pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and Bayesian network meta-analysisRecommendations for patient engagement in patient-oriented emergency medicine research2016 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillationApplying the intention-to-treat principle in practice: guidance on handling randomisation errorsImproper analysis of trials randomised using stratified blocks or minimisationThe risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studiesEmergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Resuscitation Council Guidelines 2021: adult advanced life support</div>
                            <small style="color: var(--text-muted)">12603894.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Includes exploratory/post hoc analyses without clear multiplicity correction.', 'evidence': '...Patients who were determined post hoc not to be in atrial fibrillat...'}</li><li>{'message': 'P-values reported only as thresholds (e.g., P<0.05).', 'evidence': '...rried out at the two sided 5% significance level. We also used a secondary per...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trialPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)">EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trialPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)</div>
                            <small style="color: var(--text-muted)">12609181.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsCirculating tumor DNA as a clinical test in resected pancreatic cancerAssociation of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinomaPancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer DatabaseOptimized anchor-modified peptides targeting mutated RAS are promising candidates for immunotherapyHigh-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12DGeneration of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryFrom sewer to saviour—targeting the lymphatic system to promote drug exposure and activityStructure-based programming of lymph-node targeting in molecular vaccinesLymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialMeasuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysisPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerRNA neoantigen vaccines prime long-lived CD8 T cells in pancreatic cancerT-cell responses to individualized neoantigen therapy mRNA-4157 (V940) alone or in combination with pembrolizumab in the phase 1 KEYNOTE-603 studyPersonalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trialA neoantigen vaccine generates antitumour immunity in renal cell carcinomaCirculating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancerDistinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerDistinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinomaEradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesLymph node–targeted vaccine boosting of TCR T-cell therapy enhances antitumor function and eradicates solid tumorsVaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneityJoint confidence region estimation for area under ROC curve and Youden index">Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsCirculating tumor DNA as a clinical test in resected pancreatic cancerAssociation of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinomaPancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer DatabaseOptimized anchor-modified peptides targeting mutated RAS are promising candidates for immunotherapyHigh-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12DGeneration of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryFrom sewer to saviour—targeting the lymphatic system to promote drug exposure and activityStructure-based programming of lymph-node targeting in molecular vaccinesLymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialMeasuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysisPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancerRNA neoantigen vaccines prime long-lived CD8 T cells in pancreatic cancerT-cell responses to individualized neoantigen therapy mRNA-4157 (V940) alone or in combination with pembrolizumab in the phase 1 KEYNOTE-603 studyPersonalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trialA neoantigen vaccine generates antitumour immunity in renal cell carcinomaCirculating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancerDistinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerDistinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinomaEradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesLymph node–targeted vaccine boosting of TCR T-cell therapy enhances antitumor function and eradicates solid tumorsVaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneityJoint confidence region estimation for area under ROC curve and Youden index</div>
                            <small style="color: var(--text-muted)">12618236.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Survival analysis used without verifying proportional hazards assumption.', 'evidence': '...e survival distributions. The log-rank test was used to compare the...'}</li><li>{'message': 'Diagnostic metrics reported without Confidence Intervals.', 'evidence': '...low T cell responders and the ROC analysis was performed using...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A multimodal whole-slide foundation model for pathologyArtificial intelligence for digital and computational pathologyFine-tuning and training of DenseNet for histopathology image representation using TCGA diagnostic slidesSelf supervised contrastive learning for digital histopathologyTransformer-based unsupervised contrastive learning for histopathological image classificationRetCCL: clustering-guided contrastive learning for whole-slide image retrievalA visual–language foundation model for pathology image analysis using medical TwitterRobust and data-efficient generalization of self-supervised machine learning for diagnostic imagingTowards a general-purpose foundation model for computational pathologyA visual-language foundation model for computational pathologyA foundation model for clinical-grade computational pathology and rare cancers detectionArtificial intelligence in digital pathology—new tools for diagnosis and precision oncologyDeep learning in cancer pathology: a new generation of clinical biomarkersArtificial intelligence in histopathology: enhancing cancer research and clinical oncologyA clinical benchmark of public self-supervised pathology foundation modelsPredicting non-small cell lung cancer prognosis by fully automated microscopic pathology image featuresDeep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsiesClassification and mutation prediction from non-small cell lung cancer histopathology images using deep learningClinical-grade computational pathology using weakly supervised deep learning on whole slide imagesDeep learning can predict microsatellite instability directly from histology in gastrointestinal cancerAI-based pathology predicts origins for cancers of unknown primaryPan-cancer computational histopathology reveals mutations, tumor composition and prognosisArtificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA ChallengeA graph-transformer for whole slide image classificationDeep learning for prediction of colorectal cancer outcome: a discovery and validation studyDiagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancerTransformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric studyMultistain deep learning for prediction of prognosis and therapy response in colorectal cancerDeep learning-based classification of mesothelioma improves prediction of patient outcomeDerivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learningGeneralizable biomarker prediction from cancer pathology slides with self-supervised deep learning: a retrospective multi-centric studyArtificial intelligence in healthcareSelf-supervised learning in medicine and healthcareReal-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detectionDeep learning in histopathology: the path to the clinicBurden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyContent-based multimedia information retrieval: State of the art and challengesVisual pattern mining in histology image collections using bag of featuresContent-based image retrieval of digitized histopathology in boosted spectrally embedded spacesYottixel—an image search engine for large archives of histopathology whole slide imagesFast and scalable search of whole-slide images via self-supervised deep learningHistopathological whole slide image analysis using context-based CBIRHistopathology slide indexing and search—are we there yet?Quilt-1m: one million image–text pairs for histopathologyA whole-slide foundation model for digital pathology from real-world dataGenerating dermatopathology reports from gigapixel whole slide images with HistogptData-efficient and weakly supervised computational pathology on whole-slide imagesTransmil: transformer based correlated multiple instance learning for whole slide image classificationFoundation models for fast, label-free detection of glioma infiltrationA pathology foundation model for cancer diagnosis and prognosis predictionFoundation models for generalist medical artificial intelligenceA multimodal generative AI copilot for human pathologySynthetic data in machine learning for medicine and healthcareSynthetic data in medical researchGeneration of synthetic whole-slide image tiles of tumours from RNA-sequencing data via cascaded diffusion modelsThe Cancer Genome Atlas pan-cancer analysis projectAn integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analyticsThe CPTAC data portal: a resource for cancer proteomics researchAbstract LB-242: proteomic data commons: a resource for proteogenomic analysisPathologist-level classification of histologic patterns on resected lung adenocarcinoma slides with deep neural networksDevelopment and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slidesLeakage and the reproducibility crisis in machine-learning-based scienceOncotree: a cancer classification system for precision oncologyTCGA-Reports: a machine-readable pathology report resource for benchmarking text-based AI modelsMachine learning methods for histopathological image analysisSimilar image search for histopathology: SMILYPheochromocytoma and paragangliomaHest-1k: A dataset for spatial transcriptomics and histology image analysisImage analysis: understanding and mitigating batch effects in histopathologyDemographic bias in misdiagnosis by computational pathology modelsGenerative artificial intelligence in anatomic pathologyThe genotype-tissue expression (GTEx) projectIntegrating context for superior cancer prognosisBias in cross-entropy-based training of deep survival networksThe impact of site-specific digital histology signatures on deep learning model accuracy and biasPredicting axillary lymph node metastasis in early breast cancer using deep learning on primary tumor biopsy slidesBracs: a dataset for breast carcinoma subtyping in H&E histology imagesThe Digital Brain Tumour Atlas, an open histopathology resourceCAD systems for colorectal cancer from WSI are still not ready for clinical acceptanceiMIL4PATH: a semi-supervised interpretable approach for colorectal whole-slide imagesAn interpretable machine learning system for colorectal cancer diagnosis from pathology slidesClear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expressionIntratumoral resolution of driver gene mutation heterogeneity in renal cancer using deep learningWeakly supervised joint whole-slide segmentation and classification in prostate cancerMultimodal integration of radiology, pathology and genomics for prediction of response to PD-(L) 1 blockade in patients with non-small cell lung cancer">A multimodal whole-slide foundation model for pathologyArtificial intelligence for digital and computational pathologyFine-tuning and training of DenseNet for histopathology image representation using TCGA diagnostic slidesSelf supervised contrastive learning for digital histopathologyTransformer-based unsupervised contrastive learning for histopathological image classificationRetCCL: clustering-guided contrastive learning for whole-slide image retrievalA visual–language foundation model for pathology image analysis using medical TwitterRobust and data-efficient generalization of self-supervised machine learning for diagnostic imagingTowards a general-purpose foundation model for computational pathologyA visual-language foundation model for computational pathologyA foundation model for clinical-grade computational pathology and rare cancers detectionArtificial intelligence in digital pathology—new tools for diagnosis and precision oncologyDeep learning in cancer pathology: a new generation of clinical biomarkersArtificial intelligence in histopathology: enhancing cancer research and clinical oncologyA clinical benchmark of public self-supervised pathology foundation modelsPredicting non-small cell lung cancer prognosis by fully automated microscopic pathology image featuresDeep learning-enabled assessment of cardiac allograft rejection from endomyocardial biopsiesClassification and mutation prediction from non-small cell lung cancer histopathology images using deep learningClinical-grade computational pathology using weakly supervised deep learning on whole slide imagesDeep learning can predict microsatellite instability directly from histology in gastrointestinal cancerAI-based pathology predicts origins for cancers of unknown primaryPan-cancer computational histopathology reveals mutations, tumor composition and prognosisArtificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA ChallengeA graph-transformer for whole slide image classificationDeep learning for prediction of colorectal cancer outcome: a discovery and validation studyDiagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancerTransformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric studyMultistain deep learning for prediction of prognosis and therapy response in colorectal cancerDeep learning-based classification of mesothelioma improves prediction of patient outcomeDerivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learningGeneralizable biomarker prediction from cancer pathology slides with self-supervised deep learning: a retrospective multi-centric studyArtificial intelligence in healthcareSelf-supervised learning in medicine and healthcareReal-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detectionDeep learning in histopathology: the path to the clinicBurden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyContent-based multimedia information retrieval: State of the art and challengesVisual pattern mining in histology image collections using bag of featuresContent-based image retrieval of digitized histopathology in boosted spectrally embedded spacesYottixel—an image search engine for large archives of histopathology whole slide imagesFast and scalable search of whole-slide images via self-supervised deep learningHistopathological whole slide image analysis using context-based CBIRHistopathology slide indexing and search—are we there yet?Quilt-1m: one million image–text pairs for histopathologyA whole-slide foundation model for digital pathology from real-world dataGenerating dermatopathology reports from gigapixel whole slide images with HistogptData-efficient and weakly supervised computational pathology on whole-slide imagesTransmil: transformer based correlated multiple instance learning for whole slide image classificationFoundation models for fast, label-free detection of glioma infiltrationA pathology foundation model for cancer diagnosis and prognosis predictionFoundation models for generalist medical artificial intelligenceA multimodal generative AI copilot for human pathologySynthetic data in machine learning for medicine and healthcareSynthetic data in medical researchGeneration of synthetic whole-slide image tiles of tumours from RNA-sequencing data via cascaded diffusion modelsThe Cancer Genome Atlas pan-cancer analysis projectAn integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analyticsThe CPTAC data portal: a resource for cancer proteomics researchAbstract LB-242: proteomic data commons: a resource for proteogenomic analysisPathologist-level classification of histologic patterns on resected lung adenocarcinoma slides with deep neural networksDevelopment and evaluation of a deep neural network for histologic classification of renal cell carcinoma on biopsy and surgical resection slidesLeakage and the reproducibility crisis in machine-learning-based scienceOncotree: a cancer classification system for precision oncologyTCGA-Reports: a machine-readable pathology report resource for benchmarking text-based AI modelsMachine learning methods for histopathological image analysisSimilar image search for histopathology: SMILYPheochromocytoma and paragangliomaHest-1k: A dataset for spatial transcriptomics and histology image analysisImage analysis: understanding and mitigating batch effects in histopathologyDemographic bias in misdiagnosis by computational pathology modelsGenerative artificial intelligence in anatomic pathologyThe genotype-tissue expression (GTEx) projectIntegrating context for superior cancer prognosisBias in cross-entropy-based training of deep survival networksThe impact of site-specific digital histology signatures on deep learning model accuracy and biasPredicting axillary lymph node metastasis in early breast cancer using deep learning on primary tumor biopsy slidesBracs: a dataset for breast carcinoma subtyping in H&E histology imagesThe Digital Brain Tumour Atlas, an open histopathology resourceCAD systems for colorectal cancer from WSI are still not ready for clinical acceptanceiMIL4PATH: a semi-supervised interpretable approach for colorectal whole-slide imagesAn interpretable machine learning system for colorectal cancer diagnosis from pathology slidesClear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expressionIntratumoral resolution of driver gene mutation heterogeneity in renal cancer using deep learningWeakly supervised joint whole-slide segmentation and classification in prostate cancerMultimodal integration of radiology, pathology and genomics for prediction of response to PD-(L) 1 blockade in patients with non-small cell lung cancer</div>
                            <small style="color: var(--text-muted)">12618242.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...,\\text{logit}\\,({\\mu }_{ij})=\\alpha +{\\beta }_{j}+{b}_{i},$$\\end{...'}</li><li>{'message': 'Diagnostic metrics reported without Confidence Intervals.', 'evidence': '...eport balanced accuracy and AUROC. For survival tasks, we repor...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Unmasking and Addressing COVID-19–Related Maladaptive Grief Reactions Among Suicidal Youth: Pilot Evidence for an Enhanced Psychiatry Emergency Room Safety Preventive InterventionUnderstanding the public discussion about the Centers for Disease Control and Prevention during the COVID-19 pandemic using Twitter data: text mining analysis studyEthnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis51.3. Clinical outcome of COVID-19 patients with and without diagnosed mental disorder treated at the Los Angeles County Department of Health ServicesTrends in suicide among youth aged 10 to 19 years in the United States, 1975 to 2016Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: clinical implications for U.S. young adult mental healthThe long-term clinical outcome of posttraumatic stress disorder with impaired coronary distensibilityA randomized controlled feasibility trial of reminder-focused positive psychiatry in adolescents with comorbid attention-deficit/hyperactivity disorder and posttraumatic stress disorderTrauma reminders and PTSD symptoms in children three years after a terrorist attack in BeslanEvaluating referral, screening, and assessment procedures for middle school trauma/grief-focused treatment groupsPosttraumatic stress disorder following childhood abuse increases the severity of suicide attemptsSuicide screening in schools, primary care and emergency departmentsThe emergency department: challenges and opportunities for suicide preventionPsychometric properties of the UCLA PTSD reaction index: part IPACHIQ-R: the Parent-Child Interaction Questionnaire–revisedPsychometric validation of the PERMA-profiler as a well-being measure for student veteransAffective style, psychopathology, and resilience: brain mechanisms and plasticityThe Posttraumatic Growth Inventory: factor structure and invariance among persons with chronic diseasesValidation of the Persistent Complex Bereavement Disorder (PCBD) Checklist: a developmentally informed assessment tool for bereaved youthValidation of the UCLA PTSD Reaction Index for DSM-5: a developmentally informed assessment tool for youthPerceived job insecurity and depressive symptoms among Italian dentists: the moderating role of fear of COVID-19Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United StatesGrief during the COVID-19 pandemic: considerations for palliative care providersWho suffered most after deaths due to COVID-19? Prevalence and correlates of prolonged grief disorder in COVID-19 related bereaved adultsChange in youth mental health during the COVID-19 pandemic in a majority Hispanic/Latinx US sampleLA County COVID-19 Surveillance DashboardA 4-year review of pediatric mental health emergencies in AlbertaSummary statistics for pediatric psychiatric visits to US emergency departments, 1993-1999Pediatric mental health emergencies in the emergency medical services system. American College of Emergency PhysiciansChildhood maltreatment compromises resilience against occupational trauma exposure: a retrospective study among emergency medical service personnelEmergency department as a first contact for mental health problems in children and youthEvolutionizing grief: viewing photographs of the deceased predicts misattribution of ambiguous stimuli by the bereavedAdolescent sibling bereavement: an ongoing attachmentSuicidality in parentally bereaved adolescentsEstimates and projections of COVID-19 and parental death in the USUnfinished business and self-blaming emotions among those bereaved by a COVID-19 deathThe psychiatric sequelae of the COVID-19 pandemic in adolescents, adults, and health care workersAcceptability of the systematic screening of suicidal adolescents in emergency departmentsIdentifying adolescents at highly elevated risk for suicidal behavior in the emergency departmentFirearm-related injuries in children and adolescents: an emergency and critical care perspectiveEmergency department screening for suicide and mental health riskPsychosocial problems of children whose parents visit the emergency department due to intimate partner violence, substance abuse or a suicide attemptA randomized controlled trial to engage in care of adolescent emergency department patients with mental health problems that increase suicide riskAn emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatmentReminder-focused positive psychiatry: suicide prevention among youths with comorbid posttraumatic stress disorder and suicidalitySuicide, self-harm, & traumatic stress exposure: a trauma-informed approach to the evaluation and management of suicide risk">Unmasking and Addressing COVID-19–Related Maladaptive Grief Reactions Among Suicidal Youth: Pilot Evidence for an Enhanced Psychiatry Emergency Room Safety Preventive InterventionUnderstanding the public discussion about the Centers for Disease Control and Prevention during the COVID-19 pandemic using Twitter data: text mining analysis studyEthnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis51.3. Clinical outcome of COVID-19 patients with and without diagnosed mental disorder treated at the Los Angeles County Department of Health ServicesTrends in suicide among youth aged 10 to 19 years in the United States, 1975 to 2016Factors associated with depression, anxiety, and PTSD symptomatology during the COVID-19 pandemic: clinical implications for U.S. young adult mental healthThe long-term clinical outcome of posttraumatic stress disorder with impaired coronary distensibilityA randomized controlled feasibility trial of reminder-focused positive psychiatry in adolescents with comorbid attention-deficit/hyperactivity disorder and posttraumatic stress disorderTrauma reminders and PTSD symptoms in children three years after a terrorist attack in BeslanEvaluating referral, screening, and assessment procedures for middle school trauma/grief-focused treatment groupsPosttraumatic stress disorder following childhood abuse increases the severity of suicide attemptsSuicide screening in schools, primary care and emergency departmentsThe emergency department: challenges and opportunities for suicide preventionPsychometric properties of the UCLA PTSD reaction index: part IPACHIQ-R: the Parent-Child Interaction Questionnaire–revisedPsychometric validation of the PERMA-profiler as a well-being measure for student veteransAffective style, psychopathology, and resilience: brain mechanisms and plasticityThe Posttraumatic Growth Inventory: factor structure and invariance among persons with chronic diseasesValidation of the Persistent Complex Bereavement Disorder (PCBD) Checklist: a developmentally informed assessment tool for bereaved youthValidation of the UCLA PTSD Reaction Index for DSM-5: a developmentally informed assessment tool for youthPerceived job insecurity and depressive symptoms among Italian dentists: the moderating role of fear of COVID-19Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United StatesGrief during the COVID-19 pandemic: considerations for palliative care providersWho suffered most after deaths due to COVID-19? Prevalence and correlates of prolonged grief disorder in COVID-19 related bereaved adultsChange in youth mental health during the COVID-19 pandemic in a majority Hispanic/Latinx US sampleLA County COVID-19 Surveillance DashboardA 4-year review of pediatric mental health emergencies in AlbertaSummary statistics for pediatric psychiatric visits to US emergency departments, 1993-1999Pediatric mental health emergencies in the emergency medical services system. American College of Emergency PhysiciansChildhood maltreatment compromises resilience against occupational trauma exposure: a retrospective study among emergency medical service personnelEmergency department as a first contact for mental health problems in children and youthEvolutionizing grief: viewing photographs of the deceased predicts misattribution of ambiguous stimuli by the bereavedAdolescent sibling bereavement: an ongoing attachmentSuicidality in parentally bereaved adolescentsEstimates and projections of COVID-19 and parental death in the USUnfinished business and self-blaming emotions among those bereaved by a COVID-19 deathThe psychiatric sequelae of the COVID-19 pandemic in adolescents, adults, and health care workersAcceptability of the systematic screening of suicidal adolescents in emergency departmentsIdentifying adolescents at highly elevated risk for suicidal behavior in the emergency departmentFirearm-related injuries in children and adolescents: an emergency and critical care perspectiveEmergency department screening for suicide and mental health riskPsychosocial problems of children whose parents visit the emergency department due to intimate partner violence, substance abuse or a suicide attemptA randomized controlled trial to engage in care of adolescent emergency department patients with mental health problems that increase suicide riskAn emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatmentReminder-focused positive psychiatry: suicide prevention among youths with comorbid posttraumatic stress disorder and suicidalitySuicide, self-harm, & traumatic stress exposure: a trauma-informed approach to the evaluation and management of suicide risk</div>
                            <small style="color: var(--text-muted)">12684469.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="The Challenges of Screening Master AthletesSudden death in athletesTrends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programValue of screening for the risk of sudden cardiac death in young competitive athletesCauses of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in childrenScreening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesThrombosis, physical activity, and acute coronary syndromesImpact of exercise addiction on attitude to preparticipation evaluation and adherence to medical prescriptionEvolution of incidence, management, and outcomes over time in sports-related sudden cardiac arrestPre-participation screenings frequently miss occult cardiovascular conditions in apparently healthy male middle-aged first-time marathon runnersShocking insights on resuscitation after sports-related cardiac arrest">The Challenges of Screening Master AthletesSudden death in athletesTrends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programValue of screening for the risk of sudden cardiac death in young competitive athletesCauses of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in childrenScreening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesThrombosis, physical activity, and acute coronary syndromesImpact of exercise addiction on attitude to preparticipation evaluation and adherence to medical prescriptionEvolution of incidence, management, and outcomes over time in sports-related sudden cardiac arrestPre-participation screenings frequently miss occult cardiovascular conditions in apparently healthy male middle-aged first-time marathon runnersShocking insights on resuscitation after sports-related cardiac arrest</div>
                            <small style="color: var(--text-muted)">12685328.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trialEstrogen and progesterone receptor testing in breast cancer: ASCO/CAP Guideline updateHuman epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused updateESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerHuman epidermal growth factor receptor 2 testing in breast cancerRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateHER2-low breast cancer: pathological and clinical landscapeTrastuzumab deruxtecan in previously treated HER2-low advanced breast cancerAntitumor activity and safety of trastuzumab deruxtecan in patients with HER2-low-expressing advanced breast cancer: results from a phase Ib studyESMO Expert Consensus Statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerStandardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancerClinical, pathological, and PAM50 gene expression features of HER2-low breast cancerRetrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerImpact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER databaseEstrogen-receptor-low-positive breast cancer: pathological and clinical perspectivesImpact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerBorderline ER-positive primary breast cancer gains no significant survival benefit from endocrine therapy: a systematic review and meta-analysisThe significance of highlighting the oestrogen receptor low category in breast cancerOutcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohortThe latest research and development into the antibody–drug conjugate, [fam-] trastuzumab deruxtecan (DS-8201a), for HER2 cancer therapyDS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1Assessment of predictive biomarkers in breast cancer: challenges and updatesOptimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancerMultidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis—focus on proactive monitoring, diagnosis, and managementTrastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialTrastuzumab deruxtecan after endocrine therapy in metastatic breast cancerDetermination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)Concordance between the DESTINY-Breast04 clinical trial assay (4B5[CDx]) and other HER2 IHC assays for HER2-low breast cancer in real-world practice: first phase of a large-scale, multicenter global ring studyExamination of low ERBB2 protein expression in breast cancer tissue">Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trialEstrogen and progesterone receptor testing in breast cancer: ASCO/CAP Guideline updateHuman epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused updateESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerHuman epidermal growth factor receptor 2 testing in breast cancerRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateHER2-low breast cancer: pathological and clinical landscapeTrastuzumab deruxtecan in previously treated HER2-low advanced breast cancerAntitumor activity and safety of trastuzumab deruxtecan in patients with HER2-low-expressing advanced breast cancer: results from a phase Ib studyESMO Expert Consensus Statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerStandardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancerClinical, pathological, and PAM50 gene expression features of HER2-low breast cancerRetrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerImpact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER databaseEstrogen-receptor-low-positive breast cancer: pathological and clinical perspectivesImpact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancerBorderline ER-positive primary breast cancer gains no significant survival benefit from endocrine therapy: a systematic review and meta-analysisThe significance of highlighting the oestrogen receptor low category in breast cancerOutcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohortThe latest research and development into the antibody–drug conjugate, [fam-] trastuzumab deruxtecan (DS-8201a), for HER2 cancer therapyDS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a promising antitumor efficacy with differentiation from T-DM1Assessment of predictive biomarkers in breast cancer: challenges and updatesOptimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancerMultidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis—focus on proactive monitoring, diagnosis, and managementTrastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialTrastuzumab deruxtecan after endocrine therapy in metastatic breast cancerDetermination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)Concordance between the DESTINY-Breast04 clinical trial assay (4B5[CDx]) and other HER2 IHC assays for HER2-low breast cancer in real-world practice: first phase of a large-scale, multicenter global ring studyExamination of low ERBB2 protein expression in breast cancer tissue</div>
                            <small style="color: var(--text-muted)">12705423.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...s (PFS and OS), patients with missing data were censored. Statistical an...'}</li><li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...el with treatment as the only categorical variable in the model. Confid...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="From Error to Excellence: An Evolving Paradigm for Improving the Diagnostic ProcessDiagnostic excellenceLearning the art and science of diagnosisEvaluating the effectiveness of diagnostic testsImproving efficiency in medical diagnosisAchieving equity in diagnostic excellenceDiagnostic excellence through the lens of patient-centerednessUnderstanding and communicating uncertainty in achieving diagnostic excellenceAchieving diagnostic excellence for older patients">From Error to Excellence: An Evolving Paradigm for Improving the Diagnostic ProcessDiagnostic excellenceLearning the art and science of diagnosisEvaluating the effectiveness of diagnostic testsImproving efficiency in medical diagnosisAchieving equity in diagnostic excellenceDiagnostic excellence through the lens of patient-centerednessUnderstanding and communicating uncertainty in achieving diagnostic excellenceAchieving diagnostic excellence for older patients</div>
                            <small style="color: var(--text-muted)">12708025.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignanciesGlobal burden of 5 Major types of gastrointestinal cancer, Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectivesImmunotherapy for gastric cancer and liver metastasis: Is it time to bid farewellAdvances of tumorigenesis, diagnosis at early stage, and cellular immunotherapy in gastrointestinal malignanciesTargeted immunotherapies in gastrointestinal cancer: from molecular mechanisms to implicationsA census of human rna-binding proteinsA large-scale binding and functional map of human rna-binding proteinsNon-coding RNA networks in cancerRna-binding proteins and cancer metastasisCooperation and competition by rna-binding proteins in cancerRna-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancerRNA binding proteins and regulation of mRNA translation in ErythropoiesisPost-transcriptional regulation of the ras-erk/mapk signaling pathwayPooled CRISPR screening identifies m 6 a as a positive regulator of macrophage activationTreatment of liver cancer by C/EBPA saRNAThe oncogenic and tumor suppressive roles of rna-binding proteins in human cancersRna-binding proteins: underestimated contributors in tumorigenesisHuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancerThe rna-binding protein HuRenhances exosome secretion in colorectal cancerMiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancerExosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancerTunneling nanotubes: the fuel of tumor progression?Nanotubular highways for intercellular organelle transportTunneling nanotubes: the intercellular conduits contributing to cancer pathogenesis and its therapyWiring through tunneling nanotubes–from electrical signals to organelle transferIntercellular transfer of oncogenic KRAS via tunneling nanotubes introduces intracellular mutational heterogeneity in colon cancer cellsPrimary, adaptive, and acquired resistance to cancer immunotherapyEffects of the media conditioned by various macrophage subtypes derived from THP-1 cells on tunneling nanotube formation in pancreatic cancer cellsHuman antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancerTargeting the YB-1/PD-L1 axis to enhance chemotherapy and antitumor immunityIntegrated bioinformatics and experiments reveal the roles and driving forces for HSF1 in colorectal cancerOrchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinomaInhibition of mutant kras-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancerTargeting Lin28 axis enhances glypican-3-car T cell efficacy against hepatic tumor initiating cell populationHeme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunityTristetraprolin overexpression in gastric cancer cells suppresses PD-L1 expression and inhibits tumor progression by enhancing antitumor immunityHigh glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environmentMusashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migrationRegulation of innate and adaptive antitumor immunity by IAP antagonistsIAP inhibitors enhance co-stimulation to promote tumor immunityMechanisms of subcellular mRNA localizationThe biological function of IGF2BPs and their role in tumorigenesisExpression and significance of musashi-1 in gastric cancer and precancerous lesionsDownregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1Musashi-1 expression and clinicopathological significance in young gastric cancer patients: a matched case-control studyNoncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical applicationNoncoding RNAs as novel immunotherapeutic tools against cancerA survey of regulatory interactions among RNA binding proteins and MicroRNAs in cancermicroRNAs biogenesis, functions and role in tumor angiogenesisMicroRNAs and metastasis: small RNAs play big rolesRegulation of microRNA biogenesis and its crosstalk with other cellular pathwaysDouble-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1–positive cancer stem cellsLin28 promotes transformation and is associated with advanced human malignanciesBAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACsLong noncoding RNAs in cancer-immunity cycleNew insights into the interplay between long non-coding RNAs and rna-binding proteins in cancerLong non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approachesLarge scale rna-binding proteins/LncRNAs interaction analysis to uncover lncRNA nuclear localization mechanismsLipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expressionLncRNA embryonic stem cells expressed 1 (Lncenc1) is identified as a novel regulator in neuropathic pain by interacting with EZH2 and downregulating the expression of Bai1 in mouse microgliaLINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axisPositioning determines function: wandering PKM2 performs different roles in tumor cellslncRNA HITT inhibits lactate production by repressing PKM2 oligomerization to reduce tumor growth and macrophage polarizationFunctional role of circular RNAs in cancer development and progressionThe expanding regulatory mechanisms and cellular functions of circular RNAsCRMSS: predicting circRNA-rbp binding sites based on multi-scale characterizing sequence and structure featuresCRBP-HFEF: prediction of RBP-Binding sites on circRNAs based on hierarchical feature expansion and fusionSSCRB: predicting circRNA-rbp interaction sites using a sequence and structural feature-based attention modelASCRB: multi-view based attentional feature selection for CircRNA-binding site predictionCircSSNN: circRNA-binding site prediction via sequence self-attention neural networks with pre-normalizationCircular RNAs and competing endogenous RNA (ceRNA) networksCircASPH enhances exosomal STING to facilitate M2 macrophage polarization in colorectal cancerDownregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarizationExosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinomam(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A/PD-L1 mannerThe role of m6A modification in the biological functions and diseasesWhere, when, and how: context-dependent functions of RNA methylation writers, readers, and erasersRNA modifications in gastrointestinal cancer: current status and future perspectivesTargeting the RNA m6A modification for cancer immunotherapyYTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinomaAnti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cellsLoss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cellsM 6 a RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapyALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylationALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progressionM(6)A Demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in Intrahepatic CholangiocarcinomaRecognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translationN6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancerMulti-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancerFusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancerHuR as a molecular target for cancer therapeutics and immune-related disordersAn RNA-Binding protein, hu-antigen R, in pancreatic cancer epithelial to mesenchymal transition, metastasis, and cancer stem cellsImmunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardNucleolin targeting by N6L inhibits Wnt/β-catenin pathway activation in pancreatic ductal adenocarcinomaNucleolin therapeutic targeting decreases pancreatic cancer immunosuppressionNanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentationM 6 a Reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulationMETTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancerMETTL3 drives nafld-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapymRNA delivery platform based on bacterial outer membrane vesicles for tumor vaccineThe toll like receptor 4 ligand cold-inducible rna-binding protein as vaccination platform against cancerNeoantigen vaccine: an emerging tumor immunotherapyTranscriptome-wide identification of rna-binding protein and microRNA target sites by PAR-CLIP. Nat MethodsTranslational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cellsHuman antigen R: a potential therapeutic target for liver diseasesMolecular targeting of HuR oncoprotein suppresses MITF and Induces apoptosis in melanoma cellsImage-based detection and targeting of therapy resistance in pancreatic adenocarcinomaThe RNA-Binding protein HuR confers oxaliplatin resistance of colorectal cancer by upregulating CDC6Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsLin28/let-7/Bcl-xL pathway: the underlying mechanism of drug resistance in Hep3B cellsOverexpression of Lin28 decreases the chemosensitivity of gastric cancer cells to oxaliplatin, paclitaxel, doxorubicin, and fluorouracil in part via microRNA-107Essential role of the rna-binding protein HuR in progenitor cell survival in miceDrug delivery approaches for HuR-targeted therapy for lung cancer">The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignanciesGlobal burden of 5 Major types of gastrointestinal cancer, Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectivesImmunotherapy for gastric cancer and liver metastasis: Is it time to bid farewellAdvances of tumorigenesis, diagnosis at early stage, and cellular immunotherapy in gastrointestinal malignanciesTargeted immunotherapies in gastrointestinal cancer: from molecular mechanisms to implicationsA census of human rna-binding proteinsA large-scale binding and functional map of human rna-binding proteinsNon-coding RNA networks in cancerRna-binding proteins and cancer metastasisCooperation and competition by rna-binding proteins in cancerRna-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancerRNA binding proteins and regulation of mRNA translation in ErythropoiesisPost-transcriptional regulation of the ras-erk/mapk signaling pathwayPooled CRISPR screening identifies m 6 a as a positive regulator of macrophage activationTreatment of liver cancer by C/EBPA saRNAThe oncogenic and tumor suppressive roles of rna-binding proteins in human cancersRna-binding proteins: underestimated contributors in tumorigenesisHuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancerThe rna-binding protein HuRenhances exosome secretion in colorectal cancerMiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancerExosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancerTunneling nanotubes: the fuel of tumor progression?Nanotubular highways for intercellular organelle transportTunneling nanotubes: the intercellular conduits contributing to cancer pathogenesis and its therapyWiring through tunneling nanotubes–from electrical signals to organelle transferIntercellular transfer of oncogenic KRAS via tunneling nanotubes introduces intracellular mutational heterogeneity in colon cancer cellsPrimary, adaptive, and acquired resistance to cancer immunotherapyEffects of the media conditioned by various macrophage subtypes derived from THP-1 cells on tunneling nanotube formation in pancreatic cancer cellsHuman antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancerTargeting the YB-1/PD-L1 axis to enhance chemotherapy and antitumor immunityIntegrated bioinformatics and experiments reveal the roles and driving forces for HSF1 in colorectal cancerOrchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinomaInhibition of mutant kras-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancerTargeting Lin28 axis enhances glypican-3-car T cell efficacy against hepatic tumor initiating cell populationHeme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunityTristetraprolin overexpression in gastric cancer cells suppresses PD-L1 expression and inhibits tumor progression by enhancing antitumor immunityHigh glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environmentMusashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migrationRegulation of innate and adaptive antitumor immunity by IAP antagonistsIAP inhibitors enhance co-stimulation to promote tumor immunityMechanisms of subcellular mRNA localizationThe biological function of IGF2BPs and their role in tumorigenesisExpression and significance of musashi-1 in gastric cancer and precancerous lesionsDownregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1Musashi-1 expression and clinicopathological significance in young gastric cancer patients: a matched case-control studyNoncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical applicationNoncoding RNAs as novel immunotherapeutic tools against cancerA survey of regulatory interactions among RNA binding proteins and MicroRNAs in cancermicroRNAs biogenesis, functions and role in tumor angiogenesisMicroRNAs and metastasis: small RNAs play big rolesRegulation of microRNA biogenesis and its crosstalk with other cellular pathwaysDouble-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1–positive cancer stem cellsLin28 promotes transformation and is associated with advanced human malignanciesBAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACsLong noncoding RNAs in cancer-immunity cycleNew insights into the interplay between long non-coding RNAs and rna-binding proteins in cancerLong non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approachesLarge scale rna-binding proteins/LncRNAs interaction analysis to uncover lncRNA nuclear localization mechanismsLipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expressionLncRNA embryonic stem cells expressed 1 (Lncenc1) is identified as a novel regulator in neuropathic pain by interacting with EZH2 and downregulating the expression of Bai1 in mouse microgliaLINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axisPositioning determines function: wandering PKM2 performs different roles in tumor cellslncRNA HITT inhibits lactate production by repressing PKM2 oligomerization to reduce tumor growth and macrophage polarizationFunctional role of circular RNAs in cancer development and progressionThe expanding regulatory mechanisms and cellular functions of circular RNAsCRMSS: predicting circRNA-rbp binding sites based on multi-scale characterizing sequence and structure featuresCRBP-HFEF: prediction of RBP-Binding sites on circRNAs based on hierarchical feature expansion and fusionSSCRB: predicting circRNA-rbp interaction sites using a sequence and structural feature-based attention modelASCRB: multi-view based attentional feature selection for CircRNA-binding site predictionCircSSNN: circRNA-binding site prediction via sequence self-attention neural networks with pre-normalizationCircular RNAs and competing endogenous RNA (ceRNA) networksCircASPH enhances exosomal STING to facilitate M2 macrophage polarization in colorectal cancerDownregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarizationExosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinomam(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A/PD-L1 mannerThe role of m6A modification in the biological functions and diseasesWhere, when, and how: context-dependent functions of RNA methylation writers, readers, and erasersRNA modifications in gastrointestinal cancer: current status and future perspectivesTargeting the RNA m6A modification for cancer immunotherapyYTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinomaAnti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cellsLoss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cellsM 6 a RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapyALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylationALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progressionM(6)A Demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in Intrahepatic CholangiocarcinomaRecognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translationN6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancerMulti-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancerFusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancerHuR as a molecular target for cancer therapeutics and immune-related disordersAn RNA-Binding protein, hu-antigen R, in pancreatic cancer epithelial to mesenchymal transition, metastasis, and cancer stem cellsImmunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardNucleolin targeting by N6L inhibits Wnt/β-catenin pathway activation in pancreatic ductal adenocarcinomaNucleolin therapeutic targeting decreases pancreatic cancer immunosuppressionNanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentationM 6 a Reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulationMETTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancerMETTL3 drives nafld-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapymRNA delivery platform based on bacterial outer membrane vesicles for tumor vaccineThe toll like receptor 4 ligand cold-inducible rna-binding protein as vaccination platform against cancerNeoantigen vaccine: an emerging tumor immunotherapyTranscriptome-wide identification of rna-binding protein and microRNA target sites by PAR-CLIP. Nat MethodsTranslational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cellsHuman antigen R: a potential therapeutic target for liver diseasesMolecular targeting of HuR oncoprotein suppresses MITF and Induces apoptosis in melanoma cellsImage-based detection and targeting of therapy resistance in pancreatic adenocarcinomaThe RNA-Binding protein HuR confers oxaliplatin resistance of colorectal cancer by upregulating CDC6Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsLin28/let-7/Bcl-xL pathway: the underlying mechanism of drug resistance in Hep3B cellsOverexpression of Lin28 decreases the chemosensitivity of gastric cancer cells to oxaliplatin, paclitaxel, doxorubicin, and fluorouracil in part via microRNA-107Essential role of the rna-binding protein HuR in progenitor cell survival in miceDrug delivery approaches for HuR-targeted therapy for lung cancer</div>
                            <small style="color: var(--text-muted)">12710923.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Polysomnographically mediated cognitive improvements in individuals with insomnia symptoms following continuous theta-burst stimulation of the default mode networkHomeostatic sleep regulation in habitual short sleepers and long sleepersValidation of the Insomnia Severity Index as an outcome measure for insomnia researchFitting linear mixed-effects models using lme4Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomniaAASM scoring manual updates for 2017 (version 2.4)The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchTiming of REM sleep is coupled to the circadian rhythm of body temperature in manSTOP-Bang questionnaire: a practical approach to screen for obstructive sleep apneaSlow-wave sleep and waking cognitive performance among older adults with and without insomnia complaintsAcoustic enhancement of slow wave sleep on consecutive nights improves alertness and attention in chronically short sleepersSensitivity and specificity of polysomnographic criteria for defining insomniaEffects of sleep loss on delta (0.3–3 Hz) EEG and eye movement density: new observations and hypothesesSelective slow-wave sleep deprivation and time-of-night effects on cognitive performance upon awakeningAn increase in sleep slow waves predicts better working memory performance in healthy individualsRapid eye movement sleep deprivation selectively impairs recall of fear extinction in hippocampus-independent tasks in ratsSleep characteristics and cognitive impairment in the general population: the HypnoLaus studykenward-roger approximation and parametric bootstrap methods for tests in linear mixed models–the R package pbkrtestTranscranial magnetic stimulation cortical oscillations and improve cognition in obstructive sleep apnea patientsAU-Night sleep polygraphic recordings of healthy aged persons: REM and slow-wave sleepTranscranial magnetic stimulation of the default mode network to improve sleep in individuals with insomnia symptoms: protocol for a double-blind randomized controlled trialRepetitive transcranial magnetic stimulation of the right parietal cortex for comorbid generalized anxiety disorder and insomnia: a randomized, double-blind, sham-controlled pilot studyLayers of human brain activity: a functional model based on the default mode network and slow oscillationsEfficacy and placebo response of multimodal treatments for primary insomnia: a network meta-analysisEfficacy and placebo response of repetitive transcranial magnetic stimulation for primary insomnianew method for measuring daytime sleepiness: The Epworth Sleepiness ScaleHyperarousal and beyond: new insights to the pathophysiology of insomnia disorder through functional neuroimaging studiesSmall sample inference for fixed effects from restricted maximum likelihoodFunctional connectivity of the default mode network predicts subsequent polysomnographically measured sleep in people with symptoms of insomniaThe effect of alpha rhythm sleep on EEG activity and individuals' attentionWhen thinking impairs sleep: trait, daytime and nighttime repetitive thinking in insomniaDeficits in attention performance are associated with insufficiency of slow-wave sleep in insomniaOvernight delta dynamics associated with daytime psychomotor performance in adults with insomnia and healthy controlsThe default mode network in healthy individuals: a systematic review and meta-analysisInsomnia disorder and brain's default-mode networkEffects of sleep stage and sleep episode length on the alerting, orienting, and conflict components of attentionPoor sleep quality impairs cognitive performance in older adultsProlonged sleep latency and reduced REM latency are associated with depressive symptoms in a Japanese working populationTranscranial magnetic stimulation therapeutic applications on sleep and insomnia: a reviewSleep promotes generalization of extinction of conditioned fearAberrant functional connectivity architecture in participants with chronic insomnia disorder accompanying cognitive dysfunction: a whole-brain, data-driven analysisThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validityA systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trialsInsomnia and comorbid psychiatric disordersHome is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomniaREM sleep deprivation affects extinction of cued but not contextual fear conditioningEffects of REM deprivation and an NMDA agonist on the extinction of conditioned fearSleep deprivation disrupts recall of conditioned fear extinctionREM sleep and safety signal learning in posttraumatic stress disorder: a preliminary study in military veteransThe effect of repetitive transcranial magnetic stimulation for insomnia: a systematic review and meta-analysisSlow brain oscillations of sleep, resting state, and vigilanceModels for predicting sleep latency and sleep durationSleep-dependent learning and memory consolidationOvernight therapy? The role of sleep in emotional brain processingInsomnia and cognitive performance: a systematic review and meta-analysisAstroglial mechanisms underlying chronic insomnia disorder: a Clinical StudyFocus: attention science: can slow-wave sleep enhancement improve memory? A review of current approaches and cognitive outcomes">Polysomnographically mediated cognitive improvements in individuals with insomnia symptoms following continuous theta-burst stimulation of the default mode networkHomeostatic sleep regulation in habitual short sleepers and long sleepersValidation of the Insomnia Severity Index as an outcome measure for insomnia researchFitting linear mixed-effects models using lme4Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomniaAASM scoring manual updates for 2017 (version 2.4)The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchTiming of REM sleep is coupled to the circadian rhythm of body temperature in manSTOP-Bang questionnaire: a practical approach to screen for obstructive sleep apneaSlow-wave sleep and waking cognitive performance among older adults with and without insomnia complaintsAcoustic enhancement of slow wave sleep on consecutive nights improves alertness and attention in chronically short sleepersSensitivity and specificity of polysomnographic criteria for defining insomniaEffects of sleep loss on delta (0.3–3 Hz) EEG and eye movement density: new observations and hypothesesSelective slow-wave sleep deprivation and time-of-night effects on cognitive performance upon awakeningAn increase in sleep slow waves predicts better working memory performance in healthy individualsRapid eye movement sleep deprivation selectively impairs recall of fear extinction in hippocampus-independent tasks in ratsSleep characteristics and cognitive impairment in the general population: the HypnoLaus studykenward-roger approximation and parametric bootstrap methods for tests in linear mixed models–the R package pbkrtestTranscranial magnetic stimulation cortical oscillations and improve cognition in obstructive sleep apnea patientsAU-Night sleep polygraphic recordings of healthy aged persons: REM and slow-wave sleepTranscranial magnetic stimulation of the default mode network to improve sleep in individuals with insomnia symptoms: protocol for a double-blind randomized controlled trialRepetitive transcranial magnetic stimulation of the right parietal cortex for comorbid generalized anxiety disorder and insomnia: a randomized, double-blind, sham-controlled pilot studyLayers of human brain activity: a functional model based on the default mode network and slow oscillationsEfficacy and placebo response of multimodal treatments for primary insomnia: a network meta-analysisEfficacy and placebo response of repetitive transcranial magnetic stimulation for primary insomnianew method for measuring daytime sleepiness: The Epworth Sleepiness ScaleHyperarousal and beyond: new insights to the pathophysiology of insomnia disorder through functional neuroimaging studiesSmall sample inference for fixed effects from restricted maximum likelihoodFunctional connectivity of the default mode network predicts subsequent polysomnographically measured sleep in people with symptoms of insomniaThe effect of alpha rhythm sleep on EEG activity and individuals' attentionWhen thinking impairs sleep: trait, daytime and nighttime repetitive thinking in insomniaDeficits in attention performance are associated with insufficiency of slow-wave sleep in insomniaOvernight delta dynamics associated with daytime psychomotor performance in adults with insomnia and healthy controlsThe default mode network in healthy individuals: a systematic review and meta-analysisInsomnia disorder and brain's default-mode networkEffects of sleep stage and sleep episode length on the alerting, orienting, and conflict components of attentionPoor sleep quality impairs cognitive performance in older adultsProlonged sleep latency and reduced REM latency are associated with depressive symptoms in a Japanese working populationTranscranial magnetic stimulation therapeutic applications on sleep and insomnia: a reviewSleep promotes generalization of extinction of conditioned fearAberrant functional connectivity architecture in participants with chronic insomnia disorder accompanying cognitive dysfunction: a whole-brain, data-driven analysisThe Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validityA systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trialsInsomnia and comorbid psychiatric disordersHome is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomniaREM sleep deprivation affects extinction of cued but not contextual fear conditioningEffects of REM deprivation and an NMDA agonist on the extinction of conditioned fearSleep deprivation disrupts recall of conditioned fear extinctionREM sleep and safety signal learning in posttraumatic stress disorder: a preliminary study in military veteransThe effect of repetitive transcranial magnetic stimulation for insomnia: a systematic review and meta-analysisSlow brain oscillations of sleep, resting state, and vigilanceModels for predicting sleep latency and sleep durationSleep-dependent learning and memory consolidationOvernight therapy? The role of sleep in emotional brain processingInsomnia and cognitive performance: a systematic review and meta-analysisAstroglial mechanisms underlying chronic insomnia disorder: a Clinical StudyFocus: attention science: can slow-wave sleep enhancement improve memory? A review of current approaches and cognitive outcomes</div>
                            <small style="color: var(--text-muted)">12713820.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Objective and subjective sleep characteristics in hospitalized older adults and their associations to hospital outcomesDefining existing practices to support the sleep of hospitalized patients: a mixed-methods study of top-ranked hospitalsThe role of actigraphy in the study of sleep and circadian rhythmsThe influence of environmental factors on sleep quality in hospitalized medical patientsValidation of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in older black and white womenAssociation of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep studyPoor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fracturesAssociations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep studyMelatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trialThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchCharacteristics of self-reported sleep and the risk of falls and fractures: the women's health initiative (WHI)The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trialMeasures of sleep-wake patterns and risk of mild cognitive impairment or dementia in older womenSleep and pathological wakefulness at the time of liberation from mechanical ventilation (SLEEWE). A prospective multicenter physiological studyThe association of sleep and pain: an update and a path forwardThe supplement on aging to the 1984 National Health Interview SurveyAbnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unitMeasures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Sleep assessment of hospitalised patients: a literature reviewSleep disruption in hospitalized adultsThe Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life ProgramA new method for measuring daytime sleepiness: the Epworth sleepiness scaleReliability and factor analysis of the Epworth Sleepiness ScaleFeasibility of continuous actigraphy in patients in a medical intensive care unitPerceptions and practices regarding sleep in the intensive care unit. A survey of 1,223 critical care providersPromoting sleep to improve delirium in the ICUDeveloping, implementing, and evaluating a multifaceted quality improvement intervention to promote sleep in an ICUCauses, consequences, and treatments of sleep and circadian disruption in the ICU: an official American Thoracic Society research statementChanges in montreal cognitive assessment scores over time‘Appears to have slept well': assessing sleep in an acute care settingComparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patientsDelirium assessment tools among hospitalized older adults: a systematic review and metaanalysis of diagnostic accuracySleep fragmentation delays wound healing in a mouse model of type 2 diabetesSleep in hospitalized elders: a pilot studyActigraphic monitoring in critically ill patients: preliminary results toward an “observation-guided sedation”The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentAssessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment QuestionnaireSleep in the intensive care unitMeasurement of sleep in critically ill patientsActigraphy to evaluate sleep in the intensive care unit. A systematic reviewEffect of obstructive sleep apnea on neurocognitive performanceEffect of melatonin on sleep quality of COPD intensive care patients: a pilot studySleep in hospitalized older adultsLet's not sleep on it: hospital sleep is a health issue tooActigraphy-measured sleep characteristics and risk of falls in older womenSleep disturbances and risk of falls in older community-dwelling men: the outcomes of Sleep Disorders in Older Men (MrOS Sleep) StudyInfluence of bright light therapy on postoperative patients: a pilot studyThe sleep experience of medical and surgical patientsRelationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adultsAtypical sleep in ventilated patients: empirical electroencephalography findings and the path toward revised ICU sleep scoring criteriaBench-to-bedside review: delirium in ICU patients - importance of sleep deprivationConnections between sleep and cognition in older adultsObjective and subjective characteristics of sleep after coronary artery bypass graft surgery in the early period: a prospective study with healthy subjectsSleep quality of hospitalized patients in surgical units">Objective and subjective sleep characteristics in hospitalized older adults and their associations to hospital outcomesDefining existing practices to support the sleep of hospitalized patients: a mixed-methods study of top-ranked hospitalsThe role of actigraphy in the study of sleep and circadian rhythmsThe influence of environmental factors on sleep quality in hospitalized medical patientsValidation of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in older black and white womenAssociation of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep studyPoor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fracturesAssociations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep studyMelatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trialThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchCharacteristics of self-reported sleep and the risk of falls and fractures: the women's health initiative (WHI)The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trialMeasures of sleep-wake patterns and risk of mild cognitive impairment or dementia in older womenSleep and pathological wakefulness at the time of liberation from mechanical ventilation (SLEEWE). A prospective multicenter physiological studyThe association of sleep and pain: an update and a path forwardThe supplement on aging to the 1984 National Health Interview SurveyAbnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unitMeasures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Sleep assessment of hospitalised patients: a literature reviewSleep disruption in hospitalized adultsThe Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life ProgramA new method for measuring daytime sleepiness: the Epworth sleepiness scaleReliability and factor analysis of the Epworth Sleepiness ScaleFeasibility of continuous actigraphy in patients in a medical intensive care unitPerceptions and practices regarding sleep in the intensive care unit. A survey of 1,223 critical care providersPromoting sleep to improve delirium in the ICUDeveloping, implementing, and evaluating a multifaceted quality improvement intervention to promote sleep in an ICUCauses, consequences, and treatments of sleep and circadian disruption in the ICU: an official American Thoracic Society research statementChanges in montreal cognitive assessment scores over time‘Appears to have slept well': assessing sleep in an acute care settingComparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patientsDelirium assessment tools among hospitalized older adults: a systematic review and metaanalysis of diagnostic accuracySleep fragmentation delays wound healing in a mouse model of type 2 diabetesSleep in hospitalized elders: a pilot studyActigraphic monitoring in critically ill patients: preliminary results toward an “observation-guided sedation”The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentAssessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment QuestionnaireSleep in the intensive care unitMeasurement of sleep in critically ill patientsActigraphy to evaluate sleep in the intensive care unit. A systematic reviewEffect of obstructive sleep apnea on neurocognitive performanceEffect of melatonin on sleep quality of COPD intensive care patients: a pilot studySleep in hospitalized older adultsLet's not sleep on it: hospital sleep is a health issue tooActigraphy-measured sleep characteristics and risk of falls in older womenSleep disturbances and risk of falls in older community-dwelling men: the outcomes of Sleep Disorders in Older Men (MrOS Sleep) StudyInfluence of bright light therapy on postoperative patients: a pilot studyThe sleep experience of medical and surgical patientsRelationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adultsAtypical sleep in ventilated patients: empirical electroencephalography findings and the path toward revised ICU sleep scoring criteriaBench-to-bedside review: delirium in ICU patients - importance of sleep deprivationConnections between sleep and cognition in older adultsObjective and subjective characteristics of sleep after coronary artery bypass graft surgery in the early period: a prospective study with healthy subjectsSleep quality of hospitalized patients in surgical units</div>
                            <small style="color: var(--text-muted)">12713864.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported only as thresholds (e.g., P<0.05).', 'evidence': '...race, sex, body mass index.**p < 0.05, ***p < 0.01.MoCA, Montreal C...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Child and adolescent sleep disturbances and psychopathology in a mental health clinic sampleSleep timing and quantity in ecological and family context: a nationally representative time-diary studySleep to Internalizing Pathway in Young Adolescents (SIPYA): a proposed neurodevelopmental modelThe role of sleep in childhood psychiatric disordersSleep-related problems among children and adolescents with anxiety disordersSleep and psychiatric symptoms in school-age children“Children's sleep and internalizing and externalizing symptoms,”Longitudinal study of sleep and internalizing problems in youth treated for pediatric anxiety disordersProtective and risk factors for adolescent sleep: a meta-analytic reviewSleep and adjustment in preschool children: sleep diary reports by mothers relate to behavior reports by teachersCognitive, behavioral, and functional consequences of inadequate sleep in children and adolescentsSleep and psychiatric disorders: a meta-analysisMechanisms underlying the association between insomnia, anxiety, and depression in adolescence: implications for behavioral sleep interventionsSleep problems and complexity of mental health needs in adolescent psychiatric inpatientsThree Cs in measurement models: causal indicators, composite indicators, and covariatesA review of pediatric nonpharmacological sleep interventions: effects on sleep, secondary outcomes, and populations with co-occurring mental health conditionsThe Sleep Disturbance Scale for Children (SDSC): construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescenceSleep-related problems and the effects of anxiety treatment in children and adolescentsSleep duration estimates of canadian children and adolescentsSleep-related problems in children and adolescents with anxiety disordersAn integrated sleep and anxiety intervention for anxious children: a pilot randomized controlled trialLongitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study“Sleep in the context of ADHD: a review of reviews to determine implications for research and clinical practice,”The development of psychopathology in females and males: Current progress and future challengesSleep-related problems and pediatric anxiety disordersCognitive behavioral therapy for insomnia in school-aged children and adolescentsMeasuring children's mental health in Ontario: policy issues and prospects for changeChild emotional insecurity and academic achievement: the role of sleep disruptionsSleep disruptions and emotional insecurity are pathways of risk for childrenSleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorderFactor analysis, causal indicators and quality of lifeSleep EEG changes during adolescence: An index of a fundamental brain reorganizationRelationship between sensory processing and sleep in typically developing childrenBeyond comorbidity: Toward a dimensional and hierarchical approach to understanding psychopathology across the life spanSleep during development: sex and gender differencesTransdiagnostic psychiatry: a systematic reviewSix-month prevalence of mental disorders and service contacts among children and youth in Ontario: evidence from the 2014 Ontario Child Health StudyTemperamental resistance to control increases the association between sleep problems and externalizing behavior developmentCognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trialSleep problems in childhood: A longitudinal study of developmental change and association with behavioral problemsSleep, emotional and behavioral difficulties in children and adolescentsReview of studies of risk and protective factors for psychopathology in childrenFormative measurement and academic research: In search of measurement theoryEffect of early intervention for anxiety on sleep outcomes in adolescents: a randomized trialIntroduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based ApproachAddressing sleep problems and fatigue within child and adolescent mental health services: a qualitative studyTrying to fall asleep while catastrophising: What sleep-disordered adolescents think and feelSleep problems among adolescents within child and adolescent mental health services. An epidemiological study with registry linkageSelf-reported organic and nonorganic sleep problems in schoolchildren aged 11 to 15 years in ViennaPsychiatric symptoms in children with insomnia referred to a pediatric sleep medicine centerSleep complaints and psychiatric symptoms in children evaluated at a pediatric mental health clinicSleep disruption in adolescent inpatients: prevalence, associations with clinical outcomes, and clinician perspectivesTrouble sleeping and anxiety/depression in childhoodEpidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender differenceReciprocal relations between children's sleep and their adjustment over timeThe effect of different forms of centering in hierarchical linear modelsA hierarchical causal taxonomy of psychopathology across the life spanSleep disorders in early childhood and the development of mental health problems in adolescents: a systematic review of longitudinal and prospective studiesScale development and psychometric properties of internalizing symptoms: the InterRAI child and youth mental health internalizing subscaleDevelopment and psychometric validation of the interRAI ChYMH externalizing subscaleSleep and behavior problems among preschoolersTemporal daily associations between pain and sleep in adolescents with chronic pain versus healthy adolescentsSleep-related difficulties in healthy children and adolescentsThe bidirectional relationship between sleep and externalizing behavior: a systematic reviewA meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practiceSuppressor variables in path models: definitions and interpretationsPersistent sleep disturbance is associated with treatment response in adolescents with depressionAssociation between disturbed sleep and depression in children and youths: A systematic review and meta-analysis of cohort studiesSex differences in insomnia and risk for psychopathology in adolescenceImpact of a child's chronic illness on maternal sleep and daytime functioningRisk and protective factors and processes for child sleep problems among preschool and early school-aged children: a systematic reviewClinical characteristics of adolescents referred for treatment of depressive disordersClassification and epidemiology of childhood sleep disordersPoor sleep and psychiatric symptoms at school: an epidemiological studyRecommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep MedicineThe influence of parenting style on health related behavior of children: findings from the ChiBS studyFatores de risco associados a problemas de saúde mental em adolescentes: Revisão integrativaAsymptotic and resampling strategies for assessing and comparing indirect effects in simple and multiple mediator modelsBidirectional associations between child sleep problems and internalizing and externalizing difficulties from preschool to early adolescenceThe relation between common sleep problems and emotional and behavioral problems among 2- and 3-year-olds in the context of known risk factors for psychopathologyPrevalences and correlates of sleep problems among adolescents in specialty mental health services and in the community: what differs?Sensory processing, physiological stress, and sleep behaviors in children with and without autism spectrum disordersSleep, neurobehavioral functioning, and behavior problems in school-age childrenParental psychopathology and sleep variation in childrenSleep problems predict and are predicted by generalized anxiety/depression and oppositional defiant disorderSensory hypersensitivity as a contributing factor in the relation between sleep and behavioral disorders in normal schoolchildrenIdentifying adolescent sleep problemsSleep behaviors and disorders in children and adolescents evaluated at psychiatric clinicsThe comorbidity of chronic pain and sleep disturbances in a community adolescent sample: prevalence and association with sociodemographic and psychosocial factorsStability of sleep disorders from preschool to first grade and their bidirectional relationship with psychiatric symptomsThe interRAI child and youth suite of mental health assessment instruments: an integrated approach to mental health service deliverySensory processing in children with and without autism: a comparative study using the short sensory profileSuppression situations in psychological research: definitions, implications, and applicationsDaily bidirectional relationships between sleep and mental health symptoms in youth with emotional and behavioral problemsLongitudinal bidirectional effects between sleep quality and internalizing problemsRisk and protective factors for children's and adolescents' mental health: results of the BELLA studyPatterns of sleep problems and internalizing and externalizing problems among Chinese adolescents: a latent class analysisSex differences in insomnia: a meta-analysis">Child and adolescent sleep disturbances and psychopathology in a mental health clinic sampleSleep timing and quantity in ecological and family context: a nationally representative time-diary studySleep to Internalizing Pathway in Young Adolescents (SIPYA): a proposed neurodevelopmental modelThe role of sleep in childhood psychiatric disordersSleep-related problems among children and adolescents with anxiety disordersSleep and psychiatric symptoms in school-age children“Children's sleep and internalizing and externalizing symptoms,”Longitudinal study of sleep and internalizing problems in youth treated for pediatric anxiety disordersProtective and risk factors for adolescent sleep: a meta-analytic reviewSleep and adjustment in preschool children: sleep diary reports by mothers relate to behavior reports by teachersCognitive, behavioral, and functional consequences of inadequate sleep in children and adolescentsSleep and psychiatric disorders: a meta-analysisMechanisms underlying the association between insomnia, anxiety, and depression in adolescence: implications for behavioral sleep interventionsSleep problems and complexity of mental health needs in adolescent psychiatric inpatientsThree Cs in measurement models: causal indicators, composite indicators, and covariatesA review of pediatric nonpharmacological sleep interventions: effects on sleep, secondary outcomes, and populations with co-occurring mental health conditionsThe Sleep Disturbance Scale for Children (SDSC): construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescenceSleep-related problems and the effects of anxiety treatment in children and adolescentsSleep duration estimates of canadian children and adolescentsSleep-related problems in children and adolescents with anxiety disordersAn integrated sleep and anxiety intervention for anxious children: a pilot randomized controlled trialLongitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study“Sleep in the context of ADHD: a review of reviews to determine implications for research and clinical practice,”The development of psychopathology in females and males: Current progress and future challengesSleep-related problems and pediatric anxiety disordersCognitive behavioral therapy for insomnia in school-aged children and adolescentsMeasuring children's mental health in Ontario: policy issues and prospects for changeChild emotional insecurity and academic achievement: the role of sleep disruptionsSleep disruptions and emotional insecurity are pathways of risk for childrenSleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorderFactor analysis, causal indicators and quality of lifeSleep EEG changes during adolescence: An index of a fundamental brain reorganizationRelationship between sensory processing and sleep in typically developing childrenBeyond comorbidity: Toward a dimensional and hierarchical approach to understanding psychopathology across the life spanSleep during development: sex and gender differencesTransdiagnostic psychiatry: a systematic reviewSix-month prevalence of mental disorders and service contacts among children and youth in Ontario: evidence from the 2014 Ontario Child Health StudyTemperamental resistance to control increases the association between sleep problems and externalizing behavior developmentCognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trialSleep problems in childhood: A longitudinal study of developmental change and association with behavioral problemsSleep, emotional and behavioral difficulties in children and adolescentsReview of studies of risk and protective factors for psychopathology in childrenFormative measurement and academic research: In search of measurement theoryEffect of early intervention for anxiety on sleep outcomes in adolescents: a randomized trialIntroduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based ApproachAddressing sleep problems and fatigue within child and adolescent mental health services: a qualitative studyTrying to fall asleep while catastrophising: What sleep-disordered adolescents think and feelSleep problems among adolescents within child and adolescent mental health services. An epidemiological study with registry linkageSelf-reported organic and nonorganic sleep problems in schoolchildren aged 11 to 15 years in ViennaPsychiatric symptoms in children with insomnia referred to a pediatric sleep medicine centerSleep complaints and psychiatric symptoms in children evaluated at a pediatric mental health clinicSleep disruption in adolescent inpatients: prevalence, associations with clinical outcomes, and clinician perspectivesTrouble sleeping and anxiety/depression in childhoodEpidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender differenceReciprocal relations between children's sleep and their adjustment over timeThe effect of different forms of centering in hierarchical linear modelsA hierarchical causal taxonomy of psychopathology across the life spanSleep disorders in early childhood and the development of mental health problems in adolescents: a systematic review of longitudinal and prospective studiesScale development and psychometric properties of internalizing symptoms: the InterRAI child and youth mental health internalizing subscaleDevelopment and psychometric validation of the interRAI ChYMH externalizing subscaleSleep and behavior problems among preschoolersTemporal daily associations between pain and sleep in adolescents with chronic pain versus healthy adolescentsSleep-related difficulties in healthy children and adolescentsThe bidirectional relationship between sleep and externalizing behavior: a systematic reviewA meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practiceSuppressor variables in path models: definitions and interpretationsPersistent sleep disturbance is associated with treatment response in adolescents with depressionAssociation between disturbed sleep and depression in children and youths: A systematic review and meta-analysis of cohort studiesSex differences in insomnia and risk for psychopathology in adolescenceImpact of a child's chronic illness on maternal sleep and daytime functioningRisk and protective factors and processes for child sleep problems among preschool and early school-aged children: a systematic reviewClinical characteristics of adolescents referred for treatment of depressive disordersClassification and epidemiology of childhood sleep disordersPoor sleep and psychiatric symptoms at school: an epidemiological studyRecommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep MedicineThe influence of parenting style on health related behavior of children: findings from the ChiBS studyFatores de risco associados a problemas de saúde mental em adolescentes: Revisão integrativaAsymptotic and resampling strategies for assessing and comparing indirect effects in simple and multiple mediator modelsBidirectional associations between child sleep problems and internalizing and externalizing difficulties from preschool to early adolescenceThe relation between common sleep problems and emotional and behavioral problems among 2- and 3-year-olds in the context of known risk factors for psychopathologyPrevalences and correlates of sleep problems among adolescents in specialty mental health services and in the community: what differs?Sensory processing, physiological stress, and sleep behaviors in children with and without autism spectrum disordersSleep, neurobehavioral functioning, and behavior problems in school-age childrenParental psychopathology and sleep variation in childrenSleep problems predict and are predicted by generalized anxiety/depression and oppositional defiant disorderSensory hypersensitivity as a contributing factor in the relation between sleep and behavioral disorders in normal schoolchildrenIdentifying adolescent sleep problemsSleep behaviors and disorders in children and adolescents evaluated at psychiatric clinicsThe comorbidity of chronic pain and sleep disturbances in a community adolescent sample: prevalence and association with sociodemographic and psychosocial factorsStability of sleep disorders from preschool to first grade and their bidirectional relationship with psychiatric symptomsThe interRAI child and youth suite of mental health assessment instruments: an integrated approach to mental health service deliverySensory processing in children with and without autism: a comparative study using the short sensory profileSuppression situations in psychological research: definitions, implications, and applicationsDaily bidirectional relationships between sleep and mental health symptoms in youth with emotional and behavioral problemsLongitudinal bidirectional effects between sleep quality and internalizing problemsRisk and protective factors for children's and adolescents' mental health: results of the BELLA studyPatterns of sleep problems and internalizing and externalizing problems among Chinese adolescents: a latent class analysisSex differences in insomnia: a meta-analysis</div>
                            <small style="color: var(--text-muted)">12713889.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'Software mentioned without specific versions.', 'evidence': '...ion analysis was conducted in SPSS to account for this non-rando...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Outcomes of remotely delivered behavioral insomnia interventions for children and adolescents: systematic review of randomized controlled trialsI sleep, because we sleep: a synthesis on the role of culture in sleep behavior researchCognitive and behavioral interventions to improve sleep in school-age children and adolescents: a systematic review and meta-analysisValidation of the Insomnia Severity Index as an outcome measure for insomnia researchSystematic review and meta-analysis of adolescent cognitive-behavioral sleep interventionsDevelopment of a short version of the dysfunctional beliefs about sleep questionnaire for use with children (DBAS-C10)Executive functions in preschool children with chronic insomniaThe pittsburgh sleep quality index: anew instrument for psychiatric practice and researchValidation of a brief insomnia severity measure in youth clinically referred for sleep evaluationEfficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trialInsomnia in adolescents: prevalence, help-seeking behaviors, and types of interventionsInsomnia, health-related quality of life and health outcomes in children: a seven year longitudinal cohortBetter nights/better days-distance intervention for insomnia in school-aged children with/without ADHD: a radomized controlled trialEfficacy of internet and group-administered cognitive behavioral therapy for insomnia in adolescents: a pilot studyEfficacy of cognitive behavioral therapy for insomnia in adolescents: a randomized controlled trial with internet therapy, group therapy and a waiting list conditionDifferential effects of online insomnia treatment on executive functions in adolescentsImprovements of adolescent psychopathology after insomnia treatment: results from a randomized controlled trial over 1 year. J. Child PsycholThe pittsburgh sleep quality index: validity and factor structure in young people“Amsterdam Neuropsychological Tasks: A computer-aided assessment program,”Microcomputer analyses of performance on a portable, simple visual RT task during sustained operationsInsomnia in AdolescenceExperimental restriction of sleep opportunity in children: effects on teacher ratingsNetwork meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adultsPacific families navigating responsiveness and children's sleep in Aotearoa New ZealandThe flinders fatigue scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomniaSleep problems in childhood: a longitudinal study of developmental change and association with behavioral problemsPediatric sleep problems and social-emotional problems. A population-based studyCognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparisonValidation of the Epworth Sleepiness Scale for children and adolescents using rasch analysisThe patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patientsHolland sleep disorders questionnaire: a new sleep disorders questionnaire based on the international classification of sleep disorders-2A feasibility and acceptability study of cognitive behavioural treatment for insomnia in adolescents with traumatic brain injury: A-B with follow up design, randomized baseline, and replication across participantsDigital cognitive behavioral therapy for insomnia on depression and anxiety: a systematic review and meta-analysis“Insomnia of childhood: assessment and treatment,”The associations of insomnia symptoms with daytime behavior and cognitive functioning in children with attention-deficit/hyperactivity disorderDigital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science reviewEfficacy of cognitive behavioral therapy in children and adolescents with insomnia: a systematic review and meta-analysisBehavioral treatment of insomnia: a proposal for a stepped care approach to promote public healthSleep quality subtypes predict health-related quality of life in childrenAdverse associations of infant and child sleep problems and parent health: an Australian population studyEffect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain: a randomized clinical trial“Pediatric insomnia: etiology, impact, assessment, and treatment,”Chronic sleep reduction, functioning at school and school achievement in preadolescentsRelationship between child sleep disturbances and maternal sleep, mood, and parenting stress: a pilot studySystematic review and meta-analysis of behavioral interventions for pediatric insomniaPediatric sleep health: it matters, and so does how we define itPsychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scaleEfficacy of an internet-based intervention for infant and toddler sleep disturbancesLong-term efficacy of an internet-based intervention for infant and toddler sleep disturbances: one year follow-upA nightly bedtime routine: impact on sleep in young children and maternal moodPreferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statementPractice parameters for behavioral treatment of bedtime problems and night wakings in infants and young childrenThe phenomenology of the pre-sleep state: the development of the pre-sleep arousal scaleClassification and epidemiology of childhood sleep disordersPediatric insomniaThe children's sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged childrenThe PRISMA 2020 statement: an updated guideline for reporting systematic reviewsA randomised controlled trial of cognitive-behaviour therapy for behavioural insomnia of childhood in school-aged childrenBehavioral interventions for sleep disturbances in children with neurological and neurodevelopmental disorders: a systematic review and meta-analysis of randomized controlled trialsDigital natives, digital immigrants part 1Digital natives, digital immigrants part 2: Do they really think differently?Management of chronic insomnia disorder in adults: a clinical practice guideline from the american college of physiciansAustralasian sleep association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adultsInvestigating safety behaviours in insomnia: the development of the sleep-related behaviours questionnaire (SRBQ)Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviewsComparison of online and face-to-face parent education for children with autism and sleep problemsA brief screening questionnaire for infant sleep problems: validation and findings for an Internet sampleA shortened version of the profile of mood statesThe epidemiology of insomnia and sleep duration across mental and physical health: the SHoT studyThe importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel assessing generalized anxiety disorder: the GAD-7RoB 2: a revised tool for assessing risk of bias in randomised trialsThe Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validationInternet-based cognitive behavioral therapy for insomnia: a health economic evaluationPsychometricproperties of the 7-item generalized anxiety disorder scale (GAD-7) in a large representative sample of Finnish adolescentsThe role of cognitive-behavioral therapy in behavioral childhood insomniaThe association of sleep quality and aggression: a systematic review and meta-analysis of observational studiesClinical management of behavioral insomnia of childhoodDigitally-delivered cognitive-behavioural therapy for youth insomnia: a systematic reviewChild sleep behaviors and sleep problems from infancy to school-ageThe World Health Organization quality of life assessment (WHOQOL): position paper from the World Health OrganizationA longitudinal study of insomnia, daytime sleepiness, and academic performance in chinese adolescents">Outcomes of remotely delivered behavioral insomnia interventions for children and adolescents: systematic review of randomized controlled trialsI sleep, because we sleep: a synthesis on the role of culture in sleep behavior researchCognitive and behavioral interventions to improve sleep in school-age children and adolescents: a systematic review and meta-analysisValidation of the Insomnia Severity Index as an outcome measure for insomnia researchSystematic review and meta-analysis of adolescent cognitive-behavioral sleep interventionsDevelopment of a short version of the dysfunctional beliefs about sleep questionnaire for use with children (DBAS-C10)Executive functions in preschool children with chronic insomniaThe pittsburgh sleep quality index: anew instrument for psychiatric practice and researchValidation of a brief insomnia severity measure in youth clinically referred for sleep evaluationEfficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trialInsomnia in adolescents: prevalence, help-seeking behaviors, and types of interventionsInsomnia, health-related quality of life and health outcomes in children: a seven year longitudinal cohortBetter nights/better days-distance intervention for insomnia in school-aged children with/without ADHD: a radomized controlled trialEfficacy of internet and group-administered cognitive behavioral therapy for insomnia in adolescents: a pilot studyEfficacy of cognitive behavioral therapy for insomnia in adolescents: a randomized controlled trial with internet therapy, group therapy and a waiting list conditionDifferential effects of online insomnia treatment on executive functions in adolescentsImprovements of adolescent psychopathology after insomnia treatment: results from a randomized controlled trial over 1 year. J. Child PsycholThe pittsburgh sleep quality index: validity and factor structure in young people“Amsterdam Neuropsychological Tasks: A computer-aided assessment program,”Microcomputer analyses of performance on a portable, simple visual RT task during sustained operationsInsomnia in AdolescenceExperimental restriction of sleep opportunity in children: effects on teacher ratingsNetwork meta-analysis comparing the effectiveness of a prescription digital therapeutic for chronic insomnia to medications and face-to-face cognitive behavioral therapy in adultsPacific families navigating responsiveness and children's sleep in Aotearoa New ZealandThe flinders fatigue scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomniaSleep problems in childhood: a longitudinal study of developmental change and association with behavioral problemsPediatric sleep problems and social-emotional problems. A population-based studyCognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparisonValidation of the Epworth Sleepiness Scale for children and adolescents using rasch analysisThe patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patientsHolland sleep disorders questionnaire: a new sleep disorders questionnaire based on the international classification of sleep disorders-2A feasibility and acceptability study of cognitive behavioural treatment for insomnia in adolescents with traumatic brain injury: A-B with follow up design, randomized baseline, and replication across participantsDigital cognitive behavioral therapy for insomnia on depression and anxiety: a systematic review and meta-analysis“Insomnia of childhood: assessment and treatment,”The associations of insomnia symptoms with daytime behavior and cognitive functioning in children with attention-deficit/hyperactivity disorderDigital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science reviewEfficacy of cognitive behavioral therapy in children and adolescents with insomnia: a systematic review and meta-analysisBehavioral treatment of insomnia: a proposal for a stepped care approach to promote public healthSleep quality subtypes predict health-related quality of life in childrenAdverse associations of infant and child sleep problems and parent health: an Australian population studyEffect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain: a randomized clinical trial“Pediatric insomnia: etiology, impact, assessment, and treatment,”Chronic sleep reduction, functioning at school and school achievement in preadolescentsRelationship between child sleep disturbances and maternal sleep, mood, and parenting stress: a pilot studySystematic review and meta-analysis of behavioral interventions for pediatric insomniaPediatric sleep health: it matters, and so does how we define itPsychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scaleEfficacy of an internet-based intervention for infant and toddler sleep disturbancesLong-term efficacy of an internet-based intervention for infant and toddler sleep disturbances: one year follow-upA nightly bedtime routine: impact on sleep in young children and maternal moodPreferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statementPractice parameters for behavioral treatment of bedtime problems and night wakings in infants and young childrenThe phenomenology of the pre-sleep state: the development of the pre-sleep arousal scaleClassification and epidemiology of childhood sleep disordersPediatric insomniaThe children's sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged childrenThe PRISMA 2020 statement: an updated guideline for reporting systematic reviewsA randomised controlled trial of cognitive-behaviour therapy for behavioural insomnia of childhood in school-aged childrenBehavioral interventions for sleep disturbances in children with neurological and neurodevelopmental disorders: a systematic review and meta-analysis of randomized controlled trialsDigital natives, digital immigrants part 1Digital natives, digital immigrants part 2: Do they really think differently?Management of chronic insomnia disorder in adults: a clinical practice guideline from the american college of physiciansAustralasian sleep association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adultsInvestigating safety behaviours in insomnia: the development of the sleep-related behaviours questionnaire (SRBQ)Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviewsComparison of online and face-to-face parent education for children with autism and sleep problemsA brief screening questionnaire for infant sleep problems: validation and findings for an Internet sampleA shortened version of the profile of mood statesThe epidemiology of insomnia and sleep duration across mental and physical health: the SHoT studyThe importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel assessing generalized anxiety disorder: the GAD-7RoB 2: a revised tool for assessing risk of bias in randomised trialsThe Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validationInternet-based cognitive behavioral therapy for insomnia: a health economic evaluationPsychometricproperties of the 7-item generalized anxiety disorder scale (GAD-7) in a large representative sample of Finnish adolescentsThe role of cognitive-behavioral therapy in behavioral childhood insomniaThe association of sleep quality and aggression: a systematic review and meta-analysis of observational studiesClinical management of behavioral insomnia of childhoodDigitally-delivered cognitive-behavioural therapy for youth insomnia: a systematic reviewChild sleep behaviors and sleep problems from infancy to school-ageThe World Health Organization quality of life assessment (WHOQOL): position paper from the World Health OrganizationA longitudinal study of insomnia, daytime sleepiness, and academic performance in chinese adolescents</div>
                            <small style="color: var(--text-muted)">12713916.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Sleep related movement disorders in the elderly: a review of recent literatureSleep quality and comfort reported by sleep bruxism individuals wearing the occlusal splint and mandibular advancement splint: revisiting two crossover studiesEvidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/willis-ekbom disease in adults and children: an IRLSSG task force reportRestless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria – history, rationale, description, and significanceRestless legs syndrome prevalence and impact: REST general population studySleep bruxism neurobiologyInternational classification of sleep disorders—third edition (ICSD-3)Exercise and restless legs syndrome: a randomized controlled trialThe treatment of restless legs syndrome and periodic limb movement disorder in adults–an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an american academy of sleep medicine clinical practice guidelineAlternative treatment of restless legs syndrome: an overview of the evidence for mind–body interventions, lifestyle interventions, and neutraceuticalsShort-term effect of material type and thickness of occlusal splints on maximum bite force and sleep quality in patients with sleep bruxism: a randomized controlled clinical trialSex and the risk of restless legs syndrome in the general populationEffect of treatment with a full-occlusion biofeedback splint on sleep bruxism and TMD pain: a randomized controlled clinical trialPeriodic leg movements in sleep and restless legs syndrome: considerations in geriatricsNoninvasive neuromodulation reduces symptoms of restless legs syndromeNocturnal leg cramps in older peopleAmerican Geriatrics Society 2019 Updated AGS Beers Criteria for potentially inappropriate medication use in older adultsAssociation of sleep bruxism with oral health-related quality of life and sleep qualityIncreased blood pressure dipping in restless legs syndrome with rotigotine: a randomized trialBlood pressure profile and endothelial function in restless legs syndromeUsefulness of electronic stimulation in restless legs syndrome: a pilot studyCognitive profile in restless legs syndrome: a signal-to-noise ratio accountProspective study of obesity, hypertension, high cholesterol, and risk of restless legs syndromeLack of association between periodic limb movements during sleep and neuroimaging signatures of cerebral small vessel disease in stroke-free community-dwelling older adults. the atahualpa projectAssociation between alcohol consumption and nocturnal leg cramps in patients over 60 years old: a case-control studyAssociation between physical activity and nocturnal leg cramps in patients over 60 years old: a case-control studyLarge genome-wide association study identifies three novel risk variants for restless legs syndromeCardiovascular events reported in randomized controlled trials in restless legs syndromeAssociation of proton pump inhibitor and histamine H2-receptor antagonists with restless legs syndromeRestless legs syndrome among patients receiving antipsychotic and antidepressant drugsTreating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort study with 3.4 years of follow upReduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatmentGuidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundationNocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysisOver-the-counter bite splints: a randomized controlled trial of compliance and efficacyPrevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based studyRestless legs syndrome: contemporary diagnosis and treatmentNocturnal leg cramps: prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factorsSleep disorders in the elderly: a growing challengeRestless legs syndrome and hypertension in men and women: a propensity score-matched analysisPrevalence of restless legs syndrome: a community-based study from argentinaClinical significance of periodic limb movements during sleep: the HypnoLaus studyPilot testing a stretching regimen for prevention of night time nocturnal leg crampsStretching before sleep reduces the frequency and severity of nocturnal leg cramps in older adults: a randomised trialdelicate balance: iron metabolism and diseases of the brainPeriodic limb movements during sleep are associated with cardiovascular diseases: a systematic review and meta-analysisBiofeedback for treatment of awake and sleep bruxism in adults: systematic review protocolEffects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trialParasomnias and sleep-related movement disorders in older adultsPrevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trialCognition in restless legs syndromeRestless legs syndrome and cerebrovascular/cardiovascular events: systematic review and meta-analysisAssessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurologyBotulinum toxin treatment of temporomandibular joint pain in patients with bruxism: a prospective and randomized clinical studyComparison of kinesio taping and occlusal splint in the management of myofascial pain in patients with sleep bruxismRestless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort studyThe influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic reviewDean DA2, Lutsey PL, Redline S. Periodic limb movements during sleep and prevalent hypertension in the multi-ethnic study of atherosclerosisMultiple skeletal injuries resulting from uncontrolled restless legs syndromePaeoniae radix-containing herbal medicine for patients with restless legs syndrome: a systematic review and meta-analysisReduction of sleep bruxism using a mandibular advancement device: an experimental controlled studyPeriodic limb movements in sleep are associated with greater cognitive decline in older men without dementiaCerebrovascular accident risk in a population with periodic limb movements of sleep: A preliminary meta-analysisEfficacy of botulinum toxins on bruxism: an evidence-based reviewTreatment of nocturnal leg cramps by primary care patients over the age of 60Periodic limb movements during sleep in stroke/TIA: prevalence, course, and cardiovascular burdenRestless legs syndrome and pregnancyWhen gender matters: restless legs syndrome. report of the “RLS and woman” workshop endorsed by the european RLS study groupEpidemiology of bruxism in adults: a systematic review of the literaturePeriodic leg movements during sleep and cognitive functioning in the older general populationThe approach and management of bruxism in alzheimer's disease: an under-recognized habit that concerns caregivers (innovative practice)Sleep in the aging populationEffects of glycerin oil and lavender oil massages on hemodialysis patients' restless legs syndromeNocturnal leg crampsEpidemiology of restless legs syndrome: a synthesis of the literatureOnabotulinum toxin-a injections for sleep bruxismRandomized pilot trial for the efficacy of the MMF07 foot massager and heat therapy for restless legs syndromeNocturnal blood pressure changes in patients with restless legs syndromeClinical practice guideline on management of sleep disorders in the elderlyAssessment of symptoms associated with temporomandibular dysfunction and bruxism among elderly population: an epidemiological surveyreview of nocturnal leg cramps in older peoplePrevalence of temporomandibular disorders and bruxism in seniorsNighttime agitation in persons with dementia as a manifestation of restless legs syndromeLong-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: a 24-week open-label extension studySleep-related leg movements in patients with transient ischemic attack and controlsCardiovascular risk factors in restless legs syndromeSleep correlates of trait executive function and memory in parkinson's diseaseprospective observational study of the main features of nocturnal leg cramps in primary careHealth-related quality of life associated with nocturnal leg cramps in primary care: a mixed methods studyEvaluation of sleep disorders in the primary care setting: history taking compared to questionnairesPeriodic limb movements during sleep are not associated with hypertension in a clinical cohort of Korean adultsThe management of restless legs syndrome: an updated algorithmInfluence of age and gender on sleep bruxism and snoring in non-apneic snoring patients: a polysomnographic studyCognitive behavioral therapy for insomnia in restless legs syndrome patientsEffectiveness and safety of botulinum toxin type A in treatment of restless legs syndrome: a systematic review and meta-analysisCannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studiesPeriodic limb movements in sleep are linked to decreased hippocampus and amygdala volumes in the population-based BiDirect studyEpidemiology of restless legs syndrome in french adults: a nationwide survey: the INSTANT studyThe relationship between dipping-non-dipping arterial blood pressure pattern and frequency of restless leg syndrome with related factorsComparison of kinesio taping and manual therapy in the treatment of patients with bruxism using shear-wave elastography—a randomised clinical trialAltered cortical gray matter volume and functional connectivity after transcutaneous spinal cord direct current stimulation in idiopathic restless legs syndromeRestless legs syndrome and cognitive function among adults: a systematic review and meta-analysisNon-dopaminergic vs. dopaminergic treatment options in restless legs syndromeThe most commonly used methods of treatment for bruxism – a literature reviewPractice guideline summary: treatment of restless legs syndrome in adults: tableGenetic associations of periodic limb movements of sleep in the elderly for the MrOS sleep studyAssociation of restless legs syndrome and cardiovascular disease in the sleep heart health studyClinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patientsThe relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderlyInsomnia in primary care: considerations for screening, assessment, and managementPrognostic impact of restless legs syndrome on patients with heart failureQuantitative comparison of the efficacies of 5 first-line drugs for primary restless leg syndrome">Sleep related movement disorders in the elderly: a review of recent literatureSleep quality and comfort reported by sleep bruxism individuals wearing the occlusal splint and mandibular advancement splint: revisiting two crossover studiesEvidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/willis-ekbom disease in adults and children: an IRLSSG task force reportRestless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria – history, rationale, description, and significanceRestless legs syndrome prevalence and impact: REST general population studySleep bruxism neurobiologyInternational classification of sleep disorders—third edition (ICSD-3)Exercise and restless legs syndrome: a randomized controlled trialThe treatment of restless legs syndrome and periodic limb movement disorder in adults–an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an american academy of sleep medicine clinical practice guidelineAlternative treatment of restless legs syndrome: an overview of the evidence for mind–body interventions, lifestyle interventions, and neutraceuticalsShort-term effect of material type and thickness of occlusal splints on maximum bite force and sleep quality in patients with sleep bruxism: a randomized controlled clinical trialSex and the risk of restless legs syndrome in the general populationEffect of treatment with a full-occlusion biofeedback splint on sleep bruxism and TMD pain: a randomized controlled clinical trialPeriodic leg movements in sleep and restless legs syndrome: considerations in geriatricsNoninvasive neuromodulation reduces symptoms of restless legs syndromeNocturnal leg cramps in older peopleAmerican Geriatrics Society 2019 Updated AGS Beers Criteria for potentially inappropriate medication use in older adultsAssociation of sleep bruxism with oral health-related quality of life and sleep qualityIncreased blood pressure dipping in restless legs syndrome with rotigotine: a randomized trialBlood pressure profile and endothelial function in restless legs syndromeUsefulness of electronic stimulation in restless legs syndrome: a pilot studyCognitive profile in restless legs syndrome: a signal-to-noise ratio accountProspective study of obesity, hypertension, high cholesterol, and risk of restless legs syndromeLack of association between periodic limb movements during sleep and neuroimaging signatures of cerebral small vessel disease in stroke-free community-dwelling older adults. the atahualpa projectAssociation between alcohol consumption and nocturnal leg cramps in patients over 60 years old: a case-control studyAssociation between physical activity and nocturnal leg cramps in patients over 60 years old: a case-control studyLarge genome-wide association study identifies three novel risk variants for restless legs syndromeCardiovascular events reported in randomized controlled trials in restless legs syndromeAssociation of proton pump inhibitor and histamine H2-receptor antagonists with restless legs syndromeRestless legs syndrome among patients receiving antipsychotic and antidepressant drugsTreating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort study with 3.4 years of follow upReduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatmentGuidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundationNocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysisOver-the-counter bite splints: a randomized controlled trial of compliance and efficacyPrevalence of sleep-related problems and risks in a community-dwelling older adult population: a cross-sectional survey-based studyRestless legs syndrome: contemporary diagnosis and treatmentNocturnal leg cramps: prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factorsSleep disorders in the elderly: a growing challengeRestless legs syndrome and hypertension in men and women: a propensity score-matched analysisPrevalence of restless legs syndrome: a community-based study from argentinaClinical significance of periodic limb movements during sleep: the HypnoLaus studyPilot testing a stretching regimen for prevention of night time nocturnal leg crampsStretching before sleep reduces the frequency and severity of nocturnal leg cramps in older adults: a randomised trialdelicate balance: iron metabolism and diseases of the brainPeriodic limb movements during sleep are associated with cardiovascular diseases: a systematic review and meta-analysisBiofeedback for treatment of awake and sleep bruxism in adults: systematic review protocolEffects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trialParasomnias and sleep-related movement disorders in older adultsPrevention of leg cramps by using compression stockings or magnesium supplements in the 50-84 age group: study protocol for a randomised controlled trialCognition in restless legs syndromeRestless legs syndrome and cerebrovascular/cardiovascular events: systematic review and meta-analysisAssessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurologyBotulinum toxin treatment of temporomandibular joint pain in patients with bruxism: a prospective and randomized clinical studyComparison of kinesio taping and occlusal splint in the management of myofascial pain in patients with sleep bruxismRestless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort studyThe influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic reviewDean DA2, Lutsey PL, Redline S. Periodic limb movements during sleep and prevalent hypertension in the multi-ethnic study of atherosclerosisMultiple skeletal injuries resulting from uncontrolled restless legs syndromePaeoniae radix-containing herbal medicine for patients with restless legs syndrome: a systematic review and meta-analysisReduction of sleep bruxism using a mandibular advancement device: an experimental controlled studyPeriodic limb movements in sleep are associated with greater cognitive decline in older men without dementiaCerebrovascular accident risk in a population with periodic limb movements of sleep: A preliminary meta-analysisEfficacy of botulinum toxins on bruxism: an evidence-based reviewTreatment of nocturnal leg cramps by primary care patients over the age of 60Periodic limb movements during sleep in stroke/TIA: prevalence, course, and cardiovascular burdenRestless legs syndrome and pregnancyWhen gender matters: restless legs syndrome. report of the “RLS and woman” workshop endorsed by the european RLS study groupEpidemiology of bruxism in adults: a systematic review of the literaturePeriodic leg movements during sleep and cognitive functioning in the older general populationThe approach and management of bruxism in alzheimer's disease: an under-recognized habit that concerns caregivers (innovative practice)Sleep in the aging populationEffects of glycerin oil and lavender oil massages on hemodialysis patients' restless legs syndromeNocturnal leg crampsEpidemiology of restless legs syndrome: a synthesis of the literatureOnabotulinum toxin-a injections for sleep bruxismRandomized pilot trial for the efficacy of the MMF07 foot massager and heat therapy for restless legs syndromeNocturnal blood pressure changes in patients with restless legs syndromeClinical practice guideline on management of sleep disorders in the elderlyAssessment of symptoms associated with temporomandibular dysfunction and bruxism among elderly population: an epidemiological surveyreview of nocturnal leg cramps in older peoplePrevalence of temporomandibular disorders and bruxism in seniorsNighttime agitation in persons with dementia as a manifestation of restless legs syndromeLong-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: a 24-week open-label extension studySleep-related leg movements in patients with transient ischemic attack and controlsCardiovascular risk factors in restless legs syndromeSleep correlates of trait executive function and memory in parkinson's diseaseprospective observational study of the main features of nocturnal leg cramps in primary careHealth-related quality of life associated with nocturnal leg cramps in primary care: a mixed methods studyEvaluation of sleep disorders in the primary care setting: history taking compared to questionnairesPeriodic limb movements during sleep are not associated with hypertension in a clinical cohort of Korean adultsThe management of restless legs syndrome: an updated algorithmInfluence of age and gender on sleep bruxism and snoring in non-apneic snoring patients: a polysomnographic studyCognitive behavioral therapy for insomnia in restless legs syndrome patientsEffectiveness and safety of botulinum toxin type A in treatment of restless legs syndrome: a systematic review and meta-analysisCannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studiesPeriodic limb movements in sleep are linked to decreased hippocampus and amygdala volumes in the population-based BiDirect studyEpidemiology of restless legs syndrome in french adults: a nationwide survey: the INSTANT studyThe relationship between dipping-non-dipping arterial blood pressure pattern and frequency of restless leg syndrome with related factorsComparison of kinesio taping and manual therapy in the treatment of patients with bruxism using shear-wave elastography—a randomised clinical trialAltered cortical gray matter volume and functional connectivity after transcutaneous spinal cord direct current stimulation in idiopathic restless legs syndromeRestless legs syndrome and cognitive function among adults: a systematic review and meta-analysisNon-dopaminergic vs. dopaminergic treatment options in restless legs syndromeThe most commonly used methods of treatment for bruxism – a literature reviewPractice guideline summary: treatment of restless legs syndrome in adults: tableGenetic associations of periodic limb movements of sleep in the elderly for the MrOS sleep studyAssociation of restless legs syndrome and cardiovascular disease in the sleep heart health studyClinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patientsThe relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderlyInsomnia in primary care: considerations for screening, assessment, and managementPrognostic impact of restless legs syndrome on patients with heart failureQuantitative comparison of the efficacies of 5 first-line drugs for primary restless leg syndrome</div>
                            <small style="color: var(--text-muted)">12713975.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi PanelGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesComprehensive review of hepatocellular carcinoma in India: current challenges and future directionsLiver transplantation beyond Milan CriteriaAtezolizumab plus bevacizumab in unresectable hepatocellular carcinomaTremelimumab plus durvalumab in unresectable hepatocellular carcinomaLenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trialBCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateDevelopment of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinomaTransarterial chemoembolization and (90)Y radioembolization for hepatocellular carcinoma: review of current applications beyond intermediate-stage diseaseTACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta analysisLiver resection for HCC outside the BCLC criteriaLiving donor liver transplantation for hepatocellular carcinoma in Indian patients- is the scenario different?Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelinesThe importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinomaA global view of hepatocellular carcinoma: trends, risk, prevention and managementReview article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairmentAlbumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinomaThe ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaIndependent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinomaGreen light for liver function monitoring using indocyanine green? An overview of current clinical applicationsPreoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance testAssessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resectionUse of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcomeValue of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinomaEASL clinical practice guidelines: management of hepatocellular carcinomaPalliative care in hepatocellular carcinomaClinical profile, patterns of care & adherence to guidelines in patients with hepatocellular carcinoma: prospective multi-center studyExperience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting-a retrospective descriptive analysisHepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapyHepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrenceTenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: a systematic review and meta-analysis
EASL recommendations on treatment of hepatitis C: final update of the series
Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinomaDirect-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort studyHow much remnant is enough in liver resection?The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic reviewSelection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class BStrategies for safer liver surgery and partial liver transplantationPortal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysisOutcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinomaOutcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter)Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide surveySurvival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasionA new classification for hepatocellular carcinoma with hepatic vein tumor thrombusSurgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter studyBile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?Liver resection for multiple hepatocellular carcinomas: a Japanese nationwide surveyLiver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: a multicenter analysis of 1,066 patientsAdjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinomaDownstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapyTransarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews [Internet]The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011Radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for patients with medium-to-large hepatocellular carcinoma: a retrospective analysis of long-term outcomeTranscatheter arterial chemoembolization with or without radiofrequency ablation: outcomes in patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
Conventional

drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyTransarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysisPersonalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialSequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaLong-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinomaRandomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysisProton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trialA phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacyNRG/RTOG 1112: randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) ()Combination transarterial chemoembolization and stereotactic body radiation therapy for unresectable single large hepatocellular carcinoma: results from a prospective phase 2 trialStereotactic radiotherapy after incomplete transarterial (Chemo-) embolization (TAE) versus exclusive TAE or TACE for treatment of inoperable HCC: a phase III trial ()Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trialNeoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled studySorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialRandomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialFinal results of TACTICS: a randomized, prospective trial comparing transarterial chemoembolization plus sorafenib to transarterial chemoembolization alone in patients with unresectable hepatocellular carcinomaLenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)Management of hepatocellular carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 UpdateEfficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialSIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinomaImpact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinomaAnalysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: a multicenter analysis
Sorafenib

. lenvatinib as first-line therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Sorafenib in advanced hepatocellular carcinomaEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialSurvival of trial-like and non-trial-like patients with immunotherapy in advanced hepatocellular carcinoma in real world: a collaborative multicenter Indian study (IMHEP)Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinomaAtezolizumab/bevacizumab vs. lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: a real-world, multi-center studyAtezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide populationNivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialPembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trialCheckMate 040 cohort 5: a phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosisSorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialCabozantinib in patients with advanced and progressing hepatocellular carcinomaRamucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trialRamucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialEfficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial">Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi PanelGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesComprehensive review of hepatocellular carcinoma in India: current challenges and future directionsLiver transplantation beyond Milan CriteriaAtezolizumab plus bevacizumab in unresectable hepatocellular carcinomaTremelimumab plus durvalumab in unresectable hepatocellular carcinomaLenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trialBCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateDevelopment of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinomaTransarterial chemoembolization and (90)Y radioembolization for hepatocellular carcinoma: review of current applications beyond intermediate-stage diseaseTACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta analysisLiver resection for HCC outside the BCLC criteriaLiving donor liver transplantation for hepatocellular carcinoma in Indian patients- is the scenario different?Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelinesThe importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinomaA global view of hepatocellular carcinoma: trends, risk, prevention and managementReview article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairmentAlbumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinomaThe ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaIndependent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinomaGreen light for liver function monitoring using indocyanine green? An overview of current clinical applicationsPreoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance testAssessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resectionUse of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcomeValue of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinomaEASL clinical practice guidelines: management of hepatocellular carcinomaPalliative care in hepatocellular carcinomaClinical profile, patterns of care & adherence to guidelines in patients with hepatocellular carcinoma: prospective multi-center studyExperience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting-a retrospective descriptive analysisHepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapyHepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrenceTenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: a systematic review and meta-analysis
EASL recommendations on treatment of hepatitis C: final update of the series
Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinomaDirect-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort studyHow much remnant is enough in liver resection?The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic reviewSelection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class BStrategies for safer liver surgery and partial liver transplantationPortal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysisOutcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinomaOutcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter)Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide surveySurvival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasionA new classification for hepatocellular carcinoma with hepatic vein tumor thrombusSurgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter studyBile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?Liver resection for multiple hepatocellular carcinomas: a Japanese nationwide surveyLiver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: a multicenter analysis of 1,066 patientsAdjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinomaDownstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapyTransarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews [Internet]The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011Radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for patients with medium-to-large hepatocellular carcinoma: a retrospective analysis of long-term outcomeTranscatheter arterial chemoembolization with or without radiofrequency ablation: outcomes in patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
Conventional

drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyTransarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysisPersonalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialSequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaLong-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinomaRandomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysisProton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trialA phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacyNRG/RTOG 1112: randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) ()Combination transarterial chemoembolization and stereotactic body radiation therapy for unresectable single large hepatocellular carcinoma: results from a prospective phase 2 trialStereotactic radiotherapy after incomplete transarterial (Chemo-) embolization (TAE) versus exclusive TAE or TACE for treatment of inoperable HCC: a phase III trial ()Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trialNeoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled studySorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialRandomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trialFinal results of TACTICS: a randomized, prospective trial comparing transarterial chemoembolization plus sorafenib to transarterial chemoembolization alone in patients with unresectable hepatocellular carcinomaLenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)Management of hepatocellular carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 UpdateEfficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialSIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinomaImpact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinomaAnalysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: a multicenter analysis
Sorafenib

. lenvatinib as first-line therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Sorafenib in advanced hepatocellular carcinomaEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialSurvival of trial-like and non-trial-like patients with immunotherapy in advanced hepatocellular carcinoma in real world: a collaborative multicenter Indian study (IMHEP)Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinomaAtezolizumab/bevacizumab vs. lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: a real-world, multi-center studyAtezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide populationNivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trialPembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trialCheckMate 040 cohort 5: a phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosisSorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialCabozantinib in patients with advanced and progressing hepatocellular carcinomaRamucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trialRamucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialEfficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial</div>
                            <small style="color: var(--text-muted)">12714441.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Novel Nomogram for Prediction of Lymph Node Metastases from Buccal Mucosa Squamous Carcinoma Using Histological ParametersOral cancer prevalence in Western population of Maharashtra, India, for a period of 5 yearsThe Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingSentinel lymph node biopsy for oral squamous cell carcinoma. Where are we now?Elective versus therapeutic neck dissection in node-negative oral cancerLymph node metastasis: a bearing on prognosis in squamous cell carcinomaSentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerAccuracy of the preoperative diagnostic workup in patients with head and neck cancers undergoing neck dissection in terms of nodal metastasesImpact of lymphovascular invasion in oral squamous cell carcinoma: a meta-analysisPrognostic impact of perineural invasion in oral cancer: a systematic reviewDevelopment of a new outcome prediction model in early-stage squamous cell carcinoma of the oral cavity based on histopathologic parameters with multivariate analysisTumor budding and worse pattern of invasion can predict nodal metastasis in oral cancers and associated with poor survival in early-stage tumorsClinicopathological correlation between depth of tumor and neck node metastasis in oral (tongue and buccal mucosa) carcinomaA preoperative nomogram model for the prediction of lymph node metastasis in buccal mucosa cancerA model to predict nodal metastasis in patients with oral squamous cell carcinomaCT-based radiomic signatures for predicting histopathologic features in head and neck squamous cell carcinomaMagnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer">Novel Nomogram for Prediction of Lymph Node Metastases from Buccal Mucosa Squamous Carcinoma Using Histological ParametersOral cancer prevalence in Western population of Maharashtra, India, for a period of 5 yearsThe Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer stagingSentinel lymph node biopsy for oral squamous cell carcinoma. Where are we now?Elective versus therapeutic neck dissection in node-negative oral cancerLymph node metastasis: a bearing on prognosis in squamous cell carcinomaSentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerAccuracy of the preoperative diagnostic workup in patients with head and neck cancers undergoing neck dissection in terms of nodal metastasesImpact of lymphovascular invasion in oral squamous cell carcinoma: a meta-analysisPrognostic impact of perineural invasion in oral cancer: a systematic reviewDevelopment of a new outcome prediction model in early-stage squamous cell carcinoma of the oral cavity based on histopathologic parameters with multivariate analysisTumor budding and worse pattern of invasion can predict nodal metastasis in oral cancers and associated with poor survival in early-stage tumorsClinicopathological correlation between depth of tumor and neck node metastasis in oral (tongue and buccal mucosa) carcinomaA preoperative nomogram model for the prediction of lymph node metastasis in buccal mucosa cancerA model to predict nodal metastasis in patients with oral squamous cell carcinomaCT-based radiomic signatures for predicting histopathologic features in head and neck squamous cell carcinomaMagnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer</div>
                            <small style="color: var(--text-muted)">12714475.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Examining the Connectorship Scale: Factor Structure and Correlations With Self-Efficacy and ExtraversionSelf-efficacy: Toward a unifying theory of behavioral changeImproved leadership skills and aptitudes in an excellence EMBA program: Creating synergies with dialogic leadership to achieve social impactThe leader as effective communicatorThe influence of green innovation performance on corporate advantage in TaiwanDeveloping a measure for “connectorship” as a component of engaged leadershipConnectorshipA meta-analytic examination of the effects of the agentic and affiliative aspects of extraversion on leadership outcomesWho emerges as a leader? Meta- analyses of individual differences as predictors of leadership emergenceAnalysis of social problem solving and social self-efficacy in prospective teachersCorrelates of networking behavior for managerial and professional employeesCutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesPersonality and leadership: A qualitative and quantitative reviewFacet level effects of extraversion on leadership behaviours rated by subordinatesIntegrating implicit leadership theories, leader-member exchange, self-efficacy, and attachment theory to predict job performanceLeadership versus management: What’s the difference?Social connectedness, extraversion, and subjective well-being: Testing a mediation modelConnective leadership: Female leadership styles in the 21st- century workplacePower analysis and determination of sample size for covariance structure modelingThe role of self-efficacy beliefs in leader developmentInclined but less skilled? Disentangling extraversion, communication skill, and leadership emergenceThe role of self-efficacy, emotional intelligence and leadership style as attributes of leadership effectivenessConnecting leadership and learning: Do versatile learners make connective leaders?lavaan: An R package for structural equation modelingThe ineffective police leader: Acts of commission and omissionGeneralized self-efficacy scaleLeadership effectiveness and personality: A cross cultural evaluationEthical leadership and knowledge sharing: A social cognitive approach investigating the role of self-efficacy as a key mechanismHow does transformational leadership relieve teacher burnout: The role of self-efficacy and emotional intelligenceLinking ethical leadership to employee performance: The roles of leader–member exchange, self-efficacy, and organizational identificationExtraversion">Examining the Connectorship Scale: Factor Structure and Correlations With Self-Efficacy and ExtraversionSelf-efficacy: Toward a unifying theory of behavioral changeImproved leadership skills and aptitudes in an excellence EMBA program: Creating synergies with dialogic leadership to achieve social impactThe leader as effective communicatorThe influence of green innovation performance on corporate advantage in TaiwanDeveloping a measure for “connectorship” as a component of engaged leadershipConnectorshipA meta-analytic examination of the effects of the agentic and affiliative aspects of extraversion on leadership outcomesWho emerges as a leader? Meta- analyses of individual differences as predictors of leadership emergenceAnalysis of social problem solving and social self-efficacy in prospective teachersCorrelates of networking behavior for managerial and professional employeesCutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesPersonality and leadership: A qualitative and quantitative reviewFacet level effects of extraversion on leadership behaviours rated by subordinatesIntegrating implicit leadership theories, leader-member exchange, self-efficacy, and attachment theory to predict job performanceLeadership versus management: What’s the difference?Social connectedness, extraversion, and subjective well-being: Testing a mediation modelConnective leadership: Female leadership styles in the 21st- century workplacePower analysis and determination of sample size for covariance structure modelingThe role of self-efficacy beliefs in leader developmentInclined but less skilled? Disentangling extraversion, communication skill, and leadership emergenceThe role of self-efficacy, emotional intelligence and leadership style as attributes of leadership effectivenessConnecting leadership and learning: Do versatile learners make connective leaders?lavaan: An R package for structural equation modelingThe ineffective police leader: Acts of commission and omissionGeneralized self-efficacy scaleLeadership effectiveness and personality: A cross cultural evaluationEthical leadership and knowledge sharing: A social cognitive approach investigating the role of self-efficacy as a key mechanismHow does transformational leadership relieve teacher burnout: The role of self-efficacy and emotional intelligenceLinking ethical leadership to employee performance: The roles of leader–member exchange, self-efficacy, and organizational identificationExtraversion</div>
                            <small style="color: var(--text-muted)">12717301.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Effect of adiposity status on salivary  and 
Effect of adiposity status on salivary  and 
Problems and proposals for recording gingivitis and plaqueSalivary microbiological and gingival health status evaluation of adolescents with overweight and obesity: A cluster analysisIntake of sweet foods and counts of cariogenic microorganisms in obese and normal‐weight womenIntake of sweet foods and counts of cariogenic microorganisms in relation to body mass index and psychometric variables in womenObservational study regarding the relationship between nutritional status, dental caries, Mutans Streptococci, and Lactobacillus bacterial coloniesInduction of cytokines by glucosyltransferases of 
Establishing a standard definition for child overweight and obesity worldwide: International surveyComparing the cariogenic species  and  on whole genome levelSplash!: A prospective birth cohort study of the impact of environmental, social and family‐level influences on child oral health and obesity related risk factors and outcomesSalivary profile and its correlation with dental caries and/or obesityClinical and biological indicators of dental caries and periodontal disease in adolescents with or without obesityG*power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciencesSalivary biomarkers for dental cariesNovel and conventional assays in determining abundance of  in salivaGene expression analysis of inflammation‐related genes in macrophages treated with α‐(1 → 3, 1 → 6)‐D‐glucan extracted from 
Transient acid‐impairment of growth ability of oral streptococcus, Actinomyces, and lactobacillus: A possible ecological determinant in dental plaqueBulk RNA‐seq and scRNA‐seq analysis reveal an activation of immune response and compromise of secretory function in major salivary glands of obese miceImpaired mitochondria and intracellular calcium transients in the salivary glands of obese ratsAP‐PCR detection of  and  in caries‐free and caries‐active subjectsThe infectious and transmissible nature of experimental dental caries. Findings and implicationsMutans streptococci, lactobacilli and caries prevalence in 11‐ and 12‐year‐old Icelandic childrenPractical method to facilitate estimation of  levels in saliva
 as a predominant oral bacteria related to the occurrence of dental caries in polish children at 12 years oldSalivary clearance of sugar and its effects on pH changes by streptococcus mitior in an artificial mouthFactors influencing oral colonization of mutans streptococci in young childrenLongitudinal association between obesity and dental caries in adolescentsObesity and dental caries in early childhood: A systematic review and meta‐analysesMicrobial ecology of dental plaque and its significance in health and diseaseInfluence of sample type and collection method on  and  spp. counts in the oral cavitySubmandibular gland and caries susceptibility in the obese Zucker ratMethods for collecting salivaMeasuring salivary flow: Challenges and opportunitiesEvaluation of cariogenic bacteriaIs dental caries experience associated with adiposity status in preschool children?Association between dental caries and adiposity status (general, central, and peripheral adiposity) in 12‐year‐old childrenCaries‐associated micro‐organisms in infants from different socio‐economic backgrounds in ScotlandObesity, salivary glands and oral pathology
 and  detection by polymerase chain reaction and their relation to dental caries in 12 and 15 year‐old schoolchildren in Valencia (Spain)
 and  colonization and caries experience in 3‐ and 5‐year‐old Thai childrenDental cariesColonization with mutans streptococci and lactobacilli and the caries experience of children after the age of fiveWaist circumference and waist‐to‐height ratio of Hong Kong Chinese childrenQuantitative analysis of multi‐species oral biofilms by TaqMan real‐time PCRThe role of bacteria in the caries process: Ecological perspectivesThe microbiology of primary dental caries in humansAre mutans streptococci detected in preschool children a reliable predictive factor for dental caries risk? A systematic review
 streptococci and dental caries patterns in pre‐school childrenMutans streptococci and caries prevalence in preschool childrenAn investigation into the dental health of children with obesity: An analysis of dental erosion and caries statusType IIA secreted phospholipase A2 in host defense against bacterial infectionsDiagnosis and management of xerostomia and hyposalivationSalivary cariogenic bacteria counts are associated with obesity in student women at a Malaysian universityDevelopment of a 5′ nuclease‐based real‐time PCR assay for quantitative detection of cariogenic dental pathogens  and 
Dysfunction of salivary glands, disturbances in salivary antioxidants and increased oxidative damage in saliva of overweight and obese adolescents">Effect of adiposity status on salivary  and 
Effect of adiposity status on salivary  and 
Problems and proposals for recording gingivitis and plaqueSalivary microbiological and gingival health status evaluation of adolescents with overweight and obesity: A cluster analysisIntake of sweet foods and counts of cariogenic microorganisms in obese and normal‐weight womenIntake of sweet foods and counts of cariogenic microorganisms in relation to body mass index and psychometric variables in womenObservational study regarding the relationship between nutritional status, dental caries, Mutans Streptococci, and Lactobacillus bacterial coloniesInduction of cytokines by glucosyltransferases of 
Establishing a standard definition for child overweight and obesity worldwide: International surveyComparing the cariogenic species  and  on whole genome levelSplash!: A prospective birth cohort study of the impact of environmental, social and family‐level influences on child oral health and obesity related risk factors and outcomesSalivary profile and its correlation with dental caries and/or obesityClinical and biological indicators of dental caries and periodontal disease in adolescents with or without obesityG*power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciencesSalivary biomarkers for dental cariesNovel and conventional assays in determining abundance of  in salivaGene expression analysis of inflammation‐related genes in macrophages treated with α‐(1 → 3, 1 → 6)‐D‐glucan extracted from 
Transient acid‐impairment of growth ability of oral streptococcus, Actinomyces, and lactobacillus: A possible ecological determinant in dental plaqueBulk RNA‐seq and scRNA‐seq analysis reveal an activation of immune response and compromise of secretory function in major salivary glands of obese miceImpaired mitochondria and intracellular calcium transients in the salivary glands of obese ratsAP‐PCR detection of  and  in caries‐free and caries‐active subjectsThe infectious and transmissible nature of experimental dental caries. Findings and implicationsMutans streptococci, lactobacilli and caries prevalence in 11‐ and 12‐year‐old Icelandic childrenPractical method to facilitate estimation of  levels in saliva
 as a predominant oral bacteria related to the occurrence of dental caries in polish children at 12 years oldSalivary clearance of sugar and its effects on pH changes by streptococcus mitior in an artificial mouthFactors influencing oral colonization of mutans streptococci in young childrenLongitudinal association between obesity and dental caries in adolescentsObesity and dental caries in early childhood: A systematic review and meta‐analysesMicrobial ecology of dental plaque and its significance in health and diseaseInfluence of sample type and collection method on  and  spp. counts in the oral cavitySubmandibular gland and caries susceptibility in the obese Zucker ratMethods for collecting salivaMeasuring salivary flow: Challenges and opportunitiesEvaluation of cariogenic bacteriaIs dental caries experience associated with adiposity status in preschool children?Association between dental caries and adiposity status (general, central, and peripheral adiposity) in 12‐year‐old childrenCaries‐associated micro‐organisms in infants from different socio‐economic backgrounds in ScotlandObesity, salivary glands and oral pathology
 and  detection by polymerase chain reaction and their relation to dental caries in 12 and 15 year‐old schoolchildren in Valencia (Spain)
 and  colonization and caries experience in 3‐ and 5‐year‐old Thai childrenDental cariesColonization with mutans streptococci and lactobacilli and the caries experience of children after the age of fiveWaist circumference and waist‐to‐height ratio of Hong Kong Chinese childrenQuantitative analysis of multi‐species oral biofilms by TaqMan real‐time PCRThe role of bacteria in the caries process: Ecological perspectivesThe microbiology of primary dental caries in humansAre mutans streptococci detected in preschool children a reliable predictive factor for dental caries risk? A systematic review
 streptococci and dental caries patterns in pre‐school childrenMutans streptococci and caries prevalence in preschool childrenAn investigation into the dental health of children with obesity: An analysis of dental erosion and caries statusType IIA secreted phospholipase A2 in host defense against bacterial infectionsDiagnosis and management of xerostomia and hyposalivationSalivary cariogenic bacteria counts are associated with obesity in student women at a Malaysian universityDevelopment of a 5′ nuclease‐based real‐time PCR assay for quantitative detection of cariogenic dental pathogens  and 
Dysfunction of salivary glands, disturbances in salivary antioxidants and increased oxidative damage in saliva of overweight and obese adolescents</div>
                            <small style="color: var(--text-muted)">12721701.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...up is shown in parentheses if missing data exist. Significant p‐values (...'}</li><li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': 'No direct quote found.'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialMolecular portraits of human breast tumoursTriple-negative breast cancerNeoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE StudyEvolution of adjuvant chemotherapy for breast cancerWeekly paclitaxel in the adjuvant treatment of breast cancerLong-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast CancerFluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialRandomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trialsPhase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trialSequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 TrialSWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancerEfficacy of neoadjuvant Cisplatin in triple-negative breast cancerCarboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialImpact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerLong-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialAddition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trialRandomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpressionLong-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancerComparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial ResultsCisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialAdjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysisHuman Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAmerican Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerCONSORT 2025 statement: updated guideline for reporting randomised trialsAnthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trialsOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerAdjuvant Olaparib for Patients with - or -Mutated Breast CancerInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerCamrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical TrialPembrolizumab and chemotherapy in high-risk, early-stage, ER/HER2 breast cancer: a randomized phase 3 trialPathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyNeoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trialAdjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical TrialA-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapyEffect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialPlatinum chemotherapy for early triple-negative breast cancerNeoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialEffect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialA randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trialPEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancerNRG-BR003: A randomized phase III trial comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative TNBCKi67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trialPrognostic predictive value of Ki-67 in stage I-II triple-negative breast cancerDe-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN TrialBlinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancerA randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursPembrolizumab for early triple-negative breast cancer">Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trialMolecular portraits of human breast tumoursTriple-negative breast cancerNeoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE StudyEvolution of adjuvant chemotherapy for breast cancerWeekly paclitaxel in the adjuvant treatment of breast cancerLong-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast CancerFluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialRandomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trialsPhase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trialSequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 TrialSWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancerEfficacy of neoadjuvant Cisplatin in triple-negative breast cancerCarboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialImpact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerLong-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trialAddition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trialRandomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpressionLong-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancerComparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial ResultsCisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialAdjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysisHuman Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline UpdateAmerican Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerCONSORT 2025 statement: updated guideline for reporting randomised trialsAnthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trialsOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerAdjuvant Olaparib for Patients with - or -Mutated Breast CancerInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerCamrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical TrialPembrolizumab and chemotherapy in high-risk, early-stage, ER/HER2 breast cancer: a randomized phase 3 trialPathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyNeoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trialAdjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical TrialA-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapyEffect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialPlatinum chemotherapy for early triple-negative breast cancerNeoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialEffect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialA randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trialPEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancerNRG-BR003: A randomized phase III trial comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative TNBCKi67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trialPrognostic predictive value of Ki-67 in stage I-II triple-negative breast cancerDe-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN TrialBlinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancerA randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursPembrolizumab for early triple-negative breast cancer</div>
                            <small style="color: var(--text-muted)">12723525.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...t patient. Assuming an annual dropout rate of 5%, a total of 808 pa...'}</li><li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...subgroup interaction term for categorical variables. We also reported c...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Cancer Unveiling: A Profile of Incidence and Trends in Bam City, Southeast IranGlobal, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016Global Status Report on Noncommunicable Diseases 2010Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Death Report from 10 Provinces in Iran.Review of cancer registration and cancer data in Iran, a historical prospectCancer incidence and trend analysis in Shahroud, Iran, 2000 - 2010Incidence of cancers in Kuzestan Province of Iran: trend from 2004 to 2008Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009Time trend analysis of stomach cancer incidence in the west of IranCancer incidence in southern Iran, 1998-2002: results of population-based cancer registryCancer in AfghanistanIran Cancer Statistics in 2012 and projection of cancer incidence by 2035Epidemiology of cancer in Mazandaran Province 2006Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008Time trend analysis of stomach cancer incidence in the west of IranWorld Cancer Report 2008Epidemiology and trend of cancers in the province of Kerman: southeast of IranEpidemiology and prognosis of breast cancer in young womenEstablished breast cancer risk factors and risk of intrinsic tumor subtypesPrognostic factors of breast cancer survival in the Islamic Republic of Iran: an additive empirical Bayesian approachA comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard modelsEpidemiology of bladder cancers in Fars Province, Southern Iran (2003–2008)An epidemiological review of common cancers in Iran; a review articleThe epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trendsEnvironmental and occupational causes of cancer: new evidence 2005-2007Cancer control in low-and middle-income countries: is it time to consider screening?Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysisRisk factors for lung cancer worldwideEsophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countriesThe prevalence of smoking and related factors in Kerman high school studentsIncidence trend and epidemiology of common cancers in the center of IranCancer surveillance series: recent trends in childhood cancer incidence and mortality in the United StatesTrends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer">Cancer Unveiling: A Profile of Incidence and Trends in Bam City, Southeast IranGlobal, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016Global Status Report on Noncommunicable Diseases 2010Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Death Report from 10 Provinces in Iran.Review of cancer registration and cancer data in Iran, a historical prospectCancer incidence and trend analysis in Shahroud, Iran, 2000 - 2010Incidence of cancers in Kuzestan Province of Iran: trend from 2004 to 2008Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009Time trend analysis of stomach cancer incidence in the west of IranCancer incidence in southern Iran, 1998-2002: results of population-based cancer registryCancer in AfghanistanIran Cancer Statistics in 2012 and projection of cancer incidence by 2035Epidemiology of cancer in Mazandaran Province 2006Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008Time trend analysis of stomach cancer incidence in the west of IranWorld Cancer Report 2008Epidemiology and trend of cancers in the province of Kerman: southeast of IranEpidemiology and prognosis of breast cancer in young womenEstablished breast cancer risk factors and risk of intrinsic tumor subtypesPrognostic factors of breast cancer survival in the Islamic Republic of Iran: an additive empirical Bayesian approachA comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard modelsEpidemiology of bladder cancers in Fars Province, Southern Iran (2003–2008)An epidemiological review of common cancers in Iran; a review articleThe epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trendsEnvironmental and occupational causes of cancer: new evidence 2005-2007Cancer control in low-and middle-income countries: is it time to consider screening?Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysisRisk factors for lung cancer worldwideEsophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countriesThe prevalence of smoking and related factors in Kerman high school studentsIncidence trend and epidemiology of common cancers in the center of IranCancer surveillance series: recent trends in childhood cancer incidence and mortality in the United StatesTrends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer</div>
                            <small style="color: var(--text-muted)">12727007.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Frequency and Clinical Outcomes of Respiratory Infections in Children with Cancer Presenting with Febrile IllnessRole of polymerase chain reaction-based diagnosis of respiratory viruses in febrile neutropenic patientsGuideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 updateFrequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropeniaAcute respiratory infections in children and adolescents with acute lymphoblastic leukemiaPrevalence and characteristics of acute respiratory virus infections in pediatric cancer patientsPulmonary infectious complications in children with hematologic malignancies and chemotherapy-induced neutropeniaComparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised childrenRespiratory viral infections and coinfections in children with cancer, fever and neutropenia: clinical outcome of infections caused by different respiratory virusesNasopharyngeal detection of respiratory viruses in febrile neutropenic childrenProspective detection of respiratory pathogens in symptomatic children with cancer">Frequency and Clinical Outcomes of Respiratory Infections in Children with Cancer Presenting with Febrile IllnessRole of polymerase chain reaction-based diagnosis of respiratory viruses in febrile neutropenic patientsGuideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 updateFrequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropeniaAcute respiratory infections in children and adolescents with acute lymphoblastic leukemiaPrevalence and characteristics of acute respiratory virus infections in pediatric cancer patientsPulmonary infectious complications in children with hematologic malignancies and chemotherapy-induced neutropeniaComparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised childrenRespiratory viral infections and coinfections in children with cancer, fever and neutropenia: clinical outcome of infections caused by different respiratory virusesNasopharyngeal detection of respiratory viruses in febrile neutropenic childrenProspective detection of respiratory pathogens in symptomatic children with cancer</div>
                            <small style="color: var(--text-muted)">12727044.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled TrialWHO 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitorsImatinib in chronic myeloid leukemia: an overviewChronic myeloid leukemia in IndiaMonitoring of response to therapy with imatinib mesylate in chronic myeloid leukemia in chronic phase (CML-CP)Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patientsAMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjectsChronic myeloid leukemia in the Imatinib era - compilation of Indian data from 22 centers involving 8115 patientsImatinib in combination with hydroxyurea showed significantly lower major molecular response rates at 6 months but similar MMR at 18 months in patients with CML1st CP compared to IM alone. Final results of the CML2004 study. Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinibComparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapyPredicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreCommon Terminology Criteria for Adverse Events (CTCAE)Chronic myeloid leukemia data from IndiaReport of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990-2010The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European countriesTrends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009Meeting the needs of CML patients in resource-poor countriesChronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraTo study outcomes in young CML treated with TKI. A registry data from Hematological Cancer Consortium (HCC) of IndiaFeasibility of treatment-free remission with generic imatinib: results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase studyPrevalence of anemia among chronic myeloid leukemia patients treated with imatinib: a evidence-based meta-analysisPatterns of tyrosine kinase inhibitor utilization in newly treated patients with chronic myeloid leukemia: an exhaustive population-based study in FranceCorrelation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemiaNo advantage of imatinib in combination with hydroxyurea over imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group">Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled TrialWHO 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitorsImatinib in chronic myeloid leukemia: an overviewChronic myeloid leukemia in IndiaMonitoring of response to therapy with imatinib mesylate in chronic myeloid leukemia in chronic phase (CML-CP)Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patientsAMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjectsChronic myeloid leukemia in the Imatinib era - compilation of Indian data from 22 centers involving 8115 patientsImatinib in combination with hydroxyurea showed significantly lower major molecular response rates at 6 months but similar MMR at 18 months in patients with CML1st CP compared to IM alone. Final results of the CML2004 study. Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinibComparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapyPredicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreCommon Terminology Criteria for Adverse Events (CTCAE)Chronic myeloid leukemia data from IndiaReport of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990-2010The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European countriesTrends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009Meeting the needs of CML patients in resource-poor countriesChronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraTo study outcomes in young CML treated with TKI. A registry data from Hematological Cancer Consortium (HCC) of IndiaFeasibility of treatment-free remission with generic imatinib: results of generic imatinib-free trial-in-chronic myeloid leukaemia-chronic phase studyPrevalence of anemia among chronic myeloid leukemia patients treated with imatinib: a evidence-based meta-analysisPatterns of tyrosine kinase inhibitor utilization in newly treated patients with chronic myeloid leukemia: an exhaustive population-based study in FranceCorrelation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemiaNo advantage of imatinib in combination with hydroxyurea over imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group</div>
                            <small style="color: var(--text-muted)">12727047.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'Software mentioned without specific versions.', 'evidence': '...analysis was performed using STATA version-12 (StataCorp, United...'}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Identification and Verification of a Prognostic Risk Signature in Oral Squamous Cell CarcinomaOral squamous cell carcinomas: state of the field and emerging directions.Oral microbiome and mucosal trauma as risk factors for oral cancer: beyond alcohol and tobacco. A literature review.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.Staging and grading of oral squamous cell carcinoma: An update.A brief history of bioinformatics.Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC.Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer.Regulation and metabolic functions of mTORC1 and mTORC2.mTORC1 beyond anabolic metabolism: Regulation of cell death.Ribosome biogenesis in disease: new players and therapeutic targets.Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer.Insulin signaling and insulin resistance facilitate trained immunity in macrophages through metabolic and epigenetic changes.Overview of Research into mTOR Inhibitors.Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy.A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.Prognostic Value of Necroptosis-Related Genes Signature in Oral Squamous Cell Carcinoma.Genetic changes driving immunosuppressive microenvironments in oral premalignancy.Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer.Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma.Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression.A novel mitochondrial-related nuclear gene signature predicts overall survival of lung Adenocarcinoma Patients.Annexin A11 in disease.ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer.PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.">Identification and Verification of a Prognostic Risk Signature in Oral Squamous Cell CarcinomaOral squamous cell carcinomas: state of the field and emerging directions.Oral microbiome and mucosal trauma as risk factors for oral cancer: beyond alcohol and tobacco. A literature review.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.Staging and grading of oral squamous cell carcinoma: An update.A brief history of bioinformatics.Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC.Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer.Regulation and metabolic functions of mTORC1 and mTORC2.mTORC1 beyond anabolic metabolism: Regulation of cell death.Ribosome biogenesis in disease: new players and therapeutic targets.Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer.Insulin signaling and insulin resistance facilitate trained immunity in macrophages through metabolic and epigenetic changes.Overview of Research into mTOR Inhibitors.Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy.A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.Prognostic Value of Necroptosis-Related Genes Signature in Oral Squamous Cell Carcinoma.Genetic changes driving immunosuppressive microenvironments in oral premalignancy.Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer.Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression.Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma.Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression.A novel mitochondrial-related nuclear gene signature predicts overall survival of lung Adenocarcinoma Patients.Annexin A11 in disease.ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer.PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.</div>
                            <small style="color: var(--text-muted)">12728520.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">7.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 70.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Intracellular polarization of RNAs and proteins in the human small intestinal epitheliumIntracellular polarization of RNAs and proteins in the human small intestinal epithelium.Intracellular polarization of RNAs and proteins in the human small intestinal epithelium.Tales from the crypt: new insights into intestinal stem cellsEpithelial cell polarity as reflected in enterocytesGlobal mRNA polarization regulates translation efficiency in the intestinal epitheliumA spatial expression atlas of the adult human proximal small intestineThe polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfacesProteomic analysis of the enterocyte brush borderTissue-based map of the human proteomeThe Matrisome:  Definition and  Characterization by Proteomics of Normal and Tumor Extracellular Matrices*Intestinal mucus components and secretion mechanisms: what we do and do not knowGlucose transporters in the small intestine in health and diseaseIntestinal Lipid Absorption and Lipoprotein FormationIntestinal lipid absorptionIn the right place at the right time: visualizing and understanding mRNA localizationIntracellular mRNA transport and localized translationMechanisms and consequences of subcellular RNA localization across diverse cell typesSubcellular mRNA localization in animal cells and why it mattersmRNA localization: gene expression in the spatial dimensionSystematic imaging reveals features and changing localization of mRNAs in Drosophila developmentGlobal Analysis of mRNA Localization Reveals a Prominent Role in Organizing Cellular Architecture and FunctionGenome-wide screen reveals APC-associated RNAs enriched in cell protrusionsRNA localization mechanisms transcend cell morphologyThe Local Transcriptome in the Synaptic Neuropil Revealed by Deep Sequencing and High-Resolution ImagingIdentification of Process-Localized mRNAs from Cultured Rodent Hippocampal NeuronsSingle-molecule insights into mRNA dynamics in neuronsSpatial discordances between mRNAs and proteins in the intestinal epitheliumGlobal quantification of mammalian gene expression controlAnalysis and Prediction of Translation Rate Based on Sequence and Functional Features of the mRNA.Apical-basal polarity in the gutRecognition of commensal microflora by toll-like receptors is required for intestinal homeostasisMicrobiota regulates immune defense against respiratory tract influenza A virus infectionCritical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut FloraSingle-molecule mRNA detection and counting in mammalian tissue.Sensitive and powerful single-cell RNA sequencing using mcSCRB-seqUTAP: User-friendly Transcriptome Analysis Pipeline.Suspension Trapping (S-Trap) Is Compatible with Typical Protein Extraction Buffers and Detergents for Bottom-Up Proteomics.MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationFiji: an open-source platform for biological-image analysis.Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.Dictionary learning for integrative, multimodal and scalable single-cell analysisModerated estimation of fold change and dispersion for RNA-seq data with DESeq2A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell TranscriptomicsKEGGREST: Client-side REST access to the Kyoto Encyclopedia of Genes and Genomes (KEGG).Pathview: an R/Bioconductor package for pathway-based data integration and visualizationA subcellular map of the human proteomeUniProt: the Universal Protein Knowledgebase in 2023Cells of the human intestinal tract mapped across space and timeDecision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2Author response to Decision Letter 2Decision Letter 3">Intracellular polarization of RNAs and proteins in the human small intestinal epitheliumIntracellular polarization of RNAs and proteins in the human small intestinal epithelium.Intracellular polarization of RNAs and proteins in the human small intestinal epithelium.Tales from the crypt: new insights into intestinal stem cellsEpithelial cell polarity as reflected in enterocytesGlobal mRNA polarization regulates translation efficiency in the intestinal epitheliumA spatial expression atlas of the adult human proximal small intestineThe polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfacesProteomic analysis of the enterocyte brush borderTissue-based map of the human proteomeThe Matrisome:  Definition and  Characterization by Proteomics of Normal and Tumor Extracellular Matrices*Intestinal mucus components and secretion mechanisms: what we do and do not knowGlucose transporters in the small intestine in health and diseaseIntestinal Lipid Absorption and Lipoprotein FormationIntestinal lipid absorptionIn the right place at the right time: visualizing and understanding mRNA localizationIntracellular mRNA transport and localized translationMechanisms and consequences of subcellular RNA localization across diverse cell typesSubcellular mRNA localization in animal cells and why it mattersmRNA localization: gene expression in the spatial dimensionSystematic imaging reveals features and changing localization of mRNAs in Drosophila developmentGlobal Analysis of mRNA Localization Reveals a Prominent Role in Organizing Cellular Architecture and FunctionGenome-wide screen reveals APC-associated RNAs enriched in cell protrusionsRNA localization mechanisms transcend cell morphologyThe Local Transcriptome in the Synaptic Neuropil Revealed by Deep Sequencing and High-Resolution ImagingIdentification of Process-Localized mRNAs from Cultured Rodent Hippocampal NeuronsSingle-molecule insights into mRNA dynamics in neuronsSpatial discordances between mRNAs and proteins in the intestinal epitheliumGlobal quantification of mammalian gene expression controlAnalysis and Prediction of Translation Rate Based on Sequence and Functional Features of the mRNA.Apical-basal polarity in the gutRecognition of commensal microflora by toll-like receptors is required for intestinal homeostasisMicrobiota regulates immune defense against respiratory tract influenza A virus infectionCritical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut FloraSingle-molecule mRNA detection and counting in mammalian tissue.Sensitive and powerful single-cell RNA sequencing using mcSCRB-seqUTAP: User-friendly Transcriptome Analysis Pipeline.Suspension Trapping (S-Trap) Is Compatible with Typical Protein Extraction Buffers and Detergents for Bottom-Up Proteomics.MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationFiji: an open-source platform for biological-image analysis.Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.Dictionary learning for integrative, multimodal and scalable single-cell analysisModerated estimation of fold change and dispersion for RNA-seq data with DESeq2A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell TranscriptomicsKEGGREST: Client-side REST access to the Kyoto Encyclopedia of Genes and Genomes (KEGG).Pathview: an R/Bioconductor package for pathway-based data integration and visualizationA subcellular map of the human proteomeUniProt: the Universal Protein Knowledgebase in 2023Cells of the human intestinal tract mapped across space and timeDecision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2Author response to Decision Letter 2Decision Letter 3</div>
                            <small style="color: var(--text-muted)">11637431.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...od, based on unique peptides, missing values were imputed from a low, rand...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '..., without skewing the ratios. P-values for apical/basal bias and fo...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Simultaneous noninvasive quantification of redox and downstream glycolytic fluxes reveals compartmentalized brain metabolismBrain energy metabolism: A roadmap for future researchBrain metabolism in health, aging, and neurodegenerationVariability of regional glucose metabolism and the topology of functional networks in the human brainBrain energy and oxygen metabolism: Emerging role in normal function and diseaseIsocitrate dehydrogenase variants in cancer—Cellular consequences and therapeutic opportunitiesCalcium and ROS: A mutual interplayMolecular mechanisms and genetics of oxidative stress in Alzheimer's diseaseTargeting oxidative stress in disease: Promise and limitations of antioxidant therapyMetabolic analysis as a driver for discovery, diagnosis, and therapyThe neurochemical profile quantified by in vivo H NMR spectroscopyBrain PET in suspected dementia: Patterns of altered FDG metabolismMetabolomics and isotope tracingReal-time metabolic imagingHyperpolarized C MRI: Path to clinical translation in oncologyMetabolic imaging of the human brain with hyperpolarized C pyruvate demonstrates C lactate production in brain tumor patientsQuantifying normal human brain metabolism using hyperpolarized [1-C] pyruvate and magnetic resonance imagingLactate topography of the human brain using hyperpolarized C-MRIKinetic modeling of hyperpolarized carbon-13 pyruvate metabolism in the human brainFirst in-human evaluation of [1-C]pyruvate in DO for hyperpolarized MRI of the brain: A safety and feasibility studyChemistry and biochemistry of C hyperpolarized magnetic resonance using dynamic nuclear polarizationOxidative stress in cancerLifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseasesVitamin C selectively kills  and  mutant colorectal cancer cells by targeting GAPDHHigh-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancerMammalian facilitative hexose transporters mediate the transport of dehydroascorbic acidHyperpolarized C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imagingNoninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized C dehydroascorbate magnetic resonanceImaging brain metabolism using hyperpolarized C magnetic resonance spectroscopyHyperpolarized [2-C]-fructose: A hemiketal DNP substrate for in vivo metabolic imagingKetohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imagingHyperpolarized sodium [1-C]-glycerate as a probe for assessing glycolysis in vivoPhotogenerated radical in phenylglyoxylic acid for in vivo hyperpolarized C MR with photosensitive metabolic substratesReal-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-C]dihydroxyacetoneImaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probesHyperpolarized C magnetic resonance metabolic imaging: Application to brain tumorsImmunometabolism of tissue-resident macrophages—An appraisal of the current knowledge and cutting-edge methods and technologiesMALDI Imaging mass spectrometry: Current frontiers and perspectives in pathology research and practiceImaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiencyEvidence of C-lactate oxidation in the human brain from hyperpolarized C-MRIA variable resolution approach for improved acquisition of hyperpolarized C metabolic MRIHyperpolarized [2-C]pyruvate MR molecular imaging with whole brain coverageInvestigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patientsSIVIC: Open-source, standards-based software for DICOM MR spectroscopy workflowsQuantitation of magnetic resonance spectroscopy signals: The jMRUI software packageImproved method for accurate and efficient quantification of MRS data with use of prior knowledge">Simultaneous noninvasive quantification of redox and downstream glycolytic fluxes reveals compartmentalized brain metabolismBrain energy metabolism: A roadmap for future researchBrain metabolism in health, aging, and neurodegenerationVariability of regional glucose metabolism and the topology of functional networks in the human brainBrain energy and oxygen metabolism: Emerging role in normal function and diseaseIsocitrate dehydrogenase variants in cancer—Cellular consequences and therapeutic opportunitiesCalcium and ROS: A mutual interplayMolecular mechanisms and genetics of oxidative stress in Alzheimer's diseaseTargeting oxidative stress in disease: Promise and limitations of antioxidant therapyMetabolic analysis as a driver for discovery, diagnosis, and therapyThe neurochemical profile quantified by in vivo H NMR spectroscopyBrain PET in suspected dementia: Patterns of altered FDG metabolismMetabolomics and isotope tracingReal-time metabolic imagingHyperpolarized C MRI: Path to clinical translation in oncologyMetabolic imaging of the human brain with hyperpolarized C pyruvate demonstrates C lactate production in brain tumor patientsQuantifying normal human brain metabolism using hyperpolarized [1-C] pyruvate and magnetic resonance imagingLactate topography of the human brain using hyperpolarized C-MRIKinetic modeling of hyperpolarized carbon-13 pyruvate metabolism in the human brainFirst in-human evaluation of [1-C]pyruvate in DO for hyperpolarized MRI of the brain: A safety and feasibility studyChemistry and biochemistry of C hyperpolarized magnetic resonance using dynamic nuclear polarizationOxidative stress in cancerLifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseasesVitamin C selectively kills  and  mutant colorectal cancer cells by targeting GAPDHHigh-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancerMammalian facilitative hexose transporters mediate the transport of dehydroascorbic acidHyperpolarized C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imagingNoninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized C dehydroascorbate magnetic resonanceImaging brain metabolism using hyperpolarized C magnetic resonance spectroscopyHyperpolarized [2-C]-fructose: A hemiketal DNP substrate for in vivo metabolic imagingKetohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imagingHyperpolarized sodium [1-C]-glycerate as a probe for assessing glycolysis in vivoPhotogenerated radical in phenylglyoxylic acid for in vivo hyperpolarized C MR with photosensitive metabolic substratesReal-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-C]dihydroxyacetoneImaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probesHyperpolarized C magnetic resonance metabolic imaging: Application to brain tumorsImmunometabolism of tissue-resident macrophages—An appraisal of the current knowledge and cutting-edge methods and technologiesMALDI Imaging mass spectrometry: Current frontiers and perspectives in pathology research and practiceImaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiencyEvidence of C-lactate oxidation in the human brain from hyperpolarized C-MRIA variable resolution approach for improved acquisition of hyperpolarized C metabolic MRIHyperpolarized [2-C]pyruvate MR molecular imaging with whole brain coverageInvestigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patientsSIVIC: Open-source, standards-based software for DICOM MR spectroscopy workflowsQuantitation of magnetic resonance spectroscopy signals: The jMRUI software packageImproved method for accurate and efficient quantification of MRS data with use of prior knowledge</div>
                            <small style="color: var(--text-muted)">11661454.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...In all statistical analysis, P < 0.05 was taken as significant. One...'}</li><li>{'message': 'Paired data mentioned but no paired statistical tests found.', 'evidence': '...nputless” (42). The estimated longitudinal relaxation time (T1) of each...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Spatiotemporal proteomics reveals the biosynthetic lysosomal membrane protein interactome in neuronsThe lysosome as a regulatory hubLysosomes as dynamic regulators of cell and organismal homeostasisLysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiologySorting of lysosomal proteinsIsolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycanAsparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysisLAMP proteins are required for fusion of lysosomes with phagosomeshVPS41 and VAMP7 function in direct TGN to late endosome transport of lysosomal membrane proteinsLysosome biogenesis and lysosomal membrane proteins: trafficking meets functionBORC/kinesin-1 ensemble drives polarized transport of lysosomes into the axonNeuronal soma-derived degradative lysosomes are continuously delivered to distal axons to maintain local degradation capacityLysosomal dysfunction at the centre of Parkinson’s disease and frontotemporal dementia/amyotrophic lateral sclerosisSynchronization of secretory protein traffic in populations of cellszapERtrap: a light-regulated ER release system reveals unexpected neuronal trafficking pathwaysSegregation in the Golgi complex precedes export of endolysosomal proteins in distinct transport carriersSpatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2ARF family G proteins and their regulators: roles in membrane transport, development and diseaseCargo recognition in clathrin-mediated endocytosisRab6 regulates transport and targeting of exocytotic carriersTBC1D23 is a bridging factor for endosomal vesicle capture by golgins at the trans-GolgiA Rab11/Rip11 protein complex regulates apical membrane trafficking via recycling endosomesRab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyteEARP is a multisubunit tethering complex involved in endocytic recyclingSpatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomicsCLN3 is required for the clearance of glycerophosphodiesters from lysosomesLysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tetherA lysosome membrane regeneration pathway depends on TBC1D15 and autophagic lysosomal reformation proteinsA phosphoinositide signalling pathway mediates rapid lysosomal repairDevelopment and comparative evaluation of endolysosomal proximity labeling-based proteomic methods in human IPSC-derived neuronsNon-canonical mTORC1 signaling at the lysosomeThe molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and diseaseArl8 and SKIP act together to link lysosomes to kinesin-1BORC, a multisubunit complex that regulates lysosome positioningBORC functions upstream of kinesins 1 and 3 to coordinate regional movement of lysosomes along different microtubule tracksTFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomesTRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendritesFeedback-driven mechanisms between microtubules and the endoplasmic reticulum instruct neuronal polarityPhosphatidylinositol 3,5-bisphosphate facilitates axonal vesicle transport and presynapse assemblySorting of lysosomal membrane glycoproteins lamp-1 and lamp-2 into vesicles distinct from mannose 6-phosphate receptor/γ-adaptin vesicles at the trans-Golgi networkVAMP4 regulates insulin levels by targeting secretory granules to lysosomesVAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmissionMolecular control of local translation in axon development and maintenanceLocal translation in neurons: visualization and functionLate endosomes act as mRNA translation platforms and sustain mitochondria in axonsStructural basis for the coevolution of a viral RNA–protein complexDynamic mapping of proteome trafficking within and between living cells by TransitIDCharacterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neuronsRouting of the RAB6 secretory pathway towards the lysosome related organelle of melanocytesCombined kinesin-1 and kinesin-3 activity drives axonal trafficking of TrkB receptors in Rab6 carriersPresynaptic biogenesis requires axonal transport of lysosome-related vesiclesControl of synaptic vesicle release probability via VAMP4 targeting to endolysosomesMessenger RNA transport on lysosomal vesicles maintains axonal mitochondrial homeostasis and prevents axonal degenerationGermline transmission and tissue-specific expression of transgenes delivered by lentiviral vectorsLentivirus-delivered stable gene silencing by RNAi in primary cellsmScarlet: a bright monomeric red fluorescent protein for cellular imagingKi-67 acts as a biological surfactant to disperse mitotic chromosomesVisualization of retroviral replication in living cells reveals budding into multivesicular bodiesEarly/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoformDirected evolution of APEX2 for electron microscopy and proximity labelingMental illnesses-associated Fxr1 and its negative regulator Gsk3β are modulators of anxiety and glutamatergic neurotransmissionNeuron specific Rab4 effector GRASP-1 coordinates membrane specialization and maturation of recycling endosomesSpecific KIF1A–adaptor interactions control selective cargo recognitionImaging the polarized sorting of proteins from the golgi complex in live neuronsMaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantificationThe Perseus computational platform for comprehensive analysis of (prote) omics dataVolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plotsA new phase of networking: the molecular composition and regulatory dynamics of mammalian stress granulesContext-dependent and disease-specific diversity in protein interactions within stress granulesSaturated fatty acids entrap PDX1 in stress granules and impede islet beta cell functionA guided tour into subcellular colocalization analysis in light microscopy">Spatiotemporal proteomics reveals the biosynthetic lysosomal membrane protein interactome in neuronsThe lysosome as a regulatory hubLysosomes as dynamic regulators of cell and organismal homeostasisLysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiologySorting of lysosomal proteinsIsolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycanAsparagine-linked oligosaccharides protect Lamp-1 and Lamp-2 from intracellular proteolysisLAMP proteins are required for fusion of lysosomes with phagosomeshVPS41 and VAMP7 function in direct TGN to late endosome transport of lysosomal membrane proteinsLysosome biogenesis and lysosomal membrane proteins: trafficking meets functionBORC/kinesin-1 ensemble drives polarized transport of lysosomes into the axonNeuronal soma-derived degradative lysosomes are continuously delivered to distal axons to maintain local degradation capacityLysosomal dysfunction at the centre of Parkinson’s disease and frontotemporal dementia/amyotrophic lateral sclerosisSynchronization of secretory protein traffic in populations of cellszapERtrap: a light-regulated ER release system reveals unexpected neuronal trafficking pathwaysSegregation in the Golgi complex precedes export of endolysosomal proteins in distinct transport carriersSpatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2ARF family G proteins and their regulators: roles in membrane transport, development and diseaseCargo recognition in clathrin-mediated endocytosisRab6 regulates transport and targeting of exocytotic carriersTBC1D23 is a bridging factor for endosomal vesicle capture by golgins at the trans-GolgiA Rab11/Rip11 protein complex regulates apical membrane trafficking via recycling endosomesRab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyteEARP is a multisubunit tethering complex involved in endocytic recyclingSpatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomicsCLN3 is required for the clearance of glycerophosphodiesters from lysosomesLysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tetherA lysosome membrane regeneration pathway depends on TBC1D15 and autophagic lysosomal reformation proteinsA phosphoinositide signalling pathway mediates rapid lysosomal repairDevelopment and comparative evaluation of endolysosomal proximity labeling-based proteomic methods in human IPSC-derived neuronsNon-canonical mTORC1 signaling at the lysosomeThe molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and diseaseArl8 and SKIP act together to link lysosomes to kinesin-1BORC, a multisubunit complex that regulates lysosome positioningBORC functions upstream of kinesins 1 and 3 to coordinate regional movement of lysosomes along different microtubule tracksTFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomesTRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendritesFeedback-driven mechanisms between microtubules and the endoplasmic reticulum instruct neuronal polarityPhosphatidylinositol 3,5-bisphosphate facilitates axonal vesicle transport and presynapse assemblySorting of lysosomal membrane glycoproteins lamp-1 and lamp-2 into vesicles distinct from mannose 6-phosphate receptor/γ-adaptin vesicles at the trans-Golgi networkVAMP4 regulates insulin levels by targeting secretory granules to lysosomesVAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmissionMolecular control of local translation in axon development and maintenanceLocal translation in neurons: visualization and functionLate endosomes act as mRNA translation platforms and sustain mitochondria in axonsStructural basis for the coevolution of a viral RNA–protein complexDynamic mapping of proteome trafficking within and between living cells by TransitIDCharacterization of LAMP1-labeled nondegradative lysosomal and endocytic compartments in neuronsRouting of the RAB6 secretory pathway towards the lysosome related organelle of melanocytesCombined kinesin-1 and kinesin-3 activity drives axonal trafficking of TrkB receptors in Rab6 carriersPresynaptic biogenesis requires axonal transport of lysosome-related vesiclesControl of synaptic vesicle release probability via VAMP4 targeting to endolysosomesMessenger RNA transport on lysosomal vesicles maintains axonal mitochondrial homeostasis and prevents axonal degenerationGermline transmission and tissue-specific expression of transgenes delivered by lentiviral vectorsLentivirus-delivered stable gene silencing by RNAi in primary cellsmScarlet: a bright monomeric red fluorescent protein for cellular imagingKi-67 acts as a biological surfactant to disperse mitotic chromosomesVisualization of retroviral replication in living cells reveals budding into multivesicular bodiesEarly/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoformDirected evolution of APEX2 for electron microscopy and proximity labelingMental illnesses-associated Fxr1 and its negative regulator Gsk3β are modulators of anxiety and glutamatergic neurotransmissionNeuron specific Rab4 effector GRASP-1 coordinates membrane specialization and maturation of recycling endosomesSpecific KIF1A–adaptor interactions control selective cargo recognitionImaging the polarized sorting of proteins from the golgi complex in live neuronsMaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantificationThe Perseus computational platform for comprehensive analysis of (prote) omics dataVolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plotsA new phase of networking: the molecular composition and regulatory dynamics of mammalian stress granulesContext-dependent and disease-specific diversity in protein interactions within stress granulesSaturated fatty acids entrap PDX1 in stress granules and impede islet beta cell functionA guided tour into subcellular colocalization analysis in light microscopy</div>
                            <small style="color: var(--text-muted)">11868546.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...ted using unpaired two sample t-test (p value\u2009<\u20090.05, log2 fold ch...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...Map 4\u2009h (276 proteins, D\u2009≥\u20091, p\u2009<\u20090.05) and selected lysosome proteo...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies VaccinesRabies in the tropicsRabies vaccines: WHO position paper, April 2018—recommendationsEstimating the global burden of endemic canine rabiesUse of a modified preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices—United States, 2022RabiesPreventing rabies with the Verorab vaccine: 1985–2005 twenty years of clinical experienceRabies vaccinations save lives but where are the vaccines? Global vaccine inequity and escalating rabies-related mortality in low- and middle-income countriesA serum-free, purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trialSafety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: a randomised phase II pre-exposure prophylaxis studyA next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in ChinaSafety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: a randomized, controlled, observer-blinded, phase II study with a simulated post-exposure regimen in healthy adultsSafety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® rabies) administered in a simulated rabies post-exposure regimen in healthy adultsSerum-free purified Vero rabies vaccine is safe and immunogenic in children: results of a randomized phase II pre-exposure prophylaxis regimen studyImmunogenicity and safety of a purified Vero rabies vaccine-serum free, compared with 2 licensed vaccines, in a simulated rabies post-exposure regimen in healthy adults in France: a randomized, controlled, phase 3 trialG-protein based ELISA as a potency test for rabies vaccinesReplacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA—results of an international collaborative studyRapid fluorescent focus inhibition test optimization and validation: improved detection of neutralizing antibodies to rabies virusInterval estimation for the difference between independent proportions: comparison of eleven methodsAdvanced multiplicity adjustment methods in clinical trialsTwo-sided confidence intervals for the single proportion: comparison of seven methods">Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies VaccinesRabies in the tropicsRabies vaccines: WHO position paper, April 2018—recommendationsEstimating the global burden of endemic canine rabiesUse of a modified preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices—United States, 2022RabiesPreventing rabies with the Verorab vaccine: 1985–2005 twenty years of clinical experienceRabies vaccinations save lives but where are the vaccines? Global vaccine inequity and escalating rabies-related mortality in low- and middle-income countriesA serum-free, purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trialSafety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: a randomised phase II pre-exposure prophylaxis studyA next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in ChinaSafety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: a randomized, controlled, observer-blinded, phase II study with a simulated post-exposure regimen in healthy adultsSafety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® rabies) administered in a simulated rabies post-exposure regimen in healthy adultsSerum-free purified Vero rabies vaccine is safe and immunogenic in children: results of a randomized phase II pre-exposure prophylaxis regimen studyImmunogenicity and safety of a purified Vero rabies vaccine-serum free, compared with 2 licensed vaccines, in a simulated rabies post-exposure regimen in healthy adults in France: a randomized, controlled, phase 3 trialG-protein based ELISA as a potency test for rabies vaccinesReplacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA—results of an international collaborative studyRapid fluorescent focus inhibition test optimization and validation: improved detection of neutralizing antibodies to rabies virusInterval estimation for the difference between independent proportions: comparison of eleven methodsAdvanced multiplicity adjustment methods in clinical trialsTwo-sided confidence intervals for the single proportion: comparison of seven methods</div>
                            <small style="color: var(--text-muted)">12497947.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...s virus–neutralizing antibody titer ≥0.5\u2005IU/mL at D42. Noninferio...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Designing clinical practice guidelines for equitable, inclusive, and contextualised careMedical journal editors must resist CDC order and anti-gender ideologyGuidelines International Network: toward international standards for clinical practice guidelinesA framework for sex, gender, and diversity analysis in researchSex and gender considerations in Canadian clinical practice guidelines: a systematic reviewUSPSTF Approach to Addressing Sex and Gender When Making Recommendations for Clinical Preventive ServicesConsideration of sex and gender: an analysis of Australian clinical guidelinesDifferentiating sex and gender in health research to achieve gender equitySex and gender bias in chronic coronary syndromes research: analysis of studies used to inform the 2019 European Society of Cardiology guidelinesConsideration of sex and gender in European clinical practice guidelines in internal medicine: a systematic review protocolUnderrepresentation of women in new drug trials2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceCHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)One and a half million medical papers reveal a link between author gender and attention to gender and sex analysisIntersectional inequalities in scienceAGREE II: advancing guideline development, reporting and evaluation in health careGrading quality of evidence and strength of recommendationsApplicability of European Society of Cardiology guidelines according to gross national incomeGuideline adaptation: an approach to enhance efficiency in guideline development and improve utilisationStrengthening guideline contextualization in the WHO European RegionGRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENTOncology Guidelines Usage in a Low- and Middle-Income CountryGuideline developers in low- and middle-income countries want to develop and use living guidelines, but are currently limited by important barriers: findings from a qualitative studyGuidelines in lower-middle income countriesGuideline adaptation and implementation planning: a prospective observational studySex and Gender Equity in Research: rationale for the SAGER guidelines and recommended useSystematic Incorporation of Sex-Specific Information Into Clinical Practice Guidelines for the Management of ST -Segment-Elevation Myocardial Infarction: Feasibility and OutcomesThe injustice of unfit clinical practice guidelines in low-resource realitiesCan ‘Cascades’ make guidelines global?The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspectiveScaling up context-tailored clinical guidelines and training to improve childbirth care in urban, low-resource maternity units in Tanzania: A protocol for a stepped-wedged cluster randomized trial with embedded qualitative and economic analyses (The PartoMa Scale-Up Study)Value is Gendered: The Need for Sex and Gender Considerations in Health Economic EvaluationsArtificial intelligence and the future of global healthSex and gender differences and biases in artificial intelligence for biomedicine and healthcareLiving systematic reviews: 4. Living guideline recommendations">Designing clinical practice guidelines for equitable, inclusive, and contextualised careMedical journal editors must resist CDC order and anti-gender ideologyGuidelines International Network: toward international standards for clinical practice guidelinesA framework for sex, gender, and diversity analysis in researchSex and gender considerations in Canadian clinical practice guidelines: a systematic reviewUSPSTF Approach to Addressing Sex and Gender When Making Recommendations for Clinical Preventive ServicesConsideration of sex and gender: an analysis of Australian clinical guidelinesDifferentiating sex and gender in health research to achieve gender equitySex and gender bias in chronic coronary syndromes research: analysis of studies used to inform the 2019 European Society of Cardiology guidelinesConsideration of sex and gender in European clinical practice guidelines in internal medicine: a systematic review protocolUnderrepresentation of women in new drug trials2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceCHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)One and a half million medical papers reveal a link between author gender and attention to gender and sex analysisIntersectional inequalities in scienceAGREE II: advancing guideline development, reporting and evaluation in health careGrading quality of evidence and strength of recommendationsApplicability of European Society of Cardiology guidelines according to gross national incomeGuideline adaptation: an approach to enhance efficiency in guideline development and improve utilisationStrengthening guideline contextualization in the WHO European RegionGRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENTOncology Guidelines Usage in a Low- and Middle-Income CountryGuideline developers in low- and middle-income countries want to develop and use living guidelines, but are currently limited by important barriers: findings from a qualitative studyGuidelines in lower-middle income countriesGuideline adaptation and implementation planning: a prospective observational studySex and Gender Equity in Research: rationale for the SAGER guidelines and recommended useSystematic Incorporation of Sex-Specific Information Into Clinical Practice Guidelines for the Management of ST -Segment-Elevation Myocardial Infarction: Feasibility and OutcomesThe injustice of unfit clinical practice guidelines in low-resource realitiesCan ‘Cascades’ make guidelines global?The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspectiveScaling up context-tailored clinical guidelines and training to improve childbirth care in urban, low-resource maternity units in Tanzania: A protocol for a stepped-wedged cluster randomized trial with embedded qualitative and economic analyses (The PartoMa Scale-Up Study)Value is Gendered: The Need for Sex and Gender Considerations in Health Economic EvaluationsArtificial intelligence and the future of global healthSex and gender differences and biases in artificial intelligence for biomedicine and healthcareLiving systematic reviews: 4. Living guideline recommendations</div>
                            <small style="color: var(--text-muted)">12509990.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialImmune ThrombocytopeniaPrimary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosisThe incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsHuman thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destructionAutoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)Recent advances in the mechanisms and treatment of immune thrombocytopeniaImmune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeThe 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopeniaAmerican Society of Hematology 2019 guidelines for immune thrombocytopeniaNewly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohortNovel therapeutics and future directions for refractory immune thrombocytopeniaCD38: A Target for Immunotherapeutic Approaches in Multiple MyelomaDaratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)Safety, tolerability, and efficacy of mezagitamab (TAK-079) in chronic or persistent primary immune thrombocytopenia: Interim results from a phase 2, randomized, double-blind, placebo-controlled study2025 update on clinical trials in immune thrombocytopeniaMezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseTargeting CD38 with Daratumumab in Refractory Systemic Lupus ErythematosusEfficacy of daratumumab in refractory primary Sjögren diseasePreclinical characterization of a novel investigational monoclonal antibody CM313 with potent CD38-positive cell killing activityA Novel Anti-CD38 Monoclonal Antibody for Treating Immune ThrombocytopeniaSplenectomy for immune thrombocytopenia: down but not outHow we treat primary immune thrombocytopenia in adultsDaratumumab, an original approach for treating multi-refractory autoimmune cytopeniaDaratumumab as a novel treatment option in refractory ITPPhase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopeniaEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialA multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopeniaA multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopeniaFostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsEfficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyRituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyImmune Thrombocytopenia TreatmentLong-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxProfound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literatureEfficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialHigh-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpuraNK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple MyelomaHLA-DR NK cells are mostly characterized by less mature phenotype and high functional activityInhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity">Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialImmune ThrombocytopeniaPrimary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosisThe incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsHuman thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destructionAutoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)Recent advances in the mechanisms and treatment of immune thrombocytopeniaImmune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of lifeThe 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopeniaAmerican Society of Hematology 2019 guidelines for immune thrombocytopeniaNewly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohortNovel therapeutics and future directions for refractory immune thrombocytopeniaCD38: A Target for Immunotherapeutic Approaches in Multiple MyelomaDaratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)Safety, tolerability, and efficacy of mezagitamab (TAK-079) in chronic or persistent primary immune thrombocytopenia: Interim results from a phase 2, randomized, double-blind, placebo-controlled study2025 update on clinical trials in immune thrombocytopeniaMezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseTargeting CD38 with Daratumumab in Refractory Systemic Lupus ErythematosusEfficacy of daratumumab in refractory primary Sjögren diseasePreclinical characterization of a novel investigational monoclonal antibody CM313 with potent CD38-positive cell killing activityA Novel Anti-CD38 Monoclonal Antibody for Treating Immune ThrombocytopeniaSplenectomy for immune thrombocytopenia: down but not outHow we treat primary immune thrombocytopenia in adultsDaratumumab, an original approach for treating multi-refractory autoimmune cytopeniaDaratumumab as a novel treatment option in refractory ITPPhase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopeniaEfficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialA multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopeniaA multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopeniaFostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trialsEfficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studyRituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyImmune Thrombocytopenia TreatmentLong-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-rituxProfound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literatureEfficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialHigh-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpuraNK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple MyelomaHLA-DR NK cells are mostly characterized by less mature phenotype and high functional activityInhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity</div>
                            <small style="color: var(--text-muted)">12538382.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...t were treated as missing and not imputed. WHO bleeding scores (grade 1...'}</li><li>{'message': 'Longitudinal/clustered data detected without hierarchical modeling.', 'evidence': '...ing a mixed effects model for repeated measures, with treatment group, time p...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Community based cohort studies in China: critical insights for shaping the future of population and public healthThe Rotterdam Study. Design update and major findings between 2020 and 2024Risk factors associated with heatwave mortality in Chinese adults over 65 yearsNowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS)Landscape of large scale cohort development in ChinaCohort profile: the Cebu longitudinal health and nutrition surveyProspective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and DesignSurvival after minimally invasive radical hysterectomy for early-stage cervical cancerBreadth versus depth: balancing variables, sample size, and quality in Chinese cohort studiesAge and genetic risk score and rates of blood lipid changes in ChinaMetabolomics and type 2 diabetes risk: An updated systematic review and meta-analysis of prospective cohort studiesEthnic differences in the association between body mass index and hypertensionConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in ChinaGenome-wide association study in Chinese identifies novel loci for blood pressure and hypertensionEvaluation of atherosclerotic cardiovascular risk prediction models in China: results from the CHERRY studySecular trends in salt and soy sauce intake among Chinese adults, 1997-2011Association of a province-wide intervention with salt intake and hypertension in Shandong province, China, 2011-2016The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling studyBuilding sustainable cohort studies in China: a hybrid model for public health researchA village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trialPerformance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective studyMorbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyWhy representativeness should be avoidedTobacco smoking and risks of more than 470 diseases in China: a prospective cohort studyEnhancing international collaboration in cohort studies in China: opportunities and challengesLinking air pollution exposure to blood-based metabolic features in a community-based aging cohort with and without dementiaEffect of a multicomponent intervention delivered on a web-based platform on hypertension control: a cluster randomized clinical trial">Community based cohort studies in China: critical insights for shaping the future of population and public healthThe Rotterdam Study. Design update and major findings between 2020 and 2024Risk factors associated with heatwave mortality in Chinese adults over 65 yearsNowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS)Landscape of large scale cohort development in ChinaCohort profile: the Cebu longitudinal health and nutrition surveyProspective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and DesignSurvival after minimally invasive radical hysterectomy for early-stage cervical cancerBreadth versus depth: balancing variables, sample size, and quality in Chinese cohort studiesAge and genetic risk score and rates of blood lipid changes in ChinaMetabolomics and type 2 diabetes risk: An updated systematic review and meta-analysis of prospective cohort studiesEthnic differences in the association between body mass index and hypertensionConventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in ChinaGenome-wide association study in Chinese identifies novel loci for blood pressure and hypertensionEvaluation of atherosclerotic cardiovascular risk prediction models in China: results from the CHERRY studySecular trends in salt and soy sauce intake among Chinese adults, 1997-2011Association of a province-wide intervention with salt intake and hypertension in Shandong province, China, 2011-2016The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling studyBuilding sustainable cohort studies in China: a hybrid model for public health researchA village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trialPerformance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective studyMorbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyWhy representativeness should be avoidedTobacco smoking and risks of more than 470 diseases in China: a prospective cohort studyEnhancing international collaboration in cohort studies in China: opportunities and challengesLinking air pollution exposure to blood-based metabolic features in a community-based aging cohort with and without dementiaEffect of a multicomponent intervention delivered on a web-based platform on hypertension control: a cluster randomized clinical trial</div>
                            <small style="color: var(--text-muted)">12542862.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'Paired data mentioned but no paired statistical tests found.', 'evidence': '...e China Health and Retirement Longitudinal Study (CHARLS)Landscape of la...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Risk of infection and wound dehiscence after use of prophylactic antibiotics in episiotomy or second degree tear (REPAIR study): single centre, double blind, placebo controlled randomised trial The incidence of wound infection and dehiscence following childbirth-related perineal trauma: A systematic review of the evidenceAntibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birthAntibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trialAntibiotic prophylaxis for episiotomy repair following vaginal birthClinical evaluation of the chloramphenicol use as a prophylactic antibiotic in the vaginal delivery with episiotomy [Avaliacao clinica do emprego do cloranfenicol como antibiotico profilatico no parto normal com episiotomiaA Randomized, Open-labelled, Interventional Study to Evaluate the Incidence of Infection with or Without Use of Prophylactic Antibiotics in Patients of Episiotomy in a Normal Vaginal DeliveryProphylactic antibiotics in patients with episiotomy following normal vaginal delivery: a randomised clinical trialCould subcutaneous rifampicin administration be an effective approach for reducing episiotomy infections?Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trialStill No Substantial Evidence to Use Prophylactic Antibiotic at Operative Vaginal Delivery: Systematic Review and Meta-AnalysisThe REPAIR study: oral antibiotics to prevent infection and wound dehiscence after obstetric perineal tear-a double-blinded placebo controlled randomized trialPostpartum perineal repair performed by midwives: a randomised trial comparing two suture techniques leaving the skin unsuturedObstetric perineal tears: risk factors, wound infection and dehiscence: a prospective cohort studyFactors associated with wound complications in women with obstetric anal sphincter injuries (OASIS)Breakdown of Perineal Laceration Repair After Vaginal Delivery: A Case-Control StudyLactogenesis: The transition from pregnancy to lactation: Breastfeeding 2001, Part I: The evidence for breastfeedingInfection and wound breakdown in spontaneous second-degree perineal tears: An exploratory mixed methods studyFactors associated with infection after operative vaginal birth-a secondary analysis of a randomized controlled trial of prophylactic antibiotics for the prevention of infection following operative vaginal birthLong term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records">Risk of infection and wound dehiscence after use of prophylactic antibiotics in episiotomy or second degree tear (REPAIR study): single centre, double blind, placebo controlled randomised trial The incidence of wound infection and dehiscence following childbirth-related perineal trauma: A systematic review of the evidenceAntibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birthAntibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trialAntibiotic prophylaxis for episiotomy repair following vaginal birthClinical evaluation of the chloramphenicol use as a prophylactic antibiotic in the vaginal delivery with episiotomy [Avaliacao clinica do emprego do cloranfenicol como antibiotico profilatico no parto normal com episiotomiaA Randomized, Open-labelled, Interventional Study to Evaluate the Incidence of Infection with or Without Use of Prophylactic Antibiotics in Patients of Episiotomy in a Normal Vaginal DeliveryProphylactic antibiotics in patients with episiotomy following normal vaginal delivery: a randomised clinical trialCould subcutaneous rifampicin administration be an effective approach for reducing episiotomy infections?Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trialStill No Substantial Evidence to Use Prophylactic Antibiotic at Operative Vaginal Delivery: Systematic Review and Meta-AnalysisThe REPAIR study: oral antibiotics to prevent infection and wound dehiscence after obstetric perineal tear-a double-blinded placebo controlled randomized trialPostpartum perineal repair performed by midwives: a randomised trial comparing two suture techniques leaving the skin unsuturedObstetric perineal tears: risk factors, wound infection and dehiscence: a prospective cohort studyFactors associated with wound complications in women with obstetric anal sphincter injuries (OASIS)Breakdown of Perineal Laceration Repair After Vaginal Delivery: A Case-Control StudyLactogenesis: The transition from pregnancy to lactation: Breastfeeding 2001, Part I: The evidence for breastfeedingInfection and wound breakdown in spontaneous second-degree perineal tears: An exploratory mixed methods studyFactors associated with infection after operative vaginal birth-a secondary analysis of a randomized controlled trial of prophylactic antibiotics for the prevention of infection following operative vaginal birthLong term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records</div>
                            <small style="color: var(--text-muted)">12570273.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...before enrolment and remained blinded to the staff (except repackin...'}</li><li>{'message': 'Includes exploratory/post hoc analyses without clear multiplicity correction.', 'evidence': '...ower than 15%. We performed a post hoc power calculation based on th...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialProtected to death: systematic exclusion of pregnant women from Ebola virus disease trialsSafety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: a randomised, placebo-controlled phase II clinical trial in AfricaSafety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: a randomised, placebo-controlled, multicentre phase II clinical trialSafety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialSafety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialNonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidateMonitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola vaccination campaignSmall babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve countingNational and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010Vaccination during pregnancy: current and possible future recommendationsImmunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartumPlacental transfer of antibody and its relationship to vaccination in pregnancySafety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trialLeapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in RwandaMaternal death: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataSpontaneous abortion and ectopic pregnancy: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataStillbirth: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety dataPathways to preterm birth: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataHypertensive disorders of pregnancy: case definitions & guidelines for data collection, analysis, and presentation of immunization safety dataAntenatal bleeding: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataPostpartum haemorrhage: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataCongenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataSmall for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety dataLow birth weight: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataPreterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety dataNeonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety dataFailure to thrive: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data">Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialProtected to death: systematic exclusion of pregnant women from Ebola virus disease trialsSafety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: a randomised, placebo-controlled phase II clinical trial in AfricaSafety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: a randomised, placebo-controlled, multicentre phase II clinical trialSafety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialSafety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialNonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidateMonitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola vaccination campaignSmall babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve countingNational and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010Vaccination during pregnancy: current and possible future recommendationsImmunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartumPlacental transfer of antibody and its relationship to vaccination in pregnancySafety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trialLeapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in RwandaMaternal death: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataSpontaneous abortion and ectopic pregnancy: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataStillbirth: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety dataPathways to preterm birth: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataHypertensive disorders of pregnancy: case definitions & guidelines for data collection, analysis, and presentation of immunization safety dataAntenatal bleeding: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataPostpartum haemorrhage: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataCongenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataSmall for gestational age: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety dataLow birth weight: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataPreterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety dataNeonatal death: case definition & guidelines for data collection, analysis, and presentation of immunization safety dataFailure to thrive: case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data</div>
                            <small style="color: var(--text-muted)">12618248.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...were analyzed using SAS v9.4. No formal statistical hypothesis testing was planned. To aid understan...'}</li><li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...s they experienced the event. Missing data were not imputed. Participant...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Ambient temperature and deaths from homicide in Brazil from 2010-2019: a nationwide space-time–stratified case-crossover studyThe 2020 report of the lancet countdown on health and climate change: responding to converging crisesHot and bothered? Associations between temperature and crime in AustraliaAggression and heat: the influence of ambient temperature, negative affect, and a cooling drink on physical aggressionGlobal warming and U.S. crime rates: an application of routine activity theoryImpact of climate variability and change on crime rates in TangshanSpatiotemporal association between temperature and assaults: a generalized linear mixed-model approachThe relationship between temperature and crime on the cape flats of South AfricaThe association between weather and the number of daily shootings in Chicago (2012–2016)Short-term association between ambient temperature and homicide in South Africa: a case-crossover studyAmbient temperature and intentional homicide: a multi-city case-crossover study in the USAssociation between ambient temperature and intentional injuries: a case-crossover analysis using ambulance transport records in JapanOverlap bias in the case-crossover design, with application to air pollution exposuresCase–crossover analyses of air pollution exposure data: referent selection strategies and their implications for biasHot under the collar: a 14-year association between temperature and violent behavior across 436 U.S. countiesHourly associations between heat and ambulance callsShort-term exposure to ambient fine particulate matter and out-of-hospital cardiac arrest: a nationwide case-crossover study in JapanAssociation between heat exposure and hospitalization for diabetes in Brazil during 2000–2015: a Nationwide case-crossover studyThe association between heat exposure and hospitalization for undernutrition in Brazil during 2000−2015: a nationwide case-crossover studyAssociation between ambient temperature and hospitalization for renal diseases in Brazil during 2000–2015: a nationwide case-crossover studyAn evaluation of the Brazilian mortality information systemThe ERA5 global reanalysisHumidity: calculate water vapor measures from temperature and dew pointAssociation between ambient temperature and sex offense: a case-crossover study in seven large US cities, 2007–2017Space-time-stratified case-crossover Design in Environmental Epidemiology StudyDistributed lag linear and non-linear models in R: the package dlnmMultivariate meta-analysis for non-linear and other multi-parameter associationsUrban income segregation and homicides: an analysis using Brazilian cities selected by the Salurbal projectCrime and violence in Brazil: systematic review of time trends, prevalence rates and risk factorsCrimes of opportunity or crimes of emotion? Testing two explanations of seasonal change in crimeAssociations of weather conditions with adolescents’ daily physical activity, sedentary time, and sleep durationWeather and crimeHow to deal with sleep problems during heatwaves: practical recommendations from the European insomnia networkFunctional connectivity changes in insomnia disorder: a systematic reviewEyes wide open: a systematic review of the association between insomnia and aggression in forensic contextsObservational and experimental studies on sleep duration and aggression: a systematic review and meta-analysisImpairments to thermoregulation in the elderly during heat exposure eventsHuman temperature regulation under heat stress in health, disease, and injuryTemperature-related mortality: a systematic review and investigation of effect modifiersThe influence of weather conditions on outdoor physical activity among older people with and without osteoarthritis in 6 European countriesWeather impacts on leisure activities in Halifax, Nova ScotiaCriminal behaviour among the elderly: a look into what people think about this emerging topicExplanatory theories of intimate partner homicide perpetration: a systematic reviewHomicide in Sao Paulo, Brazil: assessing spatial-temporal and weather variationsSocioeconomic inequality in vulnerability to all-cause and cause-specific hospitalisation associated with temperature variability: a time-series study in 1814 Brazilian citiesGrowth of lethal violence in Brazil 2000–2017: a space-temporal analysis of homicidesTemperature and humidity based projections of a rapid rise in global heat stress exposure during the 21st centuryPopulation attributable fraction in textbooks: time to reviseA history of the population attributable fraction and related measures">Ambient temperature and deaths from homicide in Brazil from 2010-2019: a nationwide space-time–stratified case-crossover studyThe 2020 report of the lancet countdown on health and climate change: responding to converging crisesHot and bothered? Associations between temperature and crime in AustraliaAggression and heat: the influence of ambient temperature, negative affect, and a cooling drink on physical aggressionGlobal warming and U.S. crime rates: an application of routine activity theoryImpact of climate variability and change on crime rates in TangshanSpatiotemporal association between temperature and assaults: a generalized linear mixed-model approachThe relationship between temperature and crime on the cape flats of South AfricaThe association between weather and the number of daily shootings in Chicago (2012–2016)Short-term association between ambient temperature and homicide in South Africa: a case-crossover studyAmbient temperature and intentional homicide: a multi-city case-crossover study in the USAssociation between ambient temperature and intentional injuries: a case-crossover analysis using ambulance transport records in JapanOverlap bias in the case-crossover design, with application to air pollution exposuresCase–crossover analyses of air pollution exposure data: referent selection strategies and their implications for biasHot under the collar: a 14-year association between temperature and violent behavior across 436 U.S. countiesHourly associations between heat and ambulance callsShort-term exposure to ambient fine particulate matter and out-of-hospital cardiac arrest: a nationwide case-crossover study in JapanAssociation between heat exposure and hospitalization for diabetes in Brazil during 2000–2015: a Nationwide case-crossover studyThe association between heat exposure and hospitalization for undernutrition in Brazil during 2000−2015: a nationwide case-crossover studyAssociation between ambient temperature and hospitalization for renal diseases in Brazil during 2000–2015: a nationwide case-crossover studyAn evaluation of the Brazilian mortality information systemThe ERA5 global reanalysisHumidity: calculate water vapor measures from temperature and dew pointAssociation between ambient temperature and sex offense: a case-crossover study in seven large US cities, 2007–2017Space-time-stratified case-crossover Design in Environmental Epidemiology StudyDistributed lag linear and non-linear models in R: the package dlnmMultivariate meta-analysis for non-linear and other multi-parameter associationsUrban income segregation and homicides: an analysis using Brazilian cities selected by the Salurbal projectCrime and violence in Brazil: systematic review of time trends, prevalence rates and risk factorsCrimes of opportunity or crimes of emotion? Testing two explanations of seasonal change in crimeAssociations of weather conditions with adolescents’ daily physical activity, sedentary time, and sleep durationWeather and crimeHow to deal with sleep problems during heatwaves: practical recommendations from the European insomnia networkFunctional connectivity changes in insomnia disorder: a systematic reviewEyes wide open: a systematic review of the association between insomnia and aggression in forensic contextsObservational and experimental studies on sleep duration and aggression: a systematic review and meta-analysisImpairments to thermoregulation in the elderly during heat exposure eventsHuman temperature regulation under heat stress in health, disease, and injuryTemperature-related mortality: a systematic review and investigation of effect modifiersThe influence of weather conditions on outdoor physical activity among older people with and without osteoarthritis in 6 European countriesWeather impacts on leisure activities in Halifax, Nova ScotiaCriminal behaviour among the elderly: a look into what people think about this emerging topicExplanatory theories of intimate partner homicide perpetration: a systematic reviewHomicide in Sao Paulo, Brazil: assessing spatial-temporal and weather variationsSocioeconomic inequality in vulnerability to all-cause and cause-specific hospitalisation associated with temperature variability: a time-series study in 1814 Brazilian citiesGrowth of lethal violence in Brazil 2000–2017: a space-temporal analysis of homicidesTemperature and humidity based projections of a rapid rise in global heat stress exposure during the 21st centuryPopulation attributable fraction in textbooks: time to reviseA history of the population attributable fraction and related measures</div>
                            <small style="color: var(--text-muted)">12634108.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...s used to derive the national odds ratio (OR) using whole Brazilian da...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Tai chi or cognitive behavioural therapy for treating insomnia in middle aged and older adults: randomised non-inferiority trialInsomnia disorderPrevalence of insomnia among Chinese adults in Hong Kong: a population-based studyWho reports insufficient and disturbed sleep? Results from a representative population-based health survey in Hong KongThe nature of stable insomnia phenotypesChronic insomniaSocietal costs of insomniaBehavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guidelineIntegrating technology to increase the reach of CBT-I: state of the science and challenges aheadVeterans affairs primary care provider perceptions of insomnia treatmentReferral practices for cognitive behavioral therapy for insomnia: a survey studyThe European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatmentTai Chi for health and well-being: a bibliometric analysis of published clinical studies between 2010 and 2020The science of Tai Chi and  as whole person health-part I: rationale and state of the scienceTrends and characteristics of Tai Chi and Qi Gong use among U.S. adults: results from the 2007-2017 National Health Interview SurveyEffects of Tai Chi or exercise on sleep in older adults with insomnia: a randomized clinical trialEffects of Tai Chi or conventional exercise on central obesity in middle-aged and older adults: a three-group randomized controlled trialComparative efficacy of exercise regimens on sleep quality in older adults: a systematic review and network meta-analysisReporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statementEffects of Tai Chi and cognitive behavioral therapy for insomnia on improving sleep in older adults: Study protocol for a non-inferiority trialEvidence base of clinical studies on Tai Chi: a bibliometric analysisTai Chi Chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast cancer: a randomized, partially blinded, noninferiority trialValidation of the Insomnia Severity Index as an outcome measure for insomnia researchThe Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment responseInsomnia Severity Index: psychometric properties with Chinese community-dwelling older peopleMindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trialNon-inferiority trials: design concepts and issues—the encounters of academic consultants in statisticsInsomnia and its treatment in women with breast cancerComparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysisThe neurobiology, investigation, and treatment of chronic insomniaIncidence, persistence, and remission rates of insomnia over 5 yearsThe natural history of insomnia: a population-based 3-year longitudinal studyTai Chi compared with cognitive behavioral therapy and the reversal of systemic, cellular and genomic markers of inflammation in breast cancer survivors with insomnia: a randomized clinical trialTai Chi Chuan and Baduanjin practice modulates functional connectivity of the cognitive control network in older adultsDifferent modulation effects of Tai Chi Chuan and Baduanjin on resting-state functional connectivity of the default mode network in older adultsIncreased hippocampus–medial prefrontal cortex resting-state functional connectivity and memory function after Tai Chi Chuan practice in elder adultsTai Chi Chuan and Baduanjin mind-body training changes resting-state low-frequency fluctuations in the frontal lobe of older adults: a resting-state fMRI studyNeuroimaging correlates of cognitive behavioral therapy for insomnia (CBT-I): a systematic literature reviewChanges in subcortical resting-state functional connectivity in patients with psychophysiological insomnia after cognitive-behavioral therapy: changes in resting-state FC after CBT for insomnia patientsMechanisms of cognitive behavioural therapy for insomniaEffects of mind–body exercises (Tai Chi/Yoga) on heart rate variability parameters and perceived stress: a systematic review with meta-analysis of randomized controlled trialsThe comparative effects of Tai chi versus non-mindful exercise on measures of anxiety, depression and general mental health: a systematic review and meta-analysisRepetitive transcranial magnetic stimulation and tai chi chuan for older adults with sleep disorders and mild cognitive impairment: a randomized clinical trialTrends in yoga, Tai Chi, and Qigong use among US adults, 2002-2017">Tai chi or cognitive behavioural therapy for treating insomnia in middle aged and older adults: randomised non-inferiority trialInsomnia disorderPrevalence of insomnia among Chinese adults in Hong Kong: a population-based studyWho reports insufficient and disturbed sleep? Results from a representative population-based health survey in Hong KongThe nature of stable insomnia phenotypesChronic insomniaSocietal costs of insomniaBehavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guidelineIntegrating technology to increase the reach of CBT-I: state of the science and challenges aheadVeterans affairs primary care provider perceptions of insomnia treatmentReferral practices for cognitive behavioral therapy for insomnia: a survey studyThe European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatmentTai Chi for health and well-being: a bibliometric analysis of published clinical studies between 2010 and 2020The science of Tai Chi and  as whole person health-part I: rationale and state of the scienceTrends and characteristics of Tai Chi and Qi Gong use among U.S. adults: results from the 2007-2017 National Health Interview SurveyEffects of Tai Chi or exercise on sleep in older adults with insomnia: a randomized clinical trialEffects of Tai Chi or conventional exercise on central obesity in middle-aged and older adults: a three-group randomized controlled trialComparative efficacy of exercise regimens on sleep quality in older adults: a systematic review and network meta-analysisReporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statementEffects of Tai Chi and cognitive behavioral therapy for insomnia on improving sleep in older adults: Study protocol for a non-inferiority trialEvidence base of clinical studies on Tai Chi: a bibliometric analysisTai Chi Chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast cancer: a randomized, partially blinded, noninferiority trialValidation of the Insomnia Severity Index as an outcome measure for insomnia researchThe Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment responseInsomnia Severity Index: psychometric properties with Chinese community-dwelling older peopleMindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trialNon-inferiority trials: design concepts and issues—the encounters of academic consultants in statisticsInsomnia and its treatment in women with breast cancerComparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysisThe neurobiology, investigation, and treatment of chronic insomniaIncidence, persistence, and remission rates of insomnia over 5 yearsThe natural history of insomnia: a population-based 3-year longitudinal studyTai Chi compared with cognitive behavioral therapy and the reversal of systemic, cellular and genomic markers of inflammation in breast cancer survivors with insomnia: a randomized clinical trialTai Chi Chuan and Baduanjin practice modulates functional connectivity of the cognitive control network in older adultsDifferent modulation effects of Tai Chi Chuan and Baduanjin on resting-state functional connectivity of the default mode network in older adultsIncreased hippocampus–medial prefrontal cortex resting-state functional connectivity and memory function after Tai Chi Chuan practice in elder adultsTai Chi Chuan and Baduanjin mind-body training changes resting-state low-frequency fluctuations in the frontal lobe of older adults: a resting-state fMRI studyNeuroimaging correlates of cognitive behavioral therapy for insomnia (CBT-I): a systematic literature reviewChanges in subcortical resting-state functional connectivity in patients with psychophysiological insomnia after cognitive-behavioral therapy: changes in resting-state FC after CBT for insomnia patientsMechanisms of cognitive behavioural therapy for insomniaEffects of mind–body exercises (Tai Chi/Yoga) on heart rate variability parameters and perceived stress: a systematic review with meta-analysis of randomized controlled trialsThe comparative effects of Tai chi versus non-mindful exercise on measures of anxiety, depression and general mental health: a systematic review and meta-analysisRepetitive transcranial magnetic stimulation and tai chi chuan for older adults with sleep disorders and mild cognitive impairment: a randomized clinical trialTrends in yoga, Tai Chi, and Qigong use among US adults, 2002-2017</div>
                            <small style="color: var(--text-muted)">12651913.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Detected high number of P-values (8) without explicit mention of multiplicity correction.', 'evidence': '...onsistency, with a Cronbach’s alpha of 0.81.26  Secondary outcome...'}</li><li>{'message': 'Software mentioned without specific versions.', 'evidence': '...on-inferiority using POWER in SAS OnDemand for Academics (SAS I...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence–Powered Pathology Assay: Development and Validation in an International 12-Center CohortEditorial Comment.Bladder cancer: a reviewDiagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guidelineEuropean Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)NCCN Guidelines Insights: bladder cancer, version 2.2022Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceCritical shortage in BCG immunotherapy: how did we get here and where will it take us?Background and update for ECOG-ACRIN EA8212: a randomized phase 3 trial of intravesical Bacillus Calmette-Guerin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naive high-grade non-muscle-invasive bladder cancer (BRIDGE)DLBCL-Morph: morphological features computed using deep learning for an annotated digital DLBCL image setDevelopment of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerREporting recommendations for tumour MARKer prognostic studies (REMARK)Validation of biomarker-based risk prediction modelsDefinitions, end points, and clinical trial designs for bladder cancer: recommendations from the society for immunotherapy of cancer and the International Bladder Cancer GroupDefining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definitionOpenSlide: a vendor-neutral software foundation for digital pathologyEuropean Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panelEORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-GuerinAccuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancerAccuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderMarkers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic reviewRisk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumoursValidation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): a cohort analysisUpdated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuerinBladder cancer prognosis using deep neural networks and histopathology imagesDifferentiation of urothelial carcinoma in histopathology images using deep learning and visualizationMultiresolution application of artificial intelligence in digital pathology for prediction of positive lymph nodes from primary tumors in bladder cancerUnlocking the potential of adequate Bacillus Calmette-Guerin immunotherapy in very-high-risk non-muscle-invasive bladder carcinoma: a multicenter analysis of oncological outcomes and risk dynamicsComparison of sequential intravesical gemcitabine and docetaxel vs Bacillus Calmette-Guerin for the treatment of patients with high-risk non-muscle-invasive bladder cancerElectromotive drug administration (EMDA) of mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomesLong-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer">Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence–Powered Pathology Assay: Development and Validation in an International 12-Center CohortEditorial Comment.Bladder cancer: a reviewDiagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guidelineEuropean Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)NCCN Guidelines Insights: bladder cancer, version 2.2022Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceCritical shortage in BCG immunotherapy: how did we get here and where will it take us?Background and update for ECOG-ACRIN EA8212: a randomized phase 3 trial of intravesical Bacillus Calmette-Guerin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naive high-grade non-muscle-invasive bladder cancer (BRIDGE)DLBCL-Morph: morphological features computed using deep learning for an annotated digital DLBCL image setDevelopment of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerREporting recommendations for tumour MARKer prognostic studies (REMARK)Validation of biomarker-based risk prediction modelsDefinitions, end points, and clinical trial designs for bladder cancer: recommendations from the society for immunotherapy of cancer and the International Bladder Cancer GroupDefining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definitionOpenSlide: a vendor-neutral software foundation for digital pathologyEuropean Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panelEORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-GuerinAccuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancerAccuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladderMarkers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic reviewRisk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumoursValidation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): a cohort analysisUpdated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuerinBladder cancer prognosis using deep neural networks and histopathology imagesDifferentiation of urothelial carcinoma in histopathology images using deep learning and visualizationMultiresolution application of artificial intelligence in digital pathology for prediction of positive lymph nodes from primary tumors in bladder cancerUnlocking the potential of adequate Bacillus Calmette-Guerin immunotherapy in very-high-risk non-muscle-invasive bladder carcinoma: a multicenter analysis of oncological outcomes and risk dynamicsComparison of sequential intravesical gemcitabine and docetaxel vs Bacillus Calmette-Guerin for the treatment of patients with high-risk non-muscle-invasive bladder cancerElectromotive drug administration (EMDA) of mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomesLong-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer</div>
                            <small style="color: var(--text-muted)">12674634.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...EAU 2021 risk models.15,16 No adjustment for multiplicity of testing the recurrence-fre...'}</li><li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...spectively. In the EV cohort, missing data were imputed to allow for app...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Wearable Signals for Diagnosing Attention-Deficit/Hyperactivity Disorder in Adolescents: A Feasibility StudyKey findings from the second Australian Child and Adolescent Survey of Mental Health and WellbeingAttention deficit hyperactivity disorder and premature deathFailure of healthcare provision for attention-deficit/hyperactivity disorder in the United Kingdom: a consensus statementSpecial issues in the diagnosis and treatment of ADHD in adolescentsAssociation of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individualsXGBoost: a scalable tree boosting system. In: Association for Computing Machinery Special Interest Group on Management of Data, ACM Special Interest Group on Knowledge Discovery in DataFitbit®: an accurate and reliable device for wireless physical activity trackingAddressing the HIPAA-potamus sized gap in wearable technology regulationEarly sleep deprivation and attention-deficit/hyperactivity disorderSleep duration and school readiness of Chinese preschool childrenSocioeconomic gradients in school readiness of Chinese preschool children: The mediating role of family processes and kindergarten qualityValidation of the Chinese strengths and weaknesses of ADHD-symptoms and normal-behaviors questionnaire in Hong KongCenter for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adultsPsychometric properties of the Teenage Executive Functioning Inventory (TEXI): a freely available questionnaire for assessing deficits in working memory and inhibition among adolescentsThe Affective Reactivity Index: a concise irritability scale for clinical and research settingsParent proxy-report of their children’s health-related quality of life: an analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core ScalesXGBoost model for chronic kidney disease diagnosisIrritability in ADHD: associations with depression liabilitySex differences in ADHD symptom severityPhysical functioning, emotional, and behavioral problems in children with ADHD and comorbid ASD: a cross-sectional studyAssociation between ADHD and obesity: a systematic review and meta-analysisThe management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): an update of the literatureUnderstanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionAdverse effects of stimulant interventions for attention deficit hyperactivity disorder (ADHD): a comprehensive systematic reviewChildhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescenceADHD and emotion dysregulation among children and adolescentsSocial incompetence in children with ADHD: possible moderators and mediators in social-skills trainingHyperactivity and motoric activity in ADHD: characterization, assessment, and interventionThe use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysisLocomotor activity measures in the diagnosis of attention deficit hyperactivity disorder: meta-analyses and new findingsIs hyperactivity ubiquitous in ADHD or dependent on environmental demands? Evidence from meta-analysisPredicting ADHD symptoms and diagnosis at age 14 from objective activity levels at age 7 in a large UK cohortNonlinear analysis of actigraphic signals for the assessment of the attention-deficit/hyperactivity disorder (ADHD)Objective diagnosis of ADHD using IMUsMachine learning approach for classification of ADHD adultsClassification of ADHD patients on the basis of independent ERP components using a machine learning systemMachine learning classification of ADHD and HC by multimodal serotonergic dataCrowdsourced validation of a machine-learning classification system for autism and ADHDStimulant medications decrease energy expenditure and physical activity in children with attention-deficit/hyperactivity disorder">Wearable Signals for Diagnosing Attention-Deficit/Hyperactivity Disorder in Adolescents: A Feasibility StudyKey findings from the second Australian Child and Adolescent Survey of Mental Health and WellbeingAttention deficit hyperactivity disorder and premature deathFailure of healthcare provision for attention-deficit/hyperactivity disorder in the United Kingdom: a consensus statementSpecial issues in the diagnosis and treatment of ADHD in adolescentsAssociation of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individualsXGBoost: a scalable tree boosting system. In: Association for Computing Machinery Special Interest Group on Management of Data, ACM Special Interest Group on Knowledge Discovery in DataFitbit®: an accurate and reliable device for wireless physical activity trackingAddressing the HIPAA-potamus sized gap in wearable technology regulationEarly sleep deprivation and attention-deficit/hyperactivity disorderSleep duration and school readiness of Chinese preschool childrenSocioeconomic gradients in school readiness of Chinese preschool children: The mediating role of family processes and kindergarten qualityValidation of the Chinese strengths and weaknesses of ADHD-symptoms and normal-behaviors questionnaire in Hong KongCenter for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adultsPsychometric properties of the Teenage Executive Functioning Inventory (TEXI): a freely available questionnaire for assessing deficits in working memory and inhibition among adolescentsThe Affective Reactivity Index: a concise irritability scale for clinical and research settingsParent proxy-report of their children’s health-related quality of life: an analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core ScalesXGBoost model for chronic kidney disease diagnosisIrritability in ADHD: associations with depression liabilitySex differences in ADHD symptom severityPhysical functioning, emotional, and behavioral problems in children with ADHD and comorbid ASD: a cross-sectional studyAssociation between ADHD and obesity: a systematic review and meta-analysisThe management of sleep disturbances in children with attention-deficit/hyperactivity disorder (ADHD): an update of the literatureUnderstanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionAdverse effects of stimulant interventions for attention deficit hyperactivity disorder (ADHD): a comprehensive systematic reviewChildhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescenceADHD and emotion dysregulation among children and adolescentsSocial incompetence in children with ADHD: possible moderators and mediators in social-skills trainingHyperactivity and motoric activity in ADHD: characterization, assessment, and interventionThe use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysisLocomotor activity measures in the diagnosis of attention deficit hyperactivity disorder: meta-analyses and new findingsIs hyperactivity ubiquitous in ADHD or dependent on environmental demands? Evidence from meta-analysisPredicting ADHD symptoms and diagnosis at age 14 from objective activity levels at age 7 in a large UK cohortNonlinear analysis of actigraphic signals for the assessment of the attention-deficit/hyperactivity disorder (ADHD)Objective diagnosis of ADHD using IMUsMachine learning approach for classification of ADHD adultsClassification of ADHD patients on the basis of independent ERP components using a machine learning systemMachine learning classification of ADHD and HC by multimodal serotonergic dataCrowdsourced validation of a machine-learning classification system for autism and ADHDStimulant medications decrease energy expenditure and physical activity in children with attention-deficit/hyperactivity disorder</div>
                            <small style="color: var(--text-muted)">12684460.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Effects of subject-specific professional knowledge and skills of physical education teachers on students’ learning progressDas Kompetenzmodell von COACTIVTeachers’ mathematical knowledge, cognitive activation in the classroom, and student progress„… Kompetenz ohne Performanz ist leer! Performanz ohne Kompetenz blind …!” Zu einem integrativen Kompetenzstrukturmodell von SportlehrkräftenBeyond dichotomies. Competence viewed as a continuumWie situationsbezogen ist die Kompetenz von Lehrkräften? Zur Generalisierbarkeit der Ergebnisse von videobasierten PerformanztestsOpening up the black box: Teacher competence, instructional quality, and students’ learning progressVom Theorie-Praxis-Problem zur Verwendungsforschung und wieder zurückLehrerexpertiseProfessionswissen von Sportlehrpersonen und Zusammenhänge mit motivationalen Orientierungen und Überzeugungen zum Lehren und Lernen im SportStatistical power analysisPedagogical content knowledge. A systematic review of the way in which the concept has pervaded mathematics educational researchBegle revisited: teacher knowledge and student achievement in algebraFactors influencing behavior and behavior changeKompetenzorientierter Sportunterricht 2030 – Grundlagen für eine vernunftgetragene Selbstgestaltung des lebenslangen SporttreibensAnswering the call for a standard reliability measure for coding dataFachdidaktisches Wissen von angehenden Sportlehrkräften messenBasic motor competencies of preschoolers: Construct, assessment and determinantsEffects of improved content knowledge on pedagogical content knowledge and student performance in physical educationAbout the complexities of video-based assessments: theoretical and methodological approaches to overcoming shortcomings of research on teachers’ competenceProfessional competencies of (prospective) mathematics teachers—cognitive versus situated approachesKontextualisierte Erfassung von Lehrerkompetenzen. Einführung in den ThementeilPedagogical content knowledge and content knowledge of secondary mathematics teachersCompetence as a continuum in the COACTIV study: the “cascade model”Professional competence of teachers: effects on instructional quality and student developmentZur Bedeutung von Biografie, Erfahrung und Narration für die Fallarbeit in der Sportlehrer/innenausbildungA rasch model for partial credit scoringTeachers’ professional vision, pedagogical content knowledge and beliefs: on its relation and differences between pre-service and in-service teachersWhat is the subject matter of physical education?Wissen und Können bei Lehrpersonen und Lernenden im Sportunterricht. Zum Design und zur Modellierung von Schüler*innen und Lehrer*innenkompetenzenDas Wissen der Wissensvermittler. Problemstellungen, Befunde und Perspektiven der Forschung zum LehrerwissenThe game performance assessment instrument (GPAI): Development and preliminary validationWhat do new views of knowledge and thinking have to say about research on teacher learning?The Role of Perception, Interpretation, and Decision Making in the Development of Beginning Teachers’ CompetenceThose who understand: knowledge growth in teachingKnowledge and teaching: Foundations of the new reformEntwicklung eines Testverfahrens zur Analyse fachdidaktischen WissensLehrerberuf und Professionalität. Gewandeltes Begriffsverständnis – neue HerausforderungenDas fachdidaktische Wissen und Können von Sportlehrpersonen (PCK-Sport)Drei Zugänge zur Modellierung fachdidaktischen Wissens von SportlehrpersonenThe role of content knowledge in conceptions of teaching effectiveness in physical educationFachwissen und Können von Sportlehrpersonen: Konstruktion eines Tests entlang des KompetenzkontinuumsFachspezifisches professionelles Wissen und Können von SportlehrpersonenThe impact of mathematics teachers’ professional competence on instructional quality and students’ mathematics learning outcomes">Effects of subject-specific professional knowledge and skills of physical education teachers on students’ learning progressDas Kompetenzmodell von COACTIVTeachers’ mathematical knowledge, cognitive activation in the classroom, and student progress„… Kompetenz ohne Performanz ist leer! Performanz ohne Kompetenz blind …!” Zu einem integrativen Kompetenzstrukturmodell von SportlehrkräftenBeyond dichotomies. Competence viewed as a continuumWie situationsbezogen ist die Kompetenz von Lehrkräften? Zur Generalisierbarkeit der Ergebnisse von videobasierten PerformanztestsOpening up the black box: Teacher competence, instructional quality, and students’ learning progressVom Theorie-Praxis-Problem zur Verwendungsforschung und wieder zurückLehrerexpertiseProfessionswissen von Sportlehrpersonen und Zusammenhänge mit motivationalen Orientierungen und Überzeugungen zum Lehren und Lernen im SportStatistical power analysisPedagogical content knowledge. A systematic review of the way in which the concept has pervaded mathematics educational researchBegle revisited: teacher knowledge and student achievement in algebraFactors influencing behavior and behavior changeKompetenzorientierter Sportunterricht 2030 – Grundlagen für eine vernunftgetragene Selbstgestaltung des lebenslangen SporttreibensAnswering the call for a standard reliability measure for coding dataFachdidaktisches Wissen von angehenden Sportlehrkräften messenBasic motor competencies of preschoolers: Construct, assessment and determinantsEffects of improved content knowledge on pedagogical content knowledge and student performance in physical educationAbout the complexities of video-based assessments: theoretical and methodological approaches to overcoming shortcomings of research on teachers’ competenceProfessional competencies of (prospective) mathematics teachers—cognitive versus situated approachesKontextualisierte Erfassung von Lehrerkompetenzen. Einführung in den ThementeilPedagogical content knowledge and content knowledge of secondary mathematics teachersCompetence as a continuum in the COACTIV study: the “cascade model”Professional competence of teachers: effects on instructional quality and student developmentZur Bedeutung von Biografie, Erfahrung und Narration für die Fallarbeit in der Sportlehrer/innenausbildungA rasch model for partial credit scoringTeachers’ professional vision, pedagogical content knowledge and beliefs: on its relation and differences between pre-service and in-service teachersWhat is the subject matter of physical education?Wissen und Können bei Lehrpersonen und Lernenden im Sportunterricht. Zum Design und zur Modellierung von Schüler*innen und Lehrer*innenkompetenzenDas Wissen der Wissensvermittler. Problemstellungen, Befunde und Perspektiven der Forschung zum LehrerwissenThe game performance assessment instrument (GPAI): Development and preliminary validationWhat do new views of knowledge and thinking have to say about research on teacher learning?The Role of Perception, Interpretation, and Decision Making in the Development of Beginning Teachers’ CompetenceThose who understand: knowledge growth in teachingKnowledge and teaching: Foundations of the new reformEntwicklung eines Testverfahrens zur Analyse fachdidaktischen WissensLehrerberuf und Professionalität. Gewandeltes Begriffsverständnis – neue HerausforderungenDas fachdidaktische Wissen und Können von Sportlehrpersonen (PCK-Sport)Drei Zugänge zur Modellierung fachdidaktischen Wissens von SportlehrpersonenThe role of content knowledge in conceptions of teaching effectiveness in physical educationFachwissen und Können von Sportlehrpersonen: Konstruktion eines Tests entlang des KompetenzkontinuumsFachspezifisches professionelles Wissen und Können von SportlehrpersonenThe impact of mathematics teachers’ professional competence on instructional quality and students’ mathematics learning outcomes</div>
                            <small style="color: var(--text-muted)">12686084.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...e area CAPTION: Paired-sample t-test comparing the performance of...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Comparative investigation of immune-related biomarkers related to alopecia areata subtypesA randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areataAlopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment optionsHistopathologic diagnosis of alopecia: clues and pitfalls in the follicular microcosmosAlopecia areata: an update on etiopathogenesis, diagnosis, and managementGenome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility lociFunctional interpretation of genome-wide association study evidence in alopecia areataMolecular signatures define alopecia areata subtypes and transcriptional biomarkersNCBI GEO: archive for high-throughput functional genomic datalimma powers differential expression analyses for RNA-sequencing and microarray studiesMerging K-means with hierarchical clustering for identifying general-shaped groupsRobust analysis of phylogenetic tree spaceRNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implicationsComputational methods and software tools for functional analysis of miRNA dataDifferential gene set enrichment analysis: a statistical approach to quantify the relative enrichment of two gene setsPrognostic significance of immune landscape in tumour microenvironment of endometrial cancerApplication of weighted gene co-expression network analysis for data from paired designWGCNA: an R package for weighted correlation network analysisComparative Toxicogenomics Database (CTD): update 2021Cytoscape: a community-based framework for network modelingDAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)The comparative toxicogenomics database: update 2019Alopecia areata: a multifactorial autoimmune conditionEffects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture modelsAlopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populationsB cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of alopecia areataIncreased serum levels of IFN-γ, IL-1β, and IL-6 in patients with alopecia areata and nonsegmental vitiligoCD4, CD8 and natural killer cells are depressed in patients with alopecia areata: their association with disease activityDifferential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patientsIncreased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areataCXCL10 chemokine: a critical player in RNA and DNA viral infectionsCCL13 is upregulated in alopecia areata lesions and is correlated with disease severityBioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic targetCytokine and chemokine signals of T-Cell exclusion in tumorsAdvances of long non-coding RNAs as potential biomarkers for tuberculosis: new hope for diagnosis?Long noncoding RNAs in cancer and therapeutic potentialEx vivo treatment with allogenic mesenchymal stem cells of a healthy donor on peripheral blood mononuclear cells of patients with severe alopecia areata: targeting dysregulated T cells and the acquisition of immunotoleranceThe role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications">Comparative investigation of immune-related biomarkers related to alopecia areata subtypesA randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areataAlopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment optionsHistopathologic diagnosis of alopecia: clues and pitfalls in the follicular microcosmosAlopecia areata: an update on etiopathogenesis, diagnosis, and managementGenome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility lociFunctional interpretation of genome-wide association study evidence in alopecia areataMolecular signatures define alopecia areata subtypes and transcriptional biomarkersNCBI GEO: archive for high-throughput functional genomic datalimma powers differential expression analyses for RNA-sequencing and microarray studiesMerging K-means with hierarchical clustering for identifying general-shaped groupsRobust analysis of phylogenetic tree spaceRNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implicationsComputational methods and software tools for functional analysis of miRNA dataDifferential gene set enrichment analysis: a statistical approach to quantify the relative enrichment of two gene setsPrognostic significance of immune landscape in tumour microenvironment of endometrial cancerApplication of weighted gene co-expression network analysis for data from paired designWGCNA: an R package for weighted correlation network analysisComparative Toxicogenomics Database (CTD): update 2021Cytoscape: a community-based framework for network modelingDAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)The comparative toxicogenomics database: update 2019Alopecia areata: a multifactorial autoimmune conditionEffects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture modelsAlopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populationsB cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of alopecia areataIncreased serum levels of IFN-γ, IL-1β, and IL-6 in patients with alopecia areata and nonsegmental vitiligoCD4, CD8 and natural killer cells are depressed in patients with alopecia areata: their association with disease activityDifferential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patientsIncreased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areataCXCL10 chemokine: a critical player in RNA and DNA viral infectionsCCL13 is upregulated in alopecia areata lesions and is correlated with disease severityBioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic targetCytokine and chemokine signals of T-Cell exclusion in tumorsAdvances of long non-coding RNAs as potential biomarkers for tuberculosis: new hope for diagnosis?Long noncoding RNAs in cancer and therapeutic potentialEx vivo treatment with allogenic mesenchymal stem cells of a healthy donor on peripheral blood mononuclear cells of patients with severe alopecia areata: targeting dysregulated T cells and the acquisition of immunotoleranceThe role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications</div>
                            <small style="color: var(--text-muted)">12703612.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '.... A significance threshold of p < 0.05 was applied to select the enr...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trialFirst-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialPembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyTislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialPembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trialGEMSTONE-303: prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naive advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (LBA79)First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 trialPrimary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE)The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityPhase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer (LBA-5)Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8 T cell responsesEfficacy and safety of rilvegostomig, an anti-PD-1/TIGIT bispecific, for CPI-naive metastatic NSCLC with PD-L1 1–49% or ≥50% (OA11.03)ARC-7: randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC)Fc-silent anti-TIGIT antibodies potentiate antitumor immunity without depleting regulatory T cellsPreclinical characterization of GLS-010 (zimberelimab), a novel fully human anti-PD-1 therapeutic monoclonal antibody for cancerEfficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: a multicenter, single-arm, phase II studyEfficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II studyChemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitorsPhase 2 randomized study of domvanalimab combined with zimberelimab in front-line, PD-(L)1 high, locally advanced or metastatic non-small cell lung cancer (NSCLC): results from ARC-10 part 1STAR-221: a randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinomaAnti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanismsRegulatory T cells in immune checkpoint blockade antitumor therapyFirst-line rilvegostomig (rilve) + chemotherapy (CTx) in patients (pts) with HER2-negative (HER2−) locally advanced unresectable or metastatic gastric cancers: first report of GEMINI-Gastric sub study 2 (1422P)PD-L1 immunohistochemistry in gastric cancer: comparison of combined positive score and Tumor Area Positivity across 28-8, 22C3, and SP263 assaysTumor area positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoringConcordance between PD-L1 assays 28-8 and SP263 and their respective scoring algorithms in procured upper gastrointestinal adenocarcinoma samplesHigh interobserver variability among pathologists using combined positive score to evaluate PD-L1 expression in gastric, gastroesophageal junction, and esophageal adenocarcinomaConcordance between the PD-L1 Tumor Area Positivity score and Combined Positive Score for gastric or esophageal cancers treated with tislelizumab">Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trialFirst-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialPembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyTislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialPembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trialGEMSTONE-303: prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naive advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (LBA79)First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 trialPrimary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus atezolizumab (atezo) versus placebo plus atezo as first-line (1L) treatment in patients with PD-L1-selected NSCLC (CITYSCAPE)The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityPhase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer (LBA-5)Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8 T cell responsesEfficacy and safety of rilvegostomig, an anti-PD-1/TIGIT bispecific, for CPI-naive metastatic NSCLC with PD-L1 1–49% or ≥50% (OA11.03)ARC-7: randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC)Fc-silent anti-TIGIT antibodies potentiate antitumor immunity without depleting regulatory T cellsPreclinical characterization of GLS-010 (zimberelimab), a novel fully human anti-PD-1 therapeutic monoclonal antibody for cancerEfficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: a multicenter, single-arm, phase II studyEfficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II studyChemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitorsPhase 2 randomized study of domvanalimab combined with zimberelimab in front-line, PD-(L)1 high, locally advanced or metastatic non-small cell lung cancer (NSCLC): results from ARC-10 part 1STAR-221: a randomized, open-label, multicenter, phase 3 trial of domvanalimab, zimberelimab, and chemotherapy versus nivolumab and chemotherapy in previously untreated, locally advanced, unresectable or metastatic gastric, gastroesophageal junction, and esophageal adenocarcinomaAnti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanismsRegulatory T cells in immune checkpoint blockade antitumor therapyFirst-line rilvegostomig (rilve) + chemotherapy (CTx) in patients (pts) with HER2-negative (HER2−) locally advanced unresectable or metastatic gastric cancers: first report of GEMINI-Gastric sub study 2 (1422P)PD-L1 immunohistochemistry in gastric cancer: comparison of combined positive score and Tumor Area Positivity across 28-8, 22C3, and SP263 assaysTumor area positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoringConcordance between PD-L1 assays 28-8 and SP263 and their respective scoring algorithms in procured upper gastrointestinal adenocarcinoma samplesHigh interobserver variability among pathologists using combined positive score to evaluate PD-L1 expression in gastric, gastroesophageal junction, and esophageal adenocarcinomaConcordance between the PD-L1 Tumor Area Positivity score and Combined Positive Score for gastric or esophageal cancers treated with tislelizumab</div>
                            <small style="color: var(--text-muted)">12705419.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...date, regardless of events or dropout. Statistical analyses were pe...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...ere considered nonresponders. Secondary endpoints were OS, PFS, DCR and DOR ov...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsisThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Sepsis and septic shockTime to treatment and mortality during mandated emergency care for sepsisED door-to-antibiotic time and long-term mortality in sepsisImproving sepsis treatment by embracing diagnostic uncertaintyAssociation of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the USSurvival of critically ill patients hospitalized in and out of intensive careImpact of a deep learning sepsis prediction model on quality of care and survivalPredicting patient decompensation from continuous physiologic monitoring in the emergency departmentRobust classification of bacterial and viral infections via integrated host gene expression diagnosticsA comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene setA community approach to mortality prediction in sepsis via gene expression analysisA novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational studyA 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patientsA 29-mRNA host response whole-blood signature improves prediction of 28-day mortality and 7-day intensive care unit care in adults presenting to the emergency department with suspected acute infection and/or sepsisA standardized protocol using clinical adjudication to define true infection status in patients presenting to the emergency department with suspected infections and/or sepsisA quantitative study of decision thresholds for initiation of antibiotics in suspected sepsisEarly administration of antibiotics for suspected sepsis.Antimicrobial stewardship in the emergency departmentAssociation of adverse events with antibiotic use in hospitalized patientsTarget product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: an expert consensusDiagnostic accuracy of a bacterial and viral biomarker point-of-care test in the outpatient settingMeMed BV testing in emergency department patients presenting with febrile illness concerning for respiratory tract infectionUsing a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency departmentDetection of viral infection and bacterial coinfection and superinfection in coronavirus disease 2019 patients presenting to the emergency department using the 29-mRNA host response classifier IMX-BVN-3: a multicenter studyThe role for policy in AI-assisted medical diagnosisImpact of the Centers for Medicare and Medicaid Services sepsis core measure on antibiotic usePrognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency departmentMitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention studyA host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation studyHost test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy studyA rapid host–protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy studyDevelopment of machine learning classifiers for blood-based diagnosis and prognosis of suspected acute infections and sepsisA generalizable 29-mRNA neural-network classifier for acute bacterial and viral infectionsA transcriptomic severity metric that predicts clinical outcomes in critically ill surgical sepsis patientsEvaluation of a multivalent transcriptomic metric for diagnosing surgical sepsis and estimating mortality among critically ill patientsDiagnostic host gene expression analysis by quantitative reverse transcription loop-mediated isothermal amplification to discriminate between bacterial and viral infections">Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsisThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Sepsis and septic shockTime to treatment and mortality during mandated emergency care for sepsisED door-to-antibiotic time and long-term mortality in sepsisImproving sepsis treatment by embracing diagnostic uncertaintyAssociation of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the USSurvival of critically ill patients hospitalized in and out of intensive careImpact of a deep learning sepsis prediction model on quality of care and survivalPredicting patient decompensation from continuous physiologic monitoring in the emergency departmentRobust classification of bacterial and viral infections via integrated host gene expression diagnosticsA comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene setA community approach to mortality prediction in sepsis via gene expression analysisA novel 29-messenger RNA host-response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational studyA 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patientsA 29-mRNA host response whole-blood signature improves prediction of 28-day mortality and 7-day intensive care unit care in adults presenting to the emergency department with suspected acute infection and/or sepsisA standardized protocol using clinical adjudication to define true infection status in patients presenting to the emergency department with suspected infections and/or sepsisA quantitative study of decision thresholds for initiation of antibiotics in suspected sepsisEarly administration of antibiotics for suspected sepsis.Antimicrobial stewardship in the emergency departmentAssociation of adverse events with antibiotic use in hospitalized patientsTarget product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: an expert consensusDiagnostic accuracy of a bacterial and viral biomarker point-of-care test in the outpatient settingMeMed BV testing in emergency department patients presenting with febrile illness concerning for respiratory tract infectionUsing a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency departmentDetection of viral infection and bacterial coinfection and superinfection in coronavirus disease 2019 patients presenting to the emergency department using the 29-mRNA host response classifier IMX-BVN-3: a multicenter studyThe role for policy in AI-assisted medical diagnosisImpact of the Centers for Medicare and Medicaid Services sepsis core measure on antibiotic usePrognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency departmentMitigating structural racism to reduce inequities in sepsis outcomes: a mixed methods, longitudinal intervention studyA host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation studyHost test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy studyA rapid host–protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy studyDevelopment of machine learning classifiers for blood-based diagnosis and prognosis of suspected acute infections and sepsisA generalizable 29-mRNA neural-network classifier for acute bacterial and viral infectionsA transcriptomic severity metric that predicts clinical outcomes in critically ill surgical sepsis patientsEvaluation of a multivalent transcriptomic metric for diagnosing surgical sepsis and estimating mortality among critically ill patientsDiagnostic host gene expression analysis by quantitative reverse transcription loop-mediated isothermal amplification to discriminate between bacterial and viral infections</div>
                            <small style="color: var(--text-muted)">12705421.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...ity and predictive values (post-test probabilities) dependent on t...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...infections are significantly (P\u2009<\u20090.05) higher than the overall bact...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trialGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPerioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialHistopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trialPerioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancerTrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerPembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trialEfficacy of ipilimumab vs FOLFOX in combination with nivolumab and trastuzumab in patients with previously untreated ERBB2-positive esophagogastric adenocarcinoma: the AIO INTEGA randomized clinical trial.Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: interim results from the randomized, multicenter, phase II/III DANTE/IKF-s633 trialPerioperative durvalumab in gastric and gastroesophageal junction cancerNeoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 studyPhase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: the role of M2 macrophage landscape in predicting responseTrastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study GroupPerioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: final results of the PETRARCA multicenter randomized phase II trial of the AIOEORTC-1203 GITC “INNOVATION”: integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy of HER-2 positive stomach cancer: overall survival resultsImmune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophagesTrastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretionFirst-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialInflammatory stress determines the need for chemotherapy in patients with HER2-positive esophagogastric adenocarcinoma receiving targeted therapy and immunotherapyPredictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: a systematic review and meta-analysisPembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trialOutcomes and predictive markers of trastuzumab-containing 1st-line chemotherapy in patients with HER2-positive advanced gastric cancerTrastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trialNonoperative management of mismatch repair–deficient tumors.Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studyPD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer.Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapyResults of the observational prospective RealFLOT studyPhase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinomaOptimization of detection of residual disease after neoadjuvant therapy in patients with esophageal cancerAccuracy of 18F-FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancerTrial: surgery as needed versus surgery on principle in patients with postneoadjuvant clinical complete tumor response of esophageal cancerNeoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialIncidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabSingle-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisTFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialFLOT versus FLOT/trastuzumab/pertuzumab perioperative therapy of human epidermal growth factor receptor 2-positive resectable esophagogastric adenocarcinoma: a randomized phase II trial of the AIO EGA study groupPhase II study (NO LIMIT, WJOG13320G) of first-line nivolumab plus low-dose ipilimumab for microsatellite instability-high advanced gastric or esophagogastric junction cancer.">Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trialGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPerioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trialHistopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trialPerioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancerTrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerPembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trialEfficacy of ipilimumab vs FOLFOX in combination with nivolumab and trastuzumab in patients with previously untreated ERBB2-positive esophagogastric adenocarcinoma: the AIO INTEGA randomized clinical trial.Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: interim results from the randomized, multicenter, phase II/III DANTE/IKF-s633 trialPerioperative durvalumab in gastric and gastroesophageal junction cancerNeoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 studyPhase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: the role of M2 macrophage landscape in predicting responseTrastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study GroupPerioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: final results of the PETRARCA multicenter randomized phase II trial of the AIOEORTC-1203 GITC “INNOVATION”: integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy of HER-2 positive stomach cancer: overall survival resultsImmune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophagesTrastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretionFirst-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialInflammatory stress determines the need for chemotherapy in patients with HER2-positive esophagogastric adenocarcinoma receiving targeted therapy and immunotherapyPredictive value of PD-L1 expression in response to immune checkpoint inhibitors for esophageal cancer treatment: a systematic review and meta-analysisPembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trialOutcomes and predictive markers of trastuzumab-containing 1st-line chemotherapy in patients with HER2-positive advanced gastric cancerTrastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trialNonoperative management of mismatch repair–deficient tumors.Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 studyPD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer.Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapyResults of the observational prospective RealFLOT studyPhase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinomaOptimization of detection of residual disease after neoadjuvant therapy in patients with esophageal cancerAccuracy of 18F-FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancerTrial: surgery as needed versus surgery on principle in patients with postneoadjuvant clinical complete tumor response of esophageal cancerNeoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialIncidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumabSingle-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisTFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialFLOT versus FLOT/trastuzumab/pertuzumab perioperative therapy of human epidermal growth factor receptor 2-positive resectable esophagogastric adenocarcinoma: a randomized phase II trial of the AIO EGA study groupPhase II study (NO LIMIT, WJOG13320G) of first-line nivolumab plus low-dose ipilimumab for microsatellite instability-high advanced gastric or esophagogastric junction cancer.</div>
                            <small style="color: var(--text-muted)">12705456.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...as censored measurements, and missing data for the primary endpoint were...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...lment was set at 30 patients. Secondary endpoints including overall response,...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="RETRACTION: Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)RETRACTED: Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)">RETRACTION: Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)RETRACTED: Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial)</div>
                            <small style="color: var(--text-muted)">12712797.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A single-arm pilot study of a brief cognitive-behavioral therapy for insomnia intervention among Japanese occupational therapy and physical therapy university students with sleep disturbancesA randomized controlled trial of cognitive behavioral therapy for insomnia: an effective treatment for comorbid insomnia and depressionDoes cognitive behaviour therapy for insomnia reduce repetitive negative thinking and sleep-related worry beliefs? A systematic review and meta-analysisSleep in a large, multi-university sample of college students: sleep problem prevalence, sex differences, and mental health correlatesThe two-process model of sleep regulation: a reappraisalSleep quality and perceived stress among health science students during online education-a single institution studySleep health: can we define it? Does it matter?Efficacy of brief behavioral treatment for chronic insomnia in older adultsThe consensus sleep diary: standardizing prospective sleep self-monitoringIdentifying critical beliefs about sleep in primary insomniaInsufficient sleep syndrome: is it time to classify it as a major noncommunicable disease?Longitudinal relationships among problematic mobile phone use, bedtime procrastination, sleep quality and depressive symptoms in chinese college students: a cross-lagged panel analysisQuality of sleep and depression in college students: a systematic reviewPsychometric assessment of subjective sleep quality using the japanese version of the pittsburgh sleep quality index (PSQL-J) in psychiatric disordered and control subjectsRestoring effective sleep tranquility (rest): a feasibility and pilot studyFollow-up analyses from a wait-list controlled trial of occupational therapist–delivered cognitive–behavioral therapy for insomnia among veterans with chronic insomniaMeasuring subjective sleep quality: a reviewSleep and occupational performance are inseparable: why occupational therapy practice and research should consider sleep and circadian rhythmValidation of the Japanese version of the sleep hygiene practice scaleThe efficacy of a pennebaker-like writing intervention for poor sleepersValidity of the Japanese version of the morningness-eveningness questionnaireA systematic review of studies on the prevalence of insomnia in university studentsThe Relationship between a night usage of mobile phone and sleep habit and the circadian typology of Japanese students aged 18 - 30 yrsDevelopment of the Japanese version of the engagement in meaningful activities surveyImpact of sleep problems on daytime function in school life: a cross-sectional study involving Japanese University studentsGuided online or face-to-face cognitive behavioral treatment for insomnia: a randomized wait-list controlled trialPrevalence and correlates of insufficient sleep syndrome in Japanese young adults: a web-based cross-sectional studyWe know CBT-I works, now what?Development of the Japanese version of the insomnia severity index (ISI-J)Development of the Japanese version of dysfunctional beliefs and attitudes about sleep scale (DBAS-J)Patient Health Questionnaire (PHQ-9, PHQ-15) nihongoban oyobi Generalized Anxiety Disorder−7 nihongoban-up to date-[An up-to-date letter in the Japanese version of PHQ-9, PHQ-15, GAD-7]Validation and utility of a Japanese version of the GAD-7The relationships between life satisfaction and sleep quality, sleep duration and variability of sleep in university studentsManagement of chronic insomnia disorder in adults: a clinical practice guideline from the American College of PhysiciansAtarasii yokuutusei jiko hyouka syakudo ni tuite [A new self-report depression scale]Effects of interventions on insomnia symptoms in university students using a systematic review and meta–analysisDevelopment of a Japanese version of the epworth sleepiness scale (JESS) based on item response theoryEffects of brief cognitive behavioral therapy for insomnia on improving depression among community-dwelling older adults: a randomized controlled comparative studyEpidemiology of insomnia in college students: relationship with mental health, quality of life, and substance use difficultiesA pilot randomized controlled trial of the effects of cognitive-behavioral therapy for insomnia on sleep and daytime functioning in college studentsSleep as an occupational needA multiple health behavior change, self-monitoring mobile app for adolescents: development and usability study of the health4life appAn E-mail delivered CBT for sleep-health program for college students: effects on sleep quality and depression symptomsClinical management of insomnia with brief behavioral treatment (BBTI)How does E-mail-delivered cognitive behavioral therapy work for Young adults (18–28 years) with insomnia? Mediators of changes in insomnia, depression, anxiety, and stressInsomnia, sleep duration and academic performance: a national survey of Norwegian college and university students">A single-arm pilot study of a brief cognitive-behavioral therapy for insomnia intervention among Japanese occupational therapy and physical therapy university students with sleep disturbancesA randomized controlled trial of cognitive behavioral therapy for insomnia: an effective treatment for comorbid insomnia and depressionDoes cognitive behaviour therapy for insomnia reduce repetitive negative thinking and sleep-related worry beliefs? A systematic review and meta-analysisSleep in a large, multi-university sample of college students: sleep problem prevalence, sex differences, and mental health correlatesThe two-process model of sleep regulation: a reappraisalSleep quality and perceived stress among health science students during online education-a single institution studySleep health: can we define it? Does it matter?Efficacy of brief behavioral treatment for chronic insomnia in older adultsThe consensus sleep diary: standardizing prospective sleep self-monitoringIdentifying critical beliefs about sleep in primary insomniaInsufficient sleep syndrome: is it time to classify it as a major noncommunicable disease?Longitudinal relationships among problematic mobile phone use, bedtime procrastination, sleep quality and depressive symptoms in chinese college students: a cross-lagged panel analysisQuality of sleep and depression in college students: a systematic reviewPsychometric assessment of subjective sleep quality using the japanese version of the pittsburgh sleep quality index (PSQL-J) in psychiatric disordered and control subjectsRestoring effective sleep tranquility (rest): a feasibility and pilot studyFollow-up analyses from a wait-list controlled trial of occupational therapist–delivered cognitive–behavioral therapy for insomnia among veterans with chronic insomniaMeasuring subjective sleep quality: a reviewSleep and occupational performance are inseparable: why occupational therapy practice and research should consider sleep and circadian rhythmValidation of the Japanese version of the sleep hygiene practice scaleThe efficacy of a pennebaker-like writing intervention for poor sleepersValidity of the Japanese version of the morningness-eveningness questionnaireA systematic review of studies on the prevalence of insomnia in university studentsThe Relationship between a night usage of mobile phone and sleep habit and the circadian typology of Japanese students aged 18 - 30 yrsDevelopment of the Japanese version of the engagement in meaningful activities surveyImpact of sleep problems on daytime function in school life: a cross-sectional study involving Japanese University studentsGuided online or face-to-face cognitive behavioral treatment for insomnia: a randomized wait-list controlled trialPrevalence and correlates of insufficient sleep syndrome in Japanese young adults: a web-based cross-sectional studyWe know CBT-I works, now what?Development of the Japanese version of the insomnia severity index (ISI-J)Development of the Japanese version of dysfunctional beliefs and attitudes about sleep scale (DBAS-J)Patient Health Questionnaire (PHQ-9, PHQ-15) nihongoban oyobi Generalized Anxiety Disorder−7 nihongoban-up to date-[An up-to-date letter in the Japanese version of PHQ-9, PHQ-15, GAD-7]Validation and utility of a Japanese version of the GAD-7The relationships between life satisfaction and sleep quality, sleep duration and variability of sleep in university studentsManagement of chronic insomnia disorder in adults: a clinical practice guideline from the American College of PhysiciansAtarasii yokuutusei jiko hyouka syakudo ni tuite [A new self-report depression scale]Effects of interventions on insomnia symptoms in university students using a systematic review and meta–analysisDevelopment of a Japanese version of the epworth sleepiness scale (JESS) based on item response theoryEffects of brief cognitive behavioral therapy for insomnia on improving depression among community-dwelling older adults: a randomized controlled comparative studyEpidemiology of insomnia in college students: relationship with mental health, quality of life, and substance use difficultiesA pilot randomized controlled trial of the effects of cognitive-behavioral therapy for insomnia on sleep and daytime functioning in college studentsSleep as an occupational needA multiple health behavior change, self-monitoring mobile app for adolescents: development and usability study of the health4life appAn E-mail delivered CBT for sleep-health program for college students: effects on sleep quality and depression symptomsClinical management of insomnia with brief behavioral treatment (BBTI)How does E-mail-delivered cognitive behavioral therapy work for Young adults (18–28 years) with insomnia? Mediators of changes in insomnia, depression, anxiety, and stressInsomnia, sleep duration and academic performance: a national survey of Norwegian college and university students</div>
                            <small style="color: var(--text-muted)">12713863.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...xon rank sum test, ‡dependent t-test. CAPTION: Change in outcomes...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Effect of high-risk sleep apnea on treatment-response to a tailored digital cognitive behavioral therapy for insomnia program: a quasi-experimental trialRandomized controlled trial of an integrated approach to treating insomnia and improving use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apneaThe European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatmentValidation of the insomnia severity index as an outcome measure for insomnia researchThe subjective-objective mismatch in sleep perception among those with insomnia and sleep apneaQuality of life among untreated sleep apnea patients compared with the general population and changes after treatment with positive airway pressureNo effect of a self-help book for insomnia in patients with obstructive sleep apnea and comorbid chronic insomnia–a randomized controlled trialStimulus control for the treatment of insomniaA simplified model of screening questionnaire and home monitoring for obstructive sleep apnea in primary careEffectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trialSTOP-Bang questionnaire: a practical approach to screen for obstructive sleep apneaStepped care management of insomnia co-occurring with sleep apnea: the AIR study protocolClinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults: adult obstructive sleep apnea task force of the American Academy of Sleep MedicineEffect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trialA randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web applicationThe Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomniaO048 Help seeking behaviours of Australian adults with insomnia in a community sampleA new method for measuring daytime sleepiness: The Epworth Sleepiness ScalePrevalence of insomnia symptoms in patients with sleep-disordered breathingThe Patient Health Questionnaire-2: validity of a two-item depression screenerSleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively-impaired vigilance: Implications for the clinical management of insomnia disorderCo-morbid OSA and insomnia increases depression prevalence and severity in menThe association of co-morbid insomnia and obstructive sleep apnea with prevalent cardiovascular disease and incident cardiovascular eventsCo-morbid insomnia and obstructive sleep apnea is associated with all-cause mortalityAll-cause mortality in people with co-occurring insomnia symptoms and sleep apnea: analysis of the Wisconsin Sleep CohortOccult sleep apnea in a recruited sample of older adults with insomniaComorbid insomnia and obstructive sleep apnea: challenges for clinical practice and researchTime trends in the family physician management of insomnia: the Australian experience (2000–2015)Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacyDysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16)Efficacy of an internet-delivered intervention for improving insomnia severity and functioning in veterans: randomized controlled trialA randomized controlled trial of CBT-I and PAP for obstructive sleep apnea and comorbid insomnia: main outcomes from the MATRICS studyManagement of obstructive sleep apnea and comorbid insomnia: a mixed-methods evaluationSleep apnea and insomnia: emerging evidence for effective clinical managementGuideline-concordant use of cognitive behavioral therapy for insomnia in the Veterans Health AdministrationManagement of chronic insomnia disorder in adults: a clinical practice guideline from the American College of PhysiciansAustralasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adultsEffect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trialThe joint contribution of insomnia and obstructive sleep apnea on sickness absenceEfficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trialsTreatment of chronic insomnia by restriction of time in bedA brief measure for assessing generalized anxiety disorder: the GAD-7The effect of cognitive behavioural therapy for insomnia in people with co-morbid insomnia and sleep apnea: a systematic review and meta-analysisCo-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trialsCognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with co-morbid insomnia: A randomized clinical trialDoes co-morbid obstructive sleep apnea impair the effectiveness of cognitive and behavioral therapy for insomnia?Cognitive behavioural therapy for insomnia reduces sleep apnea severity: a randomised controlled trialBi-directional relationships between co-morbid insomnia and sleep apnea (COMISA)Association of co-morbid insomnia and sleep apnea symptoms with all cause mortality: analysis of the NHANES 2005-2008 dataThe effect of cognitive and behavioral therapy for insomnia on week-to-week changes in sleepiness and sleep parameters in insomnia patients with co-morbid moderate and severe sleep apnea: a randomized controlled trialCo-morbid insomnia and sleep apnea (COMISA): recent research and future directionsDigital CBT-i versus digital sleep education control in an Australian community-based cohort: a randomised controlled trailDeveloping a successful treatment for co-morbid insomnia and sleep apneaDevelopment and perceived utility and impact of an internet intervention for insomniaNeurocognitive functioning in COMISA patients is better after PAP therapy, but worse after CBT-I: exploratory analysis of cognitive outcomes from the MATRICS studyEffects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apneaCognitive behavioral therapy for insomnia: a meta-analysis of long-term effects in controlled studiesDoes online insomnia treatment reduce depressive symptoms? A randomized controlled trial in individuals with both insomnia and depressive symptomsEffects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trialPredictors of insomnia severity index profiles in US veterans with obstructive sleep apneaAdherence to continuous positive airway pressure therapy: the challenge to effective treatmentInternet-based cognitive behavioral therapy for insomnia (ICBT-i) improves comorbid anxiety and depression—a meta-analysis of randomized controlled trials">Effect of high-risk sleep apnea on treatment-response to a tailored digital cognitive behavioral therapy for insomnia program: a quasi-experimental trialRandomized controlled trial of an integrated approach to treating insomnia and improving use of positive airway pressure therapy in veterans with comorbid insomnia disorder and obstructive sleep apneaThe European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatmentValidation of the insomnia severity index as an outcome measure for insomnia researchThe subjective-objective mismatch in sleep perception among those with insomnia and sleep apneaQuality of life among untreated sleep apnea patients compared with the general population and changes after treatment with positive airway pressureNo effect of a self-help book for insomnia in patients with obstructive sleep apnea and comorbid chronic insomnia–a randomized controlled trialStimulus control for the treatment of insomniaA simplified model of screening questionnaire and home monitoring for obstructive sleep apnea in primary careEffectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trialSTOP-Bang questionnaire: a practical approach to screen for obstructive sleep apneaStepped care management of insomnia co-occurring with sleep apnea: the AIR study protocolClinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults: adult obstructive sleep apnea task force of the American Academy of Sleep MedicineEffect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trialA randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web applicationThe Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomniaO048 Help seeking behaviours of Australian adults with insomnia in a community sampleA new method for measuring daytime sleepiness: The Epworth Sleepiness ScalePrevalence of insomnia symptoms in patients with sleep-disordered breathingThe Patient Health Questionnaire-2: validity of a two-item depression screenerSleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively-impaired vigilance: Implications for the clinical management of insomnia disorderCo-morbid OSA and insomnia increases depression prevalence and severity in menThe association of co-morbid insomnia and obstructive sleep apnea with prevalent cardiovascular disease and incident cardiovascular eventsCo-morbid insomnia and obstructive sleep apnea is associated with all-cause mortalityAll-cause mortality in people with co-occurring insomnia symptoms and sleep apnea: analysis of the Wisconsin Sleep CohortOccult sleep apnea in a recruited sample of older adults with insomniaComorbid insomnia and obstructive sleep apnea: challenges for clinical practice and researchTime trends in the family physician management of insomnia: the Australian experience (2000–2015)Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacyDysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16)Efficacy of an internet-delivered intervention for improving insomnia severity and functioning in veterans: randomized controlled trialA randomized controlled trial of CBT-I and PAP for obstructive sleep apnea and comorbid insomnia: main outcomes from the MATRICS studyManagement of obstructive sleep apnea and comorbid insomnia: a mixed-methods evaluationSleep apnea and insomnia: emerging evidence for effective clinical managementGuideline-concordant use of cognitive behavioral therapy for insomnia in the Veterans Health AdministrationManagement of chronic insomnia disorder in adults: a clinical practice guideline from the American College of PhysiciansAustralasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adultsEffect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trialThe joint contribution of insomnia and obstructive sleep apnea on sickness absenceEfficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trialsTreatment of chronic insomnia by restriction of time in bedA brief measure for assessing generalized anxiety disorder: the GAD-7The effect of cognitive behavioural therapy for insomnia in people with co-morbid insomnia and sleep apnea: a systematic review and meta-analysisCo-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trialsCognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with co-morbid insomnia: A randomized clinical trialDoes co-morbid obstructive sleep apnea impair the effectiveness of cognitive and behavioral therapy for insomnia?Cognitive behavioural therapy for insomnia reduces sleep apnea severity: a randomised controlled trialBi-directional relationships between co-morbid insomnia and sleep apnea (COMISA)Association of co-morbid insomnia and sleep apnea symptoms with all cause mortality: analysis of the NHANES 2005-2008 dataThe effect of cognitive and behavioral therapy for insomnia on week-to-week changes in sleepiness and sleep parameters in insomnia patients with co-morbid moderate and severe sleep apnea: a randomized controlled trialCo-morbid insomnia and sleep apnea (COMISA): recent research and future directionsDigital CBT-i versus digital sleep education control in an Australian community-based cohort: a randomised controlled trailDeveloping a successful treatment for co-morbid insomnia and sleep apneaDevelopment and perceived utility and impact of an internet intervention for insomniaNeurocognitive functioning in COMISA patients is better after PAP therapy, but worse after CBT-I: exploratory analysis of cognitive outcomes from the MATRICS studyEffects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apneaCognitive behavioral therapy for insomnia: a meta-analysis of long-term effects in controlled studiesDoes online insomnia treatment reduce depressive symptoms? A randomized controlled trial in individuals with both insomnia and depressive symptomsEffects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trialPredictors of insomnia severity index profiles in US veterans with obstructive sleep apneaAdherence to continuous positive airway pressure therapy: the challenge to effective treatmentInternet-based cognitive behavioral therapy for insomnia (ICBT-i) improves comorbid anxiety and depression—a meta-analysis of randomized controlled trials</div>
                            <small style="color: var(--text-muted)">12713919.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Emotion dysregulation in insomnia disorder: the possible role of psychiatric comorbidityEmotion-regulation strategies across psychopathology: a meta-analytic reviewSleep and emotions: a focus on insomniaValidation of the insomnia severity index as an outcome measure for insomnia researchImpact of comorbid anxiety and depressive disorders on treatment response to cognitive behavior therapy for insomniaRecharge: a preliminary evaluation of an emotion regulation enhanced CBT-i intervention for insomnia in early adolescenceInsomnia and emotion regulation. Recent findings and suggestions for treatmentDerivation of research diagnostic criteria for insomnia: report of an american academy of sleep medicine work groupSleep disturbance and emotion dysregulation as transdiagnostic processes in a comorbid sampleThe association between emotional dysregulation and REM sleep features in insomnia disorderTreating insomnia in patients with comorbid psychiatric disorders: a focused reviewMultidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scaleTransdiagnostic emotion regulation processes in bipolar disorder and insomniaA cognitive model of insomniaSleep and circadian functioning: Critical mechanisms in the mood disorders?Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trialAn open trial of cognitive therapy for chronic insomniaPsychometric properties of an insomnia-specific measure of worry: The anxiety and preoccupation about sleep questionnaireEmotion regulation as a moderator between anxiety symptoms and insomnia symptom severityThe PHQ-9: validity of a brief depression severity measureThe measurement of observer agreement for categorical dataQuantitative criteria for insomniaValidation and standardization of the generalized anxiety disorder screener (GAD-7) in the general populationThe emotional component of insomnia disorder: a focus on emotion regulation and affect dynamics in relation to sleep quality and insomniaThe psychometric properties of the generalized anxiety disorder-7 scale in Hispanic Americans with English or Spanish language preferenceScale designed to be sensitive to changeA new depression scale designed to be sensitive to changeThe insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment responseDysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16)The structure of common emotion regulation strategies: a meta-analytic examinationWhy might poor sleep quality lead to depression? A role for emotion regulationA new scale for measuring insomnia: The Bergen Insomnia ScaleInvestigating safety behaviours in insomnia: the development of the sleep-related behaviours questionnaire (SRBQ)Insomnia disorder: State of the science and challenges for the futureMonitoring for sleep-related threat: a pilot study of the sleep associated monitoring index (SAMI)The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10A brief measure for assessing generalized anxiety disorderInitial validation of the SLEEP-50 questionnaireComparing internet-delivered cognitive therapy and behavior therapy with telephone support for insomnia disorder: a randomized controlled trialCognitive factors and processes in models of insomnia: A systematic reviewCorrecting distorted perception of sleep in insomnia: A novel behavioural experiment?Sleep loss and affective functioning: more than just moodEmotional dysregulation, anxiety symptoms and insomnia in individuals with alcohol use disorder">Emotion dysregulation in insomnia disorder: the possible role of psychiatric comorbidityEmotion-regulation strategies across psychopathology: a meta-analytic reviewSleep and emotions: a focus on insomniaValidation of the insomnia severity index as an outcome measure for insomnia researchImpact of comorbid anxiety and depressive disorders on treatment response to cognitive behavior therapy for insomniaRecharge: a preliminary evaluation of an emotion regulation enhanced CBT-i intervention for insomnia in early adolescenceInsomnia and emotion regulation. Recent findings and suggestions for treatmentDerivation of research diagnostic criteria for insomnia: report of an american academy of sleep medicine work groupSleep disturbance and emotion dysregulation as transdiagnostic processes in a comorbid sampleThe association between emotional dysregulation and REM sleep features in insomnia disorderTreating insomnia in patients with comorbid psychiatric disorders: a focused reviewMultidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scaleTransdiagnostic emotion regulation processes in bipolar disorder and insomniaA cognitive model of insomniaSleep and circadian functioning: Critical mechanisms in the mood disorders?Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trialAn open trial of cognitive therapy for chronic insomniaPsychometric properties of an insomnia-specific measure of worry: The anxiety and preoccupation about sleep questionnaireEmotion regulation as a moderator between anxiety symptoms and insomnia symptom severityThe PHQ-9: validity of a brief depression severity measureThe measurement of observer agreement for categorical dataQuantitative criteria for insomniaValidation and standardization of the generalized anxiety disorder screener (GAD-7) in the general populationThe emotional component of insomnia disorder: a focus on emotion regulation and affect dynamics in relation to sleep quality and insomniaThe psychometric properties of the generalized anxiety disorder-7 scale in Hispanic Americans with English or Spanish language preferenceScale designed to be sensitive to changeA new depression scale designed to be sensitive to changeThe insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment responseDysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16)The structure of common emotion regulation strategies: a meta-analytic examinationWhy might poor sleep quality lead to depression? A role for emotion regulationA new scale for measuring insomnia: The Bergen Insomnia ScaleInvestigating safety behaviours in insomnia: the development of the sleep-related behaviours questionnaire (SRBQ)Insomnia disorder: State of the science and challenges for the futureMonitoring for sleep-related threat: a pilot study of the sleep associated monitoring index (SAMI)The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10A brief measure for assessing generalized anxiety disorderInitial validation of the SLEEP-50 questionnaireComparing internet-delivered cognitive therapy and behavior therapy with telephone support for insomnia disorder: a randomized controlled trialCognitive factors and processes in models of insomnia: A systematic reviewCorrecting distorted perception of sleep in insomnia: A novel behavioural experiment?Sleep loss and affective functioning: more than just moodEmotional dysregulation, anxiety symptoms and insomnia in individuals with alcohol use disorder</div>
                            <small style="color: var(--text-muted)">12713947.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...To control for the number of t-tests performed as post-hoc test,...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Induction versus Adjuvant Chemotherapy Combined with Concurrent Chemoradiation: What Is Beneficial in Locally Advanced Nasopharyngeal Carcinoma—A 5-Year Comparative Study at a Tertiary Care Center in North IndiaNasopharyngeal carcinomaNasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profilingRe-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imagingNasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upA multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicitySignificant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinomaThe current role of adjuvant chemotherapy in locally advanced nasopharyngeal carcinomaNasopharyngeal carcinomaInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialConcurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trialEffect of induction chemotherapy in nasopharyngeal carcinoma: an updated meta-analysisCisplatin and fluorouracil alone or with docetaxel in head and neck cancerInduction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trialsRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaGemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinomaInduction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialInduction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: a systematic review and meta-analysisConcurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialNasopharyngeal carcinomaConcurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trialPreliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaInduction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trialsThe efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trialsWhat is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysisThe evaluation of adding induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a meta-analysisNPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinomaChemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO GuidelineHow does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialThe changing therapeutic role of chemo-radiotherapy for loco-regionally advanced nasopharyngeal carcinoma from two/three-dimensional radiotherapy to intensity-modulated radiotherapy: a network meta-analysis">Induction versus Adjuvant Chemotherapy Combined with Concurrent Chemoradiation: What Is Beneficial in Locally Advanced Nasopharyngeal Carcinoma—A 5-Year Comparative Study at a Tertiary Care Center in North IndiaNasopharyngeal carcinomaNasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profilingRe-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imagingNasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upA multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicitySignificant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinomaThe current role of adjuvant chemotherapy in locally advanced nasopharyngeal carcinomaNasopharyngeal carcinomaInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialConcurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trialEffect of induction chemotherapy in nasopharyngeal carcinoma: an updated meta-analysisCisplatin and fluorouracil alone or with docetaxel in head and neck cancerInduction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trialsRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaGemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinomaInduction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialInduction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: a systematic review and meta-analysisConcurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialNasopharyngeal carcinomaConcurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trialPreliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaInduction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trialsThe efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trialsWhat is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysisThe evaluation of adding induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a meta-analysisNPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinomaChemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO GuidelineHow does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialThe changing therapeutic role of chemo-radiotherapy for loco-regionally advanced nasopharyngeal carcinoma from two/three-dimensional radiotherapy to intensity-modulated radiotherapy: a network meta-analysis</div>
                            <small style="color: var(--text-muted)">12714473.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyInternational trends in the incidence of testicular cancer: lessons from 35 years and 41 countriesLong-term and late effects of germ cell testicular cancer treatment and implications for follow-upLong-term relative survival after diagnosis of testicular germ cell tumorThe present and future of serum diagnostic tests for testicular germ cell tumoursSWENOTECA X management program of testicular cancerSurgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathyNerve sparing retroperitoneal lymph node dissection in clinical stage IIA/B seminoma: the COTRIMS trialPhase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA/B (PRIMETEST)Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerComplications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study GroupUnilateral or bilateral retroperitoneal lymph node dissection in nonseminoma patients with postchemotherapy residual tumour? Results from RETROP, a population-based mapping study by the Swedish Norwegian Testicular Cancer GroupIdentification of microRNAs from the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumorsSerum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell originSerum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric studyCirculating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancerSerum levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumoursSerum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumorDeveloping a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrumThe role of micro-RNAs in management of germ cell tumors: future directionsSerum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective studyEvaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissectionSerum microRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissectionEvaluation of a miRNA-371a-3p assay for predicting final histopathology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy for stage IIA/B seminoma or nonseminomaRefining the serum miR-371a-3p test for viable germ cell tumor detectionSerum level of microRNA-375-3p is not a reliable biomarker of teratomaIntegrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumorsThe combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimensSerum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissectionMicroRNAs in differentiation of embryoid bodies and the teratoma subtype of testicular cancerRadiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection">miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyInternational trends in the incidence of testicular cancer: lessons from 35 years and 41 countriesLong-term and late effects of germ cell testicular cancer treatment and implications for follow-upLong-term relative survival after diagnosis of testicular germ cell tumorThe present and future of serum diagnostic tests for testicular germ cell tumoursSWENOTECA X management program of testicular cancerSurgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathyNerve sparing retroperitoneal lymph node dissection in clinical stage IIA/B seminoma: the COTRIMS trialPhase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA/B (PRIMETEST)Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerComplications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study GroupUnilateral or bilateral retroperitoneal lymph node dissection in nonseminoma patients with postchemotherapy residual tumour? Results from RETROP, a population-based mapping study by the Swedish Norwegian Testicular Cancer GroupIdentification of microRNAs from the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumorsSerum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell originSerum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric studyCirculating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancerSerum levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumoursSerum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumorDeveloping a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrumThe role of micro-RNAs in management of germ cell tumors: future directionsSerum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective studyEvaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissectionSerum microRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissectionEvaluation of a miRNA-371a-3p assay for predicting final histopathology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy for stage IIA/B seminoma or nonseminomaRefining the serum miR-371a-3p test for viable germ cell tumor detectionSerum level of microRNA-375-3p is not a reliable biomarker of teratomaIntegrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumorsThe combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimensSerum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissectionMicroRNAs in differentiation of embryoid bodies and the teratoma subtype of testicular cancerRadiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection</div>
                            <small style="color: var(--text-muted)">12721614.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...n patient treatment were kept blinded to the results. Clinical para...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...) FOOTER: Abbreviations: AFP, alpha fetoprotein; β-hCG, beta huma...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Preimplantation genetic testing for aneuploidy versus no genetic testing in couples undergoing intracytoplasmic sperm injection for severe male infertility: multicentre, open label, randomised controlled trialTo test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A)Idiopathic recurrent miscarriage is caused mostly by aneuploid embryosLive birth with or without preimplantation genetic testing for aneuploidyMale infertilitySevere male factor in  fertilization: definition, prevalence, and treatment. An updateIntracytoplasmic sperm injection for male infertility and consequences for offspringInternational committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2008, 2009 and 2010Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryosFrequency, morbidity and equity - the case for increased research on male fertilityIntracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trialPreimplantation genetic testing for aneuploidy in severe male factor infertilityComparison of preimplantation genetic testing for aneuploidy versus intracytoplasmic sperm injection in severe male infertilityWomen’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policyPreimplantation genetic testing for aneuploidy in severe male factor infertility: protocol for a multicenter randomised controlled trialAntisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical PracticesBlastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programsFrozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trialThe use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is betterDeveloping a core outcome set for future infertility research: an international consensus development studyMultiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in JapanNeither relevant nor randomized: the use of “per embryo transfer” in the analysis of preimplantation genetic testing for aneuploidy trialsDiagnosis and treatment of infertility in men: AUA/ASRM guideline part IIThe diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunitiesEffect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cyclesDo sperm factors influence embryonic aneuploidy? Long live the oocyteThe use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinionFrom oocytes to a live birth: Are we improving the biological efficiency?Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsySteady morphokinetic progression is an independent predictor of live birth: a descriptive reference for euploid embryosImpact of trophectoderm biopsy for preimplantation genetic testing on obstetric and neonatal outcomes: a meta-analysisPreimplantation genetic testing and child health: a national register-based study">Preimplantation genetic testing for aneuploidy versus no genetic testing in couples undergoing intracytoplasmic sperm injection for severe male infertility: multicentre, open label, randomised controlled trialTo test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A)Idiopathic recurrent miscarriage is caused mostly by aneuploid embryosLive birth with or without preimplantation genetic testing for aneuploidyMale infertilitySevere male factor in  fertilization: definition, prevalence, and treatment. An updateIntracytoplasmic sperm injection for male infertility and consequences for offspringInternational committee for monitoring assisted reproductive technologies world report: assisted reproductive technology 2008, 2009 and 2010Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryosFrequency, morbidity and equity - the case for increased research on male fertilityIntracytoplasmic sperm injection versus conventional in-vitro fertilisation for couples with infertility with non-severe male factor: a multicentre, open-label, randomised controlled trialPreimplantation genetic testing for aneuploidy in severe male factor infertilityComparison of preimplantation genetic testing for aneuploidy versus intracytoplasmic sperm injection in severe male infertilityWomen’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policyPreimplantation genetic testing for aneuploidy in severe male factor infertility: protocol for a multicenter randomised controlled trialAntisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical PracticesBlastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programsFrozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trialThe use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is betterDeveloping a core outcome set for future infertility research: an international consensus development studyMultiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in JapanNeither relevant nor randomized: the use of “per embryo transfer” in the analysis of preimplantation genetic testing for aneuploidy trialsDiagnosis and treatment of infertility in men: AUA/ASRM guideline part IIThe diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunitiesEffect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cyclesDo sperm factors influence embryonic aneuploidy? Long live the oocyteThe use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinionFrom oocytes to a live birth: Are we improving the biological efficiency?Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsySteady morphokinetic progression is an independent predictor of live birth: a descriptive reference for euploid embryosImpact of trophectoderm biopsy for preimplantation genetic testing on obstetric and neonatal outcomes: a meta-analysisPreimplantation genetic testing and child health: a national register-based study</div>
                            <small style="color: var(--text-muted)">12723751.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Includes exploratory/post hoc analyses without clear multiplicity correction.', 'evidence': '...ndary outcomes, and performed post hoc analysis for primary outcomes...'}</li><li>{'message': 'Categorical data mentioned, but no appropriate categorical tests found.', 'evidence': '...e variables. We have reported categorical variables as frequencies and...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="ESGO Quality Indicators for Surgical Management of Cervical Cancer: An Audit of Compliance of a Tertiary Care CenterRecent global burden of cervical cancer incidence and mortality, predictors, and temporal trendsGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCancer of the cervix uteri: 2021 updateSurvival rate of cervical cancer from a study conducted in IndiaEuropean Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancerThe European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancerCervical cancer: formulation and implementation of Govt of India guidelines for screening and managementThe outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic reviewInfluence of gynecologic oncologists on the survival of patients with endometrial cancerImpact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancerRevised FIGO staging for carcinoma of the cervix uteriTreatment outcomes of early carcinoma cervix before and after sub-specializationThe importance of quality assurance in surgical oncologyMinimally invasive versus abdominal radical hysterectomy for cervical cancerRisk factors for recurrence after robot-assisted radical hysterectomy for early-stage cervical cancer: a multicenter retrospective studySUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancerSUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancerAssessment of ESGO quality indicators in cervical cancer surgery: a real-world study in a high-volume Chinese hospital">ESGO Quality Indicators for Surgical Management of Cervical Cancer: An Audit of Compliance of a Tertiary Care CenterRecent global burden of cervical cancer incidence and mortality, predictors, and temporal trendsGlobal Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCancer of the cervix uteri: 2021 updateSurvival rate of cervical cancer from a study conducted in IndiaEuropean Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancerThe European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancerCervical cancer: formulation and implementation of Govt of India guidelines for screening and managementThe outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic reviewInfluence of gynecologic oncologists on the survival of patients with endometrial cancerImpact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancerRevised FIGO staging for carcinoma of the cervix uteriTreatment outcomes of early carcinoma cervix before and after sub-specializationThe importance of quality assurance in surgical oncologyMinimally invasive versus abdominal radical hysterectomy for cervical cancerRisk factors for recurrence after robot-assisted radical hysterectomy for early-stage cervical cancer: a multicenter retrospective studySUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancerSUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancerAssessment of ESGO quality indicators in cervical cancer surgery: a real-world study in a high-volume Chinese hospital</div>
                            <small style="color: var(--text-muted)">12727015.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Intensive Oral Hygiene Interventions during Therapy of Acute Leukemia May Result in Detrimental Outcomes: A Randomized Clinical TrialTwo-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trialAcute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimenTreatment of children with acute lymphoblastic leukemia in India using a BFM protocolAcute lymphoblastic leukemia in young adults treated with intensive “pediatric” type protocolAssessment of oral health status of children with leukemia: a cross-sectional studyContribution of the oral and gastrointestinal microbiomes to bloodstream infections in leukemia patientsPreventive protocols and oral management in childhood leukemia: the pediatric specialist's roleDental considerations for leukemic pediatric patients: an updated review for general dental practitionerDental treatment considerations in the chemotherapy patientThe effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trialOral manifestations and complications in childhood acute myeloid leukemiaOral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemiaDysbiosis from a microbial and host perspective relative to oral health and diseasePrevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental careOral complications and management strategies for patients undergoing cancer therapyOral complications associated with cancer therapy. An M. D. Anderson Cancer Center experienceAssociation between periodontal pathogens and systemic disease">Intensive Oral Hygiene Interventions during Therapy of Acute Leukemia May Result in Detrimental Outcomes: A Randomized Clinical TrialTwo-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trialAcute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimenTreatment of children with acute lymphoblastic leukemia in India using a BFM protocolAcute lymphoblastic leukemia in young adults treated with intensive “pediatric” type protocolAssessment of oral health status of children with leukemia: a cross-sectional studyContribution of the oral and gastrointestinal microbiomes to bloodstream infections in leukemia patientsPreventive protocols and oral management in childhood leukemia: the pediatric specialist's roleDental considerations for leukemic pediatric patients: an updated review for general dental practitionerDental treatment considerations in the chemotherapy patientThe effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trialOral manifestations and complications in childhood acute myeloid leukemiaOral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemiaDysbiosis from a microbial and host perspective relative to oral health and diseasePrevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental careOral complications and management strategies for patients undergoing cancer therapyOral complications associated with cancer therapy. An M. D. Anderson Cancer Center experienceAssociation between periodontal pathogens and systemic disease</div>
                            <small style="color: var(--text-muted)">12727025.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...yses were carried out at a 5% significance level, and p -value less than 0.05...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Evaluation of the Association between Genetic Polymorphism of Interleukin-1 Beta (–511C/T and +3953C/T) and Cervical Cancer SusceptibilityGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesEpidemiologic classification of human papillomavirus types associated with cervical cancerDetection and quantitation of high risk human papillomavirus, HRHPV 16 and 18 in tissue of Indian women with cervical cancer: a case control studyMolecular biology of human papillomavirus, cervical carcinoma and its managementCancer facts and figuresEnvironmental co-factors in HPV carcinogenesisCervical carcinogenesis and immune response gene polymorphisms: a reviewThe IL-1 family: regulators of immunityInterleukin-1 receptor antagonist: role in biologyInterleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentInterleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinomaGenetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer riskGenetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North IndiansAllelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel diseaseA review of the use of human papilloma virus (HPV) in cervical screeningBurning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in HondurasInflammasomes and cancer: the dynamic role of the inflammasome in tumor developmentInterleukin 1β-A potential salivary biomarker for cancer progression?TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancerDegradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicityInflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanismInterleukin-1 beta-511 polymorphism and risk of cervical cancerGenetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancerNovel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean populationInterleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infectionFunctional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese populationPolymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancerInterleukin-1 polymorphisms associated with increased risk of gastric cancerInterleukin 1β and interleukin 1 receptor antagonist gene polymorphisms and cervical cancer: a meta-analysisInterleukin-1 gene cluster polymorphisms and its haplotypes may predict the risk to develop cervical cancer in TunisiaAssociation between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women">Evaluation of the Association between Genetic Polymorphism of Interleukin-1 Beta (–511C/T and +3953C/T) and Cervical Cancer SusceptibilityGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesEpidemiologic classification of human papillomavirus types associated with cervical cancerDetection and quantitation of high risk human papillomavirus, HRHPV 16 and 18 in tissue of Indian women with cervical cancer: a case control studyMolecular biology of human papillomavirus, cervical carcinoma and its managementCancer facts and figuresEnvironmental co-factors in HPV carcinogenesisCervical carcinogenesis and immune response gene polymorphisms: a reviewThe IL-1 family: regulators of immunityInterleukin-1 receptor antagonist: role in biologyInterleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentInterleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinomaGenetic polymorphism of interleukin-1A (IL-1A), IL-1B, and IL-1 receptor antagonist (IL-1RN) and prostate cancer riskGenetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North IndiansAllelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel diseaseA review of the use of human papilloma virus (HPV) in cervical screeningBurning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in HondurasInflammasomes and cancer: the dynamic role of the inflammasome in tumor developmentInterleukin 1β-A potential salivary biomarker for cancer progression?TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancerDegradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicityInflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanismInterleukin-1 beta-511 polymorphism and risk of cervical cancerGenetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancerNovel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean populationInterleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infectionFunctional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese populationPolymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancerInterleukin-1 polymorphisms associated with increased risk of gastric cancerInterleukin 1β and interleukin 1 receptor antagonist gene polymorphisms and cervical cancer: a meta-analysisInterleukin-1 gene cluster polymorphisms and its haplotypes may predict the risk to develop cervical cancer in TunisiaAssociation between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women</div>
                            <small style="color: var(--text-muted)">12727030.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Clinical Profile and Outcomes of Childhood Wilms Tumors Treated in a Tertiary Cancer Center from North IndiaThe diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: report of the UK experience in the SIOP UK WT 2001 trialIncidence of childhood renal tumours: an international population-based studyGlobal disparities in Wilms tumorLocalized Wilms' tumor in low-middle-income countries (LMIC): how can we get better?Wilms tumor treatment outcomes: perspectives from a low-income settingImproving care for children with cancer in low-and middle-income countries-a SIOP PODC initiativeWilms tumor in India: a systematic reviewCustomized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: a prospective studyPosition paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocolWilms tumor: “State-of-the-art” update, 2016Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomesWilms' tumor in low- and middle-income countries: survey of current practices, challenges, and prioritiesThe role of biopsy in the diagnosis of renal tumors of childhood: results of the UKCCSG Wilms tumor study 3Intravascular extension of Wilms tumor: characteristics of tumor thrombus and their impact on outcomesA higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: a study of 200 patientsClinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south IndiaOmission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialOutcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS groupGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPrognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children's Oncology GroupManagement and outcomes in massive bilateral Wilms' tumors">Clinical Profile and Outcomes of Childhood Wilms Tumors Treated in a Tertiary Cancer Center from North IndiaThe diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: report of the UK experience in the SIOP UK WT 2001 trialIncidence of childhood renal tumours: an international population-based studyGlobal disparities in Wilms tumorLocalized Wilms' tumor in low-middle-income countries (LMIC): how can we get better?Wilms tumor treatment outcomes: perspectives from a low-income settingImproving care for children with cancer in low-and middle-income countries-a SIOP PODC initiativeWilms tumor in India: a systematic reviewCustomized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: a prospective studyPosition paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocolWilms tumor: “State-of-the-art” update, 2016Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomesWilms' tumor in low- and middle-income countries: survey of current practices, challenges, and prioritiesThe role of biopsy in the diagnosis of renal tumors of childhood: results of the UKCCSG Wilms tumor study 3Intravascular extension of Wilms tumor: characteristics of tumor thrombus and their impact on outcomesA higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: a study of 200 patientsClinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south IndiaOmission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialOutcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS groupGlobal cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesPrognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children's Oncology GroupManagement and outcomes in massive bilateral Wilms' tumors</div>
                            <small style="color: var(--text-muted)">12727046.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Rank Aggregation Methods and Tools in Genomic Data AnalysisA law of comparative judgment.Positional rules of collective decision-making.Rank aggregation  nuclear norm minimization.Efficient, robust and effective rank aggregation for massive biological datasets.Rank aggregation methods for the web.Rank aggregation methods.Finding genetic overlaps among diseases based on ranked gene lists.Statistical tools for synthesizing lists of differentially expressed features in related experiments.A framework for list representation, enabling list stabilization through incorporation of gene exchangeabilities.Stability and aggregation of ranked gene lists.A comparative study of rank aggregation methods for partial and top ranked lists in genomic applications.Integration of ranked lists  cross entropy Monte Carlo with applications to mRNA and microRNA Studies.Robust rank aggregation for gene list integration and meta-analysis.RankProd: A bioconductor package for detecting differentially expressed genes in meta-analysis.Statistical methods in integrative genomics.Systematic comparison of ranking aggregation methods for gene lists in experimental results.Consensus gene co-expression network analysis identifies novel genes associated with severity of fibrotic lung disease.PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool.Identification of novel immune‐relevant drug target genes for Alzheimer’s disease by combining ontology inference with network analysis.An integrated computational strategy to predict personalized cancer drug combinations by reversing drug resistance signatures.Rank aggregation revisited.Measurement of values.Rank order as a psycho-physical method.A gene-coexpression network for global discovery of conserved genetic modules.Gene prioritization through genomic data fusion.Mean aggregation versus robust rank aggregation for ensemble gene selection.Robust rank aggregation and cibersort algorithm applied to the identification of key genes in head and neck squamous cell cancer.Identification of hub genes in papillary thyroid carcinoma: Robust rank aggregation and weighted gene co-expression network analysis.Robust rank aggregation and least absolute shrinkage and selection operator analysis of novel gene signatures in dilated cardiomyopathy.Bayesian aggregation of order-based rank data.Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregation.Combining results of microarray experiments: A rank aggregation approach.Weighted Markov chain based aggregation of bio-molecule orderings.Meta-analysis of ChIP-seq datasets through the rank aggregation approach.Network inference with Granger causality ensembles on single-cell transcriptomics.Genetic data classification based on improved rank aggregation.Ensemble feature selection using rank aggregation methods for population genomic data.Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.Ensemble feature selection with data-driven thresholding for Alzheimer’s disease biomarker discovery.Rank aggregation method for biological databases.Weighted rank aggregation of cluster validation measures: A Monte Carlo cross-entropy approach.A Bayesian latent variable approach to aggregation of partial and top‐ranked lists in genomic studies.Stochastic rank aggregation for the identification of functional neuromarkers.Social network analysis of biomedical research collaboration networks in a CTSA institution.Combining active learning suggestions.Minimization of annotation work: Diagnosis of mammographic masses  active learning.Integrated co-expression network analysis uncovers novel tissue-specific genes in major depressive disorder and bipolar disorder.A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer’s disease progression.Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer’s disease.High iodine promotes autoimmune thyroid disease by activating hexokinase 3 and inducing polarization of macrophages towards M1.Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.Identification of gene signatures for diagnosis and prognosis of hepatocellular carcinomas patients at early stage.Identification and validation of novel biomarkers for diagnosis and prognosis of hepatocellular carcinoma.Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.>Novel gene signatures predictive of patient recurrence-free survival and castration resistance in prostate cancer.Mathematics without numbers.A new measure of rank correlation.The proof and measurement of association between two things.Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.Comprehensive meta-analysis of microRNA expression using a robust rank aggregation approach.Approximate condorcet partitioning: Solving large-scale rank aggregation problems.A neural network based on positive and unlabeled learning to remove cell-free droplets and recover lost cells in scRNA-seq data.Integration of millions of transcriptomes using batch-aware triplet neural networks.DrivAER: Identification of driving transcriptional programs in single-cell RNA sequencing data.scGPT: Toward building a foundation model for single-cell multi-omics using generative AI.GENEVIC: GENetic data exploration and visualization via intelligent interactive console.">Rank Aggregation Methods and Tools in Genomic Data AnalysisA law of comparative judgment.Positional rules of collective decision-making.Rank aggregation  nuclear norm minimization.Efficient, robust and effective rank aggregation for massive biological datasets.Rank aggregation methods for the web.Rank aggregation methods.Finding genetic overlaps among diseases based on ranked gene lists.Statistical tools for synthesizing lists of differentially expressed features in related experiments.A framework for list representation, enabling list stabilization through incorporation of gene exchangeabilities.Stability and aggregation of ranked gene lists.A comparative study of rank aggregation methods for partial and top ranked lists in genomic applications.Integration of ranked lists  cross entropy Monte Carlo with applications to mRNA and microRNA Studies.Robust rank aggregation for gene list integration and meta-analysis.RankProd: A bioconductor package for detecting differentially expressed genes in meta-analysis.Statistical methods in integrative genomics.Systematic comparison of ranking aggregation methods for gene lists in experimental results.Consensus gene co-expression network analysis identifies novel genes associated with severity of fibrotic lung disease.PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool.Identification of novel immune‐relevant drug target genes for Alzheimer’s disease by combining ontology inference with network analysis.An integrated computational strategy to predict personalized cancer drug combinations by reversing drug resistance signatures.Rank aggregation revisited.Measurement of values.Rank order as a psycho-physical method.A gene-coexpression network for global discovery of conserved genetic modules.Gene prioritization through genomic data fusion.Mean aggregation versus robust rank aggregation for ensemble gene selection.Robust rank aggregation and cibersort algorithm applied to the identification of key genes in head and neck squamous cell cancer.Identification of hub genes in papillary thyroid carcinoma: Robust rank aggregation and weighted gene co-expression network analysis.Robust rank aggregation and least absolute shrinkage and selection operator analysis of novel gene signatures in dilated cardiomyopathy.Bayesian aggregation of order-based rank data.Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregation.Combining results of microarray experiments: A rank aggregation approach.Weighted Markov chain based aggregation of bio-molecule orderings.Meta-analysis of ChIP-seq datasets through the rank aggregation approach.Network inference with Granger causality ensembles on single-cell transcriptomics.Genetic data classification based on improved rank aggregation.Ensemble feature selection using rank aggregation methods for population genomic data.Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.Ensemble feature selection with data-driven thresholding for Alzheimer’s disease biomarker discovery.Rank aggregation method for biological databases.Weighted rank aggregation of cluster validation measures: A Monte Carlo cross-entropy approach.A Bayesian latent variable approach to aggregation of partial and top‐ranked lists in genomic studies.Stochastic rank aggregation for the identification of functional neuromarkers.Social network analysis of biomedical research collaboration networks in a CTSA institution.Combining active learning suggestions.Minimization of annotation work: Diagnosis of mammographic masses  active learning.Integrated co-expression network analysis uncovers novel tissue-specific genes in major depressive disorder and bipolar disorder.A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer’s disease progression.Development and validation of a 13-gene signature associated with immune function for the detection of Alzheimer’s disease.High iodine promotes autoimmune thyroid disease by activating hexokinase 3 and inducing polarization of macrophages towards M1.Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.Identification of gene signatures for diagnosis and prognosis of hepatocellular carcinomas patients at early stage.Identification and validation of novel biomarkers for diagnosis and prognosis of hepatocellular carcinoma.Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.>Novel gene signatures predictive of patient recurrence-free survival and castration resistance in prostate cancer.Mathematics without numbers.A new measure of rank correlation.The proof and measurement of association between two things.Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.Comprehensive meta-analysis of microRNA expression using a robust rank aggregation approach.Approximate condorcet partitioning: Solving large-scale rank aggregation problems.A neural network based on positive and unlabeled learning to remove cell-free droplets and recover lost cells in scRNA-seq data.Integration of millions of transcriptomes using batch-aware triplet neural networks.DrivAER: Identification of driving transcriptional programs in single-cell RNA sequencing data.scGPT: Toward building a foundation model for single-cell multi-omics using generative AI.GENEVIC: GENetic data exploration and visualization via intelligent interactive console.</div>
                            <small style="color: var(--text-muted)">12728592.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...atistics, generated corrected P-values (Q statistic) from a joint c...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="What about Your Friends? Friendship Networks and Mental Health in Critical ConsciousnessCritical consciousness: A developmental approach to addressing marginalization and oppressionNew terrain in youth development: The promise of a social justice approachInterweaving youth development, community development, and social change through youth organizingSociopolitical development as an antidote for oppression—Theory and actionLearning to dislike your opponents: Political socialization in the era of polarizationRacism and nationalism during and beyond the COVID-19 pandemicBurnout and belonging: How the costs and benefits of youth activism affect youth health and wellbeingCritical consciousness and wellbeing in adolescents and young adults: A systematic reviewThinking ourselves to liberation? Advancing sociopolitical action in critical consciousness“With politics, it’s easier to talk to them about it”: Peer racial socialization and sociopolitical development among black college studentsCivic development within the peer context: Associations between early adolescent social connectedness and civic engagementFactors associated with civic engagement in adolescence: The effects of neighborhood, school, family, and peer contextsDisentangling longitudinal trajectories of racial discrimination and critical action among Black and Latinx college students: What role do peers play?Service, activism, and friendships in high school: A longitudinal social network analysis of peer influence and critical beliefsThe mental health effects of student activism: Persisting despite psychological costsSociopolitical development: A history and overview of a black liberatory approach to youth developmentYouth and democracy: Participation for personal, relational, and collective well-beingSociopolitical development and social identitiesCritical consciousness: A critique and critical analysis of the literatureA multidimensional conceptualization and measure of youth civic agencyToward relational empowermentTerms of empowerment/exemplars of prevention: Toward a theory for community psychology“Friendship brought me into it, but commitment bought me into it”: Civic engagement motivations among highly engaged Asian American youthCritical consciousness of anti-Black racism: A practical model to prevent and resist racial traumaUnderstanding collective identity in virtual spaces: A study of the youth climate movementIntraminority solidarity: The role of critical consciousnessSexual minority youth, social connection and resilience: From personal struggle to collective identityCivic engagement and the transition to adulthoodNormative influences on adolescents’ self-reported pro-environmental behaviors: The role of parents and friendsInterpersonal racism and peer relationships: An integrative framework and directions for researchOn the microfoundations of the link between classroom social norms and behavioral developmentEmerging adults’ social justice engagement: Motivations, barriers, and social identityFriendship quality and social developmentA prospective study of the relative contribution of adolescent peer support quantity and quality to depressive symptomsA conceptual model of intergroup contact, social capital, and youth civic engagement for diverse democracyThe intersection of emotional and sociocognitive competencies with civic engagement in middle childhood and adolescenceCivic purpose: An integrated construct for understanding civic development in adolescenceElection-related sociopolitical stress and coping among college students in the United StatesSocial influence: Compliance and conformityToward understanding the functions of peer influence: A summary and synthesis of recent empirical researchHomophily, selection, and socialization in adolescent friendshipsEarly adolescents demonstrate peer-network homophily in political attitudes and valuesSimilarities between friends on service, activism, and awareness of inequities in an adolescent social networkWellness as fairnessFriends, relatives, sanity, and health: The costs of politicsIn it together: Exploring how belonging to a youth activist group enhances well-beingThe structure of communication networks matters: How network diversity, centrality, and context influence political ambivalence, participation, and knowledgeReal and perceived attitude agreement in social networksAdolescent mental health in relation to anti-racism critical actionPsychological toll of being awakened: Asian-origin youth’s critical reflection and mental healthCritical reflection and positive youth development among White and Black adolescents: Is understanding inequality connected to thriving?Culturally relevant strengths and positive development in high achieving youth of colorTowards a model of positive youth development specific to girls of color: Perspectives on development, resilience, and empowermentA bitter pill to swallow? Patterns of critical consciousness and socioemotional and academic well-being in early adolescenceFor better or worse? System-justifying beliefs in sixth-grade predict trajectories of self-esteem and behavior across early adolescenceThe role of empowerment in youth development: A study of sociopolitical control as mediator of ecological systems’ influence on developmental outcomesPsychological empowerment among urban youth: Measure development and relationship to psychosocial functioningAdolescent political activism and long-term happiness: A 21-year longitudinal study on the development of micro- and macrosocial worriesQueer solidarities: New activisms erupting at the intersection of structural precarity and radical misrecognitionPolitical engagement and wellbeing among college studentsEffects of social movement participation on political efficacy and well-being: A longitudinal study of civically engaged youthDocumenting sociopolitical development via Participatory Action Research (PAR) with women of color student activists in the neoliberal universitySupportive peer relationships and mental health in adolescence: An integrative reviewRelations of friendship experiences with depressive symptoms and loneliness in childhood and adolescence: A meta-analytic reviewSocial network determinants of depressionSocial network status and depression among adolescents: An examination of social network influences and depressive symptoms in a Chinese sampleGot bots? Practical recommendations to protect online survey data from bot attacksMaximum likelihood from incomplete data via the EM algorithmMICE: Multivariate Imputation by Chained Equations in RIndividual orientation toward engagement in social actionDevelopment and validation of the Black community activism orientation scaleYouth anti-racist engagement: Conceptualization, development, and validation of an anti-racism action scaleDevelopment and validation of the Critical Consciousness ScaleDevelopment and validation of the youth Sociopolitical Action Scale for Social Media (SASSM)Development of the Short Critical Consciousness Scale (ShoCCS)Critical consciousness and vocational development among Latina/o high school youth: Initial development and testing of a measureThe development and validation of the Contemporary Critical Consciousness MeasureSocial dominance orientation: A personality variable predicting social and political attitudesLinking critical consciousness and health: The utility of the critical reflection about social determinants of health scaleConstruction and initial validation of the Color-Blind Racial Attitudes Scale (CoBRAS)The Watts Connectedness Scale: A new scale for measuring a sense of connectedness to self, others, and worldThe Patient Health Questionnaire-2: Validity of a two-item depression screenerAnxiety disorders in primary care: Prevalence, impairment, comorbidity, and detectionPsychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6New Well-being measures: Short scales to assess flourishing and positive and negative feelingsBest practices for modeling egocentric social network data and health outcomesA meta-analysis of longitudinal peer influence effects in childhood and adolescenceStress, social support, and the buffering hypothesisA meta-analytic review of the association between perceived social support and depression in childhood and adolescenceUnintentional consequences: Facing the risks of being a youth activistComparing the costs and benefits of activism for girls with different sexual orientations and racial and ethnic identitiesNon-zero-sum collaboration, reciprocity, and the preference for similarity: Developing an adaptive model of close relational functioningMaking and keeping friends: The importance of being similarNetworks in the making: Friendship segregation and ethnic homophilyAdolescent intergroup connections and their developmental benefits: Exploring contributions from social network analysisMechanisms linking social ties and support to physical and mental healthThe mental health continuum: From languishing to flourishing in lifeInference for social network models from egocentrically sampled data, with application to understanding persistent racial disparities in HIV prevalence in the USIntroduction to stochastic actor-based models for network dynamics">What about Your Friends? Friendship Networks and Mental Health in Critical ConsciousnessCritical consciousness: A developmental approach to addressing marginalization and oppressionNew terrain in youth development: The promise of a social justice approachInterweaving youth development, community development, and social change through youth organizingSociopolitical development as an antidote for oppression—Theory and actionLearning to dislike your opponents: Political socialization in the era of polarizationRacism and nationalism during and beyond the COVID-19 pandemicBurnout and belonging: How the costs and benefits of youth activism affect youth health and wellbeingCritical consciousness and wellbeing in adolescents and young adults: A systematic reviewThinking ourselves to liberation? Advancing sociopolitical action in critical consciousness“With politics, it’s easier to talk to them about it”: Peer racial socialization and sociopolitical development among black college studentsCivic development within the peer context: Associations between early adolescent social connectedness and civic engagementFactors associated with civic engagement in adolescence: The effects of neighborhood, school, family, and peer contextsDisentangling longitudinal trajectories of racial discrimination and critical action among Black and Latinx college students: What role do peers play?Service, activism, and friendships in high school: A longitudinal social network analysis of peer influence and critical beliefsThe mental health effects of student activism: Persisting despite psychological costsSociopolitical development: A history and overview of a black liberatory approach to youth developmentYouth and democracy: Participation for personal, relational, and collective well-beingSociopolitical development and social identitiesCritical consciousness: A critique and critical analysis of the literatureA multidimensional conceptualization and measure of youth civic agencyToward relational empowermentTerms of empowerment/exemplars of prevention: Toward a theory for community psychology“Friendship brought me into it, but commitment bought me into it”: Civic engagement motivations among highly engaged Asian American youthCritical consciousness of anti-Black racism: A practical model to prevent and resist racial traumaUnderstanding collective identity in virtual spaces: A study of the youth climate movementIntraminority solidarity: The role of critical consciousnessSexual minority youth, social connection and resilience: From personal struggle to collective identityCivic engagement and the transition to adulthoodNormative influences on adolescents’ self-reported pro-environmental behaviors: The role of parents and friendsInterpersonal racism and peer relationships: An integrative framework and directions for researchOn the microfoundations of the link between classroom social norms and behavioral developmentEmerging adults’ social justice engagement: Motivations, barriers, and social identityFriendship quality and social developmentA prospective study of the relative contribution of adolescent peer support quantity and quality to depressive symptomsA conceptual model of intergroup contact, social capital, and youth civic engagement for diverse democracyThe intersection of emotional and sociocognitive competencies with civic engagement in middle childhood and adolescenceCivic purpose: An integrated construct for understanding civic development in adolescenceElection-related sociopolitical stress and coping among college students in the United StatesSocial influence: Compliance and conformityToward understanding the functions of peer influence: A summary and synthesis of recent empirical researchHomophily, selection, and socialization in adolescent friendshipsEarly adolescents demonstrate peer-network homophily in political attitudes and valuesSimilarities between friends on service, activism, and awareness of inequities in an adolescent social networkWellness as fairnessFriends, relatives, sanity, and health: The costs of politicsIn it together: Exploring how belonging to a youth activist group enhances well-beingThe structure of communication networks matters: How network diversity, centrality, and context influence political ambivalence, participation, and knowledgeReal and perceived attitude agreement in social networksAdolescent mental health in relation to anti-racism critical actionPsychological toll of being awakened: Asian-origin youth’s critical reflection and mental healthCritical reflection and positive youth development among White and Black adolescents: Is understanding inequality connected to thriving?Culturally relevant strengths and positive development in high achieving youth of colorTowards a model of positive youth development specific to girls of color: Perspectives on development, resilience, and empowermentA bitter pill to swallow? Patterns of critical consciousness and socioemotional and academic well-being in early adolescenceFor better or worse? System-justifying beliefs in sixth-grade predict trajectories of self-esteem and behavior across early adolescenceThe role of empowerment in youth development: A study of sociopolitical control as mediator of ecological systems’ influence on developmental outcomesPsychological empowerment among urban youth: Measure development and relationship to psychosocial functioningAdolescent political activism and long-term happiness: A 21-year longitudinal study on the development of micro- and macrosocial worriesQueer solidarities: New activisms erupting at the intersection of structural precarity and radical misrecognitionPolitical engagement and wellbeing among college studentsEffects of social movement participation on political efficacy and well-being: A longitudinal study of civically engaged youthDocumenting sociopolitical development via Participatory Action Research (PAR) with women of color student activists in the neoliberal universitySupportive peer relationships and mental health in adolescence: An integrative reviewRelations of friendship experiences with depressive symptoms and loneliness in childhood and adolescence: A meta-analytic reviewSocial network determinants of depressionSocial network status and depression among adolescents: An examination of social network influences and depressive symptoms in a Chinese sampleGot bots? Practical recommendations to protect online survey data from bot attacksMaximum likelihood from incomplete data via the EM algorithmMICE: Multivariate Imputation by Chained Equations in RIndividual orientation toward engagement in social actionDevelopment and validation of the Black community activism orientation scaleYouth anti-racist engagement: Conceptualization, development, and validation of an anti-racism action scaleDevelopment and validation of the Critical Consciousness ScaleDevelopment and validation of the youth Sociopolitical Action Scale for Social Media (SASSM)Development of the Short Critical Consciousness Scale (ShoCCS)Critical consciousness and vocational development among Latina/o high school youth: Initial development and testing of a measureThe development and validation of the Contemporary Critical Consciousness MeasureSocial dominance orientation: A personality variable predicting social and political attitudesLinking critical consciousness and health: The utility of the critical reflection about social determinants of health scaleConstruction and initial validation of the Color-Blind Racial Attitudes Scale (CoBRAS)The Watts Connectedness Scale: A new scale for measuring a sense of connectedness to self, others, and worldThe Patient Health Questionnaire-2: Validity of a two-item depression screenerAnxiety disorders in primary care: Prevalence, impairment, comorbidity, and detectionPsychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6New Well-being measures: Short scales to assess flourishing and positive and negative feelingsBest practices for modeling egocentric social network data and health outcomesA meta-analysis of longitudinal peer influence effects in childhood and adolescenceStress, social support, and the buffering hypothesisA meta-analytic review of the association between perceived social support and depression in childhood and adolescenceUnintentional consequences: Facing the risks of being a youth activistComparing the costs and benefits of activism for girls with different sexual orientations and racial and ethnic identitiesNon-zero-sum collaboration, reciprocity, and the preference for similarity: Developing an adaptive model of close relational functioningMaking and keeping friends: The importance of being similarNetworks in the making: Friendship segregation and ethnic homophilyAdolescent intergroup connections and their developmental benefits: Exploring contributions from social network analysisMechanisms linking social ties and support to physical and mental healthThe mental health continuum: From languishing to flourishing in lifeInference for social network models from egocentrically sampled data, with application to understanding persistent racial disparities in HIV prevalence in the USIntroduction to stochastic actor-based models for network dynamics</div>
                            <small style="color: var(--text-muted)">12735295.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Detected high number of P-values (23) without explicit mention of multiplicity correction.', 'evidence': '...at random (χ2(2,634) = 2,710; p = 0.149). Participants’ indications t...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...at random (χ2(2,634) = 2,710; p = 0.149). Participants’ indications t...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Changing the availability and positioning of more vs. less environmentally sustainable products: A randomised controlled trial in an online experimental supermarketHow do shoppers behave online? An observational study of online grocery shoppingMeta-analyses of fifteen determinants of public opinion about climate change taxes and lawsEncouraging healthier grocery purchases online: A randomised controlled trial and lessons learnedEstimating the environmental impacts of 57,000 food productsImpact on alcohol selection and online purchasing of changing the proportion of available non-alcoholic versus alcoholic drinks: A randomised controlled trialFood systems are responsible for a third of global anthropogenic GHG emissionsThe Price Knowledge and Search of Supermarket ShoppersPublic acceptability of government intervention to change health-related behaviours: A systematic review and narrative synthesisImpact of increasing vegetarian availability on meal selection and sales in cafeteriasEnvironmental performance of blue foodsDirect observation of search behavior in the purchase of two nondurable productsPublic support for healthy supermarket initiatives focused on product placement: A multi-country cross-sectional analysis of the 2018 International food policy studyNutrient composition databases in the age of big data: foodDB, a comprehensive, real-time database infrastructureThe TIPPME intervention typology for changing environments to change behaviourAltering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumptionOpen Science online grocery: A Tool for studying choice context and food choiceAn Examination of consumer decision making for a common repeat purchase productAmerican attitudes toward nudgesrstatix: Pipe-Friendly framework for basic statistical testsProminent positioning and food swaps are effective interventions to reduce the saturated fat content of the shopping basket in an experimental online supermarket: A randomized controlled trialCo-Benefits from sustainable dietary shifts for population and environmental health: An assessment from a large European cohort studyA replication and extension of the Dickson and Sawyer price-awareness studyConsumer decision making for common, repeat-purchase products: A dual replicationEffects of labelling and increasing the proportion of lower-energy density products on online food shopping: A randomised control trial in high-and low-socioeconomic position participantsThe effectiveness of nudging: A meta-analysis of choice architecture interventions across behavioral domainsA review and taxonomy of choice architecture techniquesImpact of increasing the relative availability of meat-free options on food selection: Two natural field experiments and an online randomised trialImpact of altering the available food options on selection: Potential mediation by social normsAltering the availability of products within physical micro-environments: A conceptual frameworkAcceptability of policies to reduce consumption of red and processed meat: A population-based survey experimentTesting availability, positioning, promotions, and signage of healthier food options and purchasing behaviour within major UK supermarkets: Evaluation of 6 nonrandomised controlled intervention studiesReducing food’s environmental impacts through producers and consumersImpact of decreasing the proportion of higher energy foods and reducing portion sizes on food purchased in worksite cafeterias: A stepped-wedge randomised controlled trialUnderstanding attitudes towards reducing meat consumption for environmental reasons. A Qualitative synthesis reviewConsumer attitudes towards environmental Concerns of meat consumption: A systematic reviewCONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trialsHealth and nutritional aspects of sustainable diet strategies and their association with environmental impacts: A global modelling analysis with country-level detailChanging the default order of food items in an online grocery store may nudge healthier food choicesDplyr: A Grammar of data manipulationtidyr: Tidy Messy dataCan changing the position of online menu items increase selection of fruit and vegetable snacks? A cluster randomized trial within an online canteen ordering system in Australian primary schoolsTesting the impact of overt and covert ordering interventions on sustainable consumption choices: A randomised controlled trial">Changing the availability and positioning of more vs. less environmentally sustainable products: A randomised controlled trial in an online experimental supermarketHow do shoppers behave online? An observational study of online grocery shoppingMeta-analyses of fifteen determinants of public opinion about climate change taxes and lawsEncouraging healthier grocery purchases online: A randomised controlled trial and lessons learnedEstimating the environmental impacts of 57,000 food productsImpact on alcohol selection and online purchasing of changing the proportion of available non-alcoholic versus alcoholic drinks: A randomised controlled trialFood systems are responsible for a third of global anthropogenic GHG emissionsThe Price Knowledge and Search of Supermarket ShoppersPublic acceptability of government intervention to change health-related behaviours: A systematic review and narrative synthesisImpact of increasing vegetarian availability on meal selection and sales in cafeteriasEnvironmental performance of blue foodsDirect observation of search behavior in the purchase of two nondurable productsPublic support for healthy supermarket initiatives focused on product placement: A multi-country cross-sectional analysis of the 2018 International food policy studyNutrient composition databases in the age of big data: foodDB, a comprehensive, real-time database infrastructureThe TIPPME intervention typology for changing environments to change behaviourAltering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumptionOpen Science online grocery: A Tool for studying choice context and food choiceAn Examination of consumer decision making for a common repeat purchase productAmerican attitudes toward nudgesrstatix: Pipe-Friendly framework for basic statistical testsProminent positioning and food swaps are effective interventions to reduce the saturated fat content of the shopping basket in an experimental online supermarket: A randomized controlled trialCo-Benefits from sustainable dietary shifts for population and environmental health: An assessment from a large European cohort studyA replication and extension of the Dickson and Sawyer price-awareness studyConsumer decision making for common, repeat-purchase products: A dual replicationEffects of labelling and increasing the proportion of lower-energy density products on online food shopping: A randomised control trial in high-and low-socioeconomic position participantsThe effectiveness of nudging: A meta-analysis of choice architecture interventions across behavioral domainsA review and taxonomy of choice architecture techniquesImpact of increasing the relative availability of meat-free options on food selection: Two natural field experiments and an online randomised trialImpact of altering the available food options on selection: Potential mediation by social normsAltering the availability of products within physical micro-environments: A conceptual frameworkAcceptability of policies to reduce consumption of red and processed meat: A population-based survey experimentTesting availability, positioning, promotions, and signage of healthier food options and purchasing behaviour within major UK supermarkets: Evaluation of 6 nonrandomised controlled intervention studiesReducing food’s environmental impacts through producers and consumersImpact of decreasing the proportion of higher energy foods and reducing portion sizes on food purchased in worksite cafeterias: A stepped-wedge randomised controlled trialUnderstanding attitudes towards reducing meat consumption for environmental reasons. A Qualitative synthesis reviewConsumer attitudes towards environmental Concerns of meat consumption: A systematic reviewCONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trialsHealth and nutritional aspects of sustainable diet strategies and their association with environmental impacts: A global modelling analysis with country-level detailChanging the default order of food items in an online grocery store may nudge healthier food choicesDplyr: A Grammar of data manipulationtidyr: Tidy Messy dataCan changing the position of online menu items increase selection of fruit and vegetable snacks? A cluster randomized trial within an online canteen ordering system in Australian primary schoolsTesting the impact of overt and covert ordering interventions on sustainable consumption choices: A randomised controlled trial</div>
                            <small style="color: var(--text-muted)">7618412.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-medium">5.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 55.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...tem were investigated through chi-square tests and descriptive statist...'}</li><li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...count for an estimated 10% of missing data. Participants who bought less...'}</li>
                                <li>...and 1 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Impact of retraining and data partitions on the generalizability of a deep learning model in the task of COVID-19 classification on chest radiographsCommon pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scansHundreds of AI tools have been built to catch COVID. None of them helpedPrediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisalRapid response to COVID-19 pandemicAI in medical imaging grand challenges: translation from competition to research benefit and patient careMachine learning generalizability across healthcare settings: insights from multi-site COVID-19 screeningReproducibility in machine learning for health research: still a ways to goGeneralizability of machine learning models: quantitative evaluation of three methodological pitfallsThe importance of generalizability in machine learning for systemsGeneralized out-of-distribution detection: a surveyRole of standard and soft tissue chest radiography images in deep-learning-based early diagnosis of COVID-19Assessment of a deep learning model for COVID-19 classification on chest radiographs: a comparison across image acquisition techniques and clinical factorsRANDGAN: randomized generative adversarial network for detection of COVID-19 in chest X-rayTwo public chest x-ray datasets for computer-aided screening of pulmonary diseasesCOVID-net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray imagesDensely connected convolutional networksCheXNet: radiologist-level pneumonia detection on chest X-rays with deep learningDeep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologistsCurriculum learningImageNet: a large-scale hierarchical image databaseChestX-ray8: hospital-scale chest x-ray database and benchmarks on weakly-supervised classification and localization of common thorax diseasesRSNA pneumonia detection challengeComparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachImageNet classification with deep convolutional neural networksRecent advances and applications of deep learning methods in materials scienceTent: fully test-time adaptation by entropy minimizationOptimal ratio for data splittingData splittingOptimality of training/test size and resampling effectiveness in cross-validationInfluence of data splitting on performance of machine learning models in prediction of shear strength of soilRole of sureness in evaluating AI/CADx: lesion-based repeatability of machine learning classification performance on breast MRI">Impact of retraining and data partitions on the generalizability of a deep learning model in the task of COVID-19 classification on chest radiographsCommon pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scansHundreds of AI tools have been built to catch COVID. None of them helpedPrediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisalRapid response to COVID-19 pandemicAI in medical imaging grand challenges: translation from competition to research benefit and patient careMachine learning generalizability across healthcare settings: insights from multi-site COVID-19 screeningReproducibility in machine learning for health research: still a ways to goGeneralizability of machine learning models: quantitative evaluation of three methodological pitfallsThe importance of generalizability in machine learning for systemsGeneralized out-of-distribution detection: a surveyRole of standard and soft tissue chest radiography images in deep-learning-based early diagnosis of COVID-19Assessment of a deep learning model for COVID-19 classification on chest radiographs: a comparison across image acquisition techniques and clinical factorsRANDGAN: randomized generative adversarial network for detection of COVID-19 in chest X-rayTwo public chest x-ray datasets for computer-aided screening of pulmonary diseasesCOVID-net: a tailored deep convolutional neural network design for detection of COVID-19 cases from chest X-ray imagesDensely connected convolutional networksCheXNet: radiologist-level pneumonia detection on chest X-rays with deep learningDeep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologistsCurriculum learningImageNet: a large-scale hierarchical image databaseChestX-ray8: hospital-scale chest x-ray database and benchmarks on weakly-supervised classification and localization of common thorax diseasesRSNA pneumonia detection challengeComparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachImageNet classification with deep convolutional neural networksRecent advances and applications of deep learning methods in materials scienceTent: fully test-time adaptation by entropy minimizationOptimal ratio for data splittingData splittingOptimality of training/test size and resampling effectiveness in cross-validationInfluence of data splitting on performance of machine learning models in prediction of shear strength of soilRole of sureness in evaluating AI/CADx: lesion-based repeatability of machine learning classification performance on breast MRI</div>
                            <small style="color: var(--text-muted)">11670362.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Proteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeastProteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeast.Proteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeast.Encystation: the most prevalent and underinvestigated differentiation pathway of eukaryotesThe appressorium at a glanceThe cold war of the social amoebaeSex determination in ChlamydomonasRegulation of entry into gametogenesisTOR Signaling and Nutrient SensingTarget of Rapamycin (TOR) Regulates Growth in Response to Nutritional SignalsRegulation of entry into gametogenesis by Ste11: the endless gameProtein kinase A regulates sexual development and gluconeogenesis through phosphorylation of the Zn finger transcriptional activator Rst2p in fission yeastCdc2p controls the forkhead transcription factor Fkh2p by phosphorylation during sexual differentiation in fission yeastFission yeast Tor2 promotes cell growth and represses cell differentiationFission yeast Tor2 links nitrogen signals to cell proliferation and acts downstream of the Rheb GTPaseOpposite effects of tor1 and tor2 on nitrogen starvation responses in fission yeastLoss of the TOR kinase Tor2 mimics nitrogen starvation and activates the sexual development pathway in fission yeastThe Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission yeastDistinctive responses to nitrogen starvation in the dominant active mutants of the fission yeast Rheb GTPaseLoss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvationPoint mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cellsRole of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombeNegative regulation of EGFR signalling by the human folliculin tumour suppressor proteinThe fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serineAMPK phosphorylation by Ssp1 is required for proper sexual differentiation in fission yeastNitrogen regulates AMPK to control TORC1 signalingA PP2A-B55-Mediated Crosstalk between TORC1 and TORC2 Regulates the Differentiation Response in Fission YeastTORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availabilityA focus on yeast mating: From pheromone signaling to cell-cell fusionCdc42 Explores the Cell Periphery for Mate Selection in Fission YeastLocal Pheromone Release from Dynamic Polarity Sites Underlies Cell-Cell Pairing during Yeast MatingA formin-nucleated actin aster concentrates cell wall hydrolases for cell fusion in fission yeastSpatial focalization of pheromone/MAPK signaling triggers commitment to cell-cell fusionInhibition of Ras activity coordinates cell fusion with cell-cell contact during yeast matingCell cycle-dependent and independent mating blocks ensure fungal zygote survival and ploidy maintenanceGamete fusion triggers bipartite transcription factor assembly to block re-fertilizationCDK Substrate Phosphorylation and Ordering the Cell CycleCharacterization of fus1 of Schizosaccharomyces pombe: a developmentally controlled function needed for conjugationRapid blue-light-mediated induction of protein interactions in living cellsActin assembly requirements of the formin Fus1 to build the fusion focusCondensation of the fusion focus by the intrinsically disordered region of the formin Fus1 is essential for cell-cell fusionMicroscopy of Fission Yeast Sexual LifecycleCdk phosphorylation of the Ste11 transcription factor constrains differentiation-specific transcription to G1Regulation of the start of DNA replication in Schizosaccharomyces pombeControl of cell size at division in fission yeast by a growth-modulated size control over nuclear divisionControl of the timing of cell division in fission yeast. Cell size mutants reveal a second control pathwayGrowth and the Environment of Schizosaccharomyces pombeA single cyclin-CDK complex is sufficient for both mitotic and meiotic progression in fission yeastFission Yeast Autophagy MachineryAutophagy facilitates adaptation of budding yeast to respiratory growth by recycling serine for one-carbon metabolismFission Yeast NDR/LATS Kinase Orb6 Regulates Exocytosis via Phosphorylation of the Exocyst ComplexA TOR (target of rapamycin) and nutritional phosphoproteome of fission yeast reveals novel targets in networks conserved in humansThe TOR-dependent phosphoproteome and regulation of cellular protein synthesisThe nuts and bolts of AGC protein kinasesAn atlas of substrate specificities for the human serine/threonine kinomeConserved NDR/LATS kinase controls RAS GTPase activity to regulate cell growth and chronological lifespanFission yeast orb6, a ser/thr protein kinase related to mammalian rho kinase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell morphogenesis with the cell cycleConstitutively active RAS in S. pombe causes persistent Cdc42 signalling but only transient MAPK activationFunctional analysis of the C-terminal cytoplasmic region of the M-factor receptor in fission yeastConstitutive activation of the fission yeast pheromone-responsive pathway induces ectopic meiosis and reveals ste11 as a mitogen-activated protein kinase targetMolecular mimicry in development: identification of ste11+ as a substrate and mei3+ as a pseudosubstrate inhibitor of ran1+ kinasePhosphorylation of RNA-binding protein controls cell cycle switch from mitotic to meiotic in fission yeastS. pombe TORC1 activates the ubiquitin-proteasomal degradation of the meiotic regulator Mei2 in cooperation with Pat1 kinaseFission yeast Num1p is a cortical factor anchoring dynein and is essential for the horse-tail nuclear movement during meiotic prophaseMcp5, a meiotic cell cortex protein, is required for nuclear movement mediated by dynein and microtubules in fission yeastSUMOylation is required for normal development of linear elements and wild-type meiotic recombination in Schizosaccharomyces pombeCDK contribution to DSB formation and recombination in fission yeast meiosisShugoshin-PP2A counteracts casein-kinase-1-dependent cleavage of Rec8 by separaseSpo5/Mug12, a putative meiosis-specific RNA-binding protein, is essential for meiotic progression and forms Mei2 dot-like nuclear fociThe RNA-binding protein Spo5 promotes meiosis II by regulating cyclin Cdc13 in fission yeastSpo5 phosphorylation is essential for its own timely degradation and for successful meiosis in Schizosaccharomyces pombeTranscriptional regulatory network for sexual differentiation in fission yeastCasein kinase 1 is required for efficient removal of Rec8 during meiosis IMeikin synergizes with shugoshin to protect cohesin Rec8 during meiosis IRibosomal Protein S6 Phosphorylation: Four Decades of ResearchFission yeast TORC1 regulates phosphorylation of ribosomal S6 proteins in response to nutrients and its activity is inhibited by rapamycinPsk1, an AGC kinase family member in fission yeast, is directly phosphorylated and controlled by TORC1 and functions as S6 kinaseTORC2 and the AGC kinase Gad8 regulate phosphorylation of the ribosomal protein S6 in fission yeastFission yeast tor1 functions in response to various stresses including nitrogen starvation, high osmolarity, and high temperatureSchizosaccharomyces pombe AGC family kinase Gad8p forms a conserved signaling module with TOR and PDK1-like kinasesTORC1 of fission yeast is rapamycin-sensitiveRegulation of leucine uptake by tor1+ in Schizosaccharomyces pombe is sensitive to rapamycinRapamycin blocks sexual development in fission yeast through inhibition of the cellular function of an FKBP12 homologTermination of autophagy and reformation of lysosomes regulated by mTORBidirectional regulation between TORC1 and autophagy in Saccharomyces cerevisiaeThe S. pombe CDK5 ortholog Pef1 regulates sexual differentiation through control of the TORC1 pathway and autophagyA starvation-specific serine protease gene, isp6+, is involved in both autophagy and sexual development in Schizosaccharomyces pombeGlobal analysis of fission yeast mating genes reveals new autophagy factorsFission yeast autophagy induced by nitrogen starvation generates a nitrogen source that drives adaptation processesAutophagy-deficient Schizosaccharomyces pombe mutants undergo partial sporulation during nitrogen starvationAtg1 kinase in fission yeast is activated by Atg11-mediated dimerization and cis-autophosphorylationLeucyl-tRNA synthetase controls TORC1 via the EGO complexLeucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathwayTOR and MAP kinase pathways synergistically regulate autophagy in response to nutrient depletion in fission yeastResponse to leucine in Schizosaccharomyces pombe (fission yeast)Rapamycin specifically interferes with the developmental response of fission yeast to starvationCaffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1pTORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeastIndole-3-acetic acid is a physiological inhibitor of TORC1 in yeastBroad functional profiling of fission yeast proteins using phenomics and machine learningFission yeast pheromone blocks S-phase by inhibiting the G1 cyclin B-p34cdc2 kinaseCyclin B proteolysis and the cyclin-dependent kinase inhibitor rum1p are required for pheromone-induced G1 arrest in fission yeasttRNA production links nutrient conditions to the onset of sexual differentiation through the TORC1 pathwayFission Yeast SCYL1/2 Homologue Ppk32: A Novel Regulator of TOR Signalling That Governs Survival during Brefeldin A Induced Stress to Protein TraffickingNovel WD-repeat protein Mip1p facilitates function of the meiotic regulator Mei2p in fission yeastTORC1-Dependent Phosphorylation Targets in Fission YeastThe TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permeaseMaf1-dependent transcriptional regulation of tRNAs prevents genomic instability and is associated with extended lifespanRegulation of Autophagy By Signaling Through the Atg1/ULK1 ComplexAtg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy inductionPhosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesisERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signalingIdentification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeastTsc1+ and tsc2+ regulate arginine uptake and metabolism in Schizosaccharomyces pombeThe Hippo Pathway: Biology and PathophysiologySpatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5Phosphorylation-dependent inhibition of Cdc42 GEF Gef1 by 14-3-3 protein Rad24 spatially regulates Cdc42 GTPase activity and oscillatory dynamics during cell morphogenesisHeterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombeA toolbox of Stable Integration Vectors (SIV) in the fission yeast Schizosaccharomyces pombeIsp7 is a novel regulator of amino acid uptake in the TOR signaling pathwayAnalysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombeFast and sensitive total protein and Peptide assays for proteomic analysisS-Trap, an Ultrafast Sample-Preparation Approach for Shotgun ProteomicsMaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationAndromeda: a peptide search engine integrated into the MaxQuant environmentIsobaric Matching between Runs and Novel PSM-Level Normalization in MaxQuant Strongly Improve Reporter Ion-Based QuantificationThe Perseus computational platform for comprehensive analysis of (prote)omics datalimma powers differential expression analyses for RNA-sequencing and microarray studiesPANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic treesggseqlogo: a versatile R package for drawing sequence logosRagulator and GATOR1 complexes promote fission yeast growth by attenuating TOR complex 1 through Rag GTPasesAuthor response to previous submissionDecision Letter 0Author response to Decision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2">Proteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeastProteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeast.Proteomic and phosphoproteomic analyses reveal that TORC1 is reactivated by pheromone signaling during sexual reproduction in fission yeast.Encystation: the most prevalent and underinvestigated differentiation pathway of eukaryotesThe appressorium at a glanceThe cold war of the social amoebaeSex determination in ChlamydomonasRegulation of entry into gametogenesisTOR Signaling and Nutrient SensingTarget of Rapamycin (TOR) Regulates Growth in Response to Nutritional SignalsRegulation of entry into gametogenesis by Ste11: the endless gameProtein kinase A regulates sexual development and gluconeogenesis through phosphorylation of the Zn finger transcriptional activator Rst2p in fission yeastCdc2p controls the forkhead transcription factor Fkh2p by phosphorylation during sexual differentiation in fission yeastFission yeast Tor2 promotes cell growth and represses cell differentiationFission yeast Tor2 links nitrogen signals to cell proliferation and acts downstream of the Rheb GTPaseOpposite effects of tor1 and tor2 on nitrogen starvation responses in fission yeastLoss of the TOR kinase Tor2 mimics nitrogen starvation and activates the sexual development pathway in fission yeastThe Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission yeastDistinctive responses to nitrogen starvation in the dominant active mutants of the fission yeast Rheb GTPaseLoss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvationPoint mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cellsRole of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombeNegative regulation of EGFR signalling by the human folliculin tumour suppressor proteinThe fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serineAMPK phosphorylation by Ssp1 is required for proper sexual differentiation in fission yeastNitrogen regulates AMPK to control TORC1 signalingA PP2A-B55-Mediated Crosstalk between TORC1 and TORC2 Regulates the Differentiation Response in Fission YeastTORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availabilityA focus on yeast mating: From pheromone signaling to cell-cell fusionCdc42 Explores the Cell Periphery for Mate Selection in Fission YeastLocal Pheromone Release from Dynamic Polarity Sites Underlies Cell-Cell Pairing during Yeast MatingA formin-nucleated actin aster concentrates cell wall hydrolases for cell fusion in fission yeastSpatial focalization of pheromone/MAPK signaling triggers commitment to cell-cell fusionInhibition of Ras activity coordinates cell fusion with cell-cell contact during yeast matingCell cycle-dependent and independent mating blocks ensure fungal zygote survival and ploidy maintenanceGamete fusion triggers bipartite transcription factor assembly to block re-fertilizationCDK Substrate Phosphorylation and Ordering the Cell CycleCharacterization of fus1 of Schizosaccharomyces pombe: a developmentally controlled function needed for conjugationRapid blue-light-mediated induction of protein interactions in living cellsActin assembly requirements of the formin Fus1 to build the fusion focusCondensation of the fusion focus by the intrinsically disordered region of the formin Fus1 is essential for cell-cell fusionMicroscopy of Fission Yeast Sexual LifecycleCdk phosphorylation of the Ste11 transcription factor constrains differentiation-specific transcription to G1Regulation of the start of DNA replication in Schizosaccharomyces pombeControl of cell size at division in fission yeast by a growth-modulated size control over nuclear divisionControl of the timing of cell division in fission yeast. Cell size mutants reveal a second control pathwayGrowth and the Environment of Schizosaccharomyces pombeA single cyclin-CDK complex is sufficient for both mitotic and meiotic progression in fission yeastFission Yeast Autophagy MachineryAutophagy facilitates adaptation of budding yeast to respiratory growth by recycling serine for one-carbon metabolismFission Yeast NDR/LATS Kinase Orb6 Regulates Exocytosis via Phosphorylation of the Exocyst ComplexA TOR (target of rapamycin) and nutritional phosphoproteome of fission yeast reveals novel targets in networks conserved in humansThe TOR-dependent phosphoproteome and regulation of cellular protein synthesisThe nuts and bolts of AGC protein kinasesAn atlas of substrate specificities for the human serine/threonine kinomeConserved NDR/LATS kinase controls RAS GTPase activity to regulate cell growth and chronological lifespanFission yeast orb6, a ser/thr protein kinase related to mammalian rho kinase and myotonic dystrophy kinase, is required for maintenance of cell polarity and coordinates cell morphogenesis with the cell cycleConstitutively active RAS in S. pombe causes persistent Cdc42 signalling but only transient MAPK activationFunctional analysis of the C-terminal cytoplasmic region of the M-factor receptor in fission yeastConstitutive activation of the fission yeast pheromone-responsive pathway induces ectopic meiosis and reveals ste11 as a mitogen-activated protein kinase targetMolecular mimicry in development: identification of ste11+ as a substrate and mei3+ as a pseudosubstrate inhibitor of ran1+ kinasePhosphorylation of RNA-binding protein controls cell cycle switch from mitotic to meiotic in fission yeastS. pombe TORC1 activates the ubiquitin-proteasomal degradation of the meiotic regulator Mei2 in cooperation with Pat1 kinaseFission yeast Num1p is a cortical factor anchoring dynein and is essential for the horse-tail nuclear movement during meiotic prophaseMcp5, a meiotic cell cortex protein, is required for nuclear movement mediated by dynein and microtubules in fission yeastSUMOylation is required for normal development of linear elements and wild-type meiotic recombination in Schizosaccharomyces pombeCDK contribution to DSB formation and recombination in fission yeast meiosisShugoshin-PP2A counteracts casein-kinase-1-dependent cleavage of Rec8 by separaseSpo5/Mug12, a putative meiosis-specific RNA-binding protein, is essential for meiotic progression and forms Mei2 dot-like nuclear fociThe RNA-binding protein Spo5 promotes meiosis II by regulating cyclin Cdc13 in fission yeastSpo5 phosphorylation is essential for its own timely degradation and for successful meiosis in Schizosaccharomyces pombeTranscriptional regulatory network for sexual differentiation in fission yeastCasein kinase 1 is required for efficient removal of Rec8 during meiosis IMeikin synergizes with shugoshin to protect cohesin Rec8 during meiosis IRibosomal Protein S6 Phosphorylation: Four Decades of ResearchFission yeast TORC1 regulates phosphorylation of ribosomal S6 proteins in response to nutrients and its activity is inhibited by rapamycinPsk1, an AGC kinase family member in fission yeast, is directly phosphorylated and controlled by TORC1 and functions as S6 kinaseTORC2 and the AGC kinase Gad8 regulate phosphorylation of the ribosomal protein S6 in fission yeastFission yeast tor1 functions in response to various stresses including nitrogen starvation, high osmolarity, and high temperatureSchizosaccharomyces pombe AGC family kinase Gad8p forms a conserved signaling module with TOR and PDK1-like kinasesTORC1 of fission yeast is rapamycin-sensitiveRegulation of leucine uptake by tor1+ in Schizosaccharomyces pombe is sensitive to rapamycinRapamycin blocks sexual development in fission yeast through inhibition of the cellular function of an FKBP12 homologTermination of autophagy and reformation of lysosomes regulated by mTORBidirectional regulation between TORC1 and autophagy in Saccharomyces cerevisiaeThe S. pombe CDK5 ortholog Pef1 regulates sexual differentiation through control of the TORC1 pathway and autophagyA starvation-specific serine protease gene, isp6+, is involved in both autophagy and sexual development in Schizosaccharomyces pombeGlobal analysis of fission yeast mating genes reveals new autophagy factorsFission yeast autophagy induced by nitrogen starvation generates a nitrogen source that drives adaptation processesAutophagy-deficient Schizosaccharomyces pombe mutants undergo partial sporulation during nitrogen starvationAtg1 kinase in fission yeast is activated by Atg11-mediated dimerization and cis-autophosphorylationLeucyl-tRNA synthetase controls TORC1 via the EGO complexLeucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathwayTOR and MAP kinase pathways synergistically regulate autophagy in response to nutrient depletion in fission yeastResponse to leucine in Schizosaccharomyces pombe (fission yeast)Rapamycin specifically interferes with the developmental response of fission yeast to starvationCaffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1pTORC1 signaling inhibition by rapamycin and caffeine affect lifespan, global gene expression, and cell proliferation of fission yeastIndole-3-acetic acid is a physiological inhibitor of TORC1 in yeastBroad functional profiling of fission yeast proteins using phenomics and machine learningFission yeast pheromone blocks S-phase by inhibiting the G1 cyclin B-p34cdc2 kinaseCyclin B proteolysis and the cyclin-dependent kinase inhibitor rum1p are required for pheromone-induced G1 arrest in fission yeasttRNA production links nutrient conditions to the onset of sexual differentiation through the TORC1 pathwayFission Yeast SCYL1/2 Homologue Ppk32: A Novel Regulator of TOR Signalling That Governs Survival during Brefeldin A Induced Stress to Protein TraffickingNovel WD-repeat protein Mip1p facilitates function of the meiotic regulator Mei2p in fission yeastTORC1-Dependent Phosphorylation Targets in Fission YeastThe TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permeaseMaf1-dependent transcriptional regulation of tRNAs prevents genomic instability and is associated with extended lifespanRegulation of Autophagy By Signaling Through the Atg1/ULK1 ComplexAtg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy inductionPhosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesisERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signalingIdentification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeastTsc1+ and tsc2+ regulate arginine uptake and metabolism in Schizosaccharomyces pombeThe Hippo Pathway: Biology and PathophysiologySpatial control of translation repression and polarized growth by conserved NDR kinase Orb6 and RNA-binding protein Sts5Phosphorylation-dependent inhibition of Cdc42 GEF Gef1 by 14-3-3 protein Rad24 spatially regulates Cdc42 GTPase activity and oscillatory dynamics during cell morphogenesisHeterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombeA toolbox of Stable Integration Vectors (SIV) in the fission yeast Schizosaccharomyces pombeIsp7 is a novel regulator of amino acid uptake in the TOR signaling pathwayAnalysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombeFast and sensitive total protein and Peptide assays for proteomic analysisS-Trap, an Ultrafast Sample-Preparation Approach for Shotgun ProteomicsMaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationAndromeda: a peptide search engine integrated into the MaxQuant environmentIsobaric Matching between Runs and Novel PSM-Level Normalization in MaxQuant Strongly Improve Reporter Ion-Based QuantificationThe Perseus computational platform for comprehensive analysis of (prote)omics datalimma powers differential expression analyses for RNA-sequencing and microarray studiesPANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic treesggseqlogo: a versatile R package for drawing sequence logosRagulator and GATOR1 complexes promote fission yeast growth by attenuating TOR complex 1 through Rag GTPasesAuthor response to previous submissionDecision Letter 0Author response to Decision Letter 0Decision Letter 1Author response to Decision Letter 1Decision Letter 2</div>
                            <small style="color: var(--text-muted)">11750111.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...roteomic data set. Then, log2 fold-changes values were used to fit a mu...'}</li><li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...pt sites with no more than 10 missing values out of 30 total possible valu...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Spatial analysis of murine microbiota and bile acid metabolism during amoxicillin treatmentAntibiotics: past, present and futureAntibiotic perturbations to the gut microbiomeUnravelling the collateral damage of antibiotics on gut bacteriaEvaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of AntibioticRecovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsUnderstanding Competition and Cooperation within the Mammalian Gut MicrobiomeStrain dropouts reveal interactions that govern the metabolic output of the gut microbiomeThe microbiome and gut homeostasisThe Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA SequencingAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of ResistancesShort-Term Amoxicillin-Induced Perturbation of the Gut Microbiota Promotes Acute Intestinal Immune Regulation in Brown Norway RatsA mouse model of occult intestinal colonization demonstrating antibiotic-induced outgrowth of carbapenem-resistant EnterobacteriaceaeLong-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteriaAntibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large IntestineHost-mediated sugar oxidation promotes post-antibiotic pathogen expansionDepletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of SalmonellaInteraction between microbiota and immunity in health and diseaseGut microbiota in human metabolic health and diseaseThe gut microbiome in neurological disordersAssociation of Infant Antibiotic Exposure With Childhood Health OutcomesSpatial Heterogeneity of Gut Microbial Composition along the Gastrointestinal Tract in Natural Populations of House MiceThe regional diversity of gut microbiome along the GI tract of male C57BL/6 miceRegional Diversity of the Gastrointestinal MicrobiomeGut biogeography of the bacterial microbiotaRole of the gut in lipid homeostasisBile acid metabolism and signalingBile acids and the gut microbiomeThe interaction between bacteria and bileBile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic DisordersBile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestrationSystematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel diseasePhysicochemical properties of bile acids and their relationship to biological properties: an overview of the problemComprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodentsBile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivoIn Vitro Anti-bacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureusInhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acidsAntibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat PlasmaMicrobial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut MicrobiomeFiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potentialGut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic toleranceA metabolomics pipeline for the mechanistic interrogation of the gut microbiomeGlobal chemical effects of the microbiome include new bile-acid conjugationsFXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorptionGut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonistEnterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseAssessment of Antibiotic Prescribing Patterns at Outpatient Pharmacy Using World Health Organization Prescribing IndicatorsSelf-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestineMetaWRAP—a flexible pipeline for genome-resolved metagenomic data analysisHMDB: the Human Metabolome DatabaseChEBI: a database and ontology for chemical entities of biological interestbioBakery: a meta’omic analysis environmentIntegrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3Solubility of calcium salts of unconjugated and conjugated natural bile acidsBile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH, and Ca2+ ionsAbsorption-Enhancing Effects of Bile SaltsBile salts and their importance for drug absorptionEnterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signalingDiet-derived galacturonic acid regulates virulence and intestinal colonization in enterohaemorrhagic Escherichia coli and Citrobacter rodentiumThe Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mappingMetaCyc: a multiorganism database of metabolic pathways and enzymesOleic Acid and Related Compounds as Growth Factors for Lactic Acid BacteriaIdentification of food and nutrient components as predictors of Lactobacillus colonizationCharacterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolaseMining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosisButyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-kB axisRoseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and SpeciesBacterial community mapping of the mouse gastrointestinal tractKlebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsExploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysisKlebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistanceColonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg InhibitionParasutterella excrementihominis gen. nov., sp. nov., a member of the family Alcaligenaceae isolated from human faecesDefining the role of Parasutterella, a previously uncharacterized member of the core gut microbiotaInfluence of high-fat diet on gut microbiota: a driving force for chronic disease riskSmall Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary LipidsStudies of the utilization of C14-labeled octadecenoic acids by Lactobacillus arabinosusProfiling the human intestinal environment under physiological conditionsBile acid is a significant host factor shaping the gut microbiome of diet-induced obese miceThe microbiome modulating activity of bile acidsAntibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipidsThe Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolismRegulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gutIntestinal farnesoid X receptor signaling controls hepatic fatty acid oxidationRegulation of antibacterial defense in the small intestine by the nuclear bile acid receptorThe Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the IntestineA communal catalogue reveals Earth’s multiscale microbial diversityReproducible, interactive, scalable and extensible microbiome data science using QIIME 2DADA2: High-resolution sample inference from Illumina amplicon dataFast gapped-read alignment with Bowtie 2Trimmomatic: a flexible trimmer for Illumina sequence dataImproved metagenomic analysis with Kraken 2Bracken: estimating species abundance in metagenomics datametaSPAdes: a new versatile metagenomic assemblerMEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graphBinning metagenomic contigs by coverage and compositionMaxBin 2.0: an automated binning algorithm to recover genomes from multiple metagenomic datasetsMetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assembliesTaxator-tk: precise taxonomic assignment of metagenomes by fast approximation of evolutionary neighborhoodsGenomics and taxonomy in diagnostics for food security: soft-rotting enterobacterial plant pathogensProkka: rapid prokaryotic genome annotationDeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic dataCytoscape: a software environment for integrated models of biomolecular interaction networksMetscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networksProdigal: prokaryotic gene recognition and translation initiation site identificationVSEARCH: a versatile open source tool for metagenomicsMMseqs2 enables sensitive protein sequence searching for the analysis of massive data setsFast and sensitive protein alignment using DIAMONDMultivariable association discovery in population-scale meta-omics studiesNormalizing the environment recapitulates adult human immune traits in laboratory miceThe SILVA ribosomal RNA gene database project: improved data processing and web-based toolsMetatranscriptomics Reveals Antibiotic-Induced Resistance Gene Expression in the Murine Gut MicrobiotaStreptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosisHigh-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometryStruo2: efficient metagenome profiling database construction for ever-expanding microbial genome datasets">Spatial analysis of murine microbiota and bile acid metabolism during amoxicillin treatmentAntibiotics: past, present and futureAntibiotic perturbations to the gut microbiomeUnravelling the collateral damage of antibiotics on gut bacteriaEvaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of AntibioticRecovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsUnderstanding Competition and Cooperation within the Mammalian Gut MicrobiomeStrain dropouts reveal interactions that govern the metabolic output of the gut microbiomeThe microbiome and gut homeostasisThe Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA SequencingAntibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of ResistancesShort-Term Amoxicillin-Induced Perturbation of the Gut Microbiota Promotes Acute Intestinal Immune Regulation in Brown Norway RatsA mouse model of occult intestinal colonization demonstrating antibiotic-induced outgrowth of carbapenem-resistant EnterobacteriaceaeLong-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteriaAntibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large IntestineHost-mediated sugar oxidation promotes post-antibiotic pathogen expansionDepletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of SalmonellaInteraction between microbiota and immunity in health and diseaseGut microbiota in human metabolic health and diseaseThe gut microbiome in neurological disordersAssociation of Infant Antibiotic Exposure With Childhood Health OutcomesSpatial Heterogeneity of Gut Microbial Composition along the Gastrointestinal Tract in Natural Populations of House MiceThe regional diversity of gut microbiome along the GI tract of male C57BL/6 miceRegional Diversity of the Gastrointestinal MicrobiomeGut biogeography of the bacterial microbiotaRole of the gut in lipid homeostasisBile acid metabolism and signalingBile acids and the gut microbiomeThe interaction between bacteria and bileBile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic DisordersBile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestrationSystematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel diseasePhysicochemical properties of bile acids and their relationship to biological properties: an overview of the problemComprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodentsBile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivoIn Vitro Anti-bacterial Activity of Unconjugated and Conjugated Bile Salts on Staphylococcus aureusInhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acidsAntibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat PlasmaMicrobial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut MicrobiomeFiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potentialGut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic toleranceA metabolomics pipeline for the mechanistic interrogation of the gut microbiomeGlobal chemical effects of the microbiome include new bile-acid conjugationsFXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorptionGut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonistEnterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseAssessment of Antibiotic Prescribing Patterns at Outpatient Pharmacy Using World Health Organization Prescribing IndicatorsSelf-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestineMetaWRAP—a flexible pipeline for genome-resolved metagenomic data analysisHMDB: the Human Metabolome DatabaseChEBI: a database and ontology for chemical entities of biological interestbioBakery: a meta’omic analysis environmentIntegrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3Solubility of calcium salts of unconjugated and conjugated natural bile acidsBile acid solubility and precipitation in vitro and in vivo: the role of conjugation, pH, and Ca2+ ionsAbsorption-Enhancing Effects of Bile SaltsBile salts and their importance for drug absorptionEnterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signalingDiet-derived galacturonic acid regulates virulence and intestinal colonization in enterohaemorrhagic Escherichia coli and Citrobacter rodentiumThe Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mappingMetaCyc: a multiorganism database of metabolic pathways and enzymesOleic Acid and Related Compounds as Growth Factors for Lactic Acid BacteriaIdentification of food and nutrient components as predictors of Lactobacillus colonizationCharacterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolaseMining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosisButyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-kB axisRoseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and SpeciesBacterial community mapping of the mouse gastrointestinal tractKlebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsExploring multidrug-resistant Klebsiella pneumoniae antimicrobial resistance mechanisms through whole genome sequencing analysisKlebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistanceColonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg InhibitionParasutterella excrementihominis gen. nov., sp. nov., a member of the family Alcaligenaceae isolated from human faecesDefining the role of Parasutterella, a previously uncharacterized member of the core gut microbiotaInfluence of high-fat diet on gut microbiota: a driving force for chronic disease riskSmall Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary LipidsStudies of the utilization of C14-labeled octadecenoic acids by Lactobacillus arabinosusProfiling the human intestinal environment under physiological conditionsBile acid is a significant host factor shaping the gut microbiome of diet-induced obese miceThe microbiome modulating activity of bile acidsAntibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipidsThe Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolismRegulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gutIntestinal farnesoid X receptor signaling controls hepatic fatty acid oxidationRegulation of antibacterial defense in the small intestine by the nuclear bile acid receptorThe Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the IntestineA communal catalogue reveals Earth’s multiscale microbial diversityReproducible, interactive, scalable and extensible microbiome data science using QIIME 2DADA2: High-resolution sample inference from Illumina amplicon dataFast gapped-read alignment with Bowtie 2Trimmomatic: a flexible trimmer for Illumina sequence dataImproved metagenomic analysis with Kraken 2Bracken: estimating species abundance in metagenomics datametaSPAdes: a new versatile metagenomic assemblerMEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graphBinning metagenomic contigs by coverage and compositionMaxBin 2.0: an automated binning algorithm to recover genomes from multiple metagenomic datasetsMetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assembliesTaxator-tk: precise taxonomic assignment of metagenomes by fast approximation of evolutionary neighborhoodsGenomics and taxonomy in diagnostics for food security: soft-rotting enterobacterial plant pathogensProkka: rapid prokaryotic genome annotationDeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic dataCytoscape: a software environment for integrated models of biomolecular interaction networksMetscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networksProdigal: prokaryotic gene recognition and translation initiation site identificationVSEARCH: a versatile open source tool for metagenomicsMMseqs2 enables sensitive protein sequence searching for the analysis of massive data setsFast and sensitive protein alignment using DIAMONDMultivariable association discovery in population-scale meta-omics studiesNormalizing the environment recapitulates adult human immune traits in laboratory miceThe SILVA ribosomal RNA gene database project: improved data processing and web-based toolsMetatranscriptomics Reveals Antibiotic-Induced Resistance Gene Expression in the Murine Gut MicrobiotaStreptozotocin-induced hyperglycemia alters the cecal metabolome and exacerbates antibiotic-induced dysbiosisHigh-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometryStruo2: efficient metagenome profiling database construction for ever-expanding microbial genome datasets</div>
                            <small style="color: var(--text-muted)">12232608.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...02 unique molecular formulae. T-Tests for AMX vs. untreated sample...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...lowing exceptions: Figure 2A (p < 0.01 for inclusion of differential...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Selective plasticity of layer 2/3 inputs onto distal forelimb controlling layer 5 corticospinal neurons with skilled grasp motor trainingLesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learningFunctional reorganization of the rat motor cortex following motor skill learningIn search of the motor engram: motor map plasticity as a mechanism for encoding motor experienceEvidence for active synapse formation or altered postsynaptic metabolism in visual cortex of rats reared in complex environmentsMotor learning-dependent synaptogenesis is localized to functionally reorganized motor cortexEmergence of reproducible spatiotemporal activity during motor learningStructural plasticity within highly specific neuronal populations identifies a unique parcellation of motor learning in the adult brainReach training 508 selectively alters dendritic branching in subpopulations of layer IIII pyramids in rat motor-somatosensory forelimb cortexRapid formation and selective stabilization of synapses for enduring motor memoriesReorganization of recurrent layer 5 corticospinal networks following adult motor trainingThalamocortical projections onto behaviorally relevant neurons exhibit plasticity during adult motor learningCircuits for skilled reaching and graspingSublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortexPrimary motor cortex influences on the descending and ascending systemsStudy motor skill learning by single-pellet reaching tasks in miceDifferential contributions of rostral and caudal frontal forelimb areas to compensatory process after neonatal hemidecortication in ratsCircuit organization of the excitatory sensorimotor loop through hand/forelimb S1 and M1Organization of cortical and thalamic input to pyramidal neurons in mouse motor cortexLearning in the Rodent Motor CortexTop-down laminar organization of the excitatory network in motor cortexIn Utero Intraventricular Injection and Electroporation of E16 Rat EmbryosQuantitative analysis of cervical musculature in rats: histochemical composition and motor pool organization. II. Deep dorsal musclesCervical motoneuron topography reflects the proximodistal organization of muscles and movements of the rat forelimb: a retrograde carbocyanine dye analysisSpatial characterization of the motor neuron columns supplying the rat forelimbMotor cortex maturation is associated with reductions in recurrent connectivity among functional subpopulations and increases in intrinsic excitabilityStably maintained dendritic spines are associated with lifelong memoriesImprovements in the signal-448 to-noise ratio of motor cortex cells distinguish early versus late phases of motor skill learningThe role of variability in motor learningMultiple dynamic representations in the motor cortex during sensorimotor learningCholinergic modulation of skill learning and plasticityLearning-related fine-scale specificity imaged in motor cortex circuits of behaving miceTwo distinct layer-specific dynamics of cortical ensembles during learning of a motor taskDisengagement of motor cortex from movement control during long-term learningLearning-induced LTP in neocortexTargeted photostimulation uncovers circuit motifs supporting short-term memoryDREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utilitySkilled reaching relies on a V2a propriospinal internal copy circuitThe basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injuryUnique contributions of distinct cholinergic projections to motor cortical plasticity and learningThe structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory componentToward a neurocentric view of learning">Selective plasticity of layer 2/3 inputs onto distal forelimb controlling layer 5 corticospinal neurons with skilled grasp motor trainingLesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learningFunctional reorganization of the rat motor cortex following motor skill learningIn search of the motor engram: motor map plasticity as a mechanism for encoding motor experienceEvidence for active synapse formation or altered postsynaptic metabolism in visual cortex of rats reared in complex environmentsMotor learning-dependent synaptogenesis is localized to functionally reorganized motor cortexEmergence of reproducible spatiotemporal activity during motor learningStructural plasticity within highly specific neuronal populations identifies a unique parcellation of motor learning in the adult brainReach training 508 selectively alters dendritic branching in subpopulations of layer IIII pyramids in rat motor-somatosensory forelimb cortexRapid formation and selective stabilization of synapses for enduring motor memoriesReorganization of recurrent layer 5 corticospinal networks following adult motor trainingThalamocortical projections onto behaviorally relevant neurons exhibit plasticity during adult motor learningCircuits for skilled reaching and graspingSublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortexPrimary motor cortex influences on the descending and ascending systemsStudy motor skill learning by single-pellet reaching tasks in miceDifferential contributions of rostral and caudal frontal forelimb areas to compensatory process after neonatal hemidecortication in ratsCircuit organization of the excitatory sensorimotor loop through hand/forelimb S1 and M1Organization of cortical and thalamic input to pyramidal neurons in mouse motor cortexLearning in the Rodent Motor CortexTop-down laminar organization of the excitatory network in motor cortexIn Utero Intraventricular Injection and Electroporation of E16 Rat EmbryosQuantitative analysis of cervical musculature in rats: histochemical composition and motor pool organization. II. Deep dorsal musclesCervical motoneuron topography reflects the proximodistal organization of muscles and movements of the rat forelimb: a retrograde carbocyanine dye analysisSpatial characterization of the motor neuron columns supplying the rat forelimbMotor cortex maturation is associated with reductions in recurrent connectivity among functional subpopulations and increases in intrinsic excitabilityStably maintained dendritic spines are associated with lifelong memoriesImprovements in the signal-448 to-noise ratio of motor cortex cells distinguish early versus late phases of motor skill learningThe role of variability in motor learningMultiple dynamic representations in the motor cortex during sensorimotor learningCholinergic modulation of skill learning and plasticityLearning-related fine-scale specificity imaged in motor cortex circuits of behaving miceTwo distinct layer-specific dynamics of cortical ensembles during learning of a motor taskDisengagement of motor cortex from movement control during long-term learningLearning-induced LTP in neocortexTargeted photostimulation uncovers circuit motifs supporting short-term memoryDREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utilitySkilled reaching relies on a V2a propriospinal internal copy circuitThe basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injuryUnique contributions of distinct cholinergic projections to motor cortical plasticity and learningThe structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory componentToward a neurocentric view of learning</div>
                            <small style="color: var(--text-muted)">12529104.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...es 1F; 5E). Two-tailed paired t-tests to compare differences betwe...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...evel was defined as follows: *p < 0.05, **p < 0.01,***p > 0.005, ***...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Cost-effectiveness of posterior versus anterior surgery for cervical radiculopathy: results from a multicentre randomised non-inferiority trial (FACET)Cervical radiculopathyEpidemiology of cervical radiculopathy: a population-based study from rochester, minnesota, 1976 through 1990Surgical interventions for cervical radiculopathy without myelopathyCost-utility analysis of anterior cervical discectomy and fusion with plating (ACDFP) versus posterior cervical foraminotomy (PCF) for patients with single-level cervical radiculopathy at 1-year follow-upSingle-level anterior cervical discectomy and fusion versus minimally invasive posterior cervical foraminotomy for patients with cervical radiculopathy: a cost analysisManagement of unilateral cervical radiculopathy in the military: the cost effectiveness of posterior cervical foraminotomy compared with anterior cervical discectomy and fusionComparison of anterior cervical discectomy and fusion to posterior cervical foraminotomy for cervical radiculopathy: utilization, costs, and adverse events 2003 to 2014Study protocol for a randomised controlled multicentre study: the foraminotomy ACDF cost-effectiveness trial (FACET) in patients with cervical radiculopathyConsolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task forceUpdate of the Dutch manual for costing studies in health careMeasurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyDutch tariff for the five-level version of EQ-5DUpdate of the dutch manual for costing in economic evaluationsCost assessment and price setting of inpatient care in the Netherlands. The DBC case-mix systemThe iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity lossesThe friction cost method for measuring indirect costs of diseaseMultiple imputation in health-are databases: an overview and some applicationsCost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost dataMissing presumed at random: cost-analysis of incomplete dataAnalysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methodsVarying willingness to pay based on severity of illness: impact on health technology assessment outcomes of inpatient and outpatient drug therapies in the NetherlandsThe odom criteria: validated at last: a clinimetric evaluation in cervical spine surgeryCervical disk lesionsNeck pain and disability scale and neck disability index: validity of Dutch language versionsThe friction-cost method: Replacement for nothing and leisure for free?Economics of cervical disc replacementCost-effectiveness of anterior surgical decompression surgery for cervical degenerative disk disease: a systematic review of economic evaluations">Cost-effectiveness of posterior versus anterior surgery for cervical radiculopathy: results from a multicentre randomised non-inferiority trial (FACET)Cervical radiculopathyEpidemiology of cervical radiculopathy: a population-based study from rochester, minnesota, 1976 through 1990Surgical interventions for cervical radiculopathy without myelopathyCost-utility analysis of anterior cervical discectomy and fusion with plating (ACDFP) versus posterior cervical foraminotomy (PCF) for patients with single-level cervical radiculopathy at 1-year follow-upSingle-level anterior cervical discectomy and fusion versus minimally invasive posterior cervical foraminotomy for patients with cervical radiculopathy: a cost analysisManagement of unilateral cervical radiculopathy in the military: the cost effectiveness of posterior cervical foraminotomy compared with anterior cervical discectomy and fusionComparison of anterior cervical discectomy and fusion to posterior cervical foraminotomy for cervical radiculopathy: utilization, costs, and adverse events 2003 to 2014Study protocol for a randomised controlled multicentre study: the foraminotomy ACDF cost-effectiveness trial (FACET) in patients with cervical radiculopathyConsolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task forceUpdate of the Dutch manual for costing studies in health careMeasurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyDutch tariff for the five-level version of EQ-5DUpdate of the dutch manual for costing in economic evaluationsCost assessment and price setting of inpatient care in the Netherlands. The DBC case-mix systemThe iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity lossesThe friction cost method for measuring indirect costs of diseaseMultiple imputation in health-are databases: an overview and some applicationsCost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost dataMissing presumed at random: cost-analysis of incomplete dataAnalysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methodsVarying willingness to pay based on severity of illness: impact on health technology assessment outcomes of inpatient and outpatient drug therapies in the NetherlandsThe odom criteria: validated at last: a clinimetric evaluation in cervical spine surgeryCervical disk lesionsNeck pain and disability scale and neck disability index: validity of Dutch language versionsThe friction-cost method: Replacement for nothing and leisure for free?Economics of cervical disc replacementCost-effectiveness of anterior surgical decompression surgery for cervical degenerative disk disease: a systematic review of economic evaluations</div>
                            <small style="color: var(--text-muted)">12611986.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...ivity losses, were considered secondary outcomes. The costs of healthcare res...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Targeted therapy in advanced -mutated colorectal cancer: systematic review and network meta-analysis
-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic LandscapeClinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerEffects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisBRAF mutation in metastatic colorectal cancerANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated 
-Mutant Metastatic Colorectal CancerMetastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEuropean expert panel consensus on the clinical management of BRAF-mutant metastatic colorectal cancerAddition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trialsCetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusFOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studyUpfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialIndividual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal CancerFirst line therapy in stage IV BRAF mutated colorectal cancerPhase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerPIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenibUnresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFREncorafenib Plus Cetuximab as a New Standard of Care for Previously Treated  V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON StudyRandomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Encorafenib, Cetuximab, and mFOLFOX6 in -Mutated Colorectal CancerThe PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analysesPractical methods for incorporating summary time-to-event data into meta-analysis: updated guidancePractical methods for incorporating summary time-to-event data into meta-analysisRoB 2: a revised tool for assessing risk of bias in randomised trialsMethodological index for non-randomized studies (minors): development and validation of a new instrumentDevelopment, content validation, and reliability of the Assessment of Real-World Observational Studies (ArRoWS) critical appraisal toolGeneral Methods for Monitoring Convergence of Iterative SimulationsChecking consistency in mixed treatment comparison meta-analysisFOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 StudyBiweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialFOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerBevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trialThe influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial515MO Encorafenib + cetuximab (EC) + FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trialCombined PD-1, BRAF and MEK inhibition in BRAF colorectal cancer: a phase 2 trial624P Tolerability and safety of vemurafenib, cetuximab combined with camrelizumab for BRAF V600E-mutated /MSS metastatic colorectal cancerTunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I studyCobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With  Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyPhase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancerCombined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal CancerPilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patientsVemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsA Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) StudyUpdated results from ERAS-007 plus encorafenib and cetuximab (EC) in patients (pts) with EC-naïve metastatic BRAF V600E colorectal cancer (CRC) in the phase 1b/2 HERKULES-3 studyDabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialSafety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access ProgramBinimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With  V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyA Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal CancerPhase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationA phase ib-II study of dabrafenib, trametinib, cetuximab plus irinotecan in patients with BRAF mutant metastatic colorectal cancer: Subgroup analysis and biomarker identificationEfficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trialBevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trialPhase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupAddition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialMutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient OutcomeEfficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studyPanitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerFinal analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinomaFOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of 
-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudyLong-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal CancerImpact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) studyPhase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII studyFOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trialFOLFIRINOX plus cetuximab (CET) or bevacizumab (BEV) in patients (pts) with initially unresectable colorectal liver metastases (CRLM) with BRAF mutated (mut) tumors: A subgroup analysis of the UNICANCER PRODIGE 14-ACCORD 21 (METHEP2) trialVIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort StudyPhase 2 results: Encorafenib (ENCO) and cetuximab (CETUX) with or without alpelisib (ALP) in patients with advanced <i>BRAF-</i>mutant colorectal cancer (<i>BRAFm</i> CRC)Combined BRAF, EGFR, and MEK Inhibition in Patients with 
-Mutant Colorectal CancerPanitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trialAnalysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal CancerEncorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with <i>BRAF</i> V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study448P Efficacy of combinations of BRAF inhibitors and anti-EGFR antibodies in metastatic colorectal carcinoma (mCRC) patients with mBRAF in the real clinical practiceEncorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experienceEfficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter studyTreatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in ChinaWJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United StatesEncorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: First effectiveness data of the European multi-centric, multi-national, non-interventional study—BERING-CRCAdaptive mutability of colorectal cancers in response to targeted therapiesSEAMARK: randomized phase 2 study of pembrolizumab + encorafenib + cetuximab versus pembrolizumab alone for first-line treatment of BRAF V600E-mutant and microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC)Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer">Targeted therapy in advanced -mutated colorectal cancer: systematic review and network meta-analysis
-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic LandscapeClinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerEffects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisBRAF mutation in metastatic colorectal cancerANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated 
-Mutant Metastatic Colorectal CancerMetastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upEuropean expert panel consensus on the clinical management of BRAF-mutant metastatic colorectal cancerAddition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trialsCetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusFOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studyUpfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialIndividual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal CancerFirst line therapy in stage IV BRAF mutated colorectal cancerPhase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerPIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenibUnresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFREncorafenib Plus Cetuximab as a New Standard of Care for Previously Treated  V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON StudyRandomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Encorafenib, Cetuximab, and mFOLFOX6 in -Mutated Colorectal CancerThe PRISMA extension for network meta-analysis: bringing clarity and guidance to the reporting of systematic reviews incorporating network meta-analysesPractical methods for incorporating summary time-to-event data into meta-analysis: updated guidancePractical methods for incorporating summary time-to-event data into meta-analysisRoB 2: a revised tool for assessing risk of bias in randomised trialsMethodological index for non-randomized studies (minors): development and validation of a new instrumentDevelopment, content validation, and reliability of the Assessment of Real-World Observational Studies (ArRoWS) critical appraisal toolGeneral Methods for Monitoring Convergence of Iterative SimulationsChecking consistency in mixed treatment comparison meta-analysisFOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 StudyBiweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialFOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerBevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trialThe influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial515MO Encorafenib + cetuximab (EC) + FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trialCombined PD-1, BRAF and MEK inhibition in BRAF colorectal cancer: a phase 2 trial624P Tolerability and safety of vemurafenib, cetuximab combined with camrelizumab for BRAF V600E-mutated /MSS metastatic colorectal cancerTunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I studyCobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With  Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyPhase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancerCombined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal CancerPilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patientsVemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 MutationsA Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) StudyUpdated results from ERAS-007 plus encorafenib and cetuximab (EC) in patients (pts) with EC-naïve metastatic BRAF V600E colorectal cancer (CRC) in the phase 1b/2 HERKULES-3 studyDabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialSafety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAF-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access ProgramBinimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With  V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyA Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal CancerPhase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationA phase ib-II study of dabrafenib, trametinib, cetuximab plus irinotecan in patients with BRAF mutant metastatic colorectal cancer: Subgroup analysis and biomarker identificationEfficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trialBevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trialPhase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupAddition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialMutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient OutcomeEfficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studyPanitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancerFinal analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinomaFOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of 
-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudyLong-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal CancerImpact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) studyPhase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII studyFOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trialFOLFIRINOX plus cetuximab (CET) or bevacizumab (BEV) in patients (pts) with initially unresectable colorectal liver metastases (CRLM) with BRAF mutated (mut) tumors: A subgroup analysis of the UNICANCER PRODIGE 14-ACCORD 21 (METHEP2) trialVIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort StudyPhase 2 results: Encorafenib (ENCO) and cetuximab (CETUX) with or without alpelisib (ALP) in patients with advanced <i>BRAF-</i>mutant colorectal cancer (<i>BRAFm</i> CRC)Combined BRAF, EGFR, and MEK Inhibition in Patients with 
-Mutant Colorectal CancerPanitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trialAnalysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal CancerEncorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with <i>BRAF</i> V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study448P Efficacy of combinations of BRAF inhibitors and anti-EGFR antibodies in metastatic colorectal carcinoma (mCRC) patients with mBRAF in the real clinical practiceEncorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experienceEfficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter studyTreatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in ChinaWJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAF Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United StatesEncorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: First effectiveness data of the European multi-centric, multi-national, non-interventional study—BERING-CRCAdaptive mutability of colorectal cancers in response to targeted therapiesSEAMARK: randomized phase 2 study of pembrolizumab + encorafenib + cetuximab versus pembrolizumab alone for first-line treatment of BRAF V600E-mutant and microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC)Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer</div>
                            <small style="color: var(--text-muted)">12628362.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...V600E variants; we preferred blinded independent central review as...'}</li><li>{'message': 'Survival analysis used without verifying proportional hazards assumption.', 'evidence': '...reatment line), and outcomes (hazard ratios for overall survival and pro...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Cardiopulmonary coupling-calculated sleep stability and nocturnal heart rate kinetics as a potential indicator for cardiovascular health: a relationship with blood pressure dippingAutomated apnea-hypopnea index from oximetry and spectral analysis of cardiopulmonary couplingCardiopulmonary sleep spectrograms open a novel window into sleep biology—implications for health and diseaseWhat did we learn from the international databases on ambulatory and home blood pressure in relation to cardiovascular outcome?Validation of the Insomnia Severity Index as an outcome measure for insomnia researchEstimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysisTechnical advances in the characterization of the complexity of sleep and sleep disordersScaling up scientific discovery in sleep medicine: the national sleep research resourceNocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patientsMasked hypertension: understanding its complexityCPAP versus oxygen in obstructive sleep apneaObjective sleep quality and metabolic risk in healthy weight children results from the randomized Childhood Adenotonsillectomy Trial (CHAT)Baroreflex buffering of sympathetic activation during sleep: evidence from autonomic assessment of sleep macroarchitecture and microarchitectureSleep, slow-wave sleep, and blood pressureThe link between cardiac autonomic activity and sleep delta power is altered in men with sleep apnea-hypopnea syndromeThe effect of pulse rate and blood pressure dipping status on the risk of stroke and cardiovascular disease in Japanese hypertensive patientsCardiopulmonary coupling analysis: changes before and after treatment with a mandibular advancement deviceCardiopulmonary coupling-derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high-cardiovascular riskCan improvements in sleep quality positively affect serum adiponectin-levels in patients with obstructive sleep apnea?Sleep quality, sleep apnea, and metabolic health in children treated with adenotonsillectomyAssociation between treated and untreated obstructive sleep apnea and risk of hypertensionThe global epidemiology of hypertensionData lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at dischargeUsing the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeEuropean Society of Hypertension position paper on ambulatory blood pressure monitoringDippers and non-dippersPrognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama studySleep loss and hypertension: a systematic reviewMasked hypertensionAmbulatory blood-pressure monitoringPrognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysisElectrocardiogram-based sleep spectrogram measures of sleep stability and glucose disposal in sleep disordered breathingNight-time blood pressure patterns and target organ damage: a reviewprognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysisThe epidemiology of sleep disordered breathing and hypertension in various populationsPrevalence of obstructive sleep apnea in the general population: a systematic reviewRelationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patientsHeart rate variability, sleep and sleep disorders2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurementCo-morbid insomnia and sleep apnea (COMISA): prevalence, consequences, methodological considerations, and recent randomized controlled trialsHeart rate as a predictor of cardiovascular riskDifferentiating obstructive from central and complex sleep apnea using an automated electrocardiogram-based methodAn electrocardiogram-based technique to assess cardiopulmonary coupling during sleepImpaired sleep quality in fibromyalgia: detection and quantification with ECG-based cardiopulmonary coupling spectrogramsRelationship between delta power and the electrocardiogram-derived cardiopulmonary spectrogram: possible implications for assessing the effectiveness of sleepPrevalent hypertension and stroke in the Sleep Heart Health Study: association with an ECG-derived spectrographic marker of cardiopulmonary coupling2018 ESC/ESH Guidelines for the management of arterial hypertensionMulticomponent analysis of sleep using electrocortical, respiratory, autonomic and hemodynamic signals reveals distinct features of stable and unstable NREM and REM sleepSleep state instabilities in major depressive disorder: detection and quantification with electrocardiogram-based cardiopulmonary coupling analysisEnhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram methodNew insights and potential clinical implications of the odds ratio productOdds ratio product of sleep EEG as a continuous measure of sleep state">Cardiopulmonary coupling-calculated sleep stability and nocturnal heart rate kinetics as a potential indicator for cardiovascular health: a relationship with blood pressure dippingAutomated apnea-hypopnea index from oximetry and spectral analysis of cardiopulmonary couplingCardiopulmonary sleep spectrograms open a novel window into sleep biology—implications for health and diseaseWhat did we learn from the international databases on ambulatory and home blood pressure in relation to cardiovascular outcome?Validation of the Insomnia Severity Index as an outcome measure for insomnia researchEstimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysisTechnical advances in the characterization of the complexity of sleep and sleep disordersScaling up scientific discovery in sleep medicine: the national sleep research resourceNocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patientsMasked hypertension: understanding its complexityCPAP versus oxygen in obstructive sleep apneaObjective sleep quality and metabolic risk in healthy weight children results from the randomized Childhood Adenotonsillectomy Trial (CHAT)Baroreflex buffering of sympathetic activation during sleep: evidence from autonomic assessment of sleep macroarchitecture and microarchitectureSleep, slow-wave sleep, and blood pressureThe link between cardiac autonomic activity and sleep delta power is altered in men with sleep apnea-hypopnea syndromeThe effect of pulse rate and blood pressure dipping status on the risk of stroke and cardiovascular disease in Japanese hypertensive patientsCardiopulmonary coupling analysis: changes before and after treatment with a mandibular advancement deviceCardiopulmonary coupling-derived sleep quality is associated with improvements in blood pressure in patients with obstructive sleep apnea at high-cardiovascular riskCan improvements in sleep quality positively affect serum adiponectin-levels in patients with obstructive sleep apnea?Sleep quality, sleep apnea, and metabolic health in children treated with adenotonsillectomyAssociation between treated and untreated obstructive sleep apnea and risk of hypertensionThe global epidemiology of hypertensionData lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at dischargeUsing the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeEuropean Society of Hypertension position paper on ambulatory blood pressure monitoringDippers and non-dippersPrognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama studySleep loss and hypertension: a systematic reviewMasked hypertensionAmbulatory blood-pressure monitoringPrognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysisElectrocardiogram-based sleep spectrogram measures of sleep stability and glucose disposal in sleep disordered breathingNight-time blood pressure patterns and target organ damage: a reviewprognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysisThe epidemiology of sleep disordered breathing and hypertension in various populationsPrevalence of obstructive sleep apnea in the general population: a systematic reviewRelationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patientsHeart rate variability, sleep and sleep disorders2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurementCo-morbid insomnia and sleep apnea (COMISA): prevalence, consequences, methodological considerations, and recent randomized controlled trialsHeart rate as a predictor of cardiovascular riskDifferentiating obstructive from central and complex sleep apnea using an automated electrocardiogram-based methodAn electrocardiogram-based technique to assess cardiopulmonary coupling during sleepImpaired sleep quality in fibromyalgia: detection and quantification with ECG-based cardiopulmonary coupling spectrogramsRelationship between delta power and the electrocardiogram-derived cardiopulmonary spectrogram: possible implications for assessing the effectiveness of sleepPrevalent hypertension and stroke in the Sleep Heart Health Study: association with an ECG-derived spectrographic marker of cardiopulmonary coupling2018 ESC/ESH Guidelines for the management of arterial hypertensionMulticomponent analysis of sleep using electrocortical, respiratory, autonomic and hemodynamic signals reveals distinct features of stable and unstable NREM and REM sleepSleep state instabilities in major depressive disorder: detection and quantification with electrocardiogram-based cardiopulmonary coupling analysisEnhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram methodNew insights and potential clinical implications of the odds ratio productOdds ratio product of sleep EEG as a continuous measure of sleep state</div>
                            <small style="color: var(--text-muted)">12713940.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Detected high number of P-values (8) without explicit mention of multiplicity correction.', 'evidence': '...e coefficient, the associated p-value, and an R2 for model fit. Whi...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Elucidating the Mechanism of Jisheng Shenqi Pills in the Treatment of Diabetic Kidney Disease: Network Pharmacology Combined with Experimental VerificationIDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.US renal data system 2020 annual data report: Epidemiology of kidney disease in the United States.Fecal microbiota transplant in a pre-clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease.Diabetic kidney disease.Genome-wide association studies reconstructing chronic kidney disease.Unveiling the vital role of long non-coding RNAs in cardiac oxidative stress, cell death, and fibrosis in diabetic cardiomyopathy.The role of platelets in diabetic kidney disease.Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy.Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy.Trajectories of kidney function in diabetes: A clinicopathological update.Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review.The role of histone modifications in the pathogenesis of diabetic kidney disease.New strategies to improve clinical outcomes for diabetic kidney disease.The role of sodium-glucose cotransporter-2 inhibitors in the treatment paradigm of CKD in Africa: An African association of nephrology panel position paper.11. Microvascular complications and foot care: .AA amyloidosis: A contemporary view.Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus.Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes.Linagliptin protects against endotoxin-induced acute kidney injury in rats by decreasing inflammatory cytokines and reactive oxygen species.Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy.Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease.Long noncoding  Glis2 regulates podocyte mitochondrial dysfunction and apoptosis in diabetic nephropathy  sponging -328-5p.Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling.Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis  modulating protein stability of β-catenin and β-catenin-mediated transcription.Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis  an estrogen-like pathway.TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches.Combining network pharmacology, molecular docking, molecular dynamics simulation, and experimental verification to examine the efficacy and immunoregulation mechanism of FHB granules on vitiligo.Network pharmacology and molecular docking study of the chinese miao medicine sidaxue in the treatment of rheumatoid arthritis.Molecular docking: Shifting paradigms in drug discovery.Hepatitis C virus NS3/4A inhibition and host immunomodulation by tannins from : A structural perspective.Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and  validation.DrugBank 5.0: A major update to the DrugBank database for 2018.TTD:  describing target druggability information.OMIM.org: Online mendelian inheritance in man (OMIM®), an online catalog of human genes and genetic disorders.jvenn: An interactive Venn diagram viewer.The STRING database in 2023: Protein–protein association networks and functional enrichment analyses for any sequenced genome of interest.Cytoscape Automation: Empowering workflow-based network analysis.Mechanism of  decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings.In , solving software challenges for exascale.Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.Effects of  ssp.  SA-03 supplementation on reversing phthalate-induced asthma in mice.Exploring the molecular mechanism of action of yinchen wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation.Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the “gut-kidney axis”.Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.Emodin attenuates diabetic kidney disease by inhibiting ferroptosis  upregulating Nrf2 expression.Quercetin: Its main pharmacological activity and potential application in clinical medicine.Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review.Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways.Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion.Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K/Akt/NF-κB signaling pathways.Beta-sitosterol attenuates insulin resistance in adipose tissue  IRS-1/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats.Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis.Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism.Dehydroeburicoic acid from antrodia camphorata prevents the diabetic and dyslipidemic state  modulation of glucose transporter 4, peroxisome proliferator-activated receptor α expression and AMP-activated protein kinase phosphorylation in high-fat-fed mice.Creatinine: From physiology to clinical application.Long-term statins administration exacerbates diabetic nephropathy  ectopic fat deposition in diabetic mice.Macrophage phenotype and fibrosis in diabetic nephropathy.Targeting inflammation to treat diabetic kidney disease: The road to 2030.Necroptosis, pyroptosis and apoptosis: An intricate game of cell death.Mitophagy restricts BAX/BAK-independent, Parkin-mediated apoptosis.Icariside II attenuates cerebral ischemia/reperfusion-induced blood–brain barrier dysfunction in rats  regulating the balance of MMP9/TIMP1.Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway.Cleaved caspase-3 is present in the majority of glial cells in the intact rat spinal cord during postnatal life.AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review.PI3K/AKT activation attenuates acute kidney injury following liver transplantation by inducing FoxO3a nuclear export and deacetylation.Integrative analyses of antler cartilage transcriptome and proteome of gansu red deer () at different growth stages.METTL14-regulated PI3K/Akt signaling pathway  PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease.MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: Mechanistic details and biological implications for cancer therapy.N-acetylserotonin protects PC12 cells from hydrogen peroxide induced damage through ROS mediated PI3K / AKT pathway.">Elucidating the Mechanism of Jisheng Shenqi Pills in the Treatment of Diabetic Kidney Disease: Network Pharmacology Combined with Experimental VerificationIDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.US renal data system 2020 annual data report: Epidemiology of kidney disease in the United States.Fecal microbiota transplant in a pre-clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease.Diabetic kidney disease.Genome-wide association studies reconstructing chronic kidney disease.Unveiling the vital role of long non-coding RNAs in cardiac oxidative stress, cell death, and fibrosis in diabetic cardiomyopathy.The role of platelets in diabetic kidney disease.Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy.Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy.Trajectories of kidney function in diabetes: A clinicopathological update.Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review.The role of histone modifications in the pathogenesis of diabetic kidney disease.New strategies to improve clinical outcomes for diabetic kidney disease.The role of sodium-glucose cotransporter-2 inhibitors in the treatment paradigm of CKD in Africa: An African association of nephrology panel position paper.11. Microvascular complications and foot care: .AA amyloidosis: A contemporary view.Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus.Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes.Linagliptin protects against endotoxin-induced acute kidney injury in rats by decreasing inflammatory cytokines and reactive oxygen species.Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy.Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease.Long noncoding  Glis2 regulates podocyte mitochondrial dysfunction and apoptosis in diabetic nephropathy  sponging -328-5p.Loganin and catalpol exert cooperative ameliorating effects on podocyte apoptosis upon diabetic nephropathy by targeting AGEs-RAGE signaling.Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis  modulating protein stability of β-catenin and β-catenin-mediated transcription.Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis  an estrogen-like pathway.TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches.Combining network pharmacology, molecular docking, molecular dynamics simulation, and experimental verification to examine the efficacy and immunoregulation mechanism of FHB granules on vitiligo.Network pharmacology and molecular docking study of the chinese miao medicine sidaxue in the treatment of rheumatoid arthritis.Molecular docking: Shifting paradigms in drug discovery.Hepatitis C virus NS3/4A inhibition and host immunomodulation by tannins from : A structural perspective.Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and  validation.DrugBank 5.0: A major update to the DrugBank database for 2018.TTD:  describing target druggability information.OMIM.org: Online mendelian inheritance in man (OMIM®), an online catalog of human genes and genetic disorders.jvenn: An interactive Venn diagram viewer.The STRING database in 2023: Protein–protein association networks and functional enrichment analyses for any sequenced genome of interest.Cytoscape Automation: Empowering workflow-based network analysis.Mechanism of  decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.AutoDock vina 1.2.0: New docking methods, expanded force field, and python bindings.In , solving software challenges for exascale.Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.Effects of  ssp.  SA-03 supplementation on reversing phthalate-induced asthma in mice.Exploring the molecular mechanism of action of yinchen wuling powder for the treatment of hyperlipidemia, using network pharmacology, molecular docking, and molecular dynamics simulation.Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the “gut-kidney axis”.Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.Emodin attenuates diabetic kidney disease by inhibiting ferroptosis  upregulating Nrf2 expression.Quercetin: Its main pharmacological activity and potential application in clinical medicine.Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review.Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways.Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion.Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K/Akt/NF-κB signaling pathways.Beta-sitosterol attenuates insulin resistance in adipose tissue  IRS-1/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats.Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis.Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism.Dehydroeburicoic acid from antrodia camphorata prevents the diabetic and dyslipidemic state  modulation of glucose transporter 4, peroxisome proliferator-activated receptor α expression and AMP-activated protein kinase phosphorylation in high-fat-fed mice.Creatinine: From physiology to clinical application.Long-term statins administration exacerbates diabetic nephropathy  ectopic fat deposition in diabetic mice.Macrophage phenotype and fibrosis in diabetic nephropathy.Targeting inflammation to treat diabetic kidney disease: The road to 2030.Necroptosis, pyroptosis and apoptosis: An intricate game of cell death.Mitophagy restricts BAX/BAK-independent, Parkin-mediated apoptosis.Icariside II attenuates cerebral ischemia/reperfusion-induced blood–brain barrier dysfunction in rats  regulating the balance of MMP9/TIMP1.Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway.Cleaved caspase-3 is present in the majority of glial cells in the intact rat spinal cord during postnatal life.AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review.PI3K/AKT activation attenuates acute kidney injury following liver transplantation by inducing FoxO3a nuclear export and deacetylation.Integrative analyses of antler cartilage transcriptome and proteome of gansu red deer () at different growth stages.METTL14-regulated PI3K/Akt signaling pathway  PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease.MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation.Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: Mechanistic details and biological implications for cancer therapy.N-acetylserotonin protects PC12 cells from hydrogen peroxide induced damage through ROS mediated PI3K / AKT pathway.</div>
                            <small style="color: var(--text-muted)">12715395.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-AnalysisValvular heart disease: new concepts in pathophysiology and therapeutic approachesAtrial fibrillation: pathogenesis, predisposing factors, and genetics2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelinesImpact of valvular heart disease on mortality, thromboembolic and cardiac events in japanese patients with atrial fibrillation - the Fushimi AF RegistryThromboembolic risk in nonanticoagulated patients with atrial fibrillation and valvular heart diseaseAntithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology working group on thrombosis, endorsed by the ESC working group on valvular heart disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “real-world” Michigan anticoagulation quality improvement initiative (MAQI(2)) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trialsEstimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelinesMitral valve disease, systemic embolism and anticoagulantsDabigatran versus warfarin in patients with mechanical heart valvesRivaroxaban in rheumatic heart disease-associated atrial fibrillationApixaban or warfarin in patients with an on-x mechanical aortic valveType 2 valvular heart disease affects decision making for anticoagulation in patients with atrial fibrillation: the UMBRIA-fibrillazione atriale prospective studyThe PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanationsDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patientsEdoxaban versus vitamin K antagonist for atrial fibrillation after TAVRRivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valveValvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 TrialComparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY trial (randomized evaluation of long-term anticoagulant therapy)Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot studyApixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialClinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trialEfficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trialEdoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valvesAtrial fibrillation management: a prospective survey in ESC member countries: the Euro heart survey on atrial fibrillationNon-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart diseaseWhat is ‘valvular’ atrial fibrillation?Prescription patterns of non-vitamin K oral anticoagulants across indications and factors associated with their increased prescribing in atrial fibrillation between 2012–2015: a study from the Norwegian prescription databaseTrends in the prescription of novel oral anticoagulants in UK primary careCost-effectiveness analysis of direct oral anticoagulants vs vitamin K antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world setting">Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-AnalysisValvular heart disease: new concepts in pathophysiology and therapeutic approachesAtrial fibrillation: pathogenesis, predisposing factors, and genetics2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelinesImpact of valvular heart disease on mortality, thromboembolic and cardiac events in japanese patients with atrial fibrillation - the Fushimi AF RegistryThromboembolic risk in nonanticoagulated patients with atrial fibrillation and valvular heart diseaseAntithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology working group on thrombosis, endorsed by the ESC working group on valvular heart disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “real-world” Michigan anticoagulation quality improvement initiative (MAQI(2)) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trialsEstimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelinesMitral valve disease, systemic embolism and anticoagulantsDabigatran versus warfarin in patients with mechanical heart valvesRivaroxaban in rheumatic heart disease-associated atrial fibrillationApixaban or warfarin in patients with an on-x mechanical aortic valveType 2 valvular heart disease affects decision making for anticoagulation in patients with atrial fibrillation: the UMBRIA-fibrillazione atriale prospective studyThe PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanationsDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patientsEdoxaban versus vitamin K antagonist for atrial fibrillation after TAVRRivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valveValvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 TrialComparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY trial (randomized evaluation of long-term anticoagulant therapy)Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot studyApixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialClinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trialEfficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trialEdoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valvesAtrial fibrillation management: a prospective survey in ESC member countries: the Euro heart survey on atrial fibrillationNon-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart diseaseWhat is ‘valvular’ atrial fibrillation?Prescription patterns of non-vitamin K oral anticoagulants across indications and factors associated with their increased prescribing in atrial fibrillation between 2012–2015: a study from the Norwegian prescription databaseTrends in the prescription of novel oral anticoagulants in UK primary careCost-effectiveness analysis of direct oral anticoagulants vs vitamin K antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world setting</div>
                            <small style="color: var(--text-muted)">12717196.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Detected high number of P-values (9) without explicit mention of multiplicity correction.', 'evidence': '...ss statistical heterogeneity. P\u2009>\u20090.1 and I2\u2009<\u200950% indicated no sta...'}</li><li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...d controlled trial, DB double-blinded, VHD valvular heart disease,...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate AblationA Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation: Erratum.A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation: Erratum.Editorial Comment.Editorial Comment.Cancer statistics, 2021Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trialMRI-targeted, systematic, and combined biopsy for prostate cancer diagnosisPeptide mediated in vivo tumor targeting of nanoparticles through optimization in single and multilayer in vitro cell modelsDetermining the size and shape dependence of gold nanoparticle uptake into mammalian cellsToxicologic effects of gold nanoparticles in vivo by different administration routesUnderstanding and overcoming major barriers in cancer nanomedicineDiagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyMRI-targeted or standard biopsy for prostate-cancer diagnosisFinal results of a phase I/II multicenter trial of WST11 vascular targeted photodynamic therapy for hemi-ablation of the prostate in men with unilateral low risk prostate cancer performed in the United StatesProstate radiofrequency focal ablation (ProRAFT) trial: a prospective development study evaluating a bipolar radiofrequency device to treat prostate cancerProspective multicenter phase II study on focal therapy (hemiablation) of the prostate with high intensity focused ultrasoundFocal laser ablation of prostate cancer: phase I clinical trialNanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceSelective nanoparticle-directed ablation of the canine prostateGold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device studyStandardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus projectExtensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasoundTargeted focal therapy for the management of organ confined prostate cancerOncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohortProstate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancerAssociations between prostate volume and oncologic outcomes in men undergoing focal cryoablation of the prostateRadiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerOptimizing cancer treatments to induce an acute immune response: radiation abscopal effects, PAMPs, and DAMPsEnhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapyA multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancerEarly-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry">A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate AblationA Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation: Erratum.A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation: Erratum.Editorial Comment.Editorial Comment.Cancer statistics, 2021Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trialMRI-targeted, systematic, and combined biopsy for prostate cancer diagnosisPeptide mediated in vivo tumor targeting of nanoparticles through optimization in single and multilayer in vitro cell modelsDetermining the size and shape dependence of gold nanoparticle uptake into mammalian cellsToxicologic effects of gold nanoparticles in vivo by different administration routesUnderstanding and overcoming major barriers in cancer nanomedicineDiagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyMRI-targeted or standard biopsy for prostate-cancer diagnosisFinal results of a phase I/II multicenter trial of WST11 vascular targeted photodynamic therapy for hemi-ablation of the prostate in men with unilateral low risk prostate cancer performed in the United StatesProstate radiofrequency focal ablation (ProRAFT) trial: a prospective development study evaluating a bipolar radiofrequency device to treat prostate cancerProspective multicenter phase II study on focal therapy (hemiablation) of the prostate with high intensity focused ultrasoundFocal laser ablation of prostate cancer: phase I clinical trialNanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceSelective nanoparticle-directed ablation of the canine prostateGold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device studyStandardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus projectExtensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasoundTargeted focal therapy for the management of organ confined prostate cancerOncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohortProstate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancerAssociations between prostate volume and oncologic outcomes in men undergoing focal cryoablation of the prostateRadiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerOptimizing cancer treatments to induce an acute immune response: radiation abscopal effects, PAMPs, and DAMPsEnhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapyA multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancerEarly-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry</div>
                            <small style="color: var(--text-muted)">12721635.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...for statistical analyses. The missing data were not imputed. Treatment s...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialBreaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovationEditorial Comment.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunctionThe prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) studyThe prevalence of urinary incontinence in women in four European countriesEpidemiologic survey of lower urinary tract symptoms in JapanPrevalence and risk factors of urinary incontinence in Chinese women: a population-based studyImpact of female stress urinary incontinence on quality of life, mental health, work limitation, and healthcare seeking in China, Taiwan, and South Korea (LUTS Asia): results from a cross-sectional, population-based studyEffects of urinary incontinence subtypes on women's sexual function and quality of lifeFemale urinary incontinence and wellbeing: results from a multi-national surveyUpdates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU Guideline (2023)Yentreve (duloxetine): Summary of Product CharacteristicsSerotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adultsAssociation between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trialsConsidering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reportsEffect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinenceNeurophysiology and therapeutic receptor targets for stress urinary incontinenceTAS-303, a novel selective norepinephrine reuptake inhibitor that increases urethral pressure in rats, indicating its potential as a therapeutic agent for stress urinary incontinenceSafety and pharmacokinetics of high-dose TAS-303 in healthy Japanese volunteers: a single-center, single-blind, randomized, placebo-controlled, parallel-group, multiple-ascending-dose studyTAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I studyEfficacy and safety of the noradrenaline reuptake inhibitor, TAS-303, in women with stress urinary incontinence: results of a double-blind, randomized, placebo-controlled, early phase II trialValidation of two global impression questionnaires for incontinenceQuality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOLDuloxetine versus placebo in the treatment of stress urinary incontinenceDuloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trialThe effect of group or individualised pelvic floor exercises with or without ultrasonography guidance for urinary incontinence in elderly women—a pilot studyDoes it work in the long term? A systematic review on pelvic floor muscle training for female stress urinary incontinenceThe effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinenceGuidance for industry and Food and Drug Administration staff: clinical investigations of devices indicated for the treatment of urinary incontinenceMinimal clinically important differences in incontinence quality-of-life scores in stress urinary incontinence">Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled TrialBreaking barriers in stress urinary incontinence care: TAS-303 as a game-changer in pharmacological innovationEditorial Comment.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunctionThe prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) studyThe prevalence of urinary incontinence in women in four European countriesEpidemiologic survey of lower urinary tract symptoms in JapanPrevalence and risk factors of urinary incontinence in Chinese women: a population-based studyImpact of female stress urinary incontinence on quality of life, mental health, work limitation, and healthcare seeking in China, Taiwan, and South Korea (LUTS Asia): results from a cross-sectional, population-based studyEffects of urinary incontinence subtypes on women's sexual function and quality of lifeFemale urinary incontinence and wellbeing: results from a multi-national surveyUpdates to surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU Guideline (2023)Yentreve (duloxetine): Summary of Product CharacteristicsSerotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adultsAssociation between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trialsConsidering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reportsEffect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinenceNeurophysiology and therapeutic receptor targets for stress urinary incontinenceTAS-303, a novel selective norepinephrine reuptake inhibitor that increases urethral pressure in rats, indicating its potential as a therapeutic agent for stress urinary incontinenceSafety and pharmacokinetics of high-dose TAS-303 in healthy Japanese volunteers: a single-center, single-blind, randomized, placebo-controlled, parallel-group, multiple-ascending-dose studyTAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I studyEfficacy and safety of the noradrenaline reuptake inhibitor, TAS-303, in women with stress urinary incontinence: results of a double-blind, randomized, placebo-controlled, early phase II trialValidation of two global impression questionnaires for incontinenceQuality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOLDuloxetine versus placebo in the treatment of stress urinary incontinenceDuloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trialThe effect of group or individualised pelvic floor exercises with or without ultrasonography guidance for urinary incontinence in elderly women—a pilot studyDoes it work in the long term? A systematic review on pelvic floor muscle training for female stress urinary incontinenceThe effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinenceGuidance for industry and Food and Drug Administration staff: clinical investigations of devices indicated for the treatment of urinary incontinenceMinimal clinically important differences in incontinence quality-of-life scores in stress urinary incontinence</div>
                            <small style="color: var(--text-muted)">12721661.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...ariance) model; there were no missing data in the PPS, and in the supple...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="IDEAL–compliant implementation of the Dexter surgical robot in cholecystectomy: a comprehensive framework and clinical outcomesRobotic surgery: a comprehensive review of the literature and current trendsEvolution of the digital operating room: the place of video technology in surgeryA review of robotic thoracic surgery adoption and future innovationsInnovations in minimally invasive surgery: the rise of smart flexible surgical robotsClinical applications of robotic surgery platforms: a comprehensive reviewThe IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoringFrom Leonardo to da Vinci: the history of robot‐assisted surgery in urologyThe diffusion of robotic surgery: examining technology use in the English NHSRobotic revolution in surgery: diverse applications across specialties and future prospects review articleEmerging robotic platforms for minimally invasive surgeryArtificial intelligence: revolutionizing robotic surgery: reviewNo surgical innovation without evaluation: the IDEAL recommendationsQuality of reporting of robot-assisted cholecystectomy in relation to the IDEAL recommendations: systematic reviewRobotic cholecystectomy: training of residents in use of the robotic platformCholecystectomy by using a surgical robotic systemRobot-assisted radical prostatectomy with the dexter robotic system: initial experience and insights into on-demand roboticsThe first robotic-assisted hysterectomy below the bikini line with the Dexter robotic system™Expanding robotic-assisted surgery in gynecology using the potential of an advanced robotic systemFeasibility of on-demand robotics in colorectal surgery: first casesFirst ever radical prostatectomy performed with the new dexter robotic system™On-demand robotics–the best of both worlds for robotic-assisted laparoscopic surgeryThe combination of laparoscopic and robotic surgery: first experience with the dexter robotic System™ in visceral surgeryEffect of a surgical training programme on outcome of rectal cancer in the County of StockholmSurgical simulation: the value of individualizationIntegration of robotic surgery into routine practice and impacts on communication, collaboration, and decision making: a realist process evaluation protocolThe introduction of an emergency safety protocol coupled with simulation training in robotic surgery, has enabled a more cohesive and efficient response to emergenciesDoes operative time affect complication rate in laparoscopic cholecystectomyImplementation of the dexter robot system in daily practice - first experiences in gall bladder and hernia surgeryRobotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic reviewResearch quality and transparency, outcome measurement and evidence for safety and effectiveness in robot-assisted surgery: systematic reviewOutcomes of robot-assisted surgery in rectal cancer compared with open and laparoscopic surgery[After inconspicuous elective laparoscopic cholecystectomy patients can be discharged without control of laboratory parameters]National analysis of cost disparities in robotic-assisted versus laparoscopic abdominal operationsDo the costs of robotic surgery present an insurmountable obstacle? A narrative reviewRobotic-assisted versus laparoscopic proctectomy with ileal pouch-anal anastomosis for ulcerative colitis: an analysis of clinical and financial outcomes from a tertiary referral centerCarbon footprint of robotically-assisted laparoscopy, laparoscopy and laparotomy: a comparisonNew robotic platforms in general surgery: what’s the current clinical scenario?">IDEAL–compliant implementation of the Dexter surgical robot in cholecystectomy: a comprehensive framework and clinical outcomesRobotic surgery: a comprehensive review of the literature and current trendsEvolution of the digital operating room: the place of video technology in surgeryA review of robotic thoracic surgery adoption and future innovationsInnovations in minimally invasive surgery: the rise of smart flexible surgical robotsClinical applications of robotic surgery platforms: a comprehensive reviewThe IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoringFrom Leonardo to da Vinci: the history of robot‐assisted surgery in urologyThe diffusion of robotic surgery: examining technology use in the English NHSRobotic revolution in surgery: diverse applications across specialties and future prospects review articleEmerging robotic platforms for minimally invasive surgeryArtificial intelligence: revolutionizing robotic surgery: reviewNo surgical innovation without evaluation: the IDEAL recommendationsQuality of reporting of robot-assisted cholecystectomy in relation to the IDEAL recommendations: systematic reviewRobotic cholecystectomy: training of residents in use of the robotic platformCholecystectomy by using a surgical robotic systemRobot-assisted radical prostatectomy with the dexter robotic system: initial experience and insights into on-demand roboticsThe first robotic-assisted hysterectomy below the bikini line with the Dexter robotic system™Expanding robotic-assisted surgery in gynecology using the potential of an advanced robotic systemFeasibility of on-demand robotics in colorectal surgery: first casesFirst ever radical prostatectomy performed with the new dexter robotic system™On-demand robotics–the best of both worlds for robotic-assisted laparoscopic surgeryThe combination of laparoscopic and robotic surgery: first experience with the dexter robotic System™ in visceral surgeryEffect of a surgical training programme on outcome of rectal cancer in the County of StockholmSurgical simulation: the value of individualizationIntegration of robotic surgery into routine practice and impacts on communication, collaboration, and decision making: a realist process evaluation protocolThe introduction of an emergency safety protocol coupled with simulation training in robotic surgery, has enabled a more cohesive and efficient response to emergenciesDoes operative time affect complication rate in laparoscopic cholecystectomyImplementation of the dexter robot system in daily practice - first experiences in gall bladder and hernia surgeryRobotic surgery in comparison to the open and laparoscopic approaches in the field of urology: a systematic reviewResearch quality and transparency, outcome measurement and evidence for safety and effectiveness in robot-assisted surgery: systematic reviewOutcomes of robot-assisted surgery in rectal cancer compared with open and laparoscopic surgery[After inconspicuous elective laparoscopic cholecystectomy patients can be discharged without control of laboratory parameters]National analysis of cost disparities in robotic-assisted versus laparoscopic abdominal operationsDo the costs of robotic surgery present an insurmountable obstacle? A narrative reviewRobotic-assisted versus laparoscopic proctectomy with ileal pouch-anal anastomosis for ulcerative colitis: an analysis of clinical and financial outcomes from a tertiary referral centerCarbon footprint of robotically-assisted laparoscopy, laparoscopy and laparotomy: a comparisonNew robotic platforms in general surgery: what’s the current clinical scenario?</div>
                            <small style="color: var(--text-muted)">12724488.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...deviation (SD). The unpaired t-test was utilized to compare the m...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from IndiaGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesOvarian carcinomas: at least five different diseases with distinct histological features and molecular geneticsThe WHO Classification of Tumours. Female Genital TumoursWhat is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization Classification of Female Genital TumorsWhat is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsyPatterns of pelvic and paraaortic lymph node involvement in ovarian cancerEpidemiology of ovarian cancer: a reviewClinical validation and comparison of the comprehensive complication index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancerTrends and outcomes of women with synchronous endometrial and ovarian cancerHistological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women StudyEpidemiology of epithelial ovarian cancer: a tertiary hospital based study in Goa, IndiaInternational patterns and trends in ovarian cancer incidence, overall and by histologic subtypeEpidemiology of epithelial ovarian cancerHistologic subtypes of ovarian carcinoma: selected diagnostic and classification problems in Bulgaria: is low hospital volume an issue?Ovarian cancer statistics, 2018CT scan in the prediction of lymph node involvement in ovarian cancer: a retrospective analysis of a tertiary gyneco-oncological unitRisk factors for lymph node metastasis in ovarian cancer: implications for systematic lymphadenectomyThe attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: a systematic review and meta-analysisEvaluation of factors affecting lymph node metastasis in clinical stage I–II epithelial ovarian cancerRelevance of pelvic and para-aortic node metastases in early-stage ovarian cancerRisk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical stagingLymph node metastasis in stages I and II ovarian cancer: a review">Spectrum of Surgico-Pathological Factors and Lymph Node Metastasis among Epithelial Ovarian Cancers: Experience of a Single Tertiary Care Institution from IndiaGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesOvarian carcinomas: at least five different diseases with distinct histological features and molecular geneticsThe WHO Classification of Tumours. Female Genital TumoursWhat is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization Classification of Female Genital TumorsWhat is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsyPatterns of pelvic and paraaortic lymph node involvement in ovarian cancerEpidemiology of ovarian cancer: a reviewClinical validation and comparison of the comprehensive complication index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancerTrends and outcomes of women with synchronous endometrial and ovarian cancerHistological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women StudyEpidemiology of epithelial ovarian cancer: a tertiary hospital based study in Goa, IndiaInternational patterns and trends in ovarian cancer incidence, overall and by histologic subtypeEpidemiology of epithelial ovarian cancerHistologic subtypes of ovarian carcinoma: selected diagnostic and classification problems in Bulgaria: is low hospital volume an issue?Ovarian cancer statistics, 2018CT scan in the prediction of lymph node involvement in ovarian cancer: a retrospective analysis of a tertiary gyneco-oncological unitRisk factors for lymph node metastasis in ovarian cancer: implications for systematic lymphadenectomyThe attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: a systematic review and meta-analysisEvaluation of factors affecting lymph node metastasis in clinical stage I–II epithelial ovarian cancerRelevance of pelvic and para-aortic node metastases in early-stage ovarian cancerRisk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical stagingLymph node metastasis in stages I and II ovarian cancer: a review</div>
                            <small style="color: var(--text-muted)">12727006.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Transformer technology in molecular scienceMachine learning and the physical sciencesOpportunities and obstacles for deep learning in biology and medicineDeep learning-based feature engineering methods for improved building energy predictionDeep learning—a technology with the potential to transform health careTransformer architecture and attention mechanisms in genome data analysis: a comprehensive reviewProbabilistic generative transformer language models for generative design of moleculesMachine learning methods for small data challenges in molecular scienceScientific discovery in the age of artificial intelligenceTransformer-based deep learning for predicting protein properties in the life sciencesABT-MPNN: an atom-bond transformer-based message-passing neural network for molecular property predictionClassification of highly divergent viruses from DNA/RNA sequence using transformer-based modelsLarge language model for molecular chemistryLocal self-attention in transformer for visual question answeringA systematic study of key elements underlying molecular property predictionFsmddtr: end-to-end feedback strategy for multi-objective de novo drug design using transformersMultiscale topology-enabled structure-to-sequence transformer for protein–ligand interaction predictionsExploring the applicability of transfer learning and feature engineering in epilepsy prediction using hybrid transformer modelAlgebraic graph-assisted bidirectional transformers for molecular property predictionRobustness verification for transformersUnderstanding the robustness in vision transformersMultiscale modeling at the interface of molecular mechanics and natural language through attention neural networksDeeptrasynergy: drug combinations using multimodal deep learning with transformersConsidering the possibilities and pitfalls of generative pretrained transformer 3 (GPT-3) in healthcare deliveryChat generative pre-trained transformer (ChatGPT) usage in healthcareCompressing large-scale transformer-based models: a case study on BERTPseudocode generation from source code using the BART modelTB-BCG: topic-based BART counterfeit generator for fake news detectionGraph transformer for graph-to-sequence learningHierarchical graph transformer with adaptive node samplingTransformer-XL with graph neural network for source code summarizationExploring the limits of transfer learning with a unified text-to-text transformerEnd-to-end generation of multiple choice questions using text-to-text transfer transformer modelsMultiscale vision transformersVision transformers for dense predictionYou only look at one sequence: rethinking transformer in vision through object detectionConformer: local features coupling global representations for visual recognitionContrastive language-image pre-training with knowledge graphsNon-contrastive learning meets language-image pre-trainingO (n) connections are expressive enough: universal approximability of sparse transformersEDGEVITS: competing light-weight cnns on mobile devices with vision transformersAttention is all you needA review on the attention mechanism of deep learningGet the point of my utterance! Learning towards effective responses with multi-head attention mechanismAnalyzing multi-head self-attention: specialized heads do the heavy lifting, the rest can be prunedUnderstanding convolutional neural networks for text classificationHardware accelerator for multi-head attention and position-wise feed-forward in the transformerApplications of transformer-based language models in bioinformatics: a surveyChangemask: deep multi-task encoder-transformer-decoder architecture for semantic change detectionMore than encoder: introducing transformer decoder to upsampleImproving language understanding by generative pre-trainingGpttoo: a language-model-first approach for AMR-to-text generationA text generation and prediction system: pretraining on new corpora using BERT and GPT-2Translating radiology reports into plain language using ChatGPT and GPT-4 with prompt learning: results, limitations, and potentialSentence augmentation for language translation using GPT-2The effectiveness of T5, GPT-2, and BERT on text-to-image generation taskRevolutionizing radiology with gpt-based models: current applications, future possibilities and limitations of ChatGPTMolgpt: molecular generation using a transformer-decoder modelEmpowering molecule discovery for molecule-caption translation with large language models: a ChatGPT perspectiveAutomatic generation of SBML kinetic models from natural language texts using GPTChatGPT in drug discovery: a case study on anticocaine addiction drug development with chatbotscmolgpt: a conditional generative pre-trained transformer for target-specific de novo molecular generationEfficient and enhanced sampling of drug-like chemical space for virtual screening and molecular design using modern machine learning methodsGenerative pre-trained transformer (GPT) based model with relative attention for de novo drug designPetrans: de novo drug design with protein-specific encoding based on transfer learningLearning to read and write in the language of proteinsEvaluation of GPT and BERT-based models on identifying protein–protein interactions in biomedical textGptransformer: a transformer-based deep learning method for predicting fusarium related traits in barleyAb-gen: antibody library design with generative pre-trained transformer and deep reinforcement learningChatGPT for computational topologyBERT: pre-training of deep bidirectional transformers for language understandingSPU-BERT: faster human multi-trajectory prediction from socio-physical understanding of BERTKnowledge-enabled BERT for aspect-based sentiment analysisMultimodal prediction of social responsiveness score with BERT-based text featuresBERT post-training for review reading comprehension and aspect-based sentiment analysisMulti-passage BERT: a globally normalized BERT model for open-domain question answeringBertscore: evaluating text generation with BERTPersistent spectral theory-guided protein engineeringA perspective on multi-target drug discovery and design for complex diseasesSelf-supervised learning with chemistry-aware fragmentation for effective molecular property predictionA fingerprints based molecular property prediction method using the BERT modelSurfomics: shaving live organisms for a fast proteomic identification of surface proteinsGraph-BERT and language model-based framework for protein–protein interaction identificationSmiles-BERT: large scale unsupervised pretraining for molecular property predictionMOL-BERT: an effective molecular representation with BERT for molecular property predictionEpibertope: a sequence-based pre-trained BERT model improves linear and structural epitope prediction by learning long-distance protein interactions effectivelyPETRIBERT: augmenting BERT with tridimensional encoding for inverse protein folding and designExtracting predictive representations from hundreds of millions of moleculesSVSBI: sequence-based virtual screening of biomolecular interactionsKnowledge-based BERT: a method to extract molecular features like computational chemistsBART: denoising sequence-to-sequence pre-training for natural language generation, translation, and comprehensionMultilingual denoising pre-training for neural machine translationLongformer: the long-document transformerBART-IT: an efficient sequence-to-sequence model for Italian text summarizationBART-based contrastive and retrospective network for aspect-category-opinion-sentiment quadruple extractionDifficulty in learning chirality for transformer fed with smilesSynergistic fusion of graph and transformer features for enhanced molecular property predictionMaterial transformers: deep learning language models for generative materials designDRUGEX V3: scaffold constrained drug design with graph transformer-based reinforcement learningChemformer: a pre-trained transformer for computational chemistryMs2mol: a transformer model for illuminating dark chemical space from mass spectraMolBART: generative masked language models for molecular representationsExplainability techniques for chemical language modelsThe important role of non-covalent drug–protein interactions in drug hypersensitivity reactionsEffective interactions in soft condensed matter physicsMultiscale weighted colored graphs for protein flexibility and rigidity analysisOn neighborhood inverse sum indeg index of molecular graphs with chemical significanceAgformer: efficient graph representation with anchor-graph transformerA survey on protein–DNA-binding sites in computational biologyAlphafold2-aware protein–DNA binding site prediction using graph transformerKPGT: knowledge-guided pre-training of graph transformer for molecular property predictionPath-augmented graph transformer networkHI-MGT: a hybrid molecule graph transformer for toxicity identificationEgtsyn: edge-based graph transformer for anti-cancer drug combination synergy predictionMolfpg: multi-level fingerprint based graph transformer for accurate and robust drug toxicity predictionTransformer-XL: attentive language models beyond a fixed-length contextLegal language modeling with transformersRetrieval-augmented transformer-XL for close domain dialog generationCombination of GRU and CNN deep learning models for sentiment analysis on French customer reviews using xlnet modelBetter document level machine translation with Bayes’ ruleTransformer-XL based music generation with multiple sequences of time-valued notesTransfer learning for small molecule retention predictionsSmiles transformer: pre-trained molecular fingerprint for low data drug discoveryDe novo drug design using self attention mechanismTransformer based molecule encoding for property predictionFrom theory to experiment: transformer-based generation enables rapid discovery of novel reactionsChatbot interaction with artificial intelligence: human data augmentation with T5 and language transformer ensemble for text classificationMT6: multilingual pretrained text-to-text transformer with translation pairsTask-aware representation of sentences for generic text classificationIndt5: a text-to-text transformer for 10 indigenous languagesDeep query likelihood model for information retrievalTransfer learning in proteins: evaluating novel protein learned representations for bioinformatics tasksT5-long-extract at FNS-2021 shared taskUnified deep learning model for multitask reaction predictions with explanationC5T5: controllable generation of organic molecules with transformersWrite and paint: generative vision-language models are unified modal learnersTraining a T5 using lab-sized resourcesStudying the usage of text-to-text transfer transformer to support code-related tasksAn image is worth 16×16 words: Transformers for image recognition at scaleAn empirical study of training end-to-end vision-and-language transformersExtended vision transformer (exvit) for land use and land cover classification: a multimodal deep learning frameworkDeep learning-assisted surface enhanced Raman scattering for rapid bacterial identificationSelf-supervised vision transformers accurately decode cellular state heterogeneityVisual transformers: token-based image representation and processing for computer visionTransg-net: transformer and graph neural network based multi-modal data fusion network for molecular properties predictionEnd-to-end object detection with transformers. European conference on computer visionMeta-DETR: image-level few-shot detection with inter-class correlation exploitationTowards complete tree crown delineation by instance segmentation with mask R-CNN and DETR using UAV-based multispectral imagery and lidar dataDynamic focus-aware positional queries for semantic segmentationChallenges and opportunities in cryo-EM single-particle analysisTranspicker: a transformer-based framework for particle picking in cryoEM micrographsImg2smi: translating molecular structure images to simplified molecular input line-entry systemDeep learning approaches to biomedical image segmentationAttention-based transformers for instance segmentation of cells in microstructuresEfficient DETR: improving end-to-end object detector with dense priorDeformable DETR: deformable transformers for end-to-end object detectionSparse DETR: efficient end-to-end object detection with learnable sparsityUP-DETR: unsupervised pre-training for object detection with transformersConformer: convolution-augmented transformer for speech recognitionAudio-visual efficient conformer for robust speech recognitionEAD-conformer: a conformer-based encoder-attention-decoder-network for multitask audio source separationSpoken language translation using conformer modelA Korean menu-ordering sentence text-to-speech system using conformer-based fastspeech2Text to image generation with conformer-GANRobust multi-read reconstruction from contaminated clusters using deep neural network for DNA storageNG-DTA: drug-target affinity prediction with N-gram molecular graphsLearning transferable visual models from natural language supervisionSelf-supervised learning in medicine and healthcareA review of the application of multi-modal deep learning in medicine: bibliometrics and future directionsCurrent development of bicyclic peptidesDesign of peptide-based protein degraders via contrastive deep learningpathclip: detection of genes and gene relations from biological pathway figures through image-text contrastive learningCloome: contrastive learning unlocks bioimaging databases for queries with chemical structuresGenerating long sequences with sparse transformersSwitch transformers: scaling to trillion parameter models with simple and efficient sparsityA survey of transformersSstnet: saliency sparse transformers network with tokenized dilation for salient object detectionTransmask: a compact and fast speech separation model based on transformerCombiner: full attention transformer with sparse computation costMachine learning study of the extended drug–target interaction network informed by pain related voltage gated sodium channelsAn interpretable framework for drug-target interaction with gated cross attentionAn algorithm–hardware co-optimized framework for accelerating N: M sparse transformersTinybert: distilling BERT for natural language understandingMobilebert: a compact task-agnostic BERT for resource-limited devicesAutotinybert: automatic hyperparameter optimization for efficient pre-trained language modelsMDF-SA-DDI: predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanismLearning multi-types of neighbor node attributes and semantics by heterogeneous graph transformer and multi-view attention for drug-related side-effect predictionMolormer: a lightweight self-attention-based method focused on spatial structure of molecular graph for drug–drug interactions predictionDiscovering misannotated LNCRNAS using deep learning training dynamicsIntegrating convolution and self-attention improves language model of human genome for interpreting noncoding regions at base-resolutionExplainability in transformer models for functional genomicsMetatransformer: deep metagenomic sequencing read classification using self-attention modelsMobile accelerator exploiting sparsity of multi-heads, lines, and blocks in transformers in computer visionA multi-head attention-based transformer model for traffic flow forecasting with a comparative analysis to recurrent neural networks">Transformer technology in molecular scienceMachine learning and the physical sciencesOpportunities and obstacles for deep learning in biology and medicineDeep learning-based feature engineering methods for improved building energy predictionDeep learning—a technology with the potential to transform health careTransformer architecture and attention mechanisms in genome data analysis: a comprehensive reviewProbabilistic generative transformer language models for generative design of moleculesMachine learning methods for small data challenges in molecular scienceScientific discovery in the age of artificial intelligenceTransformer-based deep learning for predicting protein properties in the life sciencesABT-MPNN: an atom-bond transformer-based message-passing neural network for molecular property predictionClassification of highly divergent viruses from DNA/RNA sequence using transformer-based modelsLarge language model for molecular chemistryLocal self-attention in transformer for visual question answeringA systematic study of key elements underlying molecular property predictionFsmddtr: end-to-end feedback strategy for multi-objective de novo drug design using transformersMultiscale topology-enabled structure-to-sequence transformer for protein–ligand interaction predictionsExploring the applicability of transfer learning and feature engineering in epilepsy prediction using hybrid transformer modelAlgebraic graph-assisted bidirectional transformers for molecular property predictionRobustness verification for transformersUnderstanding the robustness in vision transformersMultiscale modeling at the interface of molecular mechanics and natural language through attention neural networksDeeptrasynergy: drug combinations using multimodal deep learning with transformersConsidering the possibilities and pitfalls of generative pretrained transformer 3 (GPT-3) in healthcare deliveryChat generative pre-trained transformer (ChatGPT) usage in healthcareCompressing large-scale transformer-based models: a case study on BERTPseudocode generation from source code using the BART modelTB-BCG: topic-based BART counterfeit generator for fake news detectionGraph transformer for graph-to-sequence learningHierarchical graph transformer with adaptive node samplingTransformer-XL with graph neural network for source code summarizationExploring the limits of transfer learning with a unified text-to-text transformerEnd-to-end generation of multiple choice questions using text-to-text transfer transformer modelsMultiscale vision transformersVision transformers for dense predictionYou only look at one sequence: rethinking transformer in vision through object detectionConformer: local features coupling global representations for visual recognitionContrastive language-image pre-training with knowledge graphsNon-contrastive learning meets language-image pre-trainingO (n) connections are expressive enough: universal approximability of sparse transformersEDGEVITS: competing light-weight cnns on mobile devices with vision transformersAttention is all you needA review on the attention mechanism of deep learningGet the point of my utterance! Learning towards effective responses with multi-head attention mechanismAnalyzing multi-head self-attention: specialized heads do the heavy lifting, the rest can be prunedUnderstanding convolutional neural networks for text classificationHardware accelerator for multi-head attention and position-wise feed-forward in the transformerApplications of transformer-based language models in bioinformatics: a surveyChangemask: deep multi-task encoder-transformer-decoder architecture for semantic change detectionMore than encoder: introducing transformer decoder to upsampleImproving language understanding by generative pre-trainingGpttoo: a language-model-first approach for AMR-to-text generationA text generation and prediction system: pretraining on new corpora using BERT and GPT-2Translating radiology reports into plain language using ChatGPT and GPT-4 with prompt learning: results, limitations, and potentialSentence augmentation for language translation using GPT-2The effectiveness of T5, GPT-2, and BERT on text-to-image generation taskRevolutionizing radiology with gpt-based models: current applications, future possibilities and limitations of ChatGPTMolgpt: molecular generation using a transformer-decoder modelEmpowering molecule discovery for molecule-caption translation with large language models: a ChatGPT perspectiveAutomatic generation of SBML kinetic models from natural language texts using GPTChatGPT in drug discovery: a case study on anticocaine addiction drug development with chatbotscmolgpt: a conditional generative pre-trained transformer for target-specific de novo molecular generationEfficient and enhanced sampling of drug-like chemical space for virtual screening and molecular design using modern machine learning methodsGenerative pre-trained transformer (GPT) based model with relative attention for de novo drug designPetrans: de novo drug design with protein-specific encoding based on transfer learningLearning to read and write in the language of proteinsEvaluation of GPT and BERT-based models on identifying protein–protein interactions in biomedical textGptransformer: a transformer-based deep learning method for predicting fusarium related traits in barleyAb-gen: antibody library design with generative pre-trained transformer and deep reinforcement learningChatGPT for computational topologyBERT: pre-training of deep bidirectional transformers for language understandingSPU-BERT: faster human multi-trajectory prediction from socio-physical understanding of BERTKnowledge-enabled BERT for aspect-based sentiment analysisMultimodal prediction of social responsiveness score with BERT-based text featuresBERT post-training for review reading comprehension and aspect-based sentiment analysisMulti-passage BERT: a globally normalized BERT model for open-domain question answeringBertscore: evaluating text generation with BERTPersistent spectral theory-guided protein engineeringA perspective on multi-target drug discovery and design for complex diseasesSelf-supervised learning with chemistry-aware fragmentation for effective molecular property predictionA fingerprints based molecular property prediction method using the BERT modelSurfomics: shaving live organisms for a fast proteomic identification of surface proteinsGraph-BERT and language model-based framework for protein–protein interaction identificationSmiles-BERT: large scale unsupervised pretraining for molecular property predictionMOL-BERT: an effective molecular representation with BERT for molecular property predictionEpibertope: a sequence-based pre-trained BERT model improves linear and structural epitope prediction by learning long-distance protein interactions effectivelyPETRIBERT: augmenting BERT with tridimensional encoding for inverse protein folding and designExtracting predictive representations from hundreds of millions of moleculesSVSBI: sequence-based virtual screening of biomolecular interactionsKnowledge-based BERT: a method to extract molecular features like computational chemistsBART: denoising sequence-to-sequence pre-training for natural language generation, translation, and comprehensionMultilingual denoising pre-training for neural machine translationLongformer: the long-document transformerBART-IT: an efficient sequence-to-sequence model for Italian text summarizationBART-based contrastive and retrospective network for aspect-category-opinion-sentiment quadruple extractionDifficulty in learning chirality for transformer fed with smilesSynergistic fusion of graph and transformer features for enhanced molecular property predictionMaterial transformers: deep learning language models for generative materials designDRUGEX V3: scaffold constrained drug design with graph transformer-based reinforcement learningChemformer: a pre-trained transformer for computational chemistryMs2mol: a transformer model for illuminating dark chemical space from mass spectraMolBART: generative masked language models for molecular representationsExplainability techniques for chemical language modelsThe important role of non-covalent drug–protein interactions in drug hypersensitivity reactionsEffective interactions in soft condensed matter physicsMultiscale weighted colored graphs for protein flexibility and rigidity analysisOn neighborhood inverse sum indeg index of molecular graphs with chemical significanceAgformer: efficient graph representation with anchor-graph transformerA survey on protein–DNA-binding sites in computational biologyAlphafold2-aware protein–DNA binding site prediction using graph transformerKPGT: knowledge-guided pre-training of graph transformer for molecular property predictionPath-augmented graph transformer networkHI-MGT: a hybrid molecule graph transformer for toxicity identificationEgtsyn: edge-based graph transformer for anti-cancer drug combination synergy predictionMolfpg: multi-level fingerprint based graph transformer for accurate and robust drug toxicity predictionTransformer-XL: attentive language models beyond a fixed-length contextLegal language modeling with transformersRetrieval-augmented transformer-XL for close domain dialog generationCombination of GRU and CNN deep learning models for sentiment analysis on French customer reviews using xlnet modelBetter document level machine translation with Bayes’ ruleTransformer-XL based music generation with multiple sequences of time-valued notesTransfer learning for small molecule retention predictionsSmiles transformer: pre-trained molecular fingerprint for low data drug discoveryDe novo drug design using self attention mechanismTransformer based molecule encoding for property predictionFrom theory to experiment: transformer-based generation enables rapid discovery of novel reactionsChatbot interaction with artificial intelligence: human data augmentation with T5 and language transformer ensemble for text classificationMT6: multilingual pretrained text-to-text transformer with translation pairsTask-aware representation of sentences for generic text classificationIndt5: a text-to-text transformer for 10 indigenous languagesDeep query likelihood model for information retrievalTransfer learning in proteins: evaluating novel protein learned representations for bioinformatics tasksT5-long-extract at FNS-2021 shared taskUnified deep learning model for multitask reaction predictions with explanationC5T5: controllable generation of organic molecules with transformersWrite and paint: generative vision-language models are unified modal learnersTraining a T5 using lab-sized resourcesStudying the usage of text-to-text transfer transformer to support code-related tasksAn image is worth 16×16 words: Transformers for image recognition at scaleAn empirical study of training end-to-end vision-and-language transformersExtended vision transformer (exvit) for land use and land cover classification: a multimodal deep learning frameworkDeep learning-assisted surface enhanced Raman scattering for rapid bacterial identificationSelf-supervised vision transformers accurately decode cellular state heterogeneityVisual transformers: token-based image representation and processing for computer visionTransg-net: transformer and graph neural network based multi-modal data fusion network for molecular properties predictionEnd-to-end object detection with transformers. European conference on computer visionMeta-DETR: image-level few-shot detection with inter-class correlation exploitationTowards complete tree crown delineation by instance segmentation with mask R-CNN and DETR using UAV-based multispectral imagery and lidar dataDynamic focus-aware positional queries for semantic segmentationChallenges and opportunities in cryo-EM single-particle analysisTranspicker: a transformer-based framework for particle picking in cryoEM micrographsImg2smi: translating molecular structure images to simplified molecular input line-entry systemDeep learning approaches to biomedical image segmentationAttention-based transformers for instance segmentation of cells in microstructuresEfficient DETR: improving end-to-end object detector with dense priorDeformable DETR: deformable transformers for end-to-end object detectionSparse DETR: efficient end-to-end object detection with learnable sparsityUP-DETR: unsupervised pre-training for object detection with transformersConformer: convolution-augmented transformer for speech recognitionAudio-visual efficient conformer for robust speech recognitionEAD-conformer: a conformer-based encoder-attention-decoder-network for multitask audio source separationSpoken language translation using conformer modelA Korean menu-ordering sentence text-to-speech system using conformer-based fastspeech2Text to image generation with conformer-GANRobust multi-read reconstruction from contaminated clusters using deep neural network for DNA storageNG-DTA: drug-target affinity prediction with N-gram molecular graphsLearning transferable visual models from natural language supervisionSelf-supervised learning in medicine and healthcareA review of the application of multi-modal deep learning in medicine: bibliometrics and future directionsCurrent development of bicyclic peptidesDesign of peptide-based protein degraders via contrastive deep learningpathclip: detection of genes and gene relations from biological pathway figures through image-text contrastive learningCloome: contrastive learning unlocks bioimaging databases for queries with chemical structuresGenerating long sequences with sparse transformersSwitch transformers: scaling to trillion parameter models with simple and efficient sparsityA survey of transformersSstnet: saliency sparse transformers network with tokenized dilation for salient object detectionTransmask: a compact and fast speech separation model based on transformerCombiner: full attention transformer with sparse computation costMachine learning study of the extended drug–target interaction network informed by pain related voltage gated sodium channelsAn interpretable framework for drug-target interaction with gated cross attentionAn algorithm–hardware co-optimized framework for accelerating N: M sparse transformersTinybert: distilling BERT for natural language understandingMobilebert: a compact task-agnostic BERT for resource-limited devicesAutotinybert: automatic hyperparameter optimization for efficient pre-trained language modelsMDF-SA-DDI: predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanismLearning multi-types of neighbor node attributes and semantics by heterogeneous graph transformer and multi-view attention for drug-related side-effect predictionMolormer: a lightweight self-attention-based method focused on spatial structure of molecular graph for drug–drug interactions predictionDiscovering misannotated LNCRNAS using deep learning training dynamicsIntegrating convolution and self-attention improves language model of human genome for interpreting noncoding regions at base-resolutionExplainability in transformer models for functional genomicsMetatransformer: deep metagenomic sequencing read classification using self-attention modelsMobile accelerator exploiting sparsity of multi-heads, lines, and blocks in transformers in computer visionA multi-head attention-based transformer model for traffic flow forecasting with a comparative analysis to recurrent neural networks</div>
                            <small style="color: var(--text-muted)">12735360.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...ss spectraMolBART: generative masked language models for molecular...'}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Reporting of Factorial Randomized Trials Extension of the CONSORT 2010 StatementFactorial design considerationsReporting of randomized factorial trials was frequently inadequateFactorial trials in cardiology: pros and consAnalysis and reporting of factorial trials: a systematic reviewReporting of factorial trials of complex interventions in community settings: a systematic reviewDesign, analysis and presentation of factorial randomised controlled trialsFactorial designs: a graphical aid for choosing study designs accounting for interactionEconomic evaluation of factorial randomised controlled trials: challenges, methods and recommendationsPartial factorial trials: comparing methods for statistical analysis and economic evaluationTwo-by-two factorial cancer treatment trials: is sufficient attention being paid to possible interactions?Estimands for factorial trialsNon-factorial analyses of two-by-two factorial trial designsMonitoring futility in a two-by-two factorial design: the SPS3 experienceSimultaneous inference on treatment effects in survival studies with factorial designsFactorial design for randomized clinical trialsSome statistical considerations for design of cancer prevention trialsBias in randomised factorial trialsCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsCONSORT for reporting randomised trials in journal and conference abstractsCONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaborationReporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 StatementThe2×2 cluster randomized controlled factorial trial design is mainly used for efficiency and to explore intervention interactions: a systematic reviewAn examination of effect estimation in factorial and standardly-tailored designsImplementing clinical research using factorial designs: a primerCombining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficientlySample size estimation in phase III cancer clinical trialsAnalysis of factorial survival experimentsEvaluating how clear the questions being investigated in randomised trials are: systematic review of estimandsEstimands in published protocols of randomised trials: urgent improvement neededEstimation of treatment effects in short-term depression studies: an evaluation based on the ICH E9(R1) estimands frameworkSample size calculation in hierarchical 2×2 factorial trials with unequal cluster sizesChallenging issues in clinical trial design: part 4 of a 4-part series on statistics for clinical trialsJoint testing of overall and simple effects for the two-by-two factorial trial design">Reporting of Factorial Randomized Trials Extension of the CONSORT 2010 StatementFactorial design considerationsReporting of randomized factorial trials was frequently inadequateFactorial trials in cardiology: pros and consAnalysis and reporting of factorial trials: a systematic reviewReporting of factorial trials of complex interventions in community settings: a systematic reviewDesign, analysis and presentation of factorial randomised controlled trialsFactorial designs: a graphical aid for choosing study designs accounting for interactionEconomic evaluation of factorial randomised controlled trials: challenges, methods and recommendationsPartial factorial trials: comparing methods for statistical analysis and economic evaluationTwo-by-two factorial cancer treatment trials: is sufficient attention being paid to possible interactions?Estimands for factorial trialsNon-factorial analyses of two-by-two factorial trial designsMonitoring futility in a two-by-two factorial design: the SPS3 experienceSimultaneous inference on treatment effects in survival studies with factorial designsFactorial design for randomized clinical trialsSome statistical considerations for design of cancer prevention trialsBias in randomised factorial trialsCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsCONSORT for reporting randomised trials in journal and conference abstractsCONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaborationReporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 StatementThe2×2 cluster randomized controlled factorial trial design is mainly used for efficiency and to explore intervention interactions: a systematic reviewAn examination of effect estimation in factorial and standardly-tailored designsImplementing clinical research using factorial designs: a primerCombining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficientlySample size estimation in phase III cancer clinical trialsAnalysis of factorial survival experimentsEvaluating how clear the questions being investigated in randomised trials are: systematic review of estimandsEstimands in published protocols of randomised trials: urgent improvement neededEstimation of treatment effects in short-term depression studies: an evaluation based on the ICH E9(R1) estimands frameworkSample size calculation in hierarchical 2×2 factorial trials with unequal cluster sizesChallenging issues in clinical trial design: part 4 of a 4-part series on statistics for clinical trialsJoint testing of overall and simple effects for the two-by-two factorial trial design</div>
                            <small style="color: var(--text-muted)">7617336.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">4.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 40.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 2 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiencyTransforming obesity: the advancement of multi-receptor drugsTirzepatide once weekly for the treatment of obesityTirzepatide versus semaglutide once weekly in patients with type 2 diabetesThe hunger genes: pathways to obesityPolygenic prediction of weight and obesity trajectories from birth to adulthood60 years of POMC: regulation of feeding and energy homeostasis by α-MSHClinical spectrum of obesity and mutations in the melanocortin 4 receptor geneHuman MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulationProtein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityLoss-of-function mutations in the melanocortin 4 receptor in a UK birth cohortObesity treatment effect in Danish children and adolescents carrying melanocortin-4 receptor mutationsObesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretionAdults with pathogenic MC4R mutations have increased final height and thereby increased bone massSympathetic function in human carriers of melanocortin-4 receptor gene mutationsModulation of blood pressure by central melanocortinergic pathwaysLifestyle intervention in obese children with variations in the melanocortin 4 receptor geneEvaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiencyPharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesityDual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese micePatients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonistHuman gain-of-function MC4R variants show signaling bias and protect against obesityMelanocortin-4 receptor signaling is required for weight loss after gastric bypass surgeryGLP-1 receptor agonist treatment in morbid obesity and type 2 diabetes due to pathogenic homozygous melanocortin-4 receptor mutation: a case reportComputationally efficient whole-genome regression for quantitative and binary traits">Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiencyTransforming obesity: the advancement of multi-receptor drugsTirzepatide once weekly for the treatment of obesityTirzepatide versus semaglutide once weekly in patients with type 2 diabetesThe hunger genes: pathways to obesityPolygenic prediction of weight and obesity trajectories from birth to adulthood60 years of POMC: regulation of feeding and energy homeostasis by α-MSHClinical spectrum of obesity and mutations in the melanocortin 4 receptor geneHuman MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulationProtein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityLoss-of-function mutations in the melanocortin 4 receptor in a UK birth cohortObesity treatment effect in Danish children and adolescents carrying melanocortin-4 receptor mutationsObesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretionAdults with pathogenic MC4R mutations have increased final height and thereby increased bone massSympathetic function in human carriers of melanocortin-4 receptor gene mutationsModulation of blood pressure by central melanocortinergic pathwaysLifestyle intervention in obese children with variations in the melanocortin 4 receptor geneEvaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiencyPharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesityDual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese micePatients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonistHuman gain-of-function MC4R variants show signaling bias and protect against obesityMelanocortin-4 receptor signaling is required for weight loss after gastric bypass surgeryGLP-1 receptor agonist treatment in morbid obesity and type 2 diabetes due to pathogenic homozygous melanocortin-4 receptor mutation: a case reportComputationally efficient whole-genome regression for quantitative and binary traits</div>
                            <small style="color: var(--text-muted)">12532586.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'Software mentioned without specific versions.', 'evidence': '.... A mixed model was run using SAS, including baseline weight, c...'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trialLongitudinal study of use and cost of subacromial decompression surgery: the need for effective evaluation of surgical procedures to prevent overtreatment and wasted resourcesRegional variation in low-value musculoskeletal surgery: a nationwide study from the Finnish Care RegisterAppropriate care for orthopedic patients: effect of implementation of the Clinical Practice Guideline for Diagnosis and Treatment of Subacromial Pain Syndrome in the NetherlandsCommon elective orthopaedic procedures and their clinical effectiveness: umbrella review of level 1 evidenceSubacromial decompression versus diagnostic arthroscopy for shoulder impingement: randomised, placebo surgery controlled clinical trialArthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trialSubacromial decompression versus diagnostic arthroscopy for shoulder impingement: a 5-year follow-up of a randomised, placebo surgery controlled clinical trialArthroscopic surgery compared with supervised exercises in patients with rotator cuff disease (stage II impingement syndrome)[Mid-term clinical results after surgical versus conservative treatment of subacromial impingement syndrome]Exercises versus arthroscopic decompression in patients with subacromial impingement: a randomised, controlled study in 90 cases with a one year follow upDoes arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?: a two-year randomised controlled trialComparison of open acromioplasty, arthroscopic acromioplasty and physiotherapy in patients with subacromial impingement syndrome: a prospective randomised studyNon-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitationSubacromial decompression surgery for adults with shoulder pain: a clinical practice guidelineSubacromial decompression surgery for rotator cuff diseaseA Systematic Review of Clinical Practice Guidelines on the Diagnosis and Management of Various Shoulder DisordersCONSORT 2025 statement: updated guideline for reporting randomised trialsFinnish Subacromial Impingement Arthroscopy Controlled Trial (FIMPACT): a protocol for a randomised trial comparing arthroscopic subacromial decompression and diagnostic arthroscopy (placebo control), with an exercise therapy control, in the treatment of shoulder impingement syndromeArthroscopic subacromial decompression: analysis of one- to three-year resultsMinimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff diseaseThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionThe 15D instrument of health-related quality of life: properties and applicationsThe minimal detectable change of the Constant score in impingement, full-thickness tears, and massive rotator cuff tearsMinimal clinically important differences in ASES and simple shoulder test scores after nonoperative treatment of rotator cuff diseaseMultiple P-values and Bonferroni correctionArthroscopic decompression not recommended in the treatment of rotator cuff tendinopathy: a final review of a randomised controlled trial at a minimum follow-up of ten yearsSubacromial Decompression Yields a Better Clinical Outcome Than Therapy Alone: A Prospective Randomized Study of Patients With a Minimum 10-Year Follow-up">Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trialLongitudinal study of use and cost of subacromial decompression surgery: the need for effective evaluation of surgical procedures to prevent overtreatment and wasted resourcesRegional variation in low-value musculoskeletal surgery: a nationwide study from the Finnish Care RegisterAppropriate care for orthopedic patients: effect of implementation of the Clinical Practice Guideline for Diagnosis and Treatment of Subacromial Pain Syndrome in the NetherlandsCommon elective orthopaedic procedures and their clinical effectiveness: umbrella review of level 1 evidenceSubacromial decompression versus diagnostic arthroscopy for shoulder impingement: randomised, placebo surgery controlled clinical trialArthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trialSubacromial decompression versus diagnostic arthroscopy for shoulder impingement: a 5-year follow-up of a randomised, placebo surgery controlled clinical trialArthroscopic surgery compared with supervised exercises in patients with rotator cuff disease (stage II impingement syndrome)[Mid-term clinical results after surgical versus conservative treatment of subacromial impingement syndrome]Exercises versus arthroscopic decompression in patients with subacromial impingement: a randomised, controlled study in 90 cases with a one year follow upDoes arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?: a two-year randomised controlled trialComparison of open acromioplasty, arthroscopic acromioplasty and physiotherapy in patients with subacromial impingement syndrome: a prospective randomised studyNon-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitationSubacromial decompression surgery for adults with shoulder pain: a clinical practice guidelineSubacromial decompression surgery for rotator cuff diseaseA Systematic Review of Clinical Practice Guidelines on the Diagnosis and Management of Various Shoulder DisordersCONSORT 2025 statement: updated guideline for reporting randomised trialsFinnish Subacromial Impingement Arthroscopy Controlled Trial (FIMPACT): a protocol for a randomised trial comparing arthroscopic subacromial decompression and diagnostic arthroscopy (placebo control), with an exercise therapy control, in the treatment of shoulder impingement syndromeArthroscopic subacromial decompression: analysis of one- to three-year resultsMinimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff diseaseThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionThe 15D instrument of health-related quality of life: properties and applicationsThe minimal detectable change of the Constant score in impingement, full-thickness tears, and massive rotator cuff tearsMinimal clinically important differences in ASES and simple shoulder test scores after nonoperative treatment of rotator cuff diseaseMultiple P-values and Bonferroni correctionArthroscopic decompression not recommended in the treatment of rotator cuff tendinopathy: a final review of a randomised controlled trial at a minimum follow-up of ten yearsSubacromial Decompression Yields a Better Clinical Outcome Than Therapy Alone: A Prospective Randomized Study of Patients With a Minimum 10-Year Follow-up</div>
                            <small style="color: var(--text-muted)">12670246.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...MID) was set at 15 points.21  Secondary outcomes included functional assessme...'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreenMammographic density and the risk and detection of breast cancerMammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 yearsPriorities for the primary prevention of breast cancerIdentifying women with dense breasts at high risk for interval cancer: a cohort studyPrevalence of mammographically dense breasts in the United StatesDecade of ‘normal’ mammography reports--the happygramUS women must be told breast density after mammogram, says FDAShould we share breast density information during breast cancer screening in the United Kingdom? an integrative reviewBreast density notification: evidence on whether benefit outweighs harm is required to inform future screening practiceThe Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic ReviewClinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwideSupplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task ForceSupplemental MRI Screening for Women with Extremely Dense Breast TissueComparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trialBreast cancer screening at a crossroads: supplemental imaging for dense breastsDetecting Breast Cancer in Women with Dense BreastsEnsuring Clarity and Understandability of the FDA’s Breast Density NotificationsPsychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trialGeneral practitioners’ (GPs) understanding and views on breast density in Australia: a qualitative interview study“It’s about our bodies… we have the right to know this stuff”: A qualitative focus group study on Australian women’s perspectives on breast densityAustralian Women’s Intentions and Psychological Outcomes Related to Breast Density Notification and Information: A Randomized Clinical TrialBreast Density Awareness, Knowledge, and Attitudes Among US Women: National Survey Results Across 5 YearsProspective study of predictors of attendance for breast screening in inner LondonRelationships among breast cancer perceived absolute risk, comparative risk, and worriesDifferences in Breast Density Awareness, Knowledge, and Plans Based on State Legislation Status and Sociodemographic CharacteristicsWomen’s Understandings and Misunderstandings of Breast Density and Related Concepts: A Mixed Methods StudyDevelopment of a theory-informed questionnaire to assess the acceptability of healthcare interventionsPrior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trialThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionThe Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading abilityEliciting Medical Maximizing-Minimizing Preferences with a Single Question: Development and Validation of the MM1Do People Have Insight Into Their Abilities? A MetasynthesisBreast Density Notification: A Systematic Review of the Impact on Primary Care PractitionersEngaging Women with Limited Health Literacy in Mammography Decision-Making: Perspectives of Patients and Primary Care ProvidersSociodemographic Variations in Women’s Reports of Discussions With Clinicians About Breast DensityWomen’s responses to information on mammographic breast densityRandomized Trial of Personalized Breast Density and Breast Cancer Risk NotificationEffect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast DensityEffectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled TrialA randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center : Breast density notification and anxiety, breast cancer worry, and perceived risk among LatinasSupplemental breast cancer screening after negative mammography in US women with dense breastsThe impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic reviewBreast density implications and supplemental screeningCost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue">Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreenMammographic density and the risk and detection of breast cancerMammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 yearsPriorities for the primary prevention of breast cancerIdentifying women with dense breasts at high risk for interval cancer: a cohort studyPrevalence of mammographically dense breasts in the United StatesDecade of ‘normal’ mammography reports--the happygramUS women must be told breast density after mammogram, says FDAShould we share breast density information during breast cancer screening in the United Kingdom? an integrative reviewBreast density notification: evidence on whether benefit outweighs harm is required to inform future screening practiceThe Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic ReviewClinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwideSupplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task ForceSupplemental MRI Screening for Women with Extremely Dense Breast TissueComparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trialBreast cancer screening at a crossroads: supplemental imaging for dense breastsDetecting Breast Cancer in Women with Dense BreastsEnsuring Clarity and Understandability of the FDA’s Breast Density NotificationsPsychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trialGeneral practitioners’ (GPs) understanding and views on breast density in Australia: a qualitative interview study“It’s about our bodies… we have the right to know this stuff”: A qualitative focus group study on Australian women’s perspectives on breast densityAustralian Women’s Intentions and Psychological Outcomes Related to Breast Density Notification and Information: A Randomized Clinical TrialBreast Density Awareness, Knowledge, and Attitudes Among US Women: National Survey Results Across 5 YearsProspective study of predictors of attendance for breast screening in inner LondonRelationships among breast cancer perceived absolute risk, comparative risk, and worriesDifferences in Breast Density Awareness, Knowledge, and Plans Based on State Legislation Status and Sociodemographic CharacteristicsWomen’s Understandings and Misunderstandings of Breast Density and Related Concepts: A Mixed Methods StudyDevelopment of a theory-informed questionnaire to assess the acceptability of healthcare interventionsPrior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trialThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionThe Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading abilityEliciting Medical Maximizing-Minimizing Preferences with a Single Question: Development and Validation of the MM1Do People Have Insight Into Their Abilities? A MetasynthesisBreast Density Notification: A Systematic Review of the Impact on Primary Care PractitionersEngaging Women with Limited Health Literacy in Mammography Decision-Making: Perspectives of Patients and Primary Care ProvidersSociodemographic Variations in Women’s Reports of Discussions With Clinicians About Breast DensityWomen’s responses to information on mammographic breast densityRandomized Trial of Personalized Breast Density and Breast Cancer Risk NotificationEffect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast DensityEffectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled TrialA randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center : Breast density notification and anxiety, breast cancer worry, and perceived risk among LatinasSupplemental breast cancer screening after negative mammography in US women with dense breastsThe impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic reviewBreast density implications and supplemental screeningCost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue</div>
                            <small style="color: var(--text-muted)">12673659.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...ortions as small as 10% (at a Bonferroni adjusted α level of 0.017 to...'}</li><li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...as appropriate, presented as odds ratios or relative risk ratios, res...'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Brain activity associated with breakthrough food preoccupation in an individual on tirzepatideOverlapping brain circuits for homeostatic and hedonic feedingReward mechanisms in obesity: new insights and future directionsAn orexigenic subnetwork within the human hippocampusBlaming the brain for obesity: integration of hedonic and homeostatic mechanismsThe insulo-opercular cortex encodes food-specific content under controlled and naturalistic conditionsHow may GIP enhance the therapeutic efficacy of GLP-1?GLP-1 and weight loss: unraveling the diverse neural circuitryPotent incretin-based therapy for obesity: a systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safetyA pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorderGLP-1 receptor agonists: a novel pharmacotherapy for binge eating (binge eating disorder and bulimia nervosa)? A systematic reviewWhat is food noise? A conceptual model of food cue reactivityLoss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up studyPreoccupation in bulimia nervosa, binge-eating disorder, anorexia nervosa, and higher weightBinge eating disorderFood-related impulsivity in obesity and binge eating disorder–a systematic reviewThe neurobiology of binge-eating disorder compared with obesity: implications for differential therapeuticsHuman habit neural circuitry may be perturbed in eating disordersEffects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trialTwo-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5Closed-loop neuromodulation in an individual with treatment-resistant depressionPilot study of responsive nucleus accumbens deep brain stimulation for loss-of-control eatingResponsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsionBrain-responsive neurostimulation for loss of control eating: early feasibility studyClosing the loop on impulsivity via nucleus accumbens delta-band activity in mice and manOptimal detection of changepoints with a linear computational costUsing penalized contrasts for the change-point problemSub-acute delayed failure of subthalamic DBS in Parkinson’s disease: the role of micro-lesion effectTirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialCingulate dynamics track depression recovery with deep brain stimulationAn electroencephalographic signature predicts antidepressant response in major depressionLong-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorderSubthalamic nucleus deep brain stimulation in the beta frequency range boosts cortical beta oscillations and slows down movementDeep brain stimulation of the subthalamic nucleus alters the cortical profile of response inhibition in the beta frequency band: a scalp EEG study in Parkinson’s diseaseThe eating disorder examination: a semi-structured interview for the assessment of the specific psychopathology of eating disordersAppetitive mapping of the human nucleus accumbensAberrant impulse control circuitry in obesityFieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data">Brain activity associated with breakthrough food preoccupation in an individual on tirzepatideOverlapping brain circuits for homeostatic and hedonic feedingReward mechanisms in obesity: new insights and future directionsAn orexigenic subnetwork within the human hippocampusBlaming the brain for obesity: integration of hedonic and homeostatic mechanismsThe insulo-opercular cortex encodes food-specific content under controlled and naturalistic conditionsHow may GIP enhance the therapeutic efficacy of GLP-1?GLP-1 and weight loss: unraveling the diverse neural circuitryPotent incretin-based therapy for obesity: a systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safetyA pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorderGLP-1 receptor agonists: a novel pharmacotherapy for binge eating (binge eating disorder and bulimia nervosa)? A systematic reviewWhat is food noise? A conceptual model of food cue reactivityLoss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up studyPreoccupation in bulimia nervosa, binge-eating disorder, anorexia nervosa, and higher weightBinge eating disorderFood-related impulsivity in obesity and binge eating disorder–a systematic reviewThe neurobiology of binge-eating disorder compared with obesity: implications for differential therapeuticsHuman habit neural circuitry may be perturbed in eating disordersEffects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trialTwo-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5Closed-loop neuromodulation in an individual with treatment-resistant depressionPilot study of responsive nucleus accumbens deep brain stimulation for loss-of-control eatingResponsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsionBrain-responsive neurostimulation for loss of control eating: early feasibility studyClosing the loop on impulsivity via nucleus accumbens delta-band activity in mice and manOptimal detection of changepoints with a linear computational costUsing penalized contrasts for the change-point problemSub-acute delayed failure of subthalamic DBS in Parkinson’s disease: the role of micro-lesion effectTirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialCingulate dynamics track depression recovery with deep brain stimulationAn electroencephalographic signature predicts antidepressant response in major depressionLong-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive-compulsive disorderSubthalamic nucleus deep brain stimulation in the beta frequency range boosts cortical beta oscillations and slows down movementDeep brain stimulation of the subthalamic nucleus alters the cortical profile of response inhibition in the beta frequency band: a scalp EEG study in Parkinson’s diseaseThe eating disorder examination: a semi-structured interview for the assessment of the specific psychopathology of eating disordersAppetitive mapping of the human nucleus accumbensAberrant impulse control circuitry in obesityFieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data</div>
                            <small style="color: var(--text-muted)">12705427.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A consensus blood transcriptomic framework for sepsisGlobal, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudySepsis and septic shockEnhancing recovery from sepsis: a reviewWhy have clinical trials in sepsis failed?Sepsis therapies: learning from 30 years of failure of translational research to propose new leadsThe immunology of sepsisThe immunopathology of sepsis and potential therapeutic targetsGenomic landscape of the individual host response and outcomes in sepsis: a prospective cohort studyClassification of patients with sepsis according to blood genomic endotype: a prospective cohort studyShared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumoniaUnsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clustersPrognostic and predictive enrichment in sepsisTranscriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trialInterleukin-6 receptor antagonists in critically Ill patients with Covid-19Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRisk stratification and prognosis in sepsis: What have we learned from microarrays?Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineAn immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expressionThe leukocyte non-coding RNA landscape in critically ill patients with sepsiseQTLs identify regulatory networks and drivers of variation in the individual response to sepsisSilhouettes: a graphical aid to the interpretation and validation of cluster analysisControlling the false discovery rate: a practical and powerful approach to multiple testing.Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in UgandaEffect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trialNeutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisSCENIC: single-cell regulatory network inference and clusteringSepsis subclasses: a framework for development and interpretationReframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesUncovering heterogeneity in sepsis: a comparative analysis of subphenotypesDiscovering transcriptional signatures of disease for diagnosis versus mechanismBroad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsisMolecular biomarker to assist in diagnosing abdominal sepsis upon ICU admissionA molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admissionA generalizable 29-mRNA neural-network classifier for acute bacterial and viral infectionsAssociation of dendritic cell signatures with autoimmune inflammation revealed by single‐cell profiling.A CD8 T cell transcription signature predicts prognosis in autoimmune disease.Comparison of two rapid host-response tests for distinguishing bacterial and viral infection in adults with acute respiratory infectionA rapid host response blood test for bacterial/viral infection discrimination using a portable molecular diagnostic platformParadoxical roles of the neutrophil in sepsis: protective and deleteriousPAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shockNETosis: how vital is it?The role of platelets in sepsisThe role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping reviewThe pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescenceHeme-derived metabolic signals dictate immune responsesCritical illness-related corticosteroid insufficiency: latest pathophysiology and management guidelinesIdentification of key immune-related genes in the progression of septic shockDexamethasone enhances agonist induction of tissue factor in monocytes but not in endothelial cellsPrednisolone dose-dependently influences inflammation and coagulation during human endotoxemiaaffy—analysis of Affymetrix GeneChip data at the probe levelThe sva package for removing batch effects and other unwanted variation in high-throughput experimentsA framework for oligonucleotide microarray preprocessingfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresFast gapped-read alignment with Bowtie 2Leukocyte transcriptional signatures dependent on LPS dosage in human endotoxemiaMapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtIdentifying functional modules in interaction networks through overlapping Markov clusteringCMA: a comprehensive Bioconductor package for supervised classification with high dimensional dataConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesBiomarkers of sepsis: time for a reappraisalUnderstanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis">A consensus blood transcriptomic framework for sepsisGlobal, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudySepsis and septic shockEnhancing recovery from sepsis: a reviewWhy have clinical trials in sepsis failed?Sepsis therapies: learning from 30 years of failure of translational research to propose new leadsThe immunology of sepsisThe immunopathology of sepsis and potential therapeutic targetsGenomic landscape of the individual host response and outcomes in sepsis: a prospective cohort studyClassification of patients with sepsis according to blood genomic endotype: a prospective cohort studyShared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumoniaUnsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clustersPrognostic and predictive enrichment in sepsisTranscriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trialInterleukin-6 receptor antagonists in critically Ill patients with Covid-19Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRisk stratification and prognosis in sepsis: What have we learned from microarrays?Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineAn immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expressionThe leukocyte non-coding RNA landscape in critically ill patients with sepsiseQTLs identify regulatory networks and drivers of variation in the individual response to sepsisSilhouettes: a graphical aid to the interpretation and validation of cluster analysisControlling the false discovery rate: a practical and powerful approach to multiple testing.Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in UgandaEffect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trialNeutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisSCENIC: single-cell regulatory network inference and clusteringSepsis subclasses: a framework for development and interpretationReframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesUncovering heterogeneity in sepsis: a comparative analysis of subphenotypesDiscovering transcriptional signatures of disease for diagnosis versus mechanismBroad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsisMolecular biomarker to assist in diagnosing abdominal sepsis upon ICU admissionA molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admissionA generalizable 29-mRNA neural-network classifier for acute bacterial and viral infectionsAssociation of dendritic cell signatures with autoimmune inflammation revealed by single‐cell profiling.A CD8 T cell transcription signature predicts prognosis in autoimmune disease.Comparison of two rapid host-response tests for distinguishing bacterial and viral infection in adults with acute respiratory infectionA rapid host response blood test for bacterial/viral infection discrimination using a portable molecular diagnostic platformParadoxical roles of the neutrophil in sepsis: protective and deleteriousPAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shockNETosis: how vital is it?The role of platelets in sepsisThe role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping reviewThe pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescenceHeme-derived metabolic signals dictate immune responsesCritical illness-related corticosteroid insufficiency: latest pathophysiology and management guidelinesIdentification of key immune-related genes in the progression of septic shockDexamethasone enhances agonist induction of tissue factor in monocytes but not in endothelial cellsPrednisolone dose-dependently influences inflammation and coagulation during human endotoxemiaaffy—analysis of Affymetrix GeneChip data at the probe levelThe sva package for removing batch effects and other unwanted variation in high-throughput experimentsA framework for oligonucleotide microarray preprocessingfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresFast gapped-read alignment with Bowtie 2Leukocyte transcriptional signatures dependent on LPS dosage in human endotoxemiaMapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtIdentifying functional modules in interaction networks through overlapping Markov clusteringCMA: a comprehensive Bioconductor package for supervised classification with high dimensional dataConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesBiomarkers of sepsis: time for a reappraisalUnderstanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis</div>
                            <small style="color: var(--text-muted)">12705454.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...al data were compared using a chi-squared test and post hoc tests. Kap...'}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...all analyses. An FDR-adjusted P\u2009<\u20090.05 defined significant overrepre...'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Revitalizing CPAP adherence: lessons from THN study in patients with hypoglossal nerve stimulatorsTreatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trialCompliance after switching from CPAP to bilevel for patients with non-compliant OSA: big data analysisIntensive  standard follow-up to improve continuous positive airway pressure complianceDifferences between the real and the desired worlds in the results of clinical trialsPolysomnograph chart view by patients: a new educational strategy to improve CPAP adherence in sleep apnea therapyThe importance of mask selection on continuous positive airway pressure outcomes for obstructive sleep apnea. An official American Thoracic Society workshop reportInvestigating associations between social determinants, self-efficacy measurement of sleep apnea and CPAP adherence: the SEMSA studyThe impact of marital status and race in obstructive sleep apneaEffect of telemedicine education and telemonitoring on continuous positive airway pressure adherence. the Tele-OSA randomized trialWhy most published research findings are falseCompliance with positive airway pressure treatment for obstructive sleep apneaPredictive equations for CPAP titration in OSAS patientsImpact of purchasing the CPAP device on acceptance and long-term adherence: a Belgian modelLong-term adherence to home mechanical ventilation: a 10-year retrospective, single-centre cohort studyTargeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot studyLong-term health outcomes for patients with obstructive sleep apnea: placing the Agency for Healthcare Research and Quality report in context—a multisociety commentaryCPAP resumption after a first termination and impact on all-cause mortality in FranceIncreased prevalence of sleep-disordered breathing in adultsMask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life studyEffects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure(2023). Targeted hypoglossal nerve stimulation for patients with obstructive sleep apnea: a randomized clinical trialPatient-centered therapy for obstructive sleep apnea: a review">Revitalizing CPAP adherence: lessons from THN study in patients with hypoglossal nerve stimulatorsTreatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trialCompliance after switching from CPAP to bilevel for patients with non-compliant OSA: big data analysisIntensive  standard follow-up to improve continuous positive airway pressure complianceDifferences between the real and the desired worlds in the results of clinical trialsPolysomnograph chart view by patients: a new educational strategy to improve CPAP adherence in sleep apnea therapyThe importance of mask selection on continuous positive airway pressure outcomes for obstructive sleep apnea. An official American Thoracic Society workshop reportInvestigating associations between social determinants, self-efficacy measurement of sleep apnea and CPAP adherence: the SEMSA studyThe impact of marital status and race in obstructive sleep apneaEffect of telemedicine education and telemonitoring on continuous positive airway pressure adherence. the Tele-OSA randomized trialWhy most published research findings are falseCompliance with positive airway pressure treatment for obstructive sleep apneaPredictive equations for CPAP titration in OSAS patientsImpact of purchasing the CPAP device on acceptance and long-term adherence: a Belgian modelLong-term adherence to home mechanical ventilation: a 10-year retrospective, single-centre cohort studyTargeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot studyLong-term health outcomes for patients with obstructive sleep apnea: placing the Agency for Healthcare Research and Quality report in context—a multisociety commentaryCPAP resumption after a first termination and impact on all-cause mortality in FranceIncreased prevalence of sleep-disordered breathing in adultsMask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life studyEffects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure(2023). Targeted hypoglossal nerve stimulation for patients with obstructive sleep apnea: a randomized clinical trialPatient-centered therapy for obstructive sleep apnea: a review</div>
                            <small style="color: var(--text-muted)">12713931.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...ian ± SD presentation. Paired t-tests were employed to assess base...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="A global analysis of land use regulation, urban form, and greenhouse gas emissionsUrban form and air pollution: Clustering patterns of urban form factors related to particulate matter in Seoul, KoreaWhat makes cities more productive? Evidence from five OECD countries on the role of urban governanceThe fragmentation of urban landscapes: Global evidence of a key attribute of the spatial structure of cities, 1990–2000A century of sprawl in the United StatesA global assessment of street-network sprawlReversal sprawl. Land use regulation, society, and institutions in ProseccotownOSMnx: New methods for acquiring, constructing, analyzing, and visualizing complex street networksOptimal energy taxation in citiesThe welfare economics of land use planningThe long-run effects of congestion tolls, carbon tax, and land use regulations on urban CO emissionsChanging urban forms and carbon dioxide emissions in China: A case study of 30 provincial capital citiesDoes size matter? Scaling of CO emissions and U.S. urban areasThe greenness of cities: Carbon dioxide emissions and urban developmentCity density and CO efficiencyHas Mexico City’s shift to commercially produced housing increased Car ownership and car useGreenhouse gas emissions from global cities under SSP/RCP scenarios, 1990 to 2100Impacts of urban form on future US passenger-vehicle greenhouse gas emissionsCities and the environmentMapping the carbon footprint of nationsEnergy footprint of the city: Effects of urban land use and transportation policiesThe energy implications of city size and densityTelework: Urban form, energy consumption, and greenhouse gas implicationsThe influence of urban form on GHG emissions in the U.S. household sectorEffects of urban land-use regulations on greenhouse gas emissionsWhat planners know: Using surveys about local land-use regulation to understand housing developmentImpacts of land finance on urban sprawl in China: The case of ChongqingThe impacts of city size and density on CO emissions: Evidence from the Yangtze River delta urban agglomerationRelationship between urban form and CO emissions: Evidence from fifty Japanese citiesWhy do we have urban density controls?Urban land-use regulations and housing markets in developing countries: Evidence from Indonesia on the importance of enforcement–Carbon footprints of 13000 citiesMetropolitan areas in the world. Delineation and population trendsRegulation and the high cost of housing in CaliforniaThe geographic determinants of housing supplyEffects of urban forms on CO emissions in China from a multi-perspective analysisImpact of land use regulations: Evidence from India’s citiesLand use changes and land policies evolution in China’s urbanization processEstimating the impacts of urban form on CO emission efficiency in the Pearl River Delta, China">A global analysis of land use regulation, urban form, and greenhouse gas emissionsUrban form and air pollution: Clustering patterns of urban form factors related to particulate matter in Seoul, KoreaWhat makes cities more productive? Evidence from five OECD countries on the role of urban governanceThe fragmentation of urban landscapes: Global evidence of a key attribute of the spatial structure of cities, 1990–2000A century of sprawl in the United StatesA global assessment of street-network sprawlReversal sprawl. Land use regulation, society, and institutions in ProseccotownOSMnx: New methods for acquiring, constructing, analyzing, and visualizing complex street networksOptimal energy taxation in citiesThe welfare economics of land use planningThe long-run effects of congestion tolls, carbon tax, and land use regulations on urban CO emissionsChanging urban forms and carbon dioxide emissions in China: A case study of 30 provincial capital citiesDoes size matter? Scaling of CO emissions and U.S. urban areasThe greenness of cities: Carbon dioxide emissions and urban developmentCity density and CO efficiencyHas Mexico City’s shift to commercially produced housing increased Car ownership and car useGreenhouse gas emissions from global cities under SSP/RCP scenarios, 1990 to 2100Impacts of urban form on future US passenger-vehicle greenhouse gas emissionsCities and the environmentMapping the carbon footprint of nationsEnergy footprint of the city: Effects of urban land use and transportation policiesThe energy implications of city size and densityTelework: Urban form, energy consumption, and greenhouse gas implicationsThe influence of urban form on GHG emissions in the U.S. household sectorEffects of urban land-use regulations on greenhouse gas emissionsWhat planners know: Using surveys about local land-use regulation to understand housing developmentImpacts of land finance on urban sprawl in China: The case of ChongqingThe impacts of city size and density on CO emissions: Evidence from the Yangtze River delta urban agglomerationRelationship between urban form and CO emissions: Evidence from fifty Japanese citiesWhy do we have urban density controls?Urban land-use regulations and housing markets in developing countries: Evidence from Indonesia on the importance of enforcement–Carbon footprints of 13000 citiesMetropolitan areas in the world. Delineation and population trendsRegulation and the high cost of housing in CaliforniaThe geographic determinants of housing supplyEffects of urban forms on CO emissions in China from a multi-perspective analysisImpact of land use regulations: Evidence from India’s citiesLand use changes and land policies evolution in China’s urbanization processEstimating the impacts of urban form on CO emission efficiency in the Pearl River Delta, China</div>
                            <small style="color: var(--text-muted)">12726962.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessmentNon-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLDMicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseasesMediterranean diet and nonalcoholic fatty liver diseaseAssociation of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general populationmiR-122–a key factor and therapeutic target in liver diseaseThe Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general populationHepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis CCirculating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic ReviewUltrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adultsHomeostasis of glucose and lipid in non-alcoholic fatty liver diseaseSerum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagusMicroRNA deregu-lation in nonalcoholic steatohepatitis-associated liver carcinogenesisRelevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver DiseaseA new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) projectDysregulated lipid metabolism links NAFLD to cardiovascular diseaseClinical and molecular biomarkers for diagnosis and staging of NAFLDNeck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO StudyThe PI3K/AKT/mTOR interactive pathwayDifferential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLDRelative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of SpainAtherogenic index of plasma: novel predictive biomarker for cardiovascular illnessesAdipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets?Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeLifestyle factors and visceral adipose tissue: Results from the PREDIMED-PLUS study2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines99% of patients with NAFLD meet MASLD criteria and natural history is therefore identicalMicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesIdentification of postoperative prognostic microRNA predictors in hepatocellular carcinomaRole of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expressionAssessing the utility of acoustic radiation force impulse in the evaluation of non-alcoholic fatty liver disease with severe obesity or steatosisHepatic glucose utilization in hepatic steatosis and obesityCirculating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver diseaseLECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistancePolyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A reviewCirculating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patientsmiRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisThe role of exosomal miRNA in nonalcoholic fatty liver diseaseEl Cuestionario Internacional de Actividad Física. Un instrumento adecuado en el seguimiento de la actividad física poblacionalEffects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trialCirculating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19From sugar to liver fat and public health: Systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesisRetinol-binding protein 4 in obesity and metabolic dysfunctionsMetabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implicationsAdipokines in nonalcoholic fatty liver diseaseCirculating microRNA associated to different stages of liver steatosis in prader-willi syndrome and non-syndromic obesityA multisociety Delphi consensus statement on new fatty liver disease nomenclatureAssociation of circulating serum miR-34a and miR-122 with dyslipidemia among patients with non-alcoholic fatty liver diseaseValue of liver function tests in cirrhosisAstaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2Epigenetics in NAFLD/NASH: Targets and therapyA pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver diseaseMultipanel approach including mirnas, inflammatory markers, and depressive symptoms for metabolic dysfunction-associated steatotic liver disease diagnosis during 2-year nutritional interventionCell-free circulating nucleic acids as early biomarkers for NAFLD and NAFLD-associated disordersTowards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracyMicroRNAs as regulators, biomarkers and therapeutic targets in liver diseasesEfficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: A systematic review and meta-analysisGlobal Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic reviewNEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization studyNAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways">Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessmentNon-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLDMicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseasesMediterranean diet and nonalcoholic fatty liver diseaseAssociation of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general populationmiR-122–a key factor and therapeutic target in liver diseaseThe Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general populationHepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis CCirculating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic ReviewUltrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adultsHomeostasis of glucose and lipid in non-alcoholic fatty liver diseaseSerum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagusMicroRNA deregu-lation in nonalcoholic steatohepatitis-associated liver carcinogenesisRelevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver DiseaseA new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) projectDysregulated lipid metabolism links NAFLD to cardiovascular diseaseClinical and molecular biomarkers for diagnosis and staging of NAFLDNeck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO StudyThe PI3K/AKT/mTOR interactive pathwayDifferential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLDRelative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of SpainAtherogenic index of plasma: novel predictive biomarker for cardiovascular illnessesAdipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets?Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeLifestyle factors and visceral adipose tissue: Results from the PREDIMED-PLUS study2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines99% of patients with NAFLD meet MASLD criteria and natural history is therefore identicalMicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesIdentification of postoperative prognostic microRNA predictors in hepatocellular carcinomaRole of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expressionAssessing the utility of acoustic radiation force impulse in the evaluation of non-alcoholic fatty liver disease with severe obesity or steatosisHepatic glucose utilization in hepatic steatosis and obesityCirculating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver diseaseLECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistancePolyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A reviewCirculating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patientsmiRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysisThe role of exosomal miRNA in nonalcoholic fatty liver diseaseEl Cuestionario Internacional de Actividad Física. Un instrumento adecuado en el seguimiento de la actividad física poblacionalEffects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trialCirculating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19From sugar to liver fat and public health: Systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesisRetinol-binding protein 4 in obesity and metabolic dysfunctionsMetabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implicationsAdipokines in nonalcoholic fatty liver diseaseCirculating microRNA associated to different stages of liver steatosis in prader-willi syndrome and non-syndromic obesityA multisociety Delphi consensus statement on new fatty liver disease nomenclatureAssociation of circulating serum miR-34a and miR-122 with dyslipidemia among patients with non-alcoholic fatty liver diseaseValue of liver function tests in cirrhosisAstaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2Epigenetics in NAFLD/NASH: Targets and therapyA pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver diseaseMultipanel approach including mirnas, inflammatory markers, and depressive symptoms for metabolic dysfunction-associated steatotic liver disease diagnosis during 2-year nutritional interventionCell-free circulating nucleic acids as early biomarkers for NAFLD and NAFLD-associated disordersTowards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracyMicroRNAs as regulators, biomarkers and therapeutic targets in liver diseasesEfficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: A systematic review and meta-analysisGlobal Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic reviewNEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization studyNAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways</div>
                            <small style="color: var(--text-muted)">12738678.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">2.5</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 25.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 3 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Prostate specific antigen retesting intervals and trends in England: population based cohort studyLower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefitAn analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialProstate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysisGuideline of guidelines: a critical appraisal of the evidence for PSA retesting intervalsRepeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancerProstate cancer screening: Continued controversies and novel biomarker advancementsProstate-specific antigen testing rates and referral patterns from general practice data in EnglandProstate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English citiesProstate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataFactors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis AuditTemporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million testsScreening for Prostate Cancer: US Preventive Services Task Force Recommendation StatementProstate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey dataA Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal DisparitiesAre we there yet? Closing the gap of prostate cancer presentation disparities in IrelandSpatio-temporal variation in prostate cancer testing in Stockholm: A population-based studyChanges in prostate specific antigen (PSA) “screening” patterns by geographic region and socio-economic status in Australia: Analysis of medicare data in 50-69 year old menLifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological researchProstate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort studyRisk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effectImplications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the ‘Fry-Turnbull’ effectUPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosisEarly Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer ScreeningThe Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningNCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised diseaseDo Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National SurveyScreening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testingMen’s experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative studySEOM guide to primary and secondary prevention of cancer: 2014The South African Prostate Cancer Screening GuidelinesInfluence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort studyProstate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyBaseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysisEmpirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen">Prostate specific antigen retesting intervals and trends in England: population based cohort studyLower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefitAn analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialProstate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysisGuideline of guidelines: a critical appraisal of the evidence for PSA retesting intervalsRepeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancerProstate cancer screening: Continued controversies and novel biomarker advancementsProstate-specific antigen testing rates and referral patterns from general practice data in EnglandProstate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English citiesProstate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record dataFactors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis AuditTemporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million testsScreening for Prostate Cancer: US Preventive Services Task Force Recommendation StatementProstate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey dataA Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal DisparitiesAre we there yet? Closing the gap of prostate cancer presentation disparities in IrelandSpatio-temporal variation in prostate cancer testing in Stockholm: A population-based studyChanges in prostate specific antigen (PSA) “screening” patterns by geographic region and socio-economic status in Australia: Analysis of medicare data in 50-69 year old menLifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological researchProstate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort studyRisk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effectImplications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the ‘Fry-Turnbull’ effectUPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosisEarly Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer ScreeningThe Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer ScreeningNCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised diseaseDo Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National SurveyScreening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testingMen’s experiences of the Swedish Organised Prostate Cancer Testing programme: a qualitative studySEOM guide to primary and secondary prevention of cancer: 2014The South African Prostate Cancer Screening GuidelinesInfluence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort studyProstate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyBaseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysisEmpirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen</div>
                            <small style="color: var(--text-muted)">12505835.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...test. We did not replace any missing data as we aimed to describe patte...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 5 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulationDeep vein thrombosis and pulmonary embolismHeart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association30-year mortality after venous thromboembolism: a population-based cohort studyAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAmerican Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolismApixaban for extended treatment of venous thromboembolismOral rivaroxaban for symptomatic venous thromboembolismAnticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulantsSafety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC ProjectEmulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical TrialsTarget Trial Emulation: A Framework for Causal Inference From Observational DataInfluence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USAWarfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database AnalysisA systematic review of validated methods for identifying venous thromboembolism using administrative and claims dataAssociation of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous ThromboembolismAn automated database case definition for serious bleeding related to oral anticoagulant useStroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial FibrillationPrediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatmentA combined comorbidity score predicted mortality in elderly patients better than existing scoresPrediction Score for Anticoagulation Control Quality Among Older AdultsMeasuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty IndexMeasuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare DataUpdating International Classification of Diseases 9th Revision to 10th Revision of a Claims-Based Frailty IndexBalance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samplesA basic introduction to fixed-effect and random-effects models for meta-analysisTrends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020The statistical basis of meta-analysisHigh-dimensional propensity score adjustment in studies of treatment effects using health care claims dataCardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndromeHigh-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complicationsEffects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical examplePerformance of the High-dimensional Propensity Score in a Nordic Healthcare ModelA Proportional Hazards Model for the Subdistribution of a Competing RiskSensitivity Analysis in Observational Research: Introducing the E-ValueTransparency and Reproducibility of Observational Cohort Studies Using Large Healthcare DatabasesUse of Health Care Databases to Support Supplemental Indications of Approved MedicationsCardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort StudyAntithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trialsA randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous ThromboembolismEffectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence riskSystematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolismLong term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisLong-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisIncidence and mortality of venous thrombosis: a population-based studyCase fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic reviewWhen and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?Methodological considerations when analysing and interpreting real-world data">Continued versus discontinued oral anticoagulant treatment for unprovoked venous thromboembolism: target trial emulationDeep vein thrombosis and pulmonary embolismHeart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association30-year mortality after venous thromboembolism: a population-based cohort studyAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAmerican Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolismApixaban for extended treatment of venous thromboembolismOral rivaroxaban for symptomatic venous thromboembolismAnticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulantsSafety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC ProjectEmulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical TrialsTarget Trial Emulation: A Framework for Causal Inference From Observational DataInfluence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USAWarfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database AnalysisA systematic review of validated methods for identifying venous thromboembolism using administrative and claims dataAssociation of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous ThromboembolismAn automated database case definition for serious bleeding related to oral anticoagulant useStroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial FibrillationPrediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatmentA combined comorbidity score predicted mortality in elderly patients better than existing scoresPrediction Score for Anticoagulation Control Quality Among Older AdultsMeasuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty IndexMeasuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare DataUpdating International Classification of Diseases 9th Revision to 10th Revision of a Claims-Based Frailty IndexBalance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samplesA basic introduction to fixed-effect and random-effects models for meta-analysisTrends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020The statistical basis of meta-analysisHigh-dimensional propensity score adjustment in studies of treatment effects using health care claims dataCardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndromeHigh-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complicationsEffects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical examplePerformance of the High-dimensional Propensity Score in a Nordic Healthcare ModelA Proportional Hazards Model for the Subdistribution of a Competing RiskSensitivity Analysis in Observational Research: Introducing the E-ValueTransparency and Reproducibility of Observational Cohort Studies Using Large Healthcare DatabasesUse of Health Care Databases to Support Supplemental Indications of Approved MedicationsCardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort StudyAntithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trialsA randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous ThromboembolismEffectiveness and safety of oral anticoagulation treatment beyond 1 year after venous thromboembolism in patients at intermediate recurrence riskSystematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolismLong term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisLong-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisIncidence and mortality of venous thrombosis: a population-based studyCase fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic reviewWhen and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?Methodological considerations when analysing and interpreting real-world data</div>
                            <small style="color: var(--text-muted)">12607009.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...c kidney disease. We used the χ2 statistic from the Cochran’s...'}</li><li>{'message': 'Missing data handeld via complete-case analysis (potential bias).', 'evidence': '...aseline assessment period; or missing information on age or sex (see supplement...'}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialHeart failure with preserved ejection fraction: a reviewHeart failure with preserved ejection fraction:  scientific statementCharacterization of the progression from ambulatory to hospitalized heart failure with preserved ejection fractionAtrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillationCardiovascular effects of relaxin: from basic science to clinical therapyMaternal vasodilation in pregnancy: the emerging role of relaxinRelaxin family peptides and their receptorsRelaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studySerelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialSerelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trialA randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failureEffects of serelaxin in patients with acute heart failureEffects of serelaxin in patients admitted for acute heart failure: a meta-analysisDevelopment of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failurePrevalence and prognostic significance of elevated γ-glutamyltransferase in chronic heart failureIntravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trialImpact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231)Electrolyte and water excretion in arterial hypertension. II. Studies in subjects with essential hypertension after antihypertensive drug treatmentRapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone systemHigh-output heart failure: a 15-year experienceDisconnect between the effects of serelaxin on renal function and outcome in acute heart failureAltered hemodynamics and end-organ damage in heart failure: impact on the lung and kidneyAlbumin excretion rate increases during acute myocardial infarction and strongly predicts early mortalityAlbuminuria as a marker of systemic congestion in patients with heart failureTrajectory of urine albumin-creatinine ratio in patients with acute heart failureRenal protein excretion after exercise in manProteinuria in children with febrile illnessesB-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failureEstimating left ventricular filling pressure by echocardiographyUncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesityRevivifying research on relaxin receptor-targeted therapy for cardiovascular diseasesNew creatinine- and cystatin C–based equations to estimate GFR without raceRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingRecommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingLeft atrial strain performance and its application in clinical practiceNormal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysisLeft atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fractionImpaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fractionLA mechanics in decompensated heart failure: insights from strain echocardiography with invasive hemodynamicsPrognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strainInterpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care:  state-of-the-art reviewEffects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial">Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialHeart failure with preserved ejection fraction: a reviewHeart failure with preserved ejection fraction:  scientific statementCharacterization of the progression from ambulatory to hospitalized heart failure with preserved ejection fractionAtrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillationCardiovascular effects of relaxin: from basic science to clinical therapyMaternal vasodilation in pregnancy: the emerging role of relaxinRelaxin family peptides and their receptorsRelaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studySerelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialSerelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trialA randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failureEffects of serelaxin in patients with acute heart failureEffects of serelaxin in patients admitted for acute heart failure: a meta-analysisDevelopment of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failurePrevalence and prognostic significance of elevated γ-glutamyltransferase in chronic heart failureIntravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trialImpact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231)Electrolyte and water excretion in arterial hypertension. II. Studies in subjects with essential hypertension after antihypertensive drug treatmentRapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone systemHigh-output heart failure: a 15-year experienceDisconnect between the effects of serelaxin on renal function and outcome in acute heart failureAltered hemodynamics and end-organ damage in heart failure: impact on the lung and kidneyAlbumin excretion rate increases during acute myocardial infarction and strongly predicts early mortalityAlbuminuria as a marker of systemic congestion in patients with heart failureTrajectory of urine albumin-creatinine ratio in patients with acute heart failureRenal protein excretion after exercise in manProteinuria in children with febrile illnessesB-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failureEstimating left ventricular filling pressure by echocardiographyUncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesityRevivifying research on relaxin receptor-targeted therapy for cardiovascular diseasesNew creatinine- and cystatin C–based equations to estimate GFR without raceRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingRecommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingLeft atrial strain performance and its application in clinical practiceNormal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysisLeft atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fractionImpaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fractionLA mechanics in decompensated heart failure: insights from strain echocardiography with invasive hemodynamicsPrognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strainInterpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care:  state-of-the-art reviewEffects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial</div>
                            <small style="color: var(--text-muted)">12618225.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...ation of 50\u2009mg and 100\u2009mg. No adjustment for multiplicity was performed, and P values s...'}</li><li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...n is assessed using two-sided t-test based on least square means f...'}</li>
                                <li>...and 6 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trialA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomesHuntington disease: natural history, biomarkers and prospects for therapeuticsFactors influencing the total functional capacity score as a critical endpoint in Huntington’s disease researchHuntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugsTetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trialSafety and efficacy of tetrabenazine and use of concomitant medications during long-term, open-label treatment of chorea associated with Huntington’s and other diseasesAntidopaminergic medication is associated with more rapidly progressive Huntington’s diseaseAntidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)Modeling disease progression and placebo response in Huntington’s disease: insights from Enroll-HD and GENERATION HD1 cohortsPridopidine in the treatment of Huntington’s diseasePridopidine activates neuroprotective pathways impaired in Huntington diseaseThe Sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington diseasePridopidine protects neurons from mutant-huntingtin toxicity via the Sigma-1 receptorThe Sigma-1 receptor mediates pridopidine rescue of mitochondrial function in Huntington disease modelsThe Sigma-1 receptor chaperone as an inter-organelle signaling modulatorPridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptorPridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip modelSigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [F] fluspidine and [F] fallypride PET studyAdditional safety and exploratory efficacy data at 48 and 60 months from Open-HART, an open-label extension study of pridopidine in Huntington diseaseSafety and exploratory efficacy at 36 months in Open-HART, an open-label extension study of pridopidine in Huntington’s diseasePridopidine for the treatment of motor function in patients with Huntington’s disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trialSafety and efficacy of pridopidine in patients with Huntington’s disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyEffects of pridopidine on functional capacity in early-stage participants from the PRIDE-HD studyPridopidine does not significantly prolong the QTc interval at the clinically relevant therapeutic doseA randomized, double-blind, placebo-controlled trial of pridopidine in Huntington’s diseaseOne-year safety and tolerability profile of pridopidine in patients with Huntington diseasePridopidine for the treatment of ALS—results from the phase 2 Healey ALS platform trial (S5.003)Motor, cognitive, and functional declines contribute to a single progressive factor in early HDAntidopaminergic medications in Huntington’s disease.Antidopaminergic medications and clinical changes in measures of Huntington’s disease: a causal analysis.Psychopathology in verified Huntington’s disease gene carriersNeuropsychiatric aspects of Huntington’s diseaseTiming and impact of psychiatric, cognitive, and motor abnormalities in Huntington diseaseThe safety profile of pridopidine, a novel Sigma-1 receptor agonist for the treatment of Huntington’s disease.Critical periods of suicide risk in Huntington’s diseaseAnalysis of responder-based endpoints: improving power through utilising continuous componentsNatural history of Huntington diseaseThe global prevalence of depression, anxiety, and sleep disorder among patients coping with post COVID-19 syndrome (long COVID): a systematic review and meta-analysisAntipsychotic prescribing to people with dementia during COVID-19Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELYSulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteersAntipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose–response meta-analysisAntipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose–response meta-analysisA review of the important role of CYP2D6 in pharmacogenomicsThe effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteersPharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosingPridopidine for the improvement of motor function in patients with Huntington’s disease: a systematic review and meta-analysis of randomized controlled trialsPridopidine: overview of pharmacology and rationale for its use in Huntington’s diseaseMotor outcome measures in Huntington disease clinical trials.The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the σ-1 receptorNeuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseasesImpairment and restoration of homeostatic plasticity in cultured cortical neurons from a mouse model of Huntington diseaseSigma-1 receptor ligands: potential in the treatment of neuropsychiatric disordersDefining clinically meaningful change on the composite Unified Huntington’s Disease Rating Scale (cUHDRS) (P1.8-043)Safety and efficacy of laquinimod for Huntington’s disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyInterrater reliability of the Unified Huntington’s Disease Rating Scale-Total Motor Score certificationAddressing bias in responder analysis of patient-reported outcomesComparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trialCo-administration of the dopaminergic stabilizer pridopidine and tetrabenazine in rats">Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trialA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomesHuntington disease: natural history, biomarkers and prospects for therapeuticsFactors influencing the total functional capacity score as a critical endpoint in Huntington’s disease researchHuntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugsTetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trialSafety and efficacy of tetrabenazine and use of concomitant medications during long-term, open-label treatment of chorea associated with Huntington’s and other diseasesAntidopaminergic medication is associated with more rapidly progressive Huntington’s diseaseAntidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)Modeling disease progression and placebo response in Huntington’s disease: insights from Enroll-HD and GENERATION HD1 cohortsPridopidine in the treatment of Huntington’s diseasePridopidine activates neuroprotective pathways impaired in Huntington diseaseThe Sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington diseasePridopidine protects neurons from mutant-huntingtin toxicity via the Sigma-1 receptorThe Sigma-1 receptor mediates pridopidine rescue of mitochondrial function in Huntington disease modelsThe Sigma-1 receptor chaperone as an inter-organelle signaling modulatorPridopidine reduces mutant huntingtin‐induced endoplasmic reticulum stress by modulation of the Sigma‐1 receptorPridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip modelSigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [F] fluspidine and [F] fallypride PET studyAdditional safety and exploratory efficacy data at 48 and 60 months from Open-HART, an open-label extension study of pridopidine in Huntington diseaseSafety and exploratory efficacy at 36 months in Open-HART, an open-label extension study of pridopidine in Huntington’s diseasePridopidine for the treatment of motor function in patients with Huntington’s disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trialSafety and efficacy of pridopidine in patients with Huntington’s disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyEffects of pridopidine on functional capacity in early-stage participants from the PRIDE-HD studyPridopidine does not significantly prolong the QTc interval at the clinically relevant therapeutic doseA randomized, double-blind, placebo-controlled trial of pridopidine in Huntington’s diseaseOne-year safety and tolerability profile of pridopidine in patients with Huntington diseasePridopidine for the treatment of ALS—results from the phase 2 Healey ALS platform trial (S5.003)Motor, cognitive, and functional declines contribute to a single progressive factor in early HDAntidopaminergic medications in Huntington’s disease.Antidopaminergic medications and clinical changes in measures of Huntington’s disease: a causal analysis.Psychopathology in verified Huntington’s disease gene carriersNeuropsychiatric aspects of Huntington’s diseaseTiming and impact of psychiatric, cognitive, and motor abnormalities in Huntington diseaseThe safety profile of pridopidine, a novel Sigma-1 receptor agonist for the treatment of Huntington’s disease.Critical periods of suicide risk in Huntington’s diseaseAnalysis of responder-based endpoints: improving power through utilising continuous componentsNatural history of Huntington diseaseThe global prevalence of depression, anxiety, and sleep disorder among patients coping with post COVID-19 syndrome (long COVID): a systematic review and meta-analysisAntipsychotic prescribing to people with dementia during COVID-19Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients’ primary care records in situ using OpenSAFELYSulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteersAntipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose–response meta-analysisAntipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose–response meta-analysisA review of the important role of CYP2D6 in pharmacogenomicsThe effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteersPharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosingPridopidine for the improvement of motor function in patients with Huntington’s disease: a systematic review and meta-analysis of randomized controlled trialsPridopidine: overview of pharmacology and rationale for its use in Huntington’s diseaseMotor outcome measures in Huntington disease clinical trials.The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the σ-1 receptorNeuronal Sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseasesImpairment and restoration of homeostatic plasticity in cultured cortical neurons from a mouse model of Huntington diseaseSigma-1 receptor ligands: potential in the treatment of neuropsychiatric disordersDefining clinically meaningful change on the composite Unified Huntington’s Disease Rating Scale (cUHDRS) (P1.8-043)Safety and efficacy of laquinimod for Huntington’s disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyInterrater reliability of the Unified Huntington’s Disease Rating Scale-Total Motor Score certificationAddressing bias in responder analysis of patient-reported outcomesComparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trialCo-administration of the dopaminergic stabilizer pridopidine and tetrabenazine in rats</div>
                            <small style="color: var(--text-muted)">12618238.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...level of ≤0.05 to control for multiple comparisons. The endpoints included in th...'}</li><li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...s.d. of 1.9 and a two-tailed t-test. To accommodate a projected d...'}</li>
                                <li>...and 8 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Text messages to improve young child diets: Results from a cluster‐randomized controlled trial in Kanchanpur, NepalText messages to improve young child diets: Results from a cluster‐randomized controlled trial in Kanchanpur, NepalConstraints on food choices of women in the UK with lower educational attainmentNutrition in Nepal: Three decades of commitment to children and womenText messages to improve child diets: Formative research findings and protocol of a randomised controlled trial in NepalDo changes in women's household status in Nepal improve access to food and nutrition?Eggs: The uncracked potential for improving maternal and young child nutrition among the world's poorEggs in early complementary feeding and child growth: A randomized controlled trialEffect of short message service on infant feeding practice: Findings from a community‐based study in Shanghai, ChinaEffectiveness of the eggs make kids demand‐creation campaign at improving household availability of eggs and egg consumption by young children in Nigeria: A quasi experimental studyMobile phones improve antenatal care attendance in Zanzibar: A cluster randomized controlled trialLactation advice through texting can help: An analysis of intensity of engagement via two‐way text messagingDo low‐income lone mothers compromise their nutrition to feed their children?Eggs: Healthy or risky? A review of evidence from high quality studies on hen's eggsEgg consumption of children under two years of age through a child‐owned poultry and nutrition intervention in rural Ethiopia: A community based randomized controlled trialPromotion of egg and eggshell powder consumption on the nutritional status of young children in EthiopiaThe golden egg: Nutritional value, bioactivities, and emerging benefits for human healthUse of mobile phones for infant and young child feeding counseling in Sri Lankan tea estates: A formative studyThe effects on inappropriate weight for gestational age of an SMS based educational intervention for pregnant women in Xi'an China: A quasi‐randomized controlled trial">Text messages to improve young child diets: Results from a cluster‐randomized controlled trial in Kanchanpur, NepalText messages to improve young child diets: Results from a cluster‐randomized controlled trial in Kanchanpur, NepalConstraints on food choices of women in the UK with lower educational attainmentNutrition in Nepal: Three decades of commitment to children and womenText messages to improve child diets: Formative research findings and protocol of a randomised controlled trial in NepalDo changes in women's household status in Nepal improve access to food and nutrition?Eggs: The uncracked potential for improving maternal and young child nutrition among the world's poorEggs in early complementary feeding and child growth: A randomized controlled trialEffect of short message service on infant feeding practice: Findings from a community‐based study in Shanghai, ChinaEffectiveness of the eggs make kids demand‐creation campaign at improving household availability of eggs and egg consumption by young children in Nigeria: A quasi experimental studyMobile phones improve antenatal care attendance in Zanzibar: A cluster randomized controlled trialLactation advice through texting can help: An analysis of intensity of engagement via two‐way text messagingDo low‐income lone mothers compromise their nutrition to feed their children?Eggs: Healthy or risky? A review of evidence from high quality studies on hen's eggsEgg consumption of children under two years of age through a child‐owned poultry and nutrition intervention in rural Ethiopia: A community based randomized controlled trialPromotion of egg and eggshell powder consumption on the nutritional status of young children in EthiopiaThe golden egg: Nutritional value, bioactivities, and emerging benefits for human healthUse of mobile phones for infant and young child feeding counseling in Sri Lankan tea estates: A formative studyThe effects on inappropriate weight for gestational age of an SMS based educational intervention for pregnant women in Xi'an China: A quasi‐randomized controlled trial</div>
                            <small style="color: var(--text-muted)">12647978.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...iday and non‐rainy seasons. A blinded co‐author randomized clusters...'}</li><li>{'message': 'Software mentioned without specific versions.', 'evidence': '...ther variables in the models. Stata/SE 14.2 was used for all anal...'}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trialThe role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversiesTreatment guidelines in psoriatic arthritisTargeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomesExperiences and treatment preferences in patients with psoriatic arthritis: a cross-sectional study in the ArthritisPower registryImpact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: findings from a real-world study in the United States and EuropeGroup for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritisEULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateMinimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumabMeasurement properties of the minimal disease activity criteria for psoriatic arthritisPrevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials: systematic review with metaanalysisPhenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapyRole of Th17 cells in human autoimmune arthritisIL-17 receptor and its functional significance in psoriatic arthritisTargeting IL-17 in psoriatic arthritisDual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammationInterleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisLong-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 studyBimekizumab: the first dual inhibitor of interleukin (IL)-17A and IL-17F for the treatment of psoriatic disease and ankylosing spondylitisPathogenic role of IL-17 and therapeutic targeting of IL-17F in psoriatic arthritis and spondyloarthropathiesHeterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complexBimekizumab versus secukinumab in plaque psoriasisBimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patientsProgress in intra-articular therapyPermeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammationThe therapeutic potential of NanobodiesImproved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody TechnologyNanobodies and nanobody-based human heavy chain antibodies as antitumor therapeuticsNaturally occurring antibodies devoid of light chainsInfluence of molecular size on tissue distribution of antibody fragmentsA novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritisIL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b studyA randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasisComparative genomic profiling of synovium versus skin lesions in psoriatic arthritisEfficacy and safety of ixekizumab with or without methotrexate in biologic-naïve patients with psoriatic arthritis: 52-week results from SPIRIT-H2H studyPatient-reported outcomes in psoriatic arthritisA multicenter nominal group study to rank outcomes important to patients, and their representation in existing composite outcome measures for psoriatic arthritisAchieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivitySecukinumab inhibition of interleukin-17A in patients with psoriatic arthritisIxekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialTrial of upadacitinib and adalimumab for psoriatic arthritisDifferential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic diseaseComparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysisBimekizumab, a novel humanized IgG1 antibody that neutralizes both IL-17A and IL-17FFormatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritisPsychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trialsSecukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trialAdverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping reviewSuppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T cells through modification of the intestinal microbiotaTH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitisDivergent functions of IL-17-family cytokines in DSS colitis: insights from a naturally-occurring human mutation in IL-17FRisk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sourcesA review of the safety of interleukin-17A inhibitor secukinumabLong-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance dataLong-term safety of ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trialsSafety of brodalumab in plaque psoriasis: integrated pooled data from five clinical trialsSex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisResponses to ixekizumab in male and female patients with psoriatic arthritis: results from two randomized, phase 3 clinical trialsAxial involvement in psoriatic arthritis: is it unique?American college of rheumatology. Preliminary definition of improvement in rheumatoid arthritisA 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasisA patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the psoriatic arthritis impact of disease (PsAID) questionnaire, a 13-country EULAR initiative">Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trialThe role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversiesTreatment guidelines in psoriatic arthritisTargeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomesExperiences and treatment preferences in patients with psoriatic arthritis: a cross-sectional study in the ArthritisPower registryImpact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: findings from a real-world study in the United States and EuropeGroup for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritisEULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 updateMinimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumabMeasurement properties of the minimal disease activity criteria for psoriatic arthritisPrevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials: systematic review with metaanalysisPhenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapyRole of Th17 cells in human autoimmune arthritisIL-17 receptor and its functional significance in psoriatic arthritisTargeting IL-17 in psoriatic arthritisDual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammationInterleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritisLong-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 studyBimekizumab: the first dual inhibitor of interleukin (IL)-17A and IL-17F for the treatment of psoriatic disease and ankylosing spondylitisPathogenic role of IL-17 and therapeutic targeting of IL-17F in psoriatic arthritis and spondyloarthropathiesHeterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complexBimekizumab versus secukinumab in plaque psoriasisBimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patientsProgress in intra-articular therapyPermeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammationThe therapeutic potential of NanobodiesImproved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody TechnologyNanobodies and nanobody-based human heavy chain antibodies as antitumor therapeuticsNaturally occurring antibodies devoid of light chainsInfluence of molecular size on tissue distribution of antibody fragmentsA novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritisIL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b studyA randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A/F nanobody, in moderate-to-severe psoriasisComparative genomic profiling of synovium versus skin lesions in psoriatic arthritisEfficacy and safety of ixekizumab with or without methotrexate in biologic-naïve patients with psoriatic arthritis: 52-week results from SPIRIT-H2H studyPatient-reported outcomes in psoriatic arthritisA multicenter nominal group study to rank outcomes important to patients, and their representation in existing composite outcome measures for psoriatic arthritisAchieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivitySecukinumab inhibition of interleukin-17A in patients with psoriatic arthritisIxekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1Group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialTrial of upadacitinib and adalimumab for psoriatic arthritisDifferential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic diseaseComparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysisBimekizumab, a novel humanized IgG1 antibody that neutralizes both IL-17A and IL-17FFormatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritisPsychiatric adverse events during treatment with brodalumab: analysis of psoriasis clinical trialsSecukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trialAdverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping reviewSuppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T cells through modification of the intestinal microbiotaTH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitisDivergent functions of IL-17-family cytokines in DSS colitis: insights from a naturally-occurring human mutation in IL-17FRisk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sourcesA review of the safety of interleukin-17A inhibitor secukinumabLong-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance dataLong-term safety of ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trialsSafety of brodalumab in plaque psoriasis: integrated pooled data from five clinical trialsSex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisResponses to ixekizumab in male and female patients with psoriatic arthritis: results from two randomized, phase 3 clinical trialsAxial involvement in psoriatic arthritis: is it unique?American college of rheumatology. Preliminary definition of improvement in rheumatoid arthritisA 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasisA patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the psoriatic arthritis impact of disease (PsAID) questionnaire, a 13-country EULAR initiative</div>
                            <small style="color: var(--text-muted)">12705426.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Explicitly stated that no multiplicity correction or formal hypothesis testing was performed.', 'evidence': '...se arms included in ARGO, the Bonferroni–Holm procedure was applied to...'}</li><li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...d PBO; however, the study was blinded at the carton level. Patients...'}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomesAuthor Correction: Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomesThe prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysisPrevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990–2019Polycystic ovary syndromeOverweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisDetecting insulin resistance in polycystic ovary syndrome: purposes and pitfallsPolycystic ovary syndromePolycystic ovary syndrome: why widening the diagnostic criteria may be harming womenGaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndromeHealth care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequencesRecommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeDisease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial dataThe Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysisRecommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndromeTestosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlifeMaternal testosterone and offspring birth weight: a mendelian randomization studyBody mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: a national studySex hormone-binding globulin and risk of type 2 diabetes in women and menCirculating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantationFresh versus frozen embryos for infertility in the polycystic ovary syndromeSystematic review and meta-analysis of birth outcomes in women with polycystic ovary syndromeAlterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected populationThe Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndromeHabitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional studyCardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteriaAre there any sensitive and specific sex steroid markers for polycystic ovary syndrome?Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trialTranscriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndromePrevalence of polycystic ovary syndrome in women with severe obesity—effects of a structured weight loss programmeSimplified 4-item criteria for polycystic ovary syndrome: a bridge too far?Multiple imputation: dealing with missing dataNovel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variablesCluster-wise assessment of cluster stabilityMachine learning to identify metabolic subtypes of obesity: a multi-center studyData-driven subgroups of prediabetes and the associations with outcomes in Chinese adultsPredictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult populationScreening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statementChinese guideline for lipid managementBirth weight reference percentiles for Chinese">Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomesAuthor Correction: Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomesThe prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysisPrevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990–2019Polycystic ovary syndromeOverweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisDetecting insulin resistance in polycystic ovary syndrome: purposes and pitfallsPolycystic ovary syndromePolycystic ovary syndrome: why widening the diagnostic criteria may be harming womenGaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndromeHealth care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequencesRecommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndromeDisease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial dataThe Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysisRecommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndromeTestosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlifeMaternal testosterone and offspring birth weight: a mendelian randomization studyBody mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: a national studySex hormone-binding globulin and risk of type 2 diabetes in women and menCirculating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantationFresh versus frozen embryos for infertility in the polycystic ovary syndromeSystematic review and meta-analysis of birth outcomes in women with polycystic ovary syndromeAlterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected populationThe Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndromeHabitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional studyCardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteriaAre there any sensitive and specific sex steroid markers for polycystic ovary syndrome?Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trialTranscriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndromePrevalence of polycystic ovary syndrome in women with severe obesity—effects of a structured weight loss programmeSimplified 4-item criteria for polycystic ovary syndrome: a bridge too far?Multiple imputation: dealing with missing dataNovel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variablesCluster-wise assessment of cluster stabilityMachine learning to identify metabolic subtypes of obesity: a multi-center studyData-driven subgroups of prediabetes and the associations with outcomes in Chinese adultsPredictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult populationScreening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statementChinese guideline for lipid managementBirth weight reference percentiles for Chinese</div>
                            <small style="color: var(--text-muted)">12705455.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...were compared using Student’s t-test or analysis of variance with...'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Polysomnographic insights into the attention-deficit/hyperactivity disorder and obstructive sleep apnea connection in childrenEstimating sleep patterns with activity monitoring in children and adolescents: how many nights are necessary for reliable measures?The first night effect: an EEG study of sleepAASM scoring manual updates for 2017 (version 2.4)Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the sleep apnea definitions task force of the american academy of sleep medicineMental health surveillance among children - United States, 2013-2019Natural history of sleep disordered breathing in prepubertal children transitioning to adolescenceGender dimorphism in pediatric OSA: is it for real?Stimulant rebound: how common is it and what does it mean?Disruption of blood pressure circadian rhythm in children with obstructive sleep apnea-is it a pathway leading to cardiovascular morbidities?Inattention, hyperactivity, and symptoms of sleep-disordered breathingSleep disturbances in children with attention-deficit/hyperactivity disorderAssessment and management of sleep problems in youths with attention-deficit/hyperactivity disorderSleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studiesCharacteristics of EEG power spectrum during sleep spindle events in ADHD childrenSeverity, prevalence, predictors, and rate of identification of insomnia symptoms in a sample of hospitalized psychiatric patientsOutcomes of long-term iron supplementation in pediatric restless legs syndrome/periodic limb movement disorder (RLS/PLMD)Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?Pediatric obstructive sleep apneaScreening for sleep disorders in pediatric primary care: are we there yet?Time structure of leg movement activity during sleep in attention-deficit/hyperactivity disorder and effects of levodopaSex differences and the interaction of age and sleep issues in neuropsychological testing performance across the lifespan in an ADD/ADHD sample from the years 1989 to 2009Gender differences in attention deficit hyperactivity disorder: an update of the current evidenceTime to rest a hypothesis? Accumulating evidence that periodic leg movements during sleep are not increased in children with attention-deficit hyperactivity disorder (ADHD): results of a case-control study and a meta-analysisMetabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal childrenSleep characteristics of children and adolescents with attention deficit-hyperactivity disorderAssociations of sleep disturbance with ADHD: implications for treatmentCircadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorderExpert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomyCan methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?A cross-sectional comparative study of sleep disturbances in children with adhd and matched controlsRestless sleep disorder in children with attention-deficit/hyperactivity disorderPharmacological management of new-onset bipolar disorderObjectively measured sleep continuity in children and adolescents with ADHD: a systematic review and meta-analysisWomen with symptoms of sleep-disordered breathing are less likely to be diagnosed and treated for sleep apnea than menSleep disturbances in adolescents with ADHD: a systematic review and framework for future researchSleep phenotypes in attention deficit hyperactivity disorderAttention deficit hyperactivity disorder and restless leg syndrome across the lifespan: a systematic review and meta-analysisNight-to-night variability of sleep in children with ADHD and typically developing controlsBehavioral, neurocognitive, polysomnographic and cardiometabolic profiles associated with obstructive sleep apnea in adolescents with ADHDParadoxical insomnia and subjective-objective sleep discrepancy: a reviewAssociation of sleep quality, media use and book reading with behavioral problems in early childhood. The Ulm SPATZ health studyGender differences in attention-deficit/hyperactivity disorderInternational classification of sleep disorders-third edition: highlights and modificationsAttention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysisNight-to-night variability in periodic leg movements in patients with restless legs syndromeInter-movement interval as a primary stable measure of periodic limb movements of sleepEffects of automated diurnal variation in electronic screen temperature on sleep quality in young adults: a randomized controlled trialSleep and circadian rhythmicity in adult ADHD and the effect of stimulantsSleep disturbances in children with attention-deficit/hyperactivity disorderValidation of a leg movements count and periodic leg movements analysis in a custom polysomnography systemADHD treatments, sleep, and sleep problems: complex associationsADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsSleep disorders in patients with ADHD: impact and management challengesThe prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewIs obstructive sleep apnea associated with ADHD?Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis">Polysomnographic insights into the attention-deficit/hyperactivity disorder and obstructive sleep apnea connection in childrenEstimating sleep patterns with activity monitoring in children and adolescents: how many nights are necessary for reliable measures?The first night effect: an EEG study of sleepAASM scoring manual updates for 2017 (version 2.4)Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the sleep apnea definitions task force of the american academy of sleep medicineMental health surveillance among children - United States, 2013-2019Natural history of sleep disordered breathing in prepubertal children transitioning to adolescenceGender dimorphism in pediatric OSA: is it for real?Stimulant rebound: how common is it and what does it mean?Disruption of blood pressure circadian rhythm in children with obstructive sleep apnea-is it a pathway leading to cardiovascular morbidities?Inattention, hyperactivity, and symptoms of sleep-disordered breathingSleep disturbances in children with attention-deficit/hyperactivity disorderAssessment and management of sleep problems in youths with attention-deficit/hyperactivity disorderSleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studiesCharacteristics of EEG power spectrum during sleep spindle events in ADHD childrenSeverity, prevalence, predictors, and rate of identification of insomnia symptoms in a sample of hospitalized psychiatric patientsOutcomes of long-term iron supplementation in pediatric restless legs syndrome/periodic limb movement disorder (RLS/PLMD)Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?Pediatric obstructive sleep apneaScreening for sleep disorders in pediatric primary care: are we there yet?Time structure of leg movement activity during sleep in attention-deficit/hyperactivity disorder and effects of levodopaSex differences and the interaction of age and sleep issues in neuropsychological testing performance across the lifespan in an ADD/ADHD sample from the years 1989 to 2009Gender differences in attention deficit hyperactivity disorder: an update of the current evidenceTime to rest a hypothesis? Accumulating evidence that periodic leg movements during sleep are not increased in children with attention-deficit hyperactivity disorder (ADHD): results of a case-control study and a meta-analysisMetabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal childrenSleep characteristics of children and adolescents with attention deficit-hyperactivity disorderAssociations of sleep disturbance with ADHD: implications for treatmentCircadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorderExpert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomyCan methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?A cross-sectional comparative study of sleep disturbances in children with adhd and matched controlsRestless sleep disorder in children with attention-deficit/hyperactivity disorderPharmacological management of new-onset bipolar disorderObjectively measured sleep continuity in children and adolescents with ADHD: a systematic review and meta-analysisWomen with symptoms of sleep-disordered breathing are less likely to be diagnosed and treated for sleep apnea than menSleep disturbances in adolescents with ADHD: a systematic review and framework for future researchSleep phenotypes in attention deficit hyperactivity disorderAttention deficit hyperactivity disorder and restless leg syndrome across the lifespan: a systematic review and meta-analysisNight-to-night variability of sleep in children with ADHD and typically developing controlsBehavioral, neurocognitive, polysomnographic and cardiometabolic profiles associated with obstructive sleep apnea in adolescents with ADHDParadoxical insomnia and subjective-objective sleep discrepancy: a reviewAssociation of sleep quality, media use and book reading with behavioral problems in early childhood. The Ulm SPATZ health studyGender differences in attention-deficit/hyperactivity disorderInternational classification of sleep disorders-third edition: highlights and modificationsAttention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysisNight-to-night variability in periodic leg movements in patients with restless legs syndromeInter-movement interval as a primary stable measure of periodic limb movements of sleepEffects of automated diurnal variation in electronic screen temperature on sleep quality in young adults: a randomized controlled trialSleep and circadian rhythmicity in adult ADHD and the effect of stimulantsSleep disturbances in children with attention-deficit/hyperactivity disorderValidation of a leg movements count and periodic leg movements analysis in a custom polysomnography systemADHD treatments, sleep, and sleep problems: complex associationsADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsSleep disorders in patients with ADHD: impact and management challengesThe prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewIs obstructive sleep apnea associated with ADHD?Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis</div>
                            <small style="color: var(--text-muted)">12713972.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': "...were analyzed using Student's t-tests for two group comparisons an..."}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialVibegron for overactive bladder in men with benign prostatic hyperplasia/obstruction: insights from the COURAGE trialEditorial Comment.The development of human benign prostatic hyperplasia with ageThe global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical managementThe International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunctionThe AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladderThe impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC studyThe psychological impact of overactive bladder: a systematic reviewUndertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: a retrospective observational studyReal-world patterns of care for the overactive bladder syndrome in the United StatesPharmacology of the lower urinary tract: update on LUTS treatmentAnticholinergic drug exposure and the risk of dementia: a nested case-control studyAnticholinergic drugs and risk of dementia: case-control studyManagement of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023Full Prescribing InformationInternational phase III, randomized, double-blind, placebo and active controlled study to evaluate the safety and efficacy of vibegron in patients with symptoms of overactive bladder: EMPOWURMirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studiesInterpretation of the meaningfulness of symptom reduction with vibegron in patients with overactive bladder: analyses from EMPOWUREffects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind, placebo-controlled trialThe efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: a systematic review and meta-analysisEfficacy and safety of mirabegron versus placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: a randomized, phase 4 study (PLUS)Mirabegron vs placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: a safety analysis from the randomized, phase 4 PLUS studyComparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: a randomized, prospective trial using urodynamic studiesOnce-daily vibegron, a novel oral β agonist, does not inhibit CYP2D6, a common pathway for drug metabolism in patients on OAB medicationsAnticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasiaComparative effectiveness and safety of monodrug therapies for lower urinary tract symptoms associated with benign prostatic hyperplasia: a network meta-analysisIncreased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysisSUFU white paper on overactive bladder anticholinergic medications and dementia riskIncreased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study">Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialVibegron for overactive bladder in men with benign prostatic hyperplasia/obstruction: insights from the COURAGE trialEditorial Comment.The development of human benign prostatic hyperplasia with ageThe global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical managementThe International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunctionThe AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladderThe impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC studyThe psychological impact of overactive bladder: a systematic reviewUndertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: a retrospective observational studyReal-world patterns of care for the overactive bladder syndrome in the United StatesPharmacology of the lower urinary tract: update on LUTS treatmentAnticholinergic drug exposure and the risk of dementia: a nested case-control studyAnticholinergic drugs and risk of dementia: case-control studyManagement of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023Full Prescribing InformationInternational phase III, randomized, double-blind, placebo and active controlled study to evaluate the safety and efficacy of vibegron in patients with symptoms of overactive bladder: EMPOWURMirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studiesInterpretation of the meaningfulness of symptom reduction with vibegron in patients with overactive bladder: analyses from EMPOWUREffects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind, placebo-controlled trialThe efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: a systematic review and meta-analysisEfficacy and safety of mirabegron versus placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: a randomized, phase 4 study (PLUS)Mirabegron vs placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: a safety analysis from the randomized, phase 4 PLUS studyComparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: a randomized, prospective trial using urodynamic studiesOnce-daily vibegron, a novel oral β agonist, does not inhibit CYP2D6, a common pathway for drug metabolism in patients on OAB medicationsAnticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasiaComparative effectiveness and safety of monodrug therapies for lower urinary tract symptoms associated with benign prostatic hyperplasia: a network meta-analysisIncreased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysisSUFU white paper on overactive bladder anticholinergic medications and dementia riskIncreased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study</div>
                            <small style="color: var(--text-muted)">12721610.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="The Efficacy and Safety of Radiation-Free Retrograde Intrarenal Surgery: A Prospective Multicenter-Based, Randomized, Controlled TrialRadiation-free ureteroscopy: risky business or a safe alternative?Feasibility and future directions of radiation-free retrograde intrarenal surgeryRadiation-free RIRS and setting a new standard: redefining safety and efficacy in stone surgeryEditorial Comment.Comparison of two different retrograde intrarenal surgical techniques: is it mandatory to use fluoroscopy during retrograde intrarenal surgery?The impact of pelvicaliceal anatomy on the success of retrograde intrarenal surgery in patients with lower pole renal stonesGenetic background modulates lncRNA-coordinated tissue response to low dose ionizing radiationRetrograde intrarenal surgery for the treatment of renal stones: is fluoroscopy-free technique achievable?Totally fluoroless retrograde intrarenal surgery technique in prestented patients: tips and tricksFluoroless endourological surgery for stone disease: a review of the literature-tips and tricksRetrograde intrarenal surgery without fluoroscopy: is it possible? A randomized prospective study, an extraordinary experienceCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsCT-based determination of ureteral stone volume: a predictor of spontaneous passageProspective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgeryStone free rate and clinical complications in patients submitted to retrograde intrarenal surgery (RIRS): our experience in 571 consecutive casesShockwave lithotripsy versus ureteroscopic treatment as therapeutic interventions for stones of the ureter (TISU): a multicentre randomised controlled non-inferiority trialThe Cochrane Collaboration's tool for assessing risk of bias in randomised trialsDifferent failure rates of insertion of 10/12-Fr ureteral access sheaths during retrograde intrarenal surgery in patients with and without stonesStone-free rate (SFR): a new proposal for defining levels of SFRWhat is the stone-free rate following flexible ureteroscopy for kidney stones?Advances in ureterorenoscopyRecommendations of the International Commission on Radiological Protection (ICRP) 1990Fluoroscopic radiation exposure: are we protecting ourselves adequately?Fluoroscopic organ and tissue-specific radiation exposure by sex and body mass index during ureteroscopyRepeated radiological radiation exposure in patients undergoing surgery for urinary tract stone disease in Victoria, AustraliaLarge database study of urinary stone composition in South Korea: Korean Society of Endourology and Robotics (KSER) research seriesEffect of obesity and metabolic health on urolithiasis: a nationwide population-based studyRetrograde intrarenal surgery: past, present, and futureUreteroscopy without fluoroscopy: a feasibility study and comparison with conventional ureteroscopy">The Efficacy and Safety of Radiation-Free Retrograde Intrarenal Surgery: A Prospective Multicenter-Based, Randomized, Controlled TrialRadiation-free ureteroscopy: risky business or a safe alternative?Feasibility and future directions of radiation-free retrograde intrarenal surgeryRadiation-free RIRS and setting a new standard: redefining safety and efficacy in stone surgeryEditorial Comment.Comparison of two different retrograde intrarenal surgical techniques: is it mandatory to use fluoroscopy during retrograde intrarenal surgery?The impact of pelvicaliceal anatomy on the success of retrograde intrarenal surgery in patients with lower pole renal stonesGenetic background modulates lncRNA-coordinated tissue response to low dose ionizing radiationRetrograde intrarenal surgery for the treatment of renal stones: is fluoroscopy-free technique achievable?Totally fluoroless retrograde intrarenal surgery technique in prestented patients: tips and tricksFluoroless endourological surgery for stone disease: a review of the literature-tips and tricksRetrograde intrarenal surgery without fluoroscopy: is it possible? A randomized prospective study, an extraordinary experienceCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsCT-based determination of ureteral stone volume: a predictor of spontaneous passageProspective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgeryStone free rate and clinical complications in patients submitted to retrograde intrarenal surgery (RIRS): our experience in 571 consecutive casesShockwave lithotripsy versus ureteroscopic treatment as therapeutic interventions for stones of the ureter (TISU): a multicentre randomised controlled non-inferiority trialThe Cochrane Collaboration's tool for assessing risk of bias in randomised trialsDifferent failure rates of insertion of 10/12-Fr ureteral access sheaths during retrograde intrarenal surgery in patients with and without stonesStone-free rate (SFR): a new proposal for defining levels of SFRWhat is the stone-free rate following flexible ureteroscopy for kidney stones?Advances in ureterorenoscopyRecommendations of the International Commission on Radiological Protection (ICRP) 1990Fluoroscopic radiation exposure: are we protecting ourselves adequately?Fluoroscopic organ and tissue-specific radiation exposure by sex and body mass index during ureteroscopyRepeated radiological radiation exposure in patients undergoing surgery for urinary tract stone disease in Victoria, AustraliaLarge database study of urinary stone composition in South Korea: Korean Society of Endourology and Robotics (KSER) research seriesEffect of obesity and metabolic health on urolithiasis: a nationwide population-based studyRetrograde intrarenal surgery: past, present, and futureUreteroscopy without fluoroscopy: a feasibility study and comparison with conventional ureteroscopy</div>
                            <small style="color: var(--text-muted)">12721611.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li><li>{'message': 'P-values reported without effect sizes (e.g. Odds Ratio).', 'evidence': '...tic kidney stones ≤ 3 mm. The secondary end point of this study was ascertainin...'}</li>
                                <li>...and 4 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic StenosisAn update on best practice in the diagnosis and management of post-prostatectomy anastomotic stricturesProstate cancer radiation and urethral strictures: a systematic review and meta-analysisManagement of urethral stricture and bladder neck contracture following primary and salvage treatment of prostate cancerSIU/ICUD Consultation on Urethral Strictures: posterior urethral stenosis after treatment of prostate cancerImpact of prior prostate radiation on complications after radical prostatectomySalvage versus primary robot-assisted radical prostatectomy: a propensity-matched comparative effectiveness study from a high-volume tertiary centreIncidence of stress urinary incontinence after posterior urethroplasty for radiation-induced urethral stricturesImproving outcomes of bulbomembranous urethroplasty for radiation-induced urethral strictures in post-Urolume eraUrethroplasty after radiation therapy for prostate cancerUrethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experienceVesicourethral anastomotic stenosis after prostate cancer treatmentOutcomes and complications after intervention for postradiation prostatic urethral stenosisVesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapyCurrent management of membranous urethral strictures due to radiationSIU/ICUD Consultation on Urethral Strictures: epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuriesOne-sided anterior urethroplasty: a new dorsal onlay graft techniqueHistological study of the cavernous nerve mesh outside the periprostatic region: anatomical basis for erectile function after nonnerve sparing radical prostatectomyDorsal onlay urethroplasty for membranous urethral strictures: urinary and erectile functional outcomesThe International Index of Erectile Function (IIEF): a state-of-the-science reviewA pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitisDevastated bladder outlet in pelvic cancer survivors: issues on surgical reconstruction and quality of lifeSalvage prostatectomy post-definitive radiation therapy: the Vancouver experienceAdjuvant radiotherapy following radical prostatectomy for prostate cancerSalvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approachesSurgical correction of bladder neck contracture following prostate cancer treatmentOpen reconstruction of recurrent vesicourethral anastomotic stricture after radical prostatectomyBuccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)Robotic urethral reconstruction outcomes in men with posterior urethral stenosisPatency and incontinence rates after robotic bladder neck reconstruction for vesicourethral anastomotic stenosis and recalcitrant bladder neck contractures: the Trauma and Urologic Reconstructive Network of Surgeons experienceUrethroplasty for high risk, long segment urethral strictures with ventral buccal mucosa graft and gracilis muscle flapA multi-institutional critical assessment of dorsal onlay urethroplasty for post-radiation urethral stenosis">Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic StenosisAn update on best practice in the diagnosis and management of post-prostatectomy anastomotic stricturesProstate cancer radiation and urethral strictures: a systematic review and meta-analysisManagement of urethral stricture and bladder neck contracture following primary and salvage treatment of prostate cancerSIU/ICUD Consultation on Urethral Strictures: posterior urethral stenosis after treatment of prostate cancerImpact of prior prostate radiation on complications after radical prostatectomySalvage versus primary robot-assisted radical prostatectomy: a propensity-matched comparative effectiveness study from a high-volume tertiary centreIncidence of stress urinary incontinence after posterior urethroplasty for radiation-induced urethral stricturesImproving outcomes of bulbomembranous urethroplasty for radiation-induced urethral strictures in post-Urolume eraUrethroplasty after radiation therapy for prostate cancerUrethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experienceVesicourethral anastomotic stenosis after prostate cancer treatmentOutcomes and complications after intervention for postradiation prostatic urethral stenosisVesico-urethral anastomotic stenosis following radical prostatectomy: a multi-institutional outcome analysis with a focus on endoscopic approach, surgical sequence, and the impact of radiation therapyCurrent management of membranous urethral strictures due to radiationSIU/ICUD Consultation on Urethral Strictures: epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuriesOne-sided anterior urethroplasty: a new dorsal onlay graft techniqueHistological study of the cavernous nerve mesh outside the periprostatic region: anatomical basis for erectile function after nonnerve sparing radical prostatectomyDorsal onlay urethroplasty for membranous urethral strictures: urinary and erectile functional outcomesThe International Index of Erectile Function (IIEF): a state-of-the-science reviewA pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitisDevastated bladder outlet in pelvic cancer survivors: issues on surgical reconstruction and quality of lifeSalvage prostatectomy post-definitive radiation therapy: the Vancouver experienceAdjuvant radiotherapy following radical prostatectomy for prostate cancerSalvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approachesSurgical correction of bladder neck contracture following prostate cancer treatmentOpen reconstruction of recurrent vesicourethral anastomotic stricture after radical prostatectomyBuccal mucosal graft urethroplasty for radiation-induced urethral strictures: an evaluation using the extended Urethral Stricture Surgery Patient-Reported Outcome Measure (USS PROM)Robotic urethral reconstruction outcomes in men with posterior urethral stenosisPatency and incontinence rates after robotic bladder neck reconstruction for vesicourethral anastomotic stenosis and recalcitrant bladder neck contractures: the Trauma and Urologic Reconstructive Network of Surgeons experienceUrethroplasty for high risk, long segment urethral strictures with ventral buccal mucosa graft and gracilis muscle flapA multi-institutional critical assessment of dorsal onlay urethroplasty for post-radiation urethral stenosis</div>
                            <small style="color: var(--text-muted)">12721667.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Reporting of blinding or masking procedure is missing.', 'evidence': "No matches for 'blinded' or 'masked'"}</li>
                                <li>...and 5 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemiaThe WHO estimates of excess mortality associated with the COVID-19 pandemicImpact of the COVID-19 pandemic on colorectal cancer screening: a systematic reviewImpact of the COVID-19 pandemic on colorectal cancer diagnosis and treatment: a systematic reviewEpidemiology of peripheral arterial disease and critical limb ischemia in an insured national populationDritte Aktualisierung der “Retrospektiven Phaseneinteilung der COVID-19-Pandemie in DeutschlandImpact of the COVID-19 pandemic on incidence and mortality of emergency cardiovascular diseases in TokyoEarly experience of aortic surgery during the COVID-19 pandemic in the UK: a multicentre studyGerman nation-wide in-patient treatment of abdominal aortic aneurysm-trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemicCarotid artery operation delay during the Covid-19 pandemic: results of a multicenter international studyThe impact of the first 11 Months of the COVID-19 pandemic on vascular patients’ care and hospitalisation rate in the vascular surgery divisions of southern ItalyImpact of COVID-19 pandemic on clinical care of peripheral arterial disease patients: a single-centre experienceImpact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroupsSex-related factors in cardiovascular complications associated to COVID-19Impact of COVID-19 pandemic on patients affected by peripheral arterial disease: an Italian single-centre studyThe impact of the COVID-19 pandemic on time to treatment in surgical oncology: a national registry study in The NetherlandsThe impact of the COVID-19 pandemic on the workload, case mix and hospital resources at a tertiary vascular unitNorth American lower-extremity revascularization and amputation during COVID-19: observations from the vascular quality initiativeImpact of COVID-19 pandemic on the outcomes in patients with critical limb threatening ischaemia and diabetic foot infection">Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemiaThe WHO estimates of excess mortality associated with the COVID-19 pandemicImpact of the COVID-19 pandemic on colorectal cancer screening: a systematic reviewImpact of the COVID-19 pandemic on colorectal cancer diagnosis and treatment: a systematic reviewEpidemiology of peripheral arterial disease and critical limb ischemia in an insured national populationDritte Aktualisierung der “Retrospektiven Phaseneinteilung der COVID-19-Pandemie in DeutschlandImpact of the COVID-19 pandemic on incidence and mortality of emergency cardiovascular diseases in TokyoEarly experience of aortic surgery during the COVID-19 pandemic in the UK: a multicentre studyGerman nation-wide in-patient treatment of abdominal aortic aneurysm-trends between 2005 and 2019 and impact of the SARS-CoV-2 pandemicCarotid artery operation delay during the Covid-19 pandemic: results of a multicenter international studyThe impact of the first 11 Months of the COVID-19 pandemic on vascular patients’ care and hospitalisation rate in the vascular surgery divisions of southern ItalyImpact of COVID-19 pandemic on clinical care of peripheral arterial disease patients: a single-centre experienceImpact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroupsSex-related factors in cardiovascular complications associated to COVID-19Impact of COVID-19 pandemic on patients affected by peripheral arterial disease: an Italian single-centre studyThe impact of the COVID-19 pandemic on time to treatment in surgical oncology: a national registry study in The NetherlandsThe impact of the COVID-19 pandemic on the workload, case mix and hospital resources at a tertiary vascular unitNorth American lower-extremity revascularization and amputation during COVID-19: observations from the vascular quality initiativeImpact of COVID-19 pandemic on the outcomes in patients with critical limb threatening ischaemia and diabetic foot infection</div>
                            <small style="color: var(--text-muted)">12724483.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...st and post-hoc with a paired t-test. At p<0.05, the data are trea...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 5 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Profile for Brain Disease Research Infrastructure for Data Gathering and Exploration (BRIDGE) PlatformThe Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studiesRegistries for evaluating patient outcomes: a user’s guideThe Impact of Disease Registries on Advancing Knowledge and Understanding of Dementia GloballyThe FAIR Guiding Principles for scientific data management and stewardshipFrom data sharing to data publishing [version 2; peer review: 2 approved, 1 approved with reservations]Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South KoreaThe Dementias Platform UK (DPUK) Data PortalThe Association between Tau Protein Level in Cerebrospinal Fluid and Cognitive Status: A Large-Scale Analysis of GAAIN DatabaseThe pursuit of approaches to federate data to accelerate Alzheimer's disease and related dementia research: GAAIN, DPUK, and ADDIComparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data SetThe Alzheimer's disease neuroimaging initiative: progress report and future plansThe protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) RegistryOrganisational aspects and assessment practices of Australian memory clinics: an Australian Dementia Network (ADNeT) SurveyAlzheimer's Association launches ALZ-NET: A long-term data collection and sharing network for new treatmentsQuality of Life Assessment in Older Adults with Dementia: A Systematic ReviewQuality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studiesThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchThe reliability and validity of the Korean version of the Pittsburgh Sleep Quality IndexThe REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR)The utility of a Korean version of the REM sleep behavior disorder screening questionnaire in patients with obstructive sleep apneaThe reliability and validity of the Korean version of the Epworth sleepiness scaleSubtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patientsDevelopment of NQ-E, Nutrition Quotient for Korean elderly: item selection and validation of factor structure*Assessment of older people: self-maintaining and instrumental activities of daily livingRe-standardization of the Korean-Instrumental Activities of Daily Living (K-IADL): Clinical Usefulness for Various Neurodegenerative DiseasesThe Barthel ADL Index: a reliability studyValidation of the korean-version of the nonmotor symptoms scale for Parkinson's diseaseRevision of the self-monitoring scaleDevelopment of the Perceived Stress Inventory: A New Questionnaire for Korean Population SurveysAn inventory for measuring clinical anxiety: psychometric propertiesValidity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementiaThe AD8: a brief informant interview to detect dementiaDevelopment and validation of the Geriatric Anxiety InventoryDevelopment of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patientsDevelopment and validation of a geriatric depression screening scale: a preliminary reportStandardization of the korean version of the geriatric depression scale: reliability, validity, and factor structureMini-Mental State Examination (MMSE)Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experienceSeoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patientsValidation of the Korean-Everyday Cognition (K-ECog)The measurement of everyday cognition (ECog): scale development and psychometric propertiesDevelopment of methodology for conducting clinical trials in frontotemporal lobar degenerationClinical and Neuropsychological Characteristics of a Nationwide Hospital-Based Registry of Frontotemporal Dementia Patients in Korea: A CREDOS-FTD StudyNormative data on the Korean version of the Western Aphasia BatteryDonepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trialComparison of Montreal Cognitive Assessment in Korean Version for Predicting Mild Cognitive Assessment in 65-Year and Over IndividualsDevelopment of the Subjective Memory Complaints QuestionnaireTranslation and validation of the korean version of the 39-item Parkinson's disease questionnaireValidation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleValidity and reliability of the Zarit Burden Interview in assessing caregiving burdenValidating the SF-36 health survey questionnaire: new outcome measure for primary careReliability and validity of the Korean version of the Caregiver Burden InventoryCaregiver-Administered Neuropsychiatric Inventory (CGA-NPI)">Profile for Brain Disease Research Infrastructure for Data Gathering and Exploration (BRIDGE) PlatformThe Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studiesRegistries for evaluating patient outcomes: a user’s guideThe Impact of Disease Registries on Advancing Knowledge and Understanding of Dementia GloballyThe FAIR Guiding Principles for scientific data management and stewardshipFrom data sharing to data publishing [version 2; peer review: 2 approved, 1 approved with reservations]Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South KoreaThe Dementias Platform UK (DPUK) Data PortalThe Association between Tau Protein Level in Cerebrospinal Fluid and Cognitive Status: A Large-Scale Analysis of GAAIN DatabaseThe pursuit of approaches to federate data to accelerate Alzheimer's disease and related dementia research: GAAIN, DPUK, and ADDIComparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data SetThe Alzheimer's disease neuroimaging initiative: progress report and future plansThe protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) RegistryOrganisational aspects and assessment practices of Australian memory clinics: an Australian Dementia Network (ADNeT) SurveyAlzheimer's Association launches ALZ-NET: A long-term data collection and sharing network for new treatmentsQuality of Life Assessment in Older Adults with Dementia: A Systematic ReviewQuality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studiesThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchThe reliability and validity of the Korean version of the Pittsburgh Sleep Quality IndexThe REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR)The utility of a Korean version of the REM sleep behavior disorder screening questionnaire in patients with obstructive sleep apneaThe reliability and validity of the Korean version of the Epworth sleepiness scaleSubtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patientsDevelopment of NQ-E, Nutrition Quotient for Korean elderly: item selection and validation of factor structure*Assessment of older people: self-maintaining and instrumental activities of daily livingRe-standardization of the Korean-Instrumental Activities of Daily Living (K-IADL): Clinical Usefulness for Various Neurodegenerative DiseasesThe Barthel ADL Index: a reliability studyValidation of the korean-version of the nonmotor symptoms scale for Parkinson's diseaseRevision of the self-monitoring scaleDevelopment of the Perceived Stress Inventory: A New Questionnaire for Korean Population SurveysAn inventory for measuring clinical anxiety: psychometric propertiesValidity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementiaThe AD8: a brief informant interview to detect dementiaDevelopment and validation of the Geriatric Anxiety InventoryDevelopment of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patientsDevelopment and validation of a geriatric depression screening scale: a preliminary reportStandardization of the korean version of the geriatric depression scale: reliability, validity, and factor structureMini-Mental State Examination (MMSE)Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experienceSeoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patientsValidation of the Korean-Everyday Cognition (K-ECog)The measurement of everyday cognition (ECog): scale development and psychometric propertiesDevelopment of methodology for conducting clinical trials in frontotemporal lobar degenerationClinical and Neuropsychological Characteristics of a Nationwide Hospital-Based Registry of Frontotemporal Dementia Patients in Korea: A CREDOS-FTD StudyNormative data on the Korean version of the Western Aphasia BatteryDonepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trialComparison of Montreal Cognitive Assessment in Korean Version for Predicting Mild Cognitive Assessment in 65-Year and Over IndividualsDevelopment of the Subjective Memory Complaints QuestionnaireTranslation and validation of the korean version of the 39-item Parkinson's disease questionnaireValidation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleValidity and reliability of the Zarit Burden Interview in assessing caregiving burdenValidating the SF-36 health survey questionnaire: new outcome measure for primary careReliability and validity of the Korean version of the Caregiver Burden InventoryCaregiver-Administered Neuropsychiatric Inventory (CGA-NPI)</div>
                            <small style="color: var(--text-muted)">12727072.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Parametric tests used without documented normality checks.', 'evidence': '...for continuous variables and χ2 tests for categorical variabl...'}</li><li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li>
                                <li>...and 8 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                    <tr>
                        <td>
                            <div class="truncate" title="Circulating Endocannabinoids and Cognitive Function in Older AdultsAn introduction to the endogenous cannabinoid systemThe endocannabinoid system and its therapeutic exploitationThe endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disordersEndocannabinoid signalling and the deteriorating brainGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 YearsPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s DiseaseCannabinoids and the expanded endocannabinoid system in neurological disordersThe endocannabinoid system and the brainMultiple functions of endocannabinoid signaling in the brainThe Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal StudiesTherapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidenceModulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s DiseaseThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injurySex differences and the endocannabinoid system in painSex difference in brain CB1 receptor availability in manApolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signalingRelationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet interventionEndocannabinoids in Alzheimer’s disease and their impact on normative cognitive performance: a case-control and cohort studyElevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative DeclineEpidemiological approaches to heart disease: the Framingham StudyThe framingham offspring study. Design and preliminary dataThe Alzheimer’s Disease Centers’ Uniform Data Set (UDS): the neuropsychologic test batteryDifferential Effects of Endocannabinoids on Amyloid-Beta Aggregation and ToxicityCirculating Endocannabinoids: From Whence Do They Come and Where are They Going?Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short ReviewFatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic PotentialFree fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer’s diseaseCirculating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older AdultsLinoleic acid-good or bad for the brain?Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory StudyCorrelation of the Serum Fatty Acids with Cognitive Function: An NHANES 2011-2014 and Multivariate Mendelian Randomization AnalysisThe dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide productionAPOE and the Association of Fatty Acids with the Risk of Stroke, Coronary Heart Disease, and MortalityEffects of APOE4 on omega-3 brain metabolism across the lifespanImpact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and CognitionOmega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer’s disease dementiaConsumption of Oleic Acid on the Preservation of Cognitive Functions in Japanese Elderly IndividualsNeuroprotective effects of oleic acid in rodent models of cerebral ischaemiaThe Neuroinflammatory and Neurotoxic Potential of Palmitic Acid Is Mitigated by Oleic Acid in Microglial Cells and Microglial-Neuronal Co-culturesFish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive FunctionLipids and Alzheimer’s DiseasePalmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s DiseaseUltramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effectsAnandamide and other -acylethanolamines: A class of signaling lipids with therapeutic opportunitiesMicroglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent AdvancesPrimary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohortN-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsThe cell cycle in Alzheimer disease: a unique target for neuropharmacologyThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injuryNon-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature reviewEffects of menopausal hormone therapy on erythrocyte n-3 and n-6 PUFA concentrations in the Women’s Health Initiative randomized trialDietary fatty acids and risk of Alzheimer’s disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP)Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer’s Dementia in the Oldest OldThe influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysisEffects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trialsInhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female ratsSex specific effects of the fatty acid amide hydrolase inhibitor URB597 on memory and brain β2-adrenergic and D1-dopamine receptorsPotential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitorsEndocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studiesCannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolomeThe emerging role of the endocannabinoid system in cardiovascular diseaseDiets to promote healthy brain ageingRelationship Between Cognitive Performance, Physical Activity, and Socio-Demographic/Individual Characteristics Among Aging AmericansMediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammationExercise activates the endo-cannabinoid system">Circulating Endocannabinoids and Cognitive Function in Older AdultsAn introduction to the endogenous cannabinoid systemThe endocannabinoid system and its therapeutic exploitationThe endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disordersEndocannabinoid signalling and the deteriorating brainGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 YearsPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s DiseaseCannabinoids and the expanded endocannabinoid system in neurological disordersThe endocannabinoid system and the brainMultiple functions of endocannabinoid signaling in the brainThe Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal StudiesTherapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidenceModulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s DiseaseThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injurySex differences and the endocannabinoid system in painSex difference in brain CB1 receptor availability in manApolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signalingRelationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet interventionEndocannabinoids in Alzheimer’s disease and their impact on normative cognitive performance: a case-control and cohort studyElevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative DeclineEpidemiological approaches to heart disease: the Framingham StudyThe framingham offspring study. Design and preliminary dataThe Alzheimer’s Disease Centers’ Uniform Data Set (UDS): the neuropsychologic test batteryDifferential Effects of Endocannabinoids on Amyloid-Beta Aggregation and ToxicityCirculating Endocannabinoids: From Whence Do They Come and Where are They Going?Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short ReviewFatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic PotentialFree fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer’s diseaseCirculating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older AdultsLinoleic acid-good or bad for the brain?Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory StudyCorrelation of the Serum Fatty Acids with Cognitive Function: An NHANES 2011-2014 and Multivariate Mendelian Randomization AnalysisThe dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide productionAPOE and the Association of Fatty Acids with the Risk of Stroke, Coronary Heart Disease, and MortalityEffects of APOE4 on omega-3 brain metabolism across the lifespanImpact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and CognitionOmega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer’s disease dementiaConsumption of Oleic Acid on the Preservation of Cognitive Functions in Japanese Elderly IndividualsNeuroprotective effects of oleic acid in rodent models of cerebral ischaemiaThe Neuroinflammatory and Neurotoxic Potential of Palmitic Acid Is Mitigated by Oleic Acid in Microglial Cells and Microglial-Neuronal Co-culturesFish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive FunctionLipids and Alzheimer’s DiseasePalmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s DiseaseUltramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effectsAnandamide and other -acylethanolamines: A class of signaling lipids with therapeutic opportunitiesMicroglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent AdvancesPrimary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohortN-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsThe cell cycle in Alzheimer disease: a unique target for neuropharmacologyThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injuryNon-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature reviewEffects of menopausal hormone therapy on erythrocyte n-3 and n-6 PUFA concentrations in the Women’s Health Initiative randomized trialDietary fatty acids and risk of Alzheimer’s disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP)Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer’s Dementia in the Oldest OldThe influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysisEffects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trialsInhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female ratsSex specific effects of the fatty acid amide hydrolase inhibitor URB597 on memory and brain β2-adrenergic and D1-dopamine receptorsPotential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitorsEndocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studiesCannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolomeThe emerging role of the endocannabinoid system in cardiovascular diseaseDiets to promote healthy brain ageingRelationship Between Cognitive Performance, Physical Activity, and Socio-Demographic/Individual Characteristics Among Aging AmericansMediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammationExercise activates the endo-cannabinoid system</div>
                            <small style="color: var(--text-muted)">12727136.json</small>
                        </td>
                        <td>
                            <div class="score-container">
                                <span class="score-pill score-low">1.0</span>
                                <div class="score-bar-bg">
                                    <div class="score-bar-fill" style="width: 10.0%"></div>
                                </div>
                            </div>
                        </td>
                        <td>
                            <ul class="gaps-list">
                                <li>{'message': 'Sample size justification lacks explicit power calculation details.', 'evidence': 'No direct quote found.'}</li><li>{'message': 'Blinding present but allocation concealment details missing.', 'evidence': '...s (duplicated tubes that were blinded to the laboratory where the e...'}</li>
                                <li>...and 5 more</li>
                            </ul>
                        </td>
                    </tr>
                    
                </tbody>
            </table>
        </section>

        <footer>
            Generated by StatsRecommender Auditor &bull; 2025
        </footer>
    </div>
</body>
</html>
    